|
|
|
Scientific Literature, 2001
-
Aase S, Koppang HS, Solheim T, Kjaerheim A, Axell T, Storhaug K, Refsum S. Crohn disease of the oral cavity, illustrated by some cases.
Tidsskr. Nor. Laegeforen. 121: 2489-2491 (2001).
-
Abdelmalek MF, Angulo P, Jorgensen RA, Sylvestre PB, Lindor KD. Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study.
Am. J. Gastroenterol. 96: 2711-2717 (2001).
*
-
Abe T, Takeuchi T. Rheumatoid arthritis and tumor necrosis factor alpha.
Autoimmunity 34: 291-303 (2001).
-
Abergel A. Liver and pregnancy. Literature review.
Gastroenterol. Clin. Biol. 25: 802-805 (2001).
-
Abeywardena MY, Head RJ. Longchain n-3 polyunsaturated fatty acids and blood vessel function.
Cardiovasc. Res. 52: 361-371 (2001).
*
-
Abouljoud MS, Escobar F, Douzdjian V, Bajjoka I, Moonka D, Shick L, Brown KA. Recurrent disease after liver transplantation.
Transplant. Proc. 33: 2716-2719 (2001).
*
-
Abraham RS, Wen L, Marietta EV, David CS. Type 1 diabetes-predisposing MHC alleles influence the selection of glutamic acid decarboxylase (GAD) 65-specific T cells in a transgenic model.
J. Immunol. 166: 1370-1379 (2001).
*
-
Abu-Abed S, Dolle P, Metzger D, Beckett B, Chambon P, Petkovich M. The retinoic acid-metabolizing enzyme, CYP26A1, is essential for normal hindbrain patterning, vertebral identity, and development of posterior structures.
Genes Dev. 15: 226-240 (2001).
*
-
Abu-Amer Y. IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-kappaB.
J. Clin. Invest. 107: 1375-1385 (2001).
*
-
Achkar JP. Chronic diarrhea: to scope or not to scope?
Inflamm. Bowel Dis. 7: 276-277 (2001).
*
-
Acton JD, Wilmott RW. Phenotype of CF and the effects of possible modifier genes.
Paediatr. Respir. Rev. 2: 332-339 (2001).
-
Adachi Y, Itoh F, Yamamoto H, Iku S, Matsuno K, Arimura Y, Imai K. Retinoic acids reduce matrilysin (matrix metalloproteinase 7) and inhibit tumor cell invasion in human colon cancer.
Tumour Biol. 22: 247-253 (2001).
-
Adams PC. Is there a threshold of hepatic iron concentration that leads to cirrhosis in C282Y hemochromatosis?
Am. J. Gastroenterol. 96: 567-569 (2001).
*
-
Adams PC. Iron overload in Montpelier.
Gut 48: 755-766 (2001).
*
-
Adams PC, Walker AP, Acton RT. A primer for predicting risk of disease in HFE-linked hemochromatosis.
Genet. Test. 5: 311-316 (2001).
-
Adams RW, Chapman RL, Smallwood GA. Steroid withdrawal in liver transplant recipients.
Prog. Transplant. 11: 217-223 (2001).
-
Adcock IM, Caramori G. Cross-talk between pro-inflammatory transcription factors and glucocorticoids.
Immunol. Cell Biol. 79: 376-384 (2001).
*
-
Aderem A. Role of Toll-like receptors in inflammatory response in macrophages.
Crit. Care Med. 29: S16-S18 (2001).
-
Adhiyaman V, Vaishnavi A, Froese S. Drug points: hypersensitivity reaction to balsalazide.
BMJ 323: 489 (2001).
*
-
Adler M, Demols A, Franchimont D, Van Laethem JL, Van Gossum A. Screening for colorectal cancer by endoscopy: rectosigmoidoscopy or coloscopy?
Rev. Med. Brux. 22: A210-A213 (2001).
-
Afford SC, Ahmed-Choudhury J, Randhawa S, Russell C, Youster J, Crosby HA, Eliopoulos A, Hubscher SG, Young LS, Adams DH. CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB/AP-1 signaling in human intrahepatic biliary epithelial cells.
FASEB J. 15: 2345-2354 (2001).
*
-
Aganna E, Aksentijevich I, Hitman GA, Kastner DL, Hoepelman AI, Posma FD, Zweers EJ, McDermott MF. Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Dutch family: evidence for a TNFRSF1A mutation with reduced penetrance.
Eur. J. Hum. Genet. 9: 63-66 (2001).
*
-
Aggarwal S, Xie MH, Maruoka M, Foster J, Gurney AL. Acinar cells of the pancreas are a target of interleukin-22.
J. Interferon Cytokine Res. 21: 1047-1053 (2001).
-
Aguilar F, Gonzalez-Escribano MF, Sanchez-Roman J, Nunez-Roldan A. MCP-1 promoter polymorphism in Spanish patients with systemic lupus erythematosus.
Tissue Antigens 58: 335-338 (2001).
*
-
Aguilar-Martinez P, Bismuth M, Picot MC, Thelcide C, Pageaux GP, Blanc F, Blanc P, Schved JF, Larrey D. Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause?
Gut 48: 836-842 (2001).
*
-
Aguilera I, Wichmann I, Sousa JM, Bernardos A, Franco E, Garcia-Lozano JR, Nunez-Roldan A. Antibodies against glutathione S-transferase T1 (GSTT1) in patients with de novo immune hepatitis following liver transplantation.
Clin. Exp. Immunol. 126: 535-539 (2001).
*
-
Ahmad M, Riley TR 3rd. Can one predict when ultrasound will be useful with percutaneous liver biopsy?
Am. J. Gastroenterol. 96: 547-549 (2001).
*
-
Ahmad T, Satsangi J, McGovern D, Bunce M, Jewell DP. Review article: the genetics of inflammatory bowel disease.
Aliment. Pharmacol. Ther. 15: 731-748 (2001).
*
-
Ahmad YA, Bruce IN. Genetic epidemiology: systemic lupus erythematosus.
Arthritis Res. 3: 331-336 (2001).
*
-
Ahmadi KR, Hall MA, Norman P, Vaughan RW, Snieder H, Spector TD, Lanchbury JS. Genetic determinism in the relationship between human CD4+ and CD8+ T lymphocyte populations?
Genes Immun. 2: 381-387 (2001).
*
-
Ahmed S, Ihara K, Kanemitsu S, Nakashima H, Otsuka T, Tsuzaka K, Takeuchi T, Hara T. Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population.
Rheumatology (Oxford) 40: 662-667 (2001).
*
-
Ahrendt SA, Nakeeb A, Pitt HA. Cholangiocarcinoma.
Clin. Liver Dis. 5: 191-218 (2001).
-
Aithal GP, Craggs A, Day CP, Welfare M, Daly AK, Mansfield JC, Hudson M. Role of polymorphisms in the interleukin-10 gene in determining disease susceptibility and phenotype in inflamatory bowel disease.
Dig. Dis. Sci. 46: 1520-1525 (2001).
*
-
Aithal GP, Day CP, Leathart J, Daly AK, Hudson M. Association of single nucleotide polymorphisms in the interleukin-4 gene and interleukin-4 receptor gene with Crohn's disease in a British population.
Genes Immun. 2: 44-47 (2001).
*
-
Aithal GP, Mansfield JC. Review article: the risk of lymphoma associated with inflammatory bowel disease and immunosuppressive treatment.
Aliment. Pharmacol. Ther. 15: 1101-1108 (2001).
*
-
Akahoshi T, Hashizume M, Tanoue K, Morita M, Tomikawa M, Sugimachi K. Hyperbilirubinemia induced by endoscopic variceal ligation for esophageal varices in a patient with primary biliary cirrhosis: a case report.
Hepatogastroenterology 48: 1659-1661 (2001).
-
Akbar SM, Yamamoto K, Miyakawa H, Ninomiya T, Abe M, Hiasa Y, Masumoto T, Horiike N, Onji M. Peripheral blood T-cell responses to pyruvate dehydrogenase complex in primary biliary cirrhosis: role of antigen-presenting dendritic cells.
Eur. J. Clin. Invest. 31: 639-646 (2001).
*
-
Akiba Y, Furukawa O, Guth PH, Engel E, Nastaskin I, Sassani P, Dukkipatis R, Pushkin A, Kurtz I, Kaunitz JD. Cellular bicarbonate protects rat duodenal mucosa from acid-induced injury.
J. Clin. Invest. 108: 1807-1816 (2001).
*
-
Akimoto S, Abe M, Ishikawa O, Takagi H, Mori M. HLA-DRB1 and DQB1 genes in anticentromere antibody positive patients with SSc and primary biliary cirrhosis.
Ann. Rheum. Dis. 60: 639-640 (2001).
*
-
Akira S. Bacterial infections and Toll-like receptors.
Kekkaku 76: 593-600 (2001).
-
Akita H, Suzuki H, Ito K, Kinoshita S, Sato N, Takikawa H, Sugiyama Y. Characterization of bile acid transport mediated by multidrug resistance associated protein 2 and bile salt export pump.
Biochim. Biophys. Acta 1511: 7-16 (2001).
*
-
Akolkar PN, Gulwani-Akolkar B, Lin XY, Zhou Z, Daly M, Katz S, Levine J, Present D, Gelb B, Desnick R, Mayer L, Silver J. The IBD1 locus for susceptibility to Crohn's disease has a greater impact in Ashkenazi Jews with early onset disease.
Am. J. Gastroenterol. 96: 1127-1132 (2001).
*
-
Aksentijevich I, Galon J, Soares M, Mansfield E, Hull K, Oh HH, Goldbach-Mansky R, Dean J, Athreya B, Reginato AJ, Henrickson M, Pons-Estel B, O'Shea JJ, Kastner DL. The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers.
Am. J. Hum. Genet. 69: 301-314 (2001).
*
-
Aksu K, Turgan N, Oksel F, Keser G, Ozmen D, Kitapcioglu G, Gumusdis G, Bayindir O, Doganavsargil E. Hyperhomocysteinaemia in Behcet's disease.
Rheumatology (Oxford) 40: 687-690 (2001).
*
-
Al-Arfaj A. HLA-DR pattern of rheumatoid arthritis in Saudi Arabia.
Ann. Saudi Med. 21: 92-93 (2001).
-
Al-Khalidi JA, Czaja AJ. Current concepts in the diagnosis, pathogenesis, and treatment of autoimmune hepatitis.
Mayo Clin. Proc. 76: 1237-1252 (2001).
*
-
Al-Shamali MA, Kalaoui M, Hasan F, Khajah A, Siddiqe I, Al-Nakeeb B. Colonoscopy: evaluating indications and diagnostic yield.
Ann. Saudi Med. 21: 304-307 (2001).
-
Ala-Mello S, Kaariainen H, Koskimies O. Nephronophthisis and ulcerative colitis in siblings: a new association.
Pediatr. Nephrol. 16: 507-509 (2001).
-
Alaez C, Vazquez-Garcia MN, Gorodezky C. DQA1 and DQB1 promoter diversity and linkage disequilibrium with class II haplotypes in Mexican Mestizo population.
Genes Immun. 2: 216-221 (2001).
*
-
Alansari A, Hajeer AH, Bayat A, Eyre S, Carthy D, Ollier WE. Two novel polymorphisms in the human transforming growth factor beta 2 gene.
Genes Immun. 2: 295-296 (2001).
*
-
Alarcon GS. Psoriatic arthritis, methotrexate, and liver toxicity.
J. Clin. Rheumatol. 7: 213-214 (2001).
-
Alberti S, Schuster G, Parini P, Feltkamp D, Diczfalusy U, Rudling M, Angelin B, Bjorkhem I, Pettersson S, Gustafsson JA. Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice.
J. Clin. Invest. 107: 565-573 (2001).
*
-
Albishri SH, Issa S, Kneteman NM, Shapiro AM. Bile leak from duct of Luschka after liver transplantation.
Transplantation 72: 338-340 (2001).
-
Albrecht J, Dolinska M. Glutamine as a pathogenic factor in hepatic encephalopathy.
J. Neurosci. Res. 65: 1-5 (2001).
-
Alcalay J, Landau M, Zucker A. Analysis of laboratory data in acne patients treated with isotretinoin: is there really a need to perform routine laboratory tests?
J. Dermatolog. Treat. 12: 9-12 (2001).
-
Aldhous MC, Meister D, Ghosh S. Modification of enteral diets in inflammatory bowel disease.
Proc. Nutr. Soc. 60: 457-461 (2001).
*
-
Aldrighetti L, Arru M, Ronzoni M, Salvioni M, Villa E, Ferla G. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer.
Hepatogastroenterology 48: 1302-1307 (2001).
-
Alegre ML, Frauwirth KA, Thompson CB. T-cell regulation by CD28 and CTLA-4.
Nat. Rev. Immunol. 1: 220-228 (2001).
*
-
Alexander E, Pinto J, Pal GS, Kamath N, Kuruvilla M. Disease concomitance in psoriasis: a clinical study of 61 cases.
Indian J. Dermatol. Venereol. Leprol. 67: 66-68 (2001).
*
-
Alexander J, Watanabe T, Wu TT, Rashid A, Li S, Hamilton SR. Histopathological identification of colon cancer with microsatellite instability.
Am. J. Pathol. 158: 527-535 (2001).
*
-
Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.
Nature 413: 732-738 (2001).
*
-
Alison MR, Poulsom R, Forbes SJ. Update on hepatic stem cells.
Liver 21: 367-373 (2001).
-
Allcock RJ, Baluchova K, Cheong KY, Price P. Haplotypic single nucleotide polymorphisms in the central MHC gene IKBL, a potential regulator of NF-kappaB function.
Immunogenetics 52: 289-293 (2001).
-
Allcock RJ, Williams JH, Price P. The central MHC gene, BAT1, may encode a protein that down-regulates cytokine production.
Genes Cells 6: 487-494 (2001).
*
-
Alpers DH. Liver complications and failure in patients on home parenteral nutrition.
Curr. Opin. Gastroenterol. 17: 147-149 (2001).
-
Alpini G, Ueno Y, Glaser SS, Marzioni M, Phinizy JL, Francis H, Lesage G. Bile acid feeding increased proliferative activity and apical bile acid transporter expression in both small and large rat cholangiocytes.
Hepatology 34: 868-876 (2001).
*
-
Alrefai WA, Tyagi S, Nazir TM, Barakat J, Anwar SS, Hadjiagapiou C, Bavishi D, Sahi J, Malik P, Goldstein J, Layden TJ, Ramaswamy K, Dudeja PK. Human intestinal anion exchanger isoforms: expression, distribution, and membrane localization.
Biochim. Biophys. Acta 1511: 17-27 (2001).
*
-
Ambrugger P, Stoeva I, Biebermann H, Torresani T, Leitner C, Gruters A. Novel mutations of the thyroid peroxidase gene in patients with permanent congenital hypothyroidism.
Eur. J. Endocrinol. 145: 19-24 (2001).
*
-
Ameen NA, Figueroa Y, Salas PJ. Anomalous apical plasma membrane phenotype in CK8-deficient mice indicates a novel role for intermediate filaments in the polarization of simple epithelia.
J. Cell Sci. 114: 563-575 (2001).
*
-
Anania FA, Howell CD, Laurin JM, Drachenberg CI. Delayed granuloma formation in a patient with vanishing bile duct syndrome 7 years post-liver transplantation.
Liver Transpl. 7: 999-1001 (2001).
*
-
Ananthanarayanan M, Balasubramanian N, Makishima M, Mangelsdorf DJ, Suchy FJ. Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor.
J. Biol. Chem. 276: 28857-28865 (2001).
*
-
Anaya JM, Correa PA, Mantilla RD, Jimenez F, Kuffner T, McNicholl JM. Rheumatoid arthritis in African Colombians from Quibdo.
Semin. Arthritis Rheum. 31: 191-198 (2001).
*
-
Andersen LP. New Helicobacter species in humans.
Dig. Dis. 19: 112-115 (2001).
-
Anderson DW. Cytokines as drug targets.
IDrugs 4: 375-377 (2001).
-
Anderson G, Jenkinson EJ. Lymphostromal interactions in thymic development and function.
Nat. Rev. Immunol. 1: 31-40 (2001).
*
-
Anderson SP, Dunn CS, Cattley RC, Corton JC. Hepatocellular proliferation in response to a peroxisome proliferator does not require TNFalpha signaling.
Carcinogenesis 22: 1843-1851 (2001).
*
-
Andersson RE, Olaison G, Tysk C, Ekbom A. Appendectomy and protection against ulcerative colitis.
N. Engl. J. Med. 344: 808-814 (2001).
*
-
Andoh A, Saotome T, Sato H, Tsujikawa T, Araki Y, Fujiyama Y, Bamba T. Epithelial expression of caveolin-2, but not caveolin-1, is enhanced in the inflamed mucosa of patients with ulcerative colitis.
Inflamm. Bowel Dis. 7: 210-214 (2001).
*
-
Andoh A, Takaya H, Makino J, Sato H, Bamba S, Araki Y, Hata K, Shimada M, Okuno T, Fujiyama Y, Bamba T. Cooperation of interleukin-17 and interferon-gamma on chemokine secretion in human fetal intestinal epithelial cells.
Clin. Exp. Immunol. 125: 56-63 (2001).
*
-
Angulo P, El-Amin O, Carpenter HA, Lindor KD. Development of autoimmune hepatitis in the setting of long-standing primary biliary cirrhosis.
Am. J. Gastroenterol. 96: 3021-3027 (2001).
*
-
Angulo P, Jorgensen RA, Lindor KD. Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile?
Am. J. Gastroenterol. 96: 3152-3157 (2001).
*
-
Angulo P, Lindor KD. Treatment of nonalcoholic fatty liver: present and emerging therapies.
Semin. Liver Dis. 21: 81-88 (2001).
-
Angulo P, Lindor KD. Insulin resistance and mitochondrial abnormalities in NASH: a cool look into a burning issue.
Gastroenterology 120: 1281-1285 (2001).
*
-
Anlar B, Kose G, Gurer Y, Altunbasak S, Haspolat S, Okan M. Changing epidemiological features of subacute sclerosing panencephalitis.
Infection 29: 192-195 (2001).
-
Annese V, Andreoli A, Andriulli A, Dinca R, Gionchetti P, Latiano A, Lombardi G, Piepoli A, Poulain D, Sendid B, Colombel JF. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study.
Am. J. Gastroenterol. 96: 2407-2412 (2001).
*
-
Annese V, Andreoli A, Astegiano M, Campieri M, Caprilli R, Cucchiara S, D'Inca R, Giaccari S, Iaquinto G, Lombardi G, Napolitano G, Pera A, Riegler G, Valpiani D, Andriulli A; Italian Study Group for the Disease of Colon and Rectum. Clinical features in familial cases of Crohn's disease and ulcerative colitis in Italy: a GISC study. Italian Study Group for the Disease of Colon and Rectum.
Am. J. Gastroenterol. 96: 2939-2945 (2001).
*
-
Annilo T, Tammur J, Hutchinson A, Rzhetsky A, Dean M, Allikmets R. Human and mouse orthologs of a new ATP-binding cassette gene, ABCG4.
Cytogenet. Cell. Genet. 94: 196-201 (2001).
-
Anspach FB. Endotoxin removal by affinity sorbents.
J. Biochem. Biophys. Methods 49: 665-681 (2001).
*
-
Antes TJ, Levy-Wilson B. HNF-3 beta, C/EBP beta, and HNF-4 act in synergy to enhance transcription of the human apolipoprotein B gene in intestinal cells.
DNA Cell Biol. 20: 67-74 (2001).
-
Applebaum-Shapiro SE, Finch R, Pfutzer RH, Hepp LA, Gates L, Amann S, Martin S, Ulrich CD 2nd, Whitcomb DC. Hereditary pancreatitis in North America: the Pittsburgh-Midwest Multi-Center Pancreatic Study Group Study.
Pancreatology 1: 439-443 (2001).
-
Arad G, Hillman D, Levy R, Kaempfer R. Superantigen antagonist blocks Th1 cytokine gene induction and lethal shock.
J. Leukoc. Biol. 69: 921-927 (2001).
*
-
Arakawa M, Kakuto Y, Ichikawa K, Chiba J, Tabata N, Sasaki Y. Allopurinol hypersensitivity syndrome associated with systemic cytomegalovirus infection and systemic bacteremia.
Intern. Med. 40: 331-335 (2001).
*
-
Aranda A, Pascual A. Nuclear hormone receptors and gene expression.
Physiol. Rev. 81: 1269-1304 (2001).
*
-
Arnott ID, Drummond HE, Ghosh S. Frequency of continuing mucosal inflammation in clinically inactive Crohn's disease.
Scott. Med. J. 46: 136-139 (2001).
-
Arnott ID, Drummond HE, Ghosh S. Gut luminal neutrophil migration is influenced by the anatomical site of Crohn's disease.
Eur. J. Gastroenterol. Hepatol. 13: 239-243 (2001).
-
Arnott ID, McDonald D, Williams A, Ghosh S. Clinical use of infliximab in Crohn's disease: the Edinburgh experience.
Aliment. Pharmacol. Ther. 15: 1639-1646 (2001).
*
-
Aron-Maor A, Shoenfeld Y. Vaccination and systemic lupus erythematosus: the bidirectional dilemmas.
Lupus 10: 237-240 (2001).
-
Arora A, Willhite CA, Liebler DC. Interactions of beta-carotene and cigarette smoke in human bronchial epithelial cells.
Carcinogenesis 22: 1173-1178 (2001).
*
-
Aros SD, Camilleri M. Small-bowel motility.
Curr. Opin. Gastroenterol. 17: 140-146 (2001).
-
Arranz O, Ara J, Rodriguez R, Quinto L, Font J, Mirapeix E, Darnell A. Comparison of anti-PR3 capture and anti-PR3 direct ELISA for detection of antineutrophil cytoplasmic antibodies (ANCA) in long-term clinical follow-up of PR3-ANCA-associated vasculitis patients.
Clin. Nephrol. 56: 295-301 (2001).
-
Arrese M, Karpen SJ. New horizons in the regulation of bile acid and lipid homeostasis: critical role of the nuclear receptor FXR as an intracellular bile acid sensor.
Gut 49: 465-466 (2001).
*
-
Arrington JL, Chapkin RS, Switzer KC, Morris JS, McMurray DN. Dietary n-3 polyunsaturated fatty acids modulate purified murine T-cell subset activation.
Clin. Exp. Immunol. 125: 499-507 (2001).
*
-
Arrington JL, McMurray DN, Switzer KC, Fan YY, Chapkin RS. Docosahexaenoic acid suppresses function of the CD28 costimulatory membrane receptor in primary murine and Jurkat T cells.
J. Nutr. 131: 1147-1153 (2001).
*
-
Arseneau KO, Stukenborg GJ, Connors AF Jr, Cominelli F. The incidence of lymphoid and myeloid malignancies among hospitalized Crohn's disease patients.
Inflamm. Bowel Dis. 7: 106-112 (2001).
*
-
Asadullah K, Eskdale J, Wiese A, Gallagher G, Friedrich M, Sterry W. Interleukin-10 promoter polymorphism in psoriasis.
J. Invest. Dermatol. 116: 975-978 (2001).
*
-
Asaga H, Ishigami A. Protein deimination in the rat brain after kainate administration: citrulline-containing proteins as a novel marker of neurodegeneration.
Neurosci. Lett. 299: 5-8 (2001).
*
-
Asakura H, Yao T, Matsui T, Koganei K, Fukushima T, Takazoe M, Hobara R, Nakano H, Okamura S, Matsueda K, Kashida H, Makiyama K, Hiwatashi N, Kashiwagi K, Hibi T. Efficacy of treatment with chimeric monoclonal antibody (Infliximab) to tumor necrosis factor-alpha for Crohn's disease in Japan: evaluation by rapid turnover proteins, and radiologic and endoscopic findings.
J. Gastroenterol. Hepatol. 16: 763-769 (2001).
*
-
Asamoto Y, Tazuma S, Ochi H, Chayama K, Suzuki H. Bile-salt hydrophobicity is a key factor regulating rat liver plasma-membrane communication: relation to bilayer structure, fluidity and transporter expression and function.
Biochem. J. 359: 605-610 (2001).
*
-
Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hernan MA, Olek MJ, Hankinson SE, Hunter DJ. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.
JAMA 286: 3083-3088 (2001).
*
-
Ascherio A, Zhang SM, Hernan MA, Olek MJ, Coplan PM, Brodovicz K, Walker AM. Hepatitis B vaccination and the risk of multiple sclerosis.
N. Engl. J. Med. 344: 327-332 (2001).
*
-
Asherson RA, Greenblatt MA. Recurrent alveolar hemorrhage and pulmonary capillaritis in the "primary" antiphospholipid syndrome.
J. Clin. Rheumatol. 7: 30-33 (2001).
-
Ashorn M, Ruuska T, Makipernaa A. Helicobacter pylori and iron deficiency anaemia in children.
Scand. J. Gastroenterol. 36: 701-705 (2001).
-
Askling J, Dickman PW, Karlen P, Brostrom O, Lapidus A, Lofberg R, Ekbom A. Family history as a risk factor for colorectal cancer in inflammatory bowel disease.
Gastroenterology 120: 1356-1362 (2001).
*
-
Askling J, Dickman PW, Karlen P, Brostrom O, Lapidus A, Lofberg R, Ekbom A. Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study.
Lancet 357: 262-266 (2001).
*
-
Asnagli H, Murphy KM. Stability and commitment in T helper cell development.
Curr. Opin. Immunol. 13: 242-247 (2001).
-
Assies J, Lieverse R, Vreken P, Wanders RJ, Dingemans PM, Linszen DH. Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group.
Biol. Psychiatry 49: 510-522 (2001).
*
-
Astegiano M, Cammarota T, Bresso F, Sapone N, Demarchi B, Bertolusso L, Sarno A, Bruno M, Pellicano R, Rizzetto M. Abdominal pain and bowel dysfunction: diagnostic flow-chart could be semplified?
Minerva Gastroenterol. Dietol. 47: 53-60 (2001).
-
Atassi MZ, Oshima M, Deitiker P. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
Crit. Rev. Immunol. 21: 1-27 (2001).
-
Audrain MA, Sesboue R, Baranger TA, Elliott J, Testa A, Martin JP, Lockwood CM, Esnault VL. Analysis of anti-neutrophil cytoplasmic antibodies (ANCA): frequency and specificity in a sample of 191 homozygous (PiZZ) alpha1-antitrypsin-deficient subjects.
Nephrol. Dial. Transplant. 16: 39-44 (2001).
*
-
Aviles J, Macia M, Morales S, Perez F, Moreno A, Navarro J, Navazo L, Garcia J. Efficiency of dialysis with albumin in the treatment of patients with advanced hepatic insufficiency: initial experience with the MARS system in Spain.
Nefrologia 21: 376-385 (2001).
-
Avital I, Inderbitzin D, Aoki T, Tyan DB, Cohen AH, Ferraresso C, Rozga J, Arnaout WS, Demetriou AA. Isolation, characterization, and transplantation of bone marrow-derived hepatocyte stem cells.
Biochem. Biophys. Res. Commun. 288: 156-164 (2001).
*
-
Ayrton A, Morgan P. Role of transport proteins in drug absorption, distribution and excretion.
Xenobiotica 31: 469-497 (2001).
-
Bach JF. Protective role of infections and vaccinations on autoimmune diseases.
J. Autoimmun. 16: 347-353 (2001).
-
Bach JF, Chatenoud L. Tolerance to islet autoantigens in type 1 diabetes.
Annu. Rev. Immunol. 19: 131-161 (2001).
*
-
Bachelez H, Senet P, Cadranel J, Kaoukhov A, Dubertret L. The use of tetracyclines for the treatment of sarcoidosis.
Arch. Dermatol. 137: 69-73 (2001).
*
-
Bachellier P, Nakano H, Weber JC, Lemarque P, Oussoultzoglou E, Candau C, Wolf P, Jaeck D. Surgical repair after bile duct and vascular injuries during laparoscopic cholecystectomy: when and how?
World J. Surg. 25: 1335-1345 (2001).
*
-
Bacon BR. Hemochromatosis: diagnosis and management.
Gastroenterology 120: 718-725 (2001).
*
-
Badou A, Saoudi A, Dietrich G, Druet E, Druet P, Pelletier L. Mercuric chloride-induced autoimmunity.
Curr. Protoc. Immunol. Chapter 15: Unit 15.15 (2001).
-
Baert F, Rutgeerts P. 6-Thioguanine: a naked bullet? (Or how pharmacogenomics can make old drugs brand new).
Inflamm. Bowel Dis. 7: 190-191 (2001).
*
-
Baeten D, Peene I, Union A, Meheus L, Sebbag M, Serre G, Veys EM, De Keyser F. Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies.
Arthritis Rheum. 44: 2255-2262 (2001).
-
Bailen LS. Bones and Crohn's: should we treat Crohn's disease patients with alendronate?
Inflamm. Bowel Dis. 7: 175-176 (2001).
*
-
Bailey-Dell KJ, Hassel B, Doyle LA, Ross DD. Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene.
Biochim. Biophys. Acta 1520: 234-241 (2001).
*
-
Bajor J, Bero T, Garamszegi M, Grexa E, Anga B, Szilagyi K. Common bile duct tumor in a young woman with ulcerative colitis.
Orv. Hetil. 142: 1231-1234 (2001).
-
Bak T, Wachs M, Trotter J, Everson G, Trouillot T, Kugelmas M, Steinberg T, Kam I. Adult-to-adult living donor liver transplantation using right-lobe grafts: results and lessons learned from a single-center experience.
Liver Transpl. 7: 680-686 (2001).
*
-
Bakkaloglu A, Ozen S, Baskin E, Besbas N, Gur-Guven A, Kasapcopur O, Tinaztepe K. The significance of antineutrophil cytoplasmic antibody in microscopic polyangitis and classic polyarteritis nodosa.
Arch. Dis. Child. 85: 427-430 (2001).
*
-
Balbir-Gurman A, Schapira D, Nahir M. Arthritis related to ileal pouchitis following total proctocolectomy for ulcerative colitis.
Semin. Arthritis Rheum. 30: 242-248 (2001).
*
-
Baldassano RN. Anti-TNF therapies have eliminated the need for steroids in pediatric Crohn's disease: pro. Why use steroids if safer therapies are available?
Inflamm. Bowel Dis. 7: 338-341 (2001).
*
-
Baldursson O, Ostedgaard LS, Rokhlina T, Cotten JF, Welsh MJ. Cystic fibrosis transmembrane conductance regulator Cl- channels with R domain deletions and translocations show phosphorylation-dependent and -independent activity.
J. Biol. Chem. 276: 1904-1910 (2001).
*
-
Baluyut AR, Sherman S, Lehman GA, Hoen H, Chalasani N. Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis.
Gastrointest. Endosc. 53: 308-312 (2001).
*
-
Ban Y, Taniyama M, Tozaki T, Yanagawa T, Tomita M, Ban Y. SEL1L microsatellite polymorphism in Japanese patients with autoimmune thyroid diseases.
Thyroid 11: 335-338 (2001).
-
Ban Y, Taniyama M, Tozaki T, Yanagawa T, Yamada S, Maruyama T, Kasuga A, Tomita M, Ban Y. No association of type 1 diabetes with a microsatellite marker for CTLA-4 in a Japanese population.
Autoimmunity 34: 39-43 (2001).
-
Ban Y, Tozaki T, Taniyama M, Tomita M, Ban Y. Lack of association between estrogen receptor beta dinucleotide repeat polymorphism and autoimmune thyroid diseases in Japanese patients.
BMC Med. Genet. 2: 1 (2001).
*
-
Banan A, Fitzpatrick L, Zhang Y, Keshavarzian A. OPC-compounds prevent oxidant-induced carbonylation and depolymerization of the F-actin cytoskeleton and intestinal barrier hyperpermeability.
Free Radic. Biol. Med. 30: 287-298 (2001).
-
Bangsow C, Rubins N, Glusman G, Bernstein Y, Negreanu V, Goldenberg D, Lotem J, Ben-Asher E, Lancet D, Levanon D, Groner Y. The RUNX3 gene - sequence, structure and regulated expression.
Gene 279: 221-232 (2001).
-
Barbera MJ, Schluter A, Pedraza N, Iglesias R, Villarroya F, Giralt M. Peroxisome proliferator-activated receptor alpha activates transcription of the brown fat uncoupling protein-1 gene. A link between regulation of the thermogenic and lipid oxidation pathways in the brown fat cell.
J. Biol. Chem. 276: 1486-1493 (2001).
*
-
Barbot L, Topouchian A, Capet C, Magne D, Huneau JF, Kapel N, Gobert JG. Cryptosporidium parvum: functional study of the intestinal malabsorption syndrome.
Ann. Pharm. Fr. 59: 305-311 (2001).
-
Bareis P, Bises G, Bischof MG, Cross HS, Peterlik M. 25-Hydroxy-vitamin D metabolism in human colon cancer cells during tumor progression.
Biochem. Biophys. Res. Commun. 285: 1012-1017 (2001).
*
-
Barker JN. Genetic aspects of psoriasis.
Clin. Exp. Dermatol. 26: 321-325 (2001).
*
-
Barnes BJ, Moore PA, Pitha PM. Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes.
J. Biol. Chem. 276: 23382-23390 (2001).
*
-
Barnett KT, Malafa MP. Complications of hepatic artery infusion: a review of 4580 reported cases.
Int. J. Gastrointest. Cancer 30: 147-160 (2001).
-
Baron M. The search for complex disease genes: fault by linkage or fault by association?
Mol. Psychiatry 6: 143-149 (2001).
-
Barrera P, Balsa A, Alves H, Westhovens R, Maenaut K, Cornelis F, Fritz P, Bardin T, Ceu Maia M, Lopes-Vaz A, Pascual Salcedo D, de la Concha E, Radstake T, van de Putte LB, Migliorini P, Prudhomme JF, Charron D, Spyropoulou M, Mendes A, Spaepen M, et al. Noninherited maternal antigens do not increase the susceptibility for familial rheumatoid arthritis. European Consortium on Rheumatoid Arthritis Families (ECRAF).
J. Rheumatol. 28: 968-974 (2001).
-
Barrera P, Faure S, Prud'homme JF, Balsa A, Migliorini P, Chimenti D, Radstake TR, van de Putte LB, Pascual-Salcedo D, Westhovens R, Maenaut K, Alves H, Lopes-Vaz A, Stravopoulos C, Spyropoulou M, Fritz P, Bardin T, Charron D, Lepage V, et al. European genetic study on rheumatoid arthritis: is there a linkage of the interleukin-1 (IL-1), IL-10 or IL-4 genes to RA?
Clin. Exp. Rheumatol. 19: 709-714 (2001).
-
Barta Z, Csipo I, Antal-Szalmas P, Sipka S, Szabo G, Szegedi G. Anti-Saccharomyces cerevisiae antibodies in patients with Crohn's disease.
Orv. Hetil. 142: 2303-2307 (2001).
-
Barten R, Torkar M, Haude A, Trowsdale J, Wilson MJ. Divergent and convergent evolution of NK-cell receptors.
Trends Immunol. 22: 52-57 (2001).
*
-
Bartolome MJ, Martinez-Taboda VM, Lopez-Hoyos M, Blanco R, Rodriguez-Valverde V. Familial aggregation of polymyalgia rheumatica and giant cell arteritis: genetic and T cell repertoire analysis.
Clin. Exp. Rheumatol. 19: 259-264 (2001).
-
Barton A, Eyre S, Myerscough A, Brintnell B, Ward D, Ollier WE, Lorentzen JC, Klareskog L, Silman A, John S, Worthington J; Arthritis Rheumatism Campaign National Repository. High resolution linkage and association mapping identifies a novel rheumatoid arthritis susceptibility locus homologous to one linked to two rat models of inflammatory arthritis.
Hum. Mol. Genet. 10: 1901-1906 (2001).
*
-
Barton AC, Bruce IN, Silman AJ. Genetic studies of psoriatic arthritis: dissecting joints and skin.
J. Rheumatol. 28: 3-5 (2001).
-
Bataller R, Brenner DA. Hepatic stellate cells as a target for the treatment of liver fibrosis.
Semin. Liver Dis. 21: 437-451 (2001).
-
Battelli MG, Musiani S, Tazzari PL, Stirpe F. Oxidative stress to human lymphocytes by xanthine oxidoreductase activity.
Free Radic. Res. 35: 665-679 (2001).
-
Battezzati PM, Zuin M, Crosignani A, Allocca M, Invernizzi P, Selmi C, Villa E, Podda M. Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients.
Aliment. Pharmacol. Ther. 15: 1427-1434 (2001).
*
-
Baugh JA, Bucala R. Mechanisms for modulating TNF alpha in immune and inflammatory disease.
Curr. Opin. Drug Discov. Devel. 4: 635-650 (2001).
-
Baum H, Bogdanos DP, Vergani D. Antibodies to Clp protease in primary biliary cirrhosis: possible role of a mimicking T-cell epitope.
J. Hepatol. 34: 785-787 (2001).
*
-
Baxter AG. Louis Pasteur's beer of revenge.
Nat. Rev. Immunol. 1: 229-232 (2001).
*
-
Bazzini C, Botta G, Meyer G, Baroni MD, Paulmichl M. The presence of NHE1 and NHE3 Na+-H+ exchangers and an apical cAMP-independent Cl- channel indicate that both absorptive and secretory functions are present in calf gall bladder epithelium.
Exp. Physiol. 86: 571-583 (2001).
*
-
Beavers KL, Semelka RC. MRI evaluation of the liver.
Semin. Liver Dis. 21: 161-177 (2001).
-
Becker A, Fischer R, Schneider M. Bone density and 25-OH vitamin D serum level in patients with systemic lupus erythematosus.
Z. Rheumatol. 60: 352-358 (2001).
-
Beckingham IJ. ABC of diseases of liver, pancreas, and biliary system. Gallstone disease.
BMJ 322: 91-94 (2001).
*
-
Beckingham IJ, Bornman PC. ABC of diseases of liver, pancreas, and biliary system. Acute pancreatitis.
BMJ 322: 595-598 (2001).
*
-
Beckingham IJ, Krige JE. ABC of diseases of liver, pancreas, and biliary system. Liver tumours.
BMJ 322: 477-480 (2001).
*
-
Beckingham IJ, Krige JE. ABC of diseases of liver, pancreas, and biliary system. Liver and pancreatic trauma.
BMJ 322: 783-785 (2001).
*
-
Beckingham IJ, Ryder SD. ABC of diseases of liver, pancreas, and biliary system. Investigation of liver and biliary disease.
BMJ 322: 33-36 (2001).
*
-
Bell SJ, Rigby R, English N, Mann SD, Knight SC, Kamm MA, Stagg AJ. Migration and maturation of human colonic dendritic cells.
J. Immunol. 166: 4958-4967 (2001).
*
-
Bellentani S, Tiribelli C. The spectrum of liver disease in the general population: lesson from the Dionysos study.
J. Hepatol. 35: 531-537 (2001).
*
-
Ben-Ari Z, Czaja AJ. Autoimmune hepatitis and its variant syndromes.
Gut 49: 589-594 (2001).
*
-
Ben-Ari Z, Tur-Kaspa R, Schafer Z, Baruch Y, Sulkes J, Atzmon O, Greenberg A, Levi N, Fainaru M. Basal and post-methionine serum homocysteine and lipoprotein abnormalities in patients with chronic liver disease.
J. Investig. Med. 49: 325-329 (2001).
-
Ben-Shushan E, Marshak S, Shoshkes M, Cerasi E, Melloul D. A pancreatic beta-cell-specific enhancer in the human PDX-1 gene is regulated by hepatocyte nuclear factor 3beta (HNF-3beta), HNF-1alpha, and SPs transcription factors.
J. Biol. Chem. 276: 17533-17540 (2001).
*
-
Ben-Smith A, Dove SK, Martin A, Wakelam MJ, Savage CO. Antineutrophil cytoplasm autoantibodies from patients with systemic vasculitis activate neutrophils through distinct signaling cascades: comparison with conventional Fcgamma receptor ligation.
Blood 98: 1448-1455 (2001).
*
-
Bendelac A, Bonneville M, Kearney JF. Autoreactivity by design: innate B and T lymphocytes.
Nat. Rev. Immunol. 1: 177-186 (2001).
*
-
Benito-Leon J, Porta-Etessam J. Guillain-Barre syndrome and allopurinol-induced hypersensitivity.
Eur. Neurol. 45: 186-187 (2001).
-
Benoist C, Mathis D. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry?
Nat. Immunol. 2: 797-801 (2001).
*
-
Benoist S, Nordlinger B. The internal bioartifical liver.
J. Soc. Biol. 195: 91-96 (2001).
-
Benten D, Widjaja A, von Depka M, Flemming P, Trautwein C, Boker K, Vogel A, Rosenau J, Manns MP. Autoimmune hepatitis associated with coagulation disorders and immunethyreopathy.
Z. Gastroenterol. 39: 837-840 (2001).
-
Benyon RC, Arthur MJ. Extracellular matrix degradation and the role of hepatic stellate cells.
Semin. Liver Dis. 21: 373-384 (2001).
-
Bergasa NV, Link MJ, Keogh M, Yaroslavsky G, Rosenthal RN, McGee M. Pilot study of bright-light therapy reflected toward the eyes for the pruritus of chronic liver disease.
Am. J. Gastroenterol. 96: 1563-1570 (2001).
*
-
Berglund B, Nordstrom G. Symptoms and functional health status of individuals with Ehlers-Danlos syndrome (EDS).
J. Clin. Rheumatol. 7: 308-314 (2001).
-
Bergman ML, Cilio CM, Penha-Goncalves C, Lamhamedi-Cherradi SE, Lofgren A, Colucci F, Lejon K, Garchon HJ, Holmberg D. CTLA-4-/- mice display T cell-apoptosis resistance resembling that ascribed to autoimmune-prone non-obese diabetic (NOD) mice.
J. Autoimmun. 16: 105-113 (2001).
-
Bergquist A. Cholangiocarcinoma in primary sclerosing cholangitis.
Department of Gastroenterology and Hepatology, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden. Karolinska University Press (2001). *
-
Bergquist A, Broome U. Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis.
Best Pract. Res. Clin. Gastroenterol. 15: 643-656 (2001).
*
-
Bergquist A, Glaumann H, Stal P, Wang GS, Broome U. Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma.
J. Intern. Med. 249: 69-75 (2001).
*
-
Berkmen T, Echenique A, Russell E. Ultrasound guidance in accessing the afferent limb of a modified Roux-en-Y choledochojejunostomy for percutaneous dilation of biliary strictures.
J. Vasc. Interv. Radiol. 12: 1219-1222 (2001).
*
-
Bernstein CN. Extraintestinal manifestations of inflammatory bowel disease.
Curr. Gastroenterol. Rep. 3: 477-483 (2001).
-
Bernstein CN, Blanchard JF, Houston DS, Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study.
Thromb. Haemost. 85: 430-434 (2001).
-
Bernstein CN, Blanchard JF, Kliewer E, Wajda A. Cancer risk in patients with inflammatory bowel disease: a population-based study.
Cancer 91: 854-862 (2001).
*
-
Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.
Am. J. Gastroenterol. 96: 1116-1122 (2001).
*
-
Berstad AE, Hogasen K, Bukholm G, Moran AP, Brandtzaeg P. Complement activation directly induced by Helicobacter pylori.
Gastroenterology 120: 1108-1116 (2001).
*
-
Bertalot G, Villanacci V, Gramegna M, Orvieto E, Negrini R, Saleri A, Terraroli C, Ravelli P, Cestari R, Viale G. Evidence of Epstein-Barr virus infection in ulcerative colitis.
Dig. Liver Dis. 33: 551-558 (2001).
-
Berzofsky JA, Ahlers JD, Belyakov IM. Strategies for designing and optimizing new generation vaccines.
Nat. Rev. Immunol. 1: 209-219 (2001).
*
-
Besnard S, Silvestre JS, Duriez M, Bakouche J, Lemaigre-Dubreuil Y, Mariani J, Levy BI, Tedgui A. Increased ischemia-induced angiogenesis in the staggerer mouse, a mutant of the nuclear receptor Roralpha.
Circ. Res. 89: 1209-1215 (2001).
*
-
Bessis N, Boissier MC. Novel pro-inflammatory interleukins: potential therapeutic targets in rheumatoid arthritis.
Joint Bone Spine 68: 477-481 (2001).
-
Betteridge DJ. Lipid-lowering trials in diabetes.
Curr. Opin. Lipidol. 12: 619-623 (2001).
-
Betterle C, Dalpra C, Greggio N, Volpato M, Zanchetta R. Autoimmunity in isolated Addison's disease and in polyglandular autoimmune diseases type 1, 2 and 4.
Ann. Endocrinol. (Paris) 62: 193-201 (2001).
-
Beuers U, Bilzer M, Chittattu A, Kullak-Ublick GA, Keppler D, Paumgartner G, Dombrowski F. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver.
Hepatology 33: 1206-1216 (2001).
*
-
Beutler B. Autoimmunity and apoptosis: the Crohn's connection.
Immunity 15: 5-14 (2001).
*
-
Beutler E. Discrepancies between genotype and phenotype in hematology: an important frontier.
Blood 98: 2597-2602 (2001).
*
-
Beutler E, Felitti V, Gelbart T, Ho N. Genetics of iron storage and hemochromatosis.
Drug Metab. Dispos. 29: 495-499 (2001).
*
-
Bezabeh T, Somorjai RL, Smith IC, Nikulin AE, Dolenko B, Bernstein CN. The use of 1H magnetic resonance spectroscopy in inflammatory bowel diseases: distinguishing ulcerative colitis from Crohn's disease.
Am. J. Gastroenterol. 96: 442-448 (2001).
*
-
Bezprozvanny I, Maximov A. PDZ domains: more than just a glue.
Proc. Natl. Acad. Sci. U.S.A. 98: 787-789 (2001).
*
-
Bianchi L. Liver biopsy in elevated liver functions tests? An old question revisited.
J. Hepatol. 35: 290-294 (2001).
*
-
Bianchi-Salvadori B, Vesely R, Ferrari A, Canzi E, Casiraghi C, Brighenti F. Behaviour of the pharmaceutical probiotic preparation VSL#3 in human ileostomy effluent containing its own natural elements.
New Microbiol. 24: 23-33 (2001).
-
Biancone L, Pavia M, Del Vecchio Blanco G, D'Inca R, Castiglione F, De Nigris F, Doldo P, Cosco F, Vavassori P, Bresci GP, Arrigoni A, Cadau G, Monteleone I, Rispo A, Fries W, Mallardi B, Sturniolo GC, Pallone F. Hepatitis B and C virus infection in Crohn's disease.
Inflamm. Bowel Dis. 7: 287-294 (2001).
*
-
Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, McDermott MF, Oksenberg J, McNicholl J, Pociot F, Hardt C, D'Alfonso S. Cytokine gene polymorphism in human disease: on-line databases, supplement 1.
Genes Immun. 2: 61-70 (2001).
*
-
Bigger B, Coutelle C. Perspectives on gene therapy for cystic fibrosis airway disease.
BioDrugs 15: 615-634 (2001).
-
Bihl F, Lariviere L, Qureshi ST, Flaherty L, Malo D. LPS-hyporesponsiveness of mnd mice is associated with a mutation in Toll-like receptor 4.
Genes Immun. 2: 56-59 (2001).
*
-
Bilej M, De Baetselier P, Van Dijck E, Stijlemans B, Colige A, Beschin A. Distinct carbohydrate recognition domains of an invertebrate defense molecule recognize Gram-negative and Gram-positive bacteria.
J. Biol. Chem. 276: 45840-45847 (2001).
*
-
Bingham SJ, Snowden J, McGonagle D, Richards S, Isaacs J, Morgan G, Emery P. Autologous stem cell transplantation for rheumatoid arthritis - interim report of 6 patients.
J. Rheumatol. Suppl. 64: 21-24 (2001).
-
Binion DG, Alemzadeh R. Growth of an IBD controversy: growth hormone and Crohn's disease.
Inflamm. Bowel Dis. 7: 176-178 (2001).
*
-
Binks M, Passweg JR, Furst D, McSweeney P, Sullivan K, Besenthal C, Finke J, Peter HH, van Laar J, Breedveld FC, Fibbe WE, Farge D, Gluckman E, Locatelli F, Martini A, van den Hoogen F, van de Putte L, Schattenberg AV, Arnold R, Bacon PA, Emery P, et al. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease.
Ann. Rheum. Dis. 60: 577-584 (2001).
*
-
Biondi ML, Marasini B, Leviti S, Turri O, Bernini M, Seminati R, Porreca W, Guagnellini E. Genotyping method for point mutation detection in the endothelial nitric oxide synthase exon 7 using fluorescent probes. Clinical validation in systemic sclerosis patients.
Clin. Chem. Lab. Med. 39: 281-282 (2001).
-
Birchler T, Seibl R, Buchner K, Loeliger S, Seger R, Hossle JP, Aguzzi A, Lauener RP. Human Toll-like receptor 2 mediates induction of the antimicrobial peptide human beta-defensin 2 in response to bacterial lipoprotein.
Eur. J. Immunol. 31: 3131-3137 (2001).
*
-
Bisping G, Lugering N, Lutke-Brintrup S, Pauels HG, Schurmann G, Domschke W, Kucharzik T. Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells.
Clin. Exp. Immunol. 123: 15-22 (2001).
*
-
Bittencourt PL, Palacios SA, Cancado EL, Porta G, Drigo S, Carrilho FJ, Laudanna AA, Kalil J, Goldberg AC. Autoimmune hepatitis in Brazilian patients is not linked to tumor necrosis factor alpha polymorphisms at position -308.
J. Hepatol. 35: 24-28 (2001).
*
-
Bitti PP, Murgia BS, Ticca A, Ferrai R, Musu L, Piras ML, Puledda E, Campo S, Durando S, Montomoli C, Clayton DG, Mander AP, Bernardinelli L. Association between the ancestral haplotype HLA A30B18DR3 and multiple sclerosis in central Sardinia.
Genet. Epidemiol. 20: 271-283 (2001).
-
Blachar A, Federle MP, Brancatelli G. Primary biliary cirrhosis: clinical, pathologic, and helical CT findings in 53 patients.
Radiology 220: 329-336 (2001).
*
-
Blackmore CG, McNaughton PA, van Veen HW. Multidrug transporters in prokaryotic and eukaryotic cells: physiological functions and transport mechanisms.
Mol. Membr. Biol. 18: 97-103 (2001).
-
Blam ME, Stein RB, Lichtenstein GR. Integrating anti-tumor necrosis factor therapy in inflammatory bowel disease: current and future perspectives.
Am. J. Gastroenterol. 96: 1977-1997 (2001).
*
-
Blanchard JF, Bernstein CN, Wajda A, Rawsthorne P. Small-area variations and sociodemographic correlates for the incidence of Crohn's disease and ulcerative colitis.
Am. J. Epidemiol. 154: 328-335 (2001).
*
-
Blaner WS. Cellular metabolism and actions of 13-cis-retinoic acid.
J. Am. Acad. Dermatol. 45: S129-S135 (2001).
-
Blass S, Engel JM, Burmester GR. The immunologic homunculus in rheumatoid arthritis. A new viewpoint of immunopathogenesis in rheumatoid arthritis and therapeutic consequences.
Z. Rheumatol. 60: 1-16 (2001).
-
Blei AT, Cordoba J; Practice Parameters Committee of the American College of Gastroenterology. Hepatic encephalopathy.
Am. J. Gastroenterol. 96: 1968-1976 (2001).
*
-
Blomstrand E. Amino acids and central fatigue.
Amino Acids 20: 25-34 (2001).
*
-
Bloomfeld RS. Are we missing CMV infections in patients hospitalized with severe colitis?
Inflamm. Bowel Dis. 7: 348-349 (2001).
*
-
Blumberg RS, Strober W. Prospects for research in inflammatory bowel disease.
JAMA 285: 643-647 (2001).
*
-
Blumberg RS, van de Wal Y, Claypool S, Corazza N, Dickinson B, Nieuwenhuis E, Pitman R, Spiekermann G, Zhu X, Colgan S, Lencer WI. The multiple roles of major histocompatibility complex class-I-like molecules in mucosal immune function.
Acta Odontol. Scand. 59: 139-144 (2001).
-
Bo X, Broome U, Remberger M, Sumitran-Holgersson S. Tumour necrosis factor alpha impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis.
Gut 49: 131-141 (2001).
*
-
Boberg KM, Spurkland A, Rocca G, Egeland T, Saarinen S, Mitchell S, Broome U, Chapman R, Olerup O, Pares A, Rosina F, Schrumpf E. The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis.
Scand. J. Gastroenterol. 36: 886-890 (2001).
*
-
Boelsma E, Hendriks HF, Roza L. Nutritional skin care: health effects of micronutrients and fatty acids.
Am. J. Clin. Nutr. 73: 853-864 (2001).
*
-
Bogdanos DP, Choudhuri K, Vergani D. Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences.
Liver 21: 225-232 (2001).
-
Boiardi L, Salvarani C, Casali B, Olivieri I, Ciancio G, Cantini F, Salvi F, Malatesta R, Govoni M, Trotta F, Filippini D, Paolazzi G, Nicoli D, Farnetti E, Macchioni L. Intercellular adhesion molecule-1 gene polymorphisms in Behcet's disease.
J. Rheumatol. 28: 1283-1287 (2001).
-
Boland B, Beguin C, Zech F, Desager JP, Lambert M. Serum beta-carotene in anorexia nervosa patients: a case-control study.
Int. J. Eat. Disord. 30: 299-305 (2001).
-
Bolognesi E, Dalfonso S, Rolando V, Fasano ME, Praticň L, Momigliano-Richiardi P. MICA and MICB microsatellite alleles in HLA extended haplotypes.
Eur. J. Immunogenet. 28: 523-530 (2001).
*
-
Bolstad AI, Wassmuth R, Haga HJ, Jonsson R. HLA markers and clinical characteristics in Caucasians with primary Sjogren's syndrome.
J. Rheumatol. 28: 1554-1562 (2001).
-
Bonapace ES, Srinivasan R. Simultaneous occurrence of inflammatory bowel disease and thyroid disease.
Am. J. Gastroenterol. 96: 1925-1926 (2001).
*
-
Bondeson J, Maini RN. Tumour necrosis factor as a therapeutic target in rheumatoid arthritis and other chronic inflammatory diseases: the clinical experience with infliximab (REMICADE).
Int. J. Clin. Pract. 55: 211-216 (2001).
-
Bonilla S, Redonnet A, Noel-Suberville C, Groubet R, Pallet V, Higueret P. Effect of a pharmacological activation of PPAR on the expression of RAR and TR in rat liver.
J. Physiol. Biochem. 57: 1-8 (2001).
-
Bonis PA, Friedman SL, Kaplan MM. Is liver fibrosis reversible?
N. Engl. J. Med. 344: 452-454 (2001).
*
-
Bonnet F, Dubuc J, Morlat P, Delbrel X, Doutre MS, de Witte S, Bernard N, Lacoste D, Longy-Boursier M, Beylot J. Sarcoidosis and comorbidity: retrospective study of 32 cases.
Rev. Med. Interne. 22: 619-623 (2001).
-
Borgmann S, Endisch G, Urban S, Sitter T, Fricke H. A linkage disequilibrium between genes at the serine protease inhibitor gene cluster on chromosome 14q32.1 is associated with Wegener's granulomatosis.
Clin. Immunol. 98: 244-248 (2001).
*
-
Bornman PC, Beckingham IJ. ABC of diseases of liver, pancreas, and biliary system. Pancreatic tumours.
BMJ 322: 721-723 (2001).
*
-
Bornman PC, Beckingham IJ. ABC of diseases of liver, pancreas, and biliary system. Chronic pancreatitis.
BMJ 322: 660-663 (2001).
*
-
Bos NA, Jiang HQ, Cebra JJ. T cell control of the gut IgA response against commensal bacteria.
Gut 48: 762-764 (2001).
*
-
Bosy-Westphal A, Petersen S, Hinrichsen H, Czech N, J Muller M. Increased plasma homocysteine in liver cirrhosis.
Hepatol. Res. 20: 28-38 (2001).
-
Bouchier-Hayes L, Conroy H, Egan H, Adrain C, Creagh EM, MacFarlane M, Martin SJ. CARDINAL, a novel caspase recruitment domain protein, is an inhibitor of multiple NF-kappa B activation pathways.
J. Biol. Chem. 276: 44069-44077 (2001).
*
-
Boulassel MR, Deggouj N, Tomasi JP, Gersdorff M. Inner ear autoantibodies and their targets in patients with autoimmune inner ear diseases.
Acta Otolaryngol. 121: 28-34 (2001).
-
Boulassel MR, Tomasi JP, Deggouj N, Gersdorff M. COCH5B2 is a target antigen of anti-inner ear antibodies in autoimmune inner ear diseases.
Otol. Neurotol. 22: 614-618 (2001).
-
Bourgain C, Genin E, Holopainen P, Mustalahti K, Maki M, Partanen J, Clerget-Darpoux F. Use of closely related affected individuals for the genetic study of complex diseases in founder populations.
Am. J. Hum. Genet. 68: 154-159 (2001).
*
-
Bouza E, Pelaez T, Alonso R, Catalan P, Munoz P, Creixems MR. "Second-look" cytotoxicity: an evaluation of culture plus cytotoxin assay of Clostridium difficile isolates in the laboratory diagnosis of CDAD.
J. Hosp. Infect. 48: 233-237 (2001).
-
Bowcock AM, Shannon W, Du F, Duncan J, Cao K, Aftergut K, Catier J, Fernandez-Vina MA, Menter A. Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies.
Hum. Mol. Genet. 10: 1793-1805 (2001).
*
-
Bowden S. New hepatitis viruses: contenders and pretenders.
J. Gastroenterol. Hepatol. 16: 124-131 (2001).
*
-
Boyle MP. The spectrum of CFTR-related disease.
Intern. Med. 40: 522-525 (2001).
*
-
Boyle MP. Minocycline-induced pancreatitis in cystic fibrosis.
Chest 119: 1283-1285 (2001).
*
-
Bradley M, Soderhall C, Wahlgren CF, Luthman H, Nordenskjold M, Kockum I. The Wiskott-Aldrich syndrome gene as a candidate gene for atopic dermatitis.
Acta Derm. Venereol. 81: 340-342 (2001).
-
Braham A, Safer L, Bdioui F, Lejmi A, Brahmi I, Ben Chabenne N, Ben Mimoun H, Saffar H. Antiphospholipid antibodies in digestive diseases.
Presse. Med. 30: 1890-1897 (2001).
-
Brand R. The potential chemoprotective effect of ursodiol.
Am. J. Gastroenterol. 96: 1687 (2001). *
-
Brandt LJ. Patients' attitudes and apprehensions about endoscopy: how to calm troubled waters.
Am. J. Gastroenterol. 96: 280-284 (2001).
*
-
Brandtzaeg P. Inflammatory bowel disease: clinics and pathology. Do inflammatory bowel disease and periodontal disease have similar immunopathogeneses?
Acta Odontol. Scand. 59: 235-243 (2001).
*
-
Brandtzaeg P. Nature and function of gastrointestinal antigen-presenting cells.
Allergy 56 Suppl. 67: 16-20 (2001).
-
Brandtzaeg P, Baekkevold ES, Morton HC. From B to A the mucosal way.
Nat. Immunol. 2: 1093-1094 (2001).
*
-
Brandtzaeg P, Johansen FE. Confusion about the polymeric Ig receptor.
Trends Immunol. 22: 545-546 (2001).
*
-
Braun C, Zahn R, Martin K, Albert E, Folwaczny C. Polymorphisms of the ICAM-1 gene are associated with inflammatory bowel disease, regardless of the p-ANCA status.
Clin. Immunol. 101: 357-360 (2001).
*
-
Braun J, de Keyser F, Brandt J, Mielants H, Sieper J, Veys E. New treatment options in spondyloarthropathies: increasing evidence for significant efficacy of anti-tumor necrosis factor therapy.
Curr. Opin. Rheumatol. 13: 245-249 (2001).
-
Braun-Moscovici Y, Schapira D, Balbir-Gurman A, Sevilia R, Nahir AM. Ticlopidine-induced lupus.
J. Clin. Rheumatol. 7: 102-105 (2001).
-
Bravo AA, Sheth SG, Chopra S. Liver biopsy.
N. Engl. J. Med. 344: 495-500 (2001).
*
-
Breslin NP, Nash C, Hilsden RJ, Hershfield NB, Price LM, Meddings JB, Sutherland LR. Intestinal permeability is increased in a proportion of spouses of patients with Crohn's disease.
Am. J. Gastroenterol. 96: 2934-2938 (2001).
*
-
Bridges KR. Iron overload and chelation therapy.
ENCYCLOPEDIA OF LIFE SCIENCES Nature Publishing Group www.els.net (2001). *
-
Brigden ML. Detection, education and management of the asplenic or hyposplenic patient.
Am. Fam. Physician 63: 499-506, 508 (2001).
*
-
Brigden ML, Pattullo A, Brown G. Practising physician's knowledge and patterns of practice regarding the asplenic state: the need for improved education and a practical checklist.
Can. J. Surg. 44: 210-216 (2001).
-
Brigidi P, Vitali B, Swennen E, Bazzocchi G, Matteuzzi D. Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea.
Res. Microbiol. 152: 735-741 (2001).
*
-
Brinkmann U, Eichelbaum M. Polymorphisms in the ABC drug transporter gene MDR1.
Pharmacogenomics J. 1: 59-64 (2001).
*
-
British Society of Gastroenterology. Antibiotic prophylaxis in gastrointestinal endoscopy.
BSG Guidelines in Gastroenterology, p. 1-10, January (2001). *
-
Broadley S, Sawcer S, D'Alfonso S, Hensiek A, Coraddu F, Gray J, Roxburgh R, Clayton D, Buttinelli C, Quattrone A, Trojano M, Massacesi L, Compston A. A genome screen for multiple sclerosis in Italian families.
Genes Immun. 2: 205-210 (2001).
*
-
Brons RH, de Jong MC, de Boer NK, Stegeman CA, Kallenberg CG, Tervaert JW. Detection of immune deposits in skin lesions of patients with Wegener's granulomatosis.
Ann. Rheum. Dis. 60: 1097-1102 (2001).
*
-
Bronsveld I, Mekus F, Bijman J, Ballmann M, de Jonge HR, Laabs U, Halley DJ, Ellemunter H, Mastella G, Thomas S, Veeze HJ, Tummler B. Chloride conductance and genetic background modulate the cystic fibrosis phenotype of Delta F508 homozygous twins and siblings.
J. Clin. Invest. 108: 1705-1715 (2001).
*
-
Brophy S, Pavy S, Lewis P, Taylor G, Bradbury L, Robertson D, Lovell C, Calin A. Inflammatory eye, skin, and bowel disease in spondyloarthritis: genetic, phenotypic, and environmental factors.
J. Rheumatol. 28: 2667-2673 (2001).
-
Bruckner JV, Kyle GM, Luthra R, Acosta D, Mehta SM, Sethuraman S, Muralidhara S. Acute, short-term, and subchronic oral toxicity of 1,1,1-trichloroethane in rats.
Toxicol. Sci. 60: 363-372 (2001).
*
-
Brumeanu TD, Bona CA, Casares S. T-cell tolerance and autoimmune diabetes.
Int. Rev. Immunol. 20: 301-331 (2001).
-
Brunner HI, Kim KN, Ballinger SH, Bowyer SL, Griffin TA, Higgins GC, Mier R, Passo MH, Rennebohm R, Schikler K, Lovell DJ. Current medication choices in juvenile rheumatoid arthritis II - update of a survey performed in 1993.
J. Clin. Rheumatol. 7: 295-300 (2001).
-
Bruno MJ. Current insights into the pathogenesis of acute and chronic pancreatitis.
Scand. J. Gastroenterol. Suppl. 234: 103-108 (2001).
*
-
Brunt EM. Nonalcoholic steatohepatitis: definition and pathology.
Semin. Liver Dis. 21: 3-16 (2001).
-
Brzezinska-Kolarz B, Undas A, Dyczek A, Musial J. Reynolds syndrome: the combination of scleroderma and primary biliary cirrhosis. Case report.
Pol. Arch. Med. Wewn. 105: 231-234 (2001).
-
Buchs N, di Giovine FS, Silvestri T, Vannier E, Duff GW, Miossec P. IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels.
Genes Immun. 2: 222-228 (2001).
*
-
Buisine MP, Desreumaux P, Leteurtre E, Copin MC, Colombel JF, Porchet N, Aubert JP. Mucin gene expression in intestinal epithelial cells in Crohn's disease.
Gut 49: 544-551 (2001).
*
-
Bullimore D. ERCP training.
Gut 49: 597 (2001).
*
-
Burak KW, Lee SS, Beck PL. Portal hypertensive gastropathy and gastric antral vascular ectasia (GAVE) syndrome.
Gut 49: 866-872 (2001).
*
-
Burak KW, Urbanski SJ, Swain MG. A case of coexisting primary biliary cirrhosis and primary sclerosing cholangitis: a new overlap of autoimmune liver diseases.
Dig. Dis. Sci. 46: 2043-2047 (2001).
*
-
Burich A, Hershberg R, Waggie K, Zeng W, Brabb T, Westrich G, Viney JL, Maggio-Price L. Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice.
Am. J. Physiol. Gastrointest. Liver Physiol. 281: G764-G778 (2001).
*
-
Burk RF. Selenium: recent clinical advances.
Curr. Opin. Gastroenterol. 17: 162-166 (2001).
-
Burke PA, Ling PR, Forse RA, Lewis DW, Jenkins R, Bistrian BR. Sites of conditional essential fatty acid deficiency in end stage liver disease.
JPEN J. Parenter. Enteral Nutr. 25: 188-193 (2001).
-
Burkhart CG, Burkhart CN. Propionibacterium acnes: an indigenous bacterium may be pathogenic in several cutaneous disease states.
Arch. Dermatol. 137: 1250 (2001).
*
-
Burnevich EZ, Timoshina EV, Krel' PE, Filatova AL, Popova IV. Primary sclerosing cholangitis associated with autoimmune hepatitis.
Ter. Arkh. 73: 61-63 (2001).
-
Burrows RF, Clavisi O, Burrows E. Interventions for treating cholestasis in pregnancy.
Cochrane Database Syst. Rev. 4: CD000493 (2001).
*
-
Butler P, McIntyre N, Mistry PK. Molecular diagnosis of Wilson disease.
Mol. Genet. Metab. 72: 223-230 (2001).
*
-
Byers J, Sladen RN. Renal function and dysfunction.
Curr. Opin. Anaesthesiol. 14: 699-706 (2001).
-
Cabre E, Gassull MA. Nutrition in inflammatory bowel disease: impact on disease and therapy.
Curr. Opin. Gastroenterol. 17: 342-349 (2001).
-
Cabrero A, Alegret M, Sanchez RM, Adzet T, Laguna JC, Vazquez M. Bezafibrate reduces mRNA levels of adipocyte markers and increases fatty acid oxidation in primary culture of adipocytes.
Diabetes 50: 1883-1890 (2001).
*
-
Caca K, Ferenci P, Kuhn HJ, Polli C, Willgerodt H, Kunath B, Hermann W, Mossner J, Berr F. High prevalence of the H1069Q mutation in East German patients with Wilson disease: rapid detection of mutations by limited sequencing and phenotype-genotype analysis.
J. Hepatol. 35: 575-581 (2001).
*
-
Cadranel JF, Lebiez E, Di Martino V, Bernard B, El Koury S, Tourbah A, Pidoux B, Valla D, Opolon P. Focal neurological signs in hepatic encephalopathy in cirrhotic patients: an underestimated entity?
Am. J. Gastroenterol. 96: 515-518 (2001).
*
-
Cai L, Lumsden A, Guenther UP, Neldner SA, Zach S, Knoblauch H, Ramesar R, Hohl D, Callen DF, Neldner KH, Lindpaintner K, Richards RI, Struk B. A novel Q378X mutation exists in the transmembrane transporter protein ABCC6 and its pseudogene: implications for mutation analysis in pseudoxanthoma elasticum.
J. Mol. Med. 79: 536-546 (2001).
*
-
Cai L, Yin JP, Starovasnik MA, Hogue DA, Hillan KJ, Mort JS, Filvaroff EH. Pathways by which interleukin 17 induces articular cartilage breakdown in vitro and in vivo.
Cytokine 16: 10-21 (2001).
-
Cai SY, Wang L, Ballatori N, Boyer JL. Bile salt export pump is highly conserved during vertebrate evolution and its expression is inhibited by PFIC type II mutations.
Am. J. Physiol. Gastrointest. Liver Physiol. 281: G316-G322 (2001).
*
-
Calatayud S, Ramirez MC, Sanz MJ, Moreno L, Hernandez C, Bosch J, Pique JM, Esplugues JV. Gastric mucosal resistance to acute injury in experimental portal hypertension.
Br. J. Pharmacol. 132: 309-317 (2001).
*
-
Calder PC. Polyunsaturated fatty acids, inflammation, and immunity.
Lipids 36: 1007-1024 (2001).
-
Caldwell SH, Bickston SJ. Cholangioscopy to screen for cholangiocarcinoma in primary sclerosing cholangitis.
Liver Transpl. 7: 380 (2001).
*
-
Caldwell SH, Hespenheide EE, Harris D, de Lange EE. Imaging and clinical characteristics of focal atrophy of segments 2 and 3 in primary sclerosing cholangitis.
J. Gastroenterol. Hepatol. 16: 220-224 (2001).
*
-
Caldwell SH, Hespenheide EE, Redick JA, Iezzoni JC, Battle EH, Sheppard BL. A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis.
Am. J. Gastroenterol. 96: 519-525 (2001).
*
-
Caliz R, Atsumi T, Kondeatis E, Amengual O, Khamashta MA, Vaughan RW, Lanchbury JS, Hughes GR. HLA class II gene polymorphisms in antiphospholipid syndrome: haplotype analysis in 83 Caucasoid patients.
Rheumatology (Oxford) 40: 31-36 (2001).
*
-
Camarena A, Juarez A, Mejia M, Estrada A, Carrillo G, Falfan R, Zuniga J, Navarro C, Granados J, Selman M. Major histocompatibility complex and tumor necrosis factor-alpha polymorphisms in pigeon breeder's disease.
Am. J. Respir. Crit. Care Med. 163: 1528-1533 (2001).
*
-
Cameron RG, Blendis LM, Neuman MG. Accumulation of macrophages in primary sclerosing cholangitis.
Clin. Biochem. 34: 195-201 (2001).
*
-
Campbell JD, Cook G, Robertson SE, Fraser A, Boyd KS, Gracie JA, Franklin IM. Suppression of IL-2-induced T cell proliferation and phosphorylation of STAT3 and STAT5 by tumor-derived TGF beta is reversed by IL-15.
J. Immunol. 167: 553-561 (2001).
*
-
Campbell JJ, Murphy KE, Kunkel EJ, Brightling CE, Soler D, Shen Z, Boisvert J, Greenberg HB, Vierra MA, Goodman SB, Genovese MC, Wardlaw AJ, Butcher EC, Wu L. CCR7 expression and memory T cell diversity in humans.
J. Immunol. 166: 877-884 (2001).
*
-
Campbell KS, Colonna M. Human natural killer cell receptors and signal transduction.
Int. Rev. Immunol. 20: 333-370 (2001).
-
Campbell WL, Peterson MS, Federle MP, Siqueira ES, Slivka A, Grazioli L, Ichikawa T, Oliver JH 3rd, Kim T, Li W. Using CT and cholangiography to diagnose biliary tract carcinoma complicating primary sclerosing cholangitis.
AJR Am. J. Roentgenol. 177: 1095-1100 (2001).
*
-
Campieri M, Gionchetti P. Bacteria as the cause of ulcerative colitis.
Gut 48: 132-135 (2001).
*
-
Capon F, Semprini S, Chimenti S, Fabrizi G, Zambruno G, Murgia S, Carcassi C, Fazio M, Mingarelli R, Dallapiccola B, Novelli G. Fine mapping of the PSORS4 psoriasis susceptibility region on chromosome 1q21.
J. Invest. Dermatol. 116: 728-730 (2001).
*
-
Capurso G, Lahner E, Marcheggiano A, Caruana P, Carnuccio A, Bordi C, Delle Fave G, Annibale B. Involvement of the corporal mucosa and related changes in gastric acid secretion characterize patients with iron deficiency anaemia associated with Helicobacter pylori infection.
Aliment. Pharmacol. Ther. 15: 1753-1761 (2001).
-
Cardenas A, Gines P. Pathogenesis and treatment of fluid and electrolyte imbalance in cirrhosis.
Semin. Nephrol. 21: 308-316 (2001).
-
Cardenas A, Gines P, Uriz J, Bessa X, Salmeron JM, Mas A, Ortega R, Calahorra B, De Las Heras D, Bosch J, Arroyo V, Rodes J. Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis.
Hepatology 34: 671-676 (2001).
*
-
Carr PD, Gustin SE, Church AP, Murphy JM, Ford SC, Mann DA, Woltring DM, Walker I, Ollis DL, Young IG. Structure of the complete extracellular domain of the common beta subunit of the human GM-CSF, IL-3, and IL-5 receptors reveals a novel dimer configuration.
Cell 104: 291-300 (2001).
*
-
Carramolino L, Zaballos A, Kremer L, Villares R, Martin P, Ardavín C, Martinez-A C, Marquez G. Expression of CCR9 beta-chemokine receptor is modulated in thymocyte differentiation and is selectively maintained in CD8(+) T cells from secondary lymphoid organs.
Blood 97: 850-857 (2001).
*
-
Carroccio A, Giannitrapani L, Soresi M, Not T, Iacono G, Di Rosa C, Panfili E, Notarbartolo A, Montalto G. Guinea pig transglutaminase immunolinked assay does not predict coeliac disease in patients with chronic liver disease.
Gut 49: 506-511 (2001).
*
-
Carter JD, Vasey FB. Psoriatic arthritis: genetics, immunology, and therapies.
J. Clin. Rheumatol. 7: 363-365 (2001).
-
Carter JD, Vasey FB, Kanik KS, Valeriano-Marcet J. Polymyalgia rheumatica and temporal arteritis with sacroiliitis and osteitis pubis.
J. Clin. Rheumatol. 7: 261-264 (2001).
-
Carter MJ, Di Giovine FS, Cox A, Goodfellow P, Jones S, Shorthouse AJ, Duff GW, Lobo AJ. The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis.
Gastroenterology 121: 805-811 (2001).
*
-
Carter MJ, di Giovine FS, Jones S, Mee J, Camp NJ, Lobo AJ, Duff GW. Association of the interleukin 1 receptor antagonist gene with ulcerative colitis in Northern European Caucasians.
Gut 48: 461-467 (2001).
*
-
Cascalho M, Platt JL. Xenotransplantation and other means of organ replacement.
Nat. Rev. Immunol. 1: 154-160 (2001).
*
-
Castaldo G, Fuccio A, Salvatore D, Raia V, Santostasi T, Leonardi S, Lizzi N, La Rosa M, Rigillo N, Salvatore F. Liver expression in cystic fibrosis could be modulated by genetic factors different from the cystic fibrosis transmembrane regulator genotype.
Am. J. Med. Genet. 98: 294-297 (2001).
*
-
Castellani C, Gomez Lira M, Frulloni L, Delmarco A, Marzari M, Bonizzato A, Cavallini G, Pignatti P, Mastella G. Analysis of the entire coding region of the cystic fibrosis transmembrane regulator gene in idiopathic pancreatitis.
Hum. Mutat. 18: 166 (2001).
*
-
Castellani C, Quinzii C, Altieri S, Mastella G, Assael BM. A pilot survey of cystic fibrosis clinical manifestations in CFTR mutation heterozygotes.
Genet. Test. 5: 249-254 (2001).
-
Castro F, Acevedo E, Ciusani E, Angulo JA, Wollheim FA, Sandberg-Wollheim M. Tumour necrosis factor microsatellites and HLA-DRB1*, HLA-DQA1*, and HLA-DQB1* alleles in Peruvian patients with rheumatoid arthritis.
Ann. Rheum. Dis. 60: 791-795 (2001).
*
-
Catella-Lawson F, Reilly MP, Kapoor SC, Cucchiara AJ, DeMarco S, Tournier B, Vyas SN, FitzGerald GA. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.
N. Engl. J. Med. 345: 1809-1817 (2001).
*
-
Cavallini G, Frulloni L. Autoimmunity and chronic pancreatitis: a concealed relationship.
JOP 2: 61-68 (2001).
*
-
Cavanaugh J; IBD International Genetics Consortium. International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn disease and chromosome 16.
Am. J. Hum. Genet. 68: 1165-1171 (2001).
*
-
Cavelier LB, Qiu Y, Bielicki JK, Afzal V, Cheng JF, Rubin EM. Regulation and activity of the human ABCA1 gene in transgenic mice.
J. Biol. Chem. 276: 18046-18051 (2001).
*
-
Cazzola R, Rondanelli M, Russo Volpe S, Barzaghi E, Ferrari E, Cestaro B. The hypocaloric balanced diet therapy and the supplementation with antioxidant and omega-3. What are the effects on the oxidative balance and erythrocytes membrane fluidity status?
Minerva Gastroenterol. Dietol. 47: 187-194 (2001).
-
Cerwenka A, Lanier LL. Natural killer cells, viruses and cancer.
Nat. Rev. Immunol. 1: 41-49 (2001).
*
-
Cetani F, Barbesino G, Borsari S, Pardi E, Cianferotti L, Pinchera A, Marcocci C. A novel mutation of the autoimmune regulator gene in an Italian kindred with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, acting in a dominant fashion and strongly cosegregating with hypothyroid autoimmune thyroiditis.
J. Clin. Endocrinol. Metab. 86: 4747-4752 (2001).
*
-
Chabaud M, Lubberts E, Joosten L, van Den Berg W, Miossec P. IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis.
Arthritis Res. 3: 168-177 (2001).
*
-
Chabaud M, Miossec P. The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model.
Arthritis Rheum. 44: 1293-1303 (2001).
*
-
Chabaud M, Page G, Miossec P. Enhancing effect of IL-1, IL-17, and TNF-alpha on macrophage inflammatory protein-3alpha production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines.
J. Immunol. 167: 6015-6020 (2001).
*
-
Chamberlin W, Graham DY, Hulten K, El-Zimaity HM, Schwartz MR, Naser S, Shafran I, El-Zaatari FA. Review article: Mycobacterium avium subsp. paratuberculosis as one cause of Crohn's disease.
Aliment. Pharmacol. Ther. 15: 337-346 (2001).
*
-
Chambers CA, Kuhns MS, Egen JG, Allison JP. CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy.
Annu. Rev. Immunol. 19: 565-594 (2001).
*
-
Chan AW, Butzner JD, McKenna R, Fritzler MJ. Tissue transglutaminase enzyme-linked immunosorbent assay as a screening test for celiac disease in pediatric patients.
Pediatrics 107: e8 (2001).
*
-
Chang TM. Bioencapsulated hepatocytes for experimental liver support.
J. Hepatol. 34: 148-149 (2001).
*
-
Changani KK, Jalan R, Cox IJ, Ala-Korpela M, Bhakoo K, Taylor-Robinson SD, Bell JD. Evidence for altered hepatic gluconeogenesis in patients with cirrhosis using in vivo 31-phosphorus magnetic resonance spectroscopy.
Gut 49: 557-564 (2001).
*
-
Chanson M, Berclaz PY, Scerri I, Dudez T, Wernke-Dollries K, Pizurki L, Pavirani A, Fiedler MA, Suter S. Regulation of gap junctional communication by a pro-inflammatory cytokine in cystic fibrosis transmembrane conductance regulator-expressing but not cystic fibrosis airway cells.
Am. J. Pathol. 158: 1775-1784 (2001).
*
-
Chapman MA. The role of the colonic flora in maintaining a healthy large bowel mucosa.
Ann. R. Coll. Surg. Engl. 83: 75-80 (2001).
-
Charlton M, Kasparova P, Weston S, Lindor K, Maor-Kendler Y, Wiesner RH, Rosen CB, Batts KP. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease.
Liver Transpl. 7: 608-614 (2001).
*
-
Chatterjee M. Vitamin D and genomic stability.
Mutat. Res. 475: 69-87 (2001).
-
Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ. Nuclear receptors and lipid physiology: opening the X-files.
Science 294: 1866-1870 (2001).
*
-
Chazouilleres O. Auto-immune biliary diseases.
Gastroenterol. Clin. Biol. 25: 113-116 (2001).
-
Cheema GS, Roschke V, Hilbert DM, Stohl W. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.
Arthritis Rheum. 44: 1313-1319 (2001).
*
-
Chen F, Ma L, Al-Ansari N, Shneider B. The role of AP-1 in the transcriptional regulation of the rat apical sodium-dependent bile acid transporter.
J. Biol. Chem. 276: 38703-38714 (2001).
*
-
Chen HL, Chang PS, Hsu HC, Lee JH, Ni YH, Hsu HY, Jeng YM, Chang MH. Progressive familial intrahepatic cholestasis with high gamma-glutamyltranspeptidase levels in Taiwanese infants: role of MDR3 gene defect?
Pediatr. Res. 50: 50-55 (2001).
*
-
Chen JM, Mercier B, Audrezet MP, Raguenes O, Quere I, Ferec C. Mutations of the pancreatic secretory trypsin inhibitor (PSTI) gene in idiopathic chronic pancreatitis.
Gastroenterology 120: 1061-1064 (2001).
*
-
Chen JM, Piepoli Bis A, Le Bodic L, Ruszniewski P, Robaszkiewicz M, Deprez PH, Raguenes O, Quere I, Andriulli A, Ferec C. Mutational screening of the cationic trypsinogen gene in a large cohort of subjects with idiopathic chronic pancreatitis.
Clin. Genet. 59: 189-193 (2001).
*
-
Chen NJ, Huang MW, Hsieh SL. Enhanced secretion of IFN-gamma by activated Th1 cells occurs via reverse signaling through TNF-related activation-induced cytokine.
J. Immunol. 166: 270-276 (2001).
*
-
Chen RT, Pless R, Destefano F. Epidemiology of autoimmune reactions induced by vaccination.
J. Autoimmun. 16: 309-318 (2001).
-
Chen W, Li D, Paulus B, Wilson I, Chadwick VS. High prevalence of Mycoplasma pneumoniae in intestinal mucosal biopsies from patients with inflammatory bowel disease and controls.
Dig. Dis. Sci. 46: 2529-2535 (2001).
*
-
Chen W, Owsley E, Yang Y, Stroup D, Chiang JY. Nuclear receptor-mediated repression of human cholesterol 7alpha-hydroxylase gene transcription by bile acids.
J. Lipid Res. 42: 1402-1412 (2001).
*
-
Cheng B, Zhao S, Luo J, Sprague E, Bonewald LF, Jiang JX. Expression of functional gap junctions and regulation by fluid flow in osteocyte-like MLO-Y4 cells.
J. Bone Miner. Res. 16: 249-259 (2001).
-
Cheng J, Tu Y, Li J, Huang C, Liu Z, Liu D. A study on the expression of interleukin (IL)-10 and IL-12 P35, P40 mRNA in the psoriatic lesions.
J. Tongji. Med. Univ. 21: 86-88 (2001).
-
Cheong KY, Allcock RJ, Eerligh P, Witt CS, Christiansen FT, McCann V, Price P. Localization of central MHC genes influencing type I diabetes.
Hum. Immunol. 62: 1363-1370 (2001).
-
Cherkaoui-Malki M, Meyer K, Cao WQ, Latruffe N, Yeldandi AV, Rao MS, Bradfield CA, Reddy JK. Identification of novel peroxisome proliferator-activated receptor alpha (PPARalpha) target genes in mouse liver using cDNA microarray analysis.
Gene Expr. 9: 291-304 (2001).
-
Chern CL, Huang RF, Chen YH, Cheng JT, Liu TZ. Folate deficiency-induced oxidative stress and apoptosis are mediated via homocysteine-dependent overproduction of hydrogen peroxide and enhanced activation of NF-kappaB in human Hep G2 cells.
Biomed. Pharmacother. 55: 434-442 (2001).
-
Cheung AM. Post-liver transplantation osteoporosis.
J. Hepatol. 34: 337-338 (2001).
*
-
Cheung RC, Cooper S, Keeffe EB. Endoscopic gastrointestinal manifestations of liver disease.
Gastrointest. Endosc. Clin. N. Am. 11: 15-44 (2001).
-
Chey WY. Infliximab for patients with refractory ulcerative colitis.
Inflamm. Bowel Dis. 7 Suppl. 1: S30-S33 (2001).
*
-
Chiang JY, Kimmel R, Stroup D. Regulation of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRalpha).
Gene 262: 257-265 (2001).
*
-
Chiappini E, Taccetti G, Campana S, Turchini S, Marianelli L. Anti-Pseudomonas aeruginosa antibodies, circulating immune complexes, and anticytoplasm antibodies of neutrophils in patients with cystic fibrosis with and without Pseudomonas aeruginosa colonization.
Pediatr. Med. Chir. 23: 27-30 (2001).
-
Chiba M, Yamano H, Fujiwara K, Abe T, Iizuka M, Watanabe S. Lymph folliculitis in ulcerative colitis.
Scand. J. Gastroenterol. 36: 332-336 (2001).
*
-
Chignard N, Mergey M, Veissiere D, Parc R, Capeau J, Poupon R, Paul A, Housset C. Bile acid transport and regulating functions in the human biliary epithelium.
Hepatology 33: 496-503 (2001).
*
-
Chinetti G, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wall.
Z. Kardiol. 90 Suppl. 3: 125-132 (2001).
-
Chisaki K, Nakajima T, Iwasawa K, Iida H, Matsumoto A, Tada M, Komatsu Y, Hirose K, Miyamoto K, Okuda Y, Shiratori Y, Goto A, Hirata Y, Nagai R, Omata M. Enhancement of endothelial nitric oxide production by chenodeoxycholic acids in patients with hepatobiliary diseases.
Jpn. Heart J. 42: 339-353 (2001).
*
-
Chistiakov DA, Savost'anov KV, Nosikov VV. CTLA4 gene polymorphisms are associated with, and linked to, insulin-dependent diabetes mellitus in a Russian population.
BMC Genet. 2: 6 (2001).
*
-
Chitturi S, Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis.
Semin. Liver Dis. 21: 27-41 (2001).
-
Chitturi S, Farrell GC. Drug-induced cholestasis.
Semin. Gastrointest. Dis. 12: 113-124 (2001).
-
Cho JH. Update on the genetics of inflammatory bowel disease.
Curr. Gastroenterol. Rep. 3: 458-463 (2001).
-
Cho JH. The Nod2 gene in Crohn's disease: implications for future research into the genetics and immunology of Crohn's disease.
Inflamm. Bowel Dis. 7: 271-275 (2001).
*
-
Choi HK, Liu S, Merkel PA, Colditz GA, Niles JL. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies.
J. Rheumatol. 28: 1584-1590 (2001).
-
Choi JY, Lee MG, Ko S, Muallem S. Cl(-)-dependent HCO3- transport by cystic fibrosis transmembrane conductance regulator.
JOP 2: S243-S246 (2001).
*
-
Choi JY, Muallem D, Kiselyov K, Lee MG, Thomas PJ, Muallem S. Aberrant CFTR-dependent HCO3- transport in mutations associated with cystic fibrosis.
Nature 410: 94-97 (2001).
*
-
Chomiki N, Voss JC, Warden CH. Structure-function relationships in UCP1, UCP2 and chimeras: EPR analysis and retinoic acid activation of UCP2.
Eur. J. Biochem. 268: 903-913 (2001).
*
-
Chou AH, Tsai HF, Lin LL, Hsieh SL, Hsu PI, Hsu PN. Enhanced proliferation and increased IFN-gamma production in T cells by signal transduced through TNF-related apoptosis-inducing ligand.
J. Immunol. 167: 1347-1352 (2001).
*
-
Chou SW. Cytomegalovirus drug resistance and clinical implications.
Transpl. Infect. Dis. 3 Suppl. 2: 20-24 (2001).
-
Christensen T, Sorensen PD, Hansen HJ, Moller-Larsen A. Endogenous retroviruses in multiple sclerosis.
Ugeskr. Laeger. 163: 297-301 (2001).
-
Christophe A, Robberecht E. Directed modification instead of normalization of fatty acid patterns in cystic fibrosis: an emerging concept.
Curr. Opin. Clin. Nutr. Metab. Care 4: 111-113 (2001).
-
Citarda F, Tomaselli G, Capocaccia R, Barcherini S, Crespi M; Italian Multicentre Study Group. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence.
Gut 48: 812-815 (2001).
*
-
Clapper ML, Chang WC, Meropol NJ. Chemoprevention of colorectal cancer.
Curr. Opin. Oncol. 13: 307-313 (2001).
-
Claria J, Rodes J. Sodium in preascitic cirrhosis: please pass the salt.
Gut 49: 748-749 (2001).
*
-
Clarke LL, Stien X, Walker NM. Intestinal bicarbonate secretion in cystic fibrosis mice.
JOP 2: S263-S267 (2001).
*
-
Clarke SD. Nonalcoholic steatosis and steatohepatitis. I. Molecular mechanism for polyunsaturated fatty acid regulation of gene transcription.
Am. J. Physiol. Gastrointest. Liver Physiol. 281: G865-G869 (2001).
*
-
Claudel T, Leibowitz MD, Fievet C, Tailleux A, Wagner B, Repa JJ, Torpier G, Lobaccaro JM, Paterniti JR, Mangelsdorf DJ, Heyman RA, Auwerx J. Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor.
Proc. Natl. Acad. Sci. U.S.A. 98: 2610-2615 (2001).
*
-
Cohen P. Murine models of immunodeficiency and autoimmune disease.
Curr. Protoc. Immunol. Appendix 1: Appendix 1E (2001).
-
Cohen RD. Efficacy and safety of repeated infliximab infusions for Crohn's disease: 1-year clinical experience.
Inflamm. Bowel Dis. 7 Suppl. 1: S17-S22 (2001).
*
-
Collett ED, Davidson LA, Fan YY, Lupton JR, Chapkin RS. n-6 and n-3 polyunsaturated fatty acids differentially modulate oncogenic Ras activation in colonocytes.
Am. J. Physiol. Cell. Physiol. 280: C1066-C1075 (2001).
*
-
Collins RW, Harmer AW, Heads AJ, Kondeatis E, Page G, Vaughan RW. The clinical importance of variation within the HLA-Bw4 complex.
Transplantation 72: 1851-1853 (2001).
-
Colombel JF, Rutgeerts P, Malchow H, Jacyna M, Nielsen OH, Rask-Madsen J, Van Deventer S, Ferguson A, Desreumaux P, Forbes A, Geboes K, Melani L, Cohard M. Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease.
Gut 49: 42-46 (2001).
*
-
Colon AL, Menchen LA, Hurtado O, De Cristobal J, Lizasoain I, Leza JC, Lorenzo P, Moro MA. Implication of TNF-alpha convertase (TACE/ADAM17) in inducible nitric oxide synthase expression and inflammation in an experimental model of colitis.
Cytokine 16: 220-226 (2001).
-
Colville-Nash PR, Gilroy DW. Potential adverse effects of cyclooxygenase-2 inhibition: evidence from animal models of inflammation.
BioDrugs 15: 1-9 (2001).
-
Compher CW, Kinosian BP, Evans-Stoner N, Huzinec J, Buzby GP. Hyperhomocysteinemia is associated with venous thrombosis in patients with short bowel syndrome.
JPEN J. Parenter. Enteral Nutr. 25: 1-7 (2001).
-
Cong Y, Oliver AO, Elson CO. Effects of cholera toxin on macrophage production of co-stimulatory cytokines.
Eur. J. Immunol. 31: 64-71 (2001).
*
-
Connolly MK. Sjogren's syndrome.
Semin. Cutan. Med. Surg. 20: 46-52 (2001).
-
Conrad S, Kauffmann HM, Ito K, Deeley RG, Cole SP, Schrenk D. Identification of human multidrug resistance protein 1 (MRP1) mutations and characterization of a G671V substitution.
J. Hum. Genet. 46: 656-663 (2001).
-
Constantin A, Navaux F, Lauwers-Cances V, Abbal M, van Meerwijk JP, Mazieres B, Cambon-Thomsen A, Cantagrel A. Interferon gamma gene polymorphism and susceptibility to, and severity of, rheumatoid arthritis.
Lancet 358: 2051-2052 (2001).
*
-
Contos MJ, Cales W, Sterling RK, Luketic VA, Shiffman ML, Mills AS, Fisher RA, Ham J, Sanyal AJ. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.
Liver Transpl. 7: 363-373 (2001).
*
-
Cooke EL, Uings IJ, Xia CL, Woo P, Ray KP. Functional analysis of the interleukin-1-receptor-associated kinase (IRAK-1) in interleukin-1 beta-stimulated nuclear factor kappa B (NF-kappa B) pathway activation: IRAK-1 associates with the NF-kappa B essential modulator (NEMO) upon receptor …
Biochem. J. 359: 403-410 (2001).
*
-
Cooke GS, Hill AV. Genetics of susceptibility to human infectious disease.
Nat. Rev. Genet. 2: 967-977 (2001).
*
-
Cookson WO, Ubhi B, Lawrence R, Abecasis GR, Walley AJ, Cox HE, Coleman R, Leaves NI, Trembath RC, Moffatt MF, Harper JI. Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci.
Nat. Genet. 27: 372-373 (2001).
*
-
Corfield AP, Carroll D, Myerscough N, Probert CS. Mucins in the gastrointestinal tract in health and disease.
Front. Biosci. 6: D1321-D1357 (2001).
-
Cornillie F, Shealy D, D'Haens G, Geboes K, Van Assche G, Ceuppens J, Wagner C, Schaible T, Plevy SE, Targan SR, Rutgeerts P. Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease.
Aliment. Pharmacol. Ther. 15: 463-473 (2001).
*
-
Corpechot C, Benlian P, Barbu V, Chazouilleres O, Poupon RE, Poupon R. Apolipoprotein E polymorphism, a marker of disease severity in primary biliary cirrhosis?
J. Hepatol. 35: 324-328 (2001).
*
-
Corrao G, Zambon A, Bagnardi V, D'Amicis A, Klatsky A; Collaborative SIDECIR Group. Coffee, caffeine, and the risk of liver cirrhosis.
Ann. Epidemiol. 11: 458-465 (2001).
-
Correia L, Podevin P, Borderie D, Verthier N, Montet JC, Feldmann G, Poupon R, Weill B, Calmus Y. Effects of bile acids on the humoral immune response: a mechanistic approach.
Life Sci. 69: 2337-2348 (2001).
-
Costabel U. Sarcoidosis: clinical update.
Eur. Respir. J. Suppl. 32: 56s-68s (2001).
*
-
Costello P, FitzGerald O. Disease mechanisms in psoriasis and psoriatic arthritis.
Curr. Rheumatol. Rep. 3: 419-427 (2001).
-
Cotler SJ, Jakate S, Jensen DM. Resolution of cirrhosis in autoimmune hepatitis with corticosteroid therapy.
J. Clin. Gastroenterol. 32: 428-430 (2001).
-
Cott J, Hibbeln JR. Lack of seasonal mood change in Icelanders.
Am. J. Psychiatry 158: 328 (2001).
*
-
Coulie B, Camilleri M, Bharucha AE, Sandborn WJ, Burton D. Colonic motility in chronic ulcerative proctosigmoiditis and the effects of nicotine on colonic motility in patients and healthy subjects.
Aliment. Pharmacol. Ther. 15: 653-663 (2001).
*
-
Courtois G, Smahi A, Israel A. NEMO/IKK gamma: linking NF-kappa B to human disease.
Trends Mol. Med. 7: 427-430 (2001).
*
-
Coussens PM. Mycobacterium paratuberculosis and the bovine immune system.
Anim. Health Res. Rev. 2: 141-161 (2001).
-
Cowan MJ, Gladwin MT, Shelhamer JH. Disorders of ciliary motility.
Am. J. Med. Sci. 321: 3-10 (2001).
-
Cox FE. Concomitant infections, parasites and immune responses.
Parasitology 122: S23-S38 (2001).
-
Cox NJ, Wapelhorst B, Morrison VA, Johnson L, Pinchuk L, Spielman RS, Todd JA, Concannon P. Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families.
Am. J. Hum. Genet. 69: 820-830 (2001).
*
-
Crabb DW, Pinaire J, Chou WY, Sissom S, Peters JM, Harris RA, Stewart M. Peroxisome proliferator-activated receptors (PPAR) and the mitochondrial aldehyde dehydrogenase (ALDH2) promoter in vitro and in vivo.
Alcohol Clin. Exp. Res. 25: 945-952 (2001).
-
Crabb DW, Pinairs J, Hasanadka R, Fang M, Leo MA, Lieber CS, Tsukamoto H, Motomura K, Miyahara T, Ohata M, Bosron W, Sanghani S, Kedishvili N, Shiraishi H, Yokoyama H, Miyagi M, Ishii H, Bergheim I, Menzl I, Parlesak A, Bode C. Alcohol and retinoids.
Alcohol Clin. Exp. Res. 25 (5 Suppl. ISBRA): 207S-217S (2001).
-
Craggs A, Welfare M, Donaldson PT, Mansfield JC. The CC chemokine receptor 5 delta32 mutation is not associated with inflammatory bowel disease (IBD) in NE England.
Genes Immun. 2: 114-116 (2001).
*
-
Craggs A, West S, Curtis A, Welfare M, Hudson M, Donaldson P, Mansfield J. Absence of a genetic association between IL-1RN and IL-1B gene polymorphisms in ulcerative colitis and Crohn disease in multiple populations from northeast England.
Scand. J. Gastroenterol. 36: 1173-1178 (2001).
*
-
Craig TA, Benson LM, Naylor S, Kumar R. Modulation effects of zinc on the formation of vitamin D receptor and retinoid X receptor alpha-DNA transcription complexes: analysis by microelectrospray mass spectrometry.
Rapid Commun. Mass Spectrom. 15: 1011-1016 (2001).
-
Craven NM, Jackson CW, Kirby B, Perrey C, Pravica V, Hutchinson IV, Griffiths CE. Cytokine gene polymorphisms in psoriasis.
Br. J. Dermatol. 144: 849-853 (2001).
*
-
Critch J, Griffiths AM. Getting the NOD to move ahead.
Pediatr. Res. 50: 431-432 (2001).
*
-
Criton S, Sofia B. Acute generalised exanthematous pustulosis.
Indian J. Dermatol. Venereol. Leprol. 67: 93-95 (2001).
*
-
Crocenzi FA, Sanchez Pozzi EJ, Pellegrino JM, Favre CO, Rodriguez Garay EA, Mottino AD, Coleman R, Roma MG. Beneficial effects of silymarin on estrogen-induced cholestasis in the rat: a study in vivo and in isolated hepatocyte couplets.
Hepatology 34: 329-339 (2001).
*
-
Crosdale DJ, Poulton KV, Ollier WE, Thomson W, Denning DW. Mannose-binding lectin gene polymorphisms as a susceptibility factor for chronic necrotizing pulmonary aspergillosis.
J. Infect. Dis. 184: 653-656 (2001).
*
-
Csaszar A, Abel T. Receptor polymorphisms and diseases.
Eur. J. Pharmacol. 414: 9-22 (2001).
*
-
Cucca F, Dudbridge F, Loddo M, Mulargia AP, Lampis R, Angius E, De Virgiliis S, Koeleman BP, Bain SC, Barnett AH, Gilchrist F, Cordell H, Welsh K, Todd JA. The HLA-DPB1-associated component of the IDDM1 and its relationship to the major loci HLA-DQB1, -DQA1, and -DRB1.
Diabetes 50: 1200-1205 (2001).
*
-
Cucca F, Lampis R, Congia M, Angius E, Nutland S, Bain SC, Barnett AH, Todd JA. A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins.
Hum. Mol. Genet. 10: 2025-2037 (2001).
*
-
Cucino C, Sonnenberg A. The comorbid occurrence of other diagnoses in patients with ulcerative colitis and Crohn's disease.
Am. J. Gastroenterol. 96: 2107-2112 (2001).
*
-
Cucino C, Sonnenberg A. Cause of death in patients with inflammatory bowel disease.
Inflamm. Bowel Dis. 7: 250-255 (2001).
*
-
Cuenca J, Perez CA, Aguirre AJ, Schiattino I, Aguillon JC. Genetic polymorphism at position-308 in the promoter region of the tumor necrosis factor (TNF): implications of its allelic distribution on susceptibility or resistance to diseases in the Chilean population.
Biol. Res. 34: 237-241 (2001).
-
Cuffari C, Hunt S, Bayless T. Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease.
Gut 48: 642-646 (2001).
*
-
Cui Y, Konig J, Keppler D. Vectorial transport by double-transfected cells expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2.
Mol. Pharmacol. 60: 934-943 (2001).
*
-
Cui Y, Konig J, Leier I, Buchholz U, Keppler D. Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6.
J. Biol. Chem. 276: 9626-9630 (2001).
*
-
Cullen S, Chapman R. Aetiopathogenesis of primary sclerosing cholangitis.
Best Pract. Res. Clin. Gastroenterol. 15: 577-589 (2001).
*
-
Cunliffe RN, Rose FR, Keyte J, Abberley L, Chan WC, Mahida YR. Human defensin 5 is stored in precursor form in normal Paneth cells and is expressed by some villous epithelial cells and by metaplastic Paneth cells in the colon in inflammatory bowel disease.
Gut 48: 176-185 (2001).
*
-
Cunningham-Rundles C. Physiology of IgA and IgA deficiency.
J. Clin. Immunol. 21: 303-309 (2001).
*
-
Cunningham-Rundles S. Nutrition and the mucosal immune system.
Curr. Opin. Gastroenterol. 17: 171-176 (2001).
-
Cuoco L, Cammarota G, Jorizzo RA, Santarelli L, Cianci R, Montalto M, Gasbarrini A, Gasbarrini G. Link between Helicobacter pylori infection and iron-deficiency anaemia in patients with coeliac disease.
Scand. J. Gastroenterol. 36: 1284-1288 (2001).
-
Curreli S, Romerio F, Mirandola P, Barion P, Bemis K, Zella D. Human primary CD4 + T cells activated in the presence of IFN-alpha 2b express functional indoleamine 2,3-dioxygenase.
J. Interferon Cytokine Res. 21: 431-437 (2001).
-
Currie CG, McCallum K, Poxton IR. Mucosal and systemic antibody responses to the lipopolysaccharide of Escherichia coli O157 in health and disease.
J. Med. Microbiol. 50: 345-354 (2001).
*
-
Cuskelly GJ, Stacpoole PW, Williamson J, Baumgartner TG, Gregory JF 3rd. Deficiencies of folate and vitamin B(6) exert distinct effects on homocysteine, serine, and methionine kinetics.
Am. J. Physiol. Endocrinol. Metab. 281: E1182-E1190 (2001).
*
-
Cuthbert AW. Bicarbonate secretion in the murine gallbladder - lessons for the treatment of cystic fibrosis.
JOP 2: S257-S262 (2001).
*
-
Cuzzocrea S, McDonald MC, Mazzon E, Mota-Filipe H, Centorrino T, Terranova ML, Ciccolo A, Britti D, Caputi AP, Thiemermann C. Calpain inhibitor I reduces colon injury caused by dinitrobenzene sulphonic acid in the rat.
Gut 48: 478-488 (2001).
*
-
Czaja AJ. Autoimmune liver disease.
Curr. Opin. Gastroenterol. 17: 268-275 (2001).
-
Czaja AJ. Understanding the pathogenesis of autoimmune hepatitis.
Am. J. Gastroenterol. 96: 1224-1231 (2001).
*
-
Czaja AJ, Carpenter HA. Autoimmune hepatitis with incidental histologic features of bile duct injury.
Hepatology 34: 659-665 (2001).
*
-
Czaja AJ, Homburger HA. Autoantibodies in liver disease.
Gastroenterology 120: 239-249 (2001).
*
-
Czaja AJ, Santrach PJ, Breanndan Moore S. Shared genetic risk factors in autoimmune liver disease.
Dig. Dis. Sci. 46: 140-147 (2001).
*
-
D'Adamo PJ, Kelly GS. Metabolic and immunologic consequences of ABH secretor and Lewis subtype status.
Altern. Med. Rev. 6: 390-405 (2001).
*
-
D'Addio F, Giunta R, Scarfiglieri D, De Fanis U, Dalla Mora L, Pezone L, Bresciano E, Mancino D, Lucivero G. Late onset immunodeficiency with hypo-IgG and hyper-IgM, T CD4+ lymphocytopenia and vitiligo.
Recenti Prog. Med. 92: 392-394 (2001).
-
D'Odorico A, Bortolan S, Cardin R, D'Inca' R, Martines D, Ferronato A, Sturniolo GC. Reduced plasma antioxidant concentrations and increased oxidative DNA damage in inflammatory bowel disease.
Scand. J. Gastroenterol. 36: 1289-1294 (2001).
-
D'Souza R, MacFadyen RJ, Kerr F, Peacock A, Steven MM. Lessons to be learned: a case study approach a case study of the temporal onset of pulmonary hypertension with pre-existent cirrhotic portal hypertension.
J. R. Soc. Health 121: 257-261 (2001).
-
da Rosa Utiyama SR, da Silva Kotze LM, Nisihara RM, Carvalho RF, de Carvalho EG, de Sena MG, de Messias Reason IJ. Spectrum of autoantibodies in celiac patients and relatives.
Dig. Dis. Sci. 46: 2624-2630 (2001).
*
-
Dagher L, Moore K. The hepatorenal syndrome.
Gut 49: 729-737 (2001).
*
-
Dai KZ, Harbo HF, Celius EG, Oturai A, Sorensen PS, Ryder LP, Datta P, Svejgaard A, Hillert J, Fredrikson S, Sandberg-Wollheim M, Laaksonen M, Myhr KM, Nyland H, Vartdal F, Spurkland A. The T cell regulator gene SH2D2A contributes to the genetic susceptibility of multiple sclerosis.
Genes Immun. 2: 263-268 (2001).
*
-
Dai Y, Xu C, Holmberg M, Oturai A, Fredrikson S, Sandberg-Wollheim M, Laaksonen M, Spurkland A, Myhr KM, Ryder LP, Sorensen PS, Svejgaard A, Hillert J. Linkage analysis suggests a region of importance for multiple sclerosis in 3p14-13.
Genes Immun. 2: 451-454 (2001).
*
-
Dalwadi H, Wei B, Kronenberg M, Sutton CL, Braun J. The Crohn's disease-associated bacterial protein I2 is a novel enteric T cell superantigen.
Immunity 15: 149-158 (2001).
*
-
Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, Lander ES. High-resolution haplotype structure in the human genome.
Nat. Genet. 29: 229-232 (2001).
*
-
Danchenko E, Petermann H, Chirkin A, Dargel R. Effect of bile acids on the proliferative activity and apoptosis of rat hepatocytes.
Exp. Toxicol. Pathol. 53: 227-233 (2001).
-
Danchenko EO. Effects of bile acid preparations on DNA biosynthesis, apoptosis, and necrosis in hepatocytes in vitro.
Vopr. Med. Khim. 47: 236-242 (2001).
-
Dassopoulos T. Diagnostic methodologies: serology, endoscopy, and radiology.
Curr. Gastroenterol. Rep. 3: 491-499 (2001).
-
Dauncey MJ, White P, Burton KA, Katsumata M. Nutrition-hormone receptor-gene interactions: implications for development and disease.
Proc. Nutr. Soc. 60: 63-72 (2001).
-
Davey HW, Xie T, McLachlan MJ, Wilkins RJ, Waxman DJ, Grattan DR. STAT5b is required for GH-induced liver IGF-I gene expression.
Endocrinology 142: 3836-3841 (2001).
*
-
Davidson A, Diamond B. Autoimmune diseases.
N. Engl. J. Med. 345: 340-350 (2001).
*
-
Davidson DJ, Dorin JR. The CF mouse: an important tool for studying cystic fibrosis.
Expert Rev. Mol. Med. 3: 1-27 (2001).
*
-
Davidson DJ, Rolfe M. Mouse models of cystic fibrosis.
Trends Genet. 17: S29-S37 (2001).
*
-
Davis RL, Bohlke K. Measles vaccination and inflammatory bowel disease: controversy laid to rest?
Drug Saf. 24: 939-946 (2001).
-
Davis RL, Kramarz P, Bohlke K, Benson P, Thompson RS, Mullooly J, Black S, Shinefield H, Lewis E, Ward J, Marcy SM, Eriksen E, Destefano F, Chen R; Vaccine Safety Datalink Team. Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the Vaccine Safety Datalink project.
Arch. Pediatr. Adolesc. Med. 155: 354-359 (2001).
*
-
De Cat B, David G. Developmental roles of the glypicans.
Semin. Cell Dev. Biol. 12: 117-125 (2001).
*
-
De Fabiani E, Mitro N, Anzulovich AC, Pinelli A, Galli G, Crestani M. The negative effects of bile acids and tumor necrosis factor-alpha on the transcription of cholesterol 7alpha-hydroxylase gene (CYP7A1) converge to hepatic nuclear factor-4: a novel mechanism of feedback regulation of bile acid synthesis…
J. Biol. Chem. 276: 30708-30716 (2001).
*
-
de Jong D, Mulder CJ, van Sorge AA. Why measure thiopurine methyltransferase activity? Direct administration of 6-thioguanine might be the alternative for 6-mercaptopurine or azathioprine.
Gut 49: 874 (2001).
*
-
de Seze J, Dubucquoi S, Lefranc D, Virecoulon F, Nuez I, Dutoit V, Vermersch P, Prin L. IgG reactivity against citrullinated myelin basic protein in multiple sclerosis.
J. Neuroimmunol. 117: 149-155 (2001).
-
Dean M, Allikmets R. Complete characterization of the human ABC gene family.
J. Bioenerg. Biomembr. 33: 475-479 (2001).
*
-
Dean M, Hamon Y, Chimini G. The human ATP-binding cassette (ABC) transporter superfamily.
J. Lipid Res. 42: 1007-1017 (2001).
*
-
Dean M, Rzhetsky A, Allikmets R. The human ATP-binding cassette (ABC) transporter superfamily.
Genome Res. 11: 1156-1166 (2001).
*
-
Dear KL, Compston JE, Hunter JO. Treatments for Crohn's disease that minimise steroid doses are associated with a reduced risk of osteoporosis.
Clin. Nutr. 20: 541-546 (2001).
-
Debril MB, Renaud JP, Fajas L, Auwerx J. The pleiotropic functions of peroxisome proliferator-activated receptor gamma.
J. Mol. Med. 79: 30-47 (2001).
*
-
Dechairo B, Dimon C, van Heel D, Mackay I, Edwards M, Scambler P, Jewell D, Cardon L, Lench N, Carey A. Replication and extension studies of inflammatory bowel disease susceptibility regions confirm linkage to chromosome 6p (IBD3).
Eur. J. Hum. Genet. 9: 627-633 (2001).
*
-
DeCicco KL, Youngdahl JD, Ross AC. All-trans-retinoic acid and polyriboinosinic : polyribocytidylic acid in combination potentiate specific antibody production and cell-mediated immunity.
Immunology 104: 341-348 (2001).
*
-
Decker GA, Loftus EV Jr, Pasha TM, Tremaine WJ, Sandborn WJ. Crohn's disease of the esophagus: clinical features and outcomes.
Inflamm. Bowel Dis. 7: 113-119 (2001).
*
-
Dejaco C, Mittermaier C, Reinisch W, Gasche C, Waldhoer T, Strohmer H, Moser G. Azathioprine treatment and male fertility in inflammatory bowel disease.
Gastroenterology 121: 1048-1053 (2001).
*
-
Dejica D. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
Roum. Arch. Microbiol. Immunol. 60: 183-201 (2001).
-
del Mar Cabrera M, Valle J, Pajares JM, Romero I, Zomeno M, Mate J. Expression of the Kp43 (CD 94) receptor by natural killer (NK) cells in ulcerative colitis.
Hepatogastroenterology 48: 1316-1320 (2001).
-
Del Puppo M, Galli Kienle M, Crosignani A, Petroni ML, Amati B, Zuin M, Podda M. Cholesterol metabolism in primary biliary cirrhosis during simvastatin and UDCA administration.
J. Lipid Res. 42: 437-441 (2001).
*
-
Delanghe JR, Langlois MR. Hemopexin: a review of biological aspects and the role in laboratory medicine.
Clin. Chim. Acta 312: 13-23 (2001).
*
-
Delerive P, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors in inflammation control.
J. Endocrinol. 169: 453-459 (2001).
*
-
Delomenie C, Fouix S, Longuemaux S, Brahimi N, Bizet C, Picard B, Denamur E, Dupret JM. Identification and functional characterization of arylamine N-acetyltransferases in eubacteria: evidence for highly selective acetylation of 5-aminosalicylic acid.
J. Bacteriol. 183: 3417-3427 (2001).
*
-
Deloukas P, Matthews LH, Ashurst J, Burton J, Gilbert JG, Jones M, Stavrides G et al. The DNA sequence and comparative analysis of human chromosome 20.
Nature 414: 865-871 (2001).
*
-
Deltenre P, Denninger MH, Hillaire S, Guillin MC, Casadevall N, Briere J, Erlinger S, Valla DC. Factor V Leiden related Budd-Chiari syndrome.
Gut 48: 264-268 (2001).
*
-
Deluca HF, Cantorna MT. Vitamin D: its role and uses in immunology.
FASEB J. 15: 2579-2585 (2001).
*
-
Demerjian N, Brocq O, Chiaverini C, Schneider SM, Rampal P, Hebuterne X. Atrophic polychondritis associated with ulcerative colitis.
Gastroenterol. Clin. Biol. 25: 310-312 (2001).
-
Demols A, Van Laethem JL, Gay F, Franchimont D, Adler M, Van Gossum A. Individual screening for colorectal cancer: which strategy for which patient?
Rev. Med. Brux. 22: A203-A209 (2001).
-
Dempke W, Rie C, Grothey A, Schmoll HJ. Cyclooxygenase-2: a novel target for cancer chemotherapy?
J. Cancer Res. Clin. Oncol. 127: 411-417 (2001).
*
-
Denson LA, Sturm E, Echevarria W, Zimmerman TL, Makishima M, Mangelsdorf DJ, Karpen SJ. The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp.
Gastroenterology 121: 140-147 (2001).
*
-
Denys A, Hichami A, Khan NA. Eicosapentaenoic acid and docosahexaenoic acid modulate MAP kinase (ERK1/ERK2) signaling in human T cells.
J. Lipid Res. 42: 2015-2020 (2001).
*
-
Deplancke B, Gaskins HR. Microbial modulation of innate defense: goblet cells and the intestinal mucus layer.
Am. J. Clin. Nutr. 73: 1131S-1141S (2001).
*
-
Depoix C, Delmotte MH, Formstecher P, Lefebvre P. Control of retinoic acid receptor heterodimerization by ligand-induced structural transitions. A novel mechanism of action for retinoid antagonists.
J. Biol. Chem. 276: 9452-9459 (2001).
*
-
Depoortere I. Motilin and motilin receptors: characterization and functional significance.
Verh. K. Acad. Geneeskd. Belg. 63: 511-529 (2001).
-
Derijk RH, Schaaf MJ, Turner G, Datson NA, Vreugdenhil E, Cidlowski J, de Kloet ER, Emery P, Sternberg EM, Detera-Wadleigh SD. A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis.
J. Rheumatol. 28: 2383-2388 (2001).
-
Desreumaux P. New inflammatory bowel disease drugs targeting the inflammatory cascade.
Gastroenterol. Clin. Biol. 25: B72-B78 (2001).
-
Desreumaux P, Dubuquoy L, Nutten S, Peuchmaur M, Englaro W, Schoonjans K, Derijard B, Desvergne B, Wahli W, Chambon P, Leibowitz MD, Colombel JF, Auwerx J. Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies.
J. Exp. Med. 193: 827-838 (2001).
*
-
DeStefano F, Mullooly JP, Okoro CA, Chen RT, Marcy SM, Ward JI, Vadheim CM, Black SB, Shinefield HR, Davis RL, Bohlke K; Vaccine Safety Datalink Team. Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus.
Pediatrics 108: e112 (2001).
*
-
Deurloo DT, van Esch BC, Hofstra CL, Nijkamp FP, van Oosterhout AJ. CTLA4-IgG reverses asthma manifestations in a mild but not in a more "severe" ongoing murine model.
Am. J. Respir. Cell. Mol. Biol. 25: 751-760 (2001).
*
-
Deutsch GH, Sokol RJ, Stathos TH, Knisely AS. Proliferation to paucity: evolution of bile duct abnormalities in a case of Alagille syndrome.
Pediatr. Dev. Pathol. 4: 559-563 (2001).
-
Devaux Y, Seguin C, Grosjean S, de Talance N, Schwartz M, Burlet A, Zannad F, Meistelman C, Mertes PM, Ungureanu-Longrois D. Retinoic acid and lipopolysaccharide act synergistically to increase prostanoid concentrations in rats in vivo.
J. Nutr. 131: 2628-2635 (2001).
*
-
Dewandel P, Schraepen T, Vanbeckevoort D, Geboes K, Delvaux V, Gevers A, Aerts R, Ponette E. Colitis cystica profunda.
JBR-BTR 84: 111-113 (2001).
-
Di Cesare E, Previti M, Lombardo F, Di Benedetto A, Mazzu N, Romano G, De Luca F, Lasco A, Cucinotta D. Serum anti-p53 autoantibodies in patients with type 1 diabetes.
Ann. Clin. Lab. Sci. 31: 253-258 (2001).
-
Di Paolo MC, Paoluzi OA, Pica R, Iacopini F, Crispino P, Rivera M, Spera G, Paoluzi P. Sulphasalazine and 5-aminosalicylic acid in long-term treatment of ulcerative colitis: report on tolerance and side-effects.
Dig. Liver Dis. 33: 563-569 (2001).
-
Di Pierro M, Lu R, Uzzau S, Wang W, Margaretten K, Pazzani C, Maimone F, Fasano A. Zonula occludens toxin structure-function analysis. Identification of the fragment biologically active on tight junctions and of the zonulin receptor binding domain.
J. Biol. Chem. 276: 19160-19165 (2001).
*
-
Di Sabatino A, Ciccocioppo R, D'Alo S, Parroni R, Millimaggi D, Cifone MG, Corazza GR. Intraepithelial and lamina propria lymphocytes show distinct patterns of apoptosis whereas both populations are active in Fas based cytotoxicity in coeliac disease.
Gut 49: 380-386 (2001).
*
-
Di Sabatino A, Corazza GR. Surviving too long in Crohn's disease.
Gut 49: 6-8 (2001).
*
-
Di Sario A, Svegliati Baroni G, Bendia E, Ridolfi F, Saccomanno S, Ugili L, Trozzi L, Marzioni M, Jezequel AM, Macarri G, Benedetti A. Intracellular pH regulation and Na+/H+ exchange activity in human hepatic stellate cells: effect of platelet-derived growth factor, insulin-like growth factor 1 and insulin.
J. Hepatol. 34: 378-385 (2001).
-
Di Sebastiano P, di Mola FF, Artese L, Rossi C, Mascetta G, Pernthaler H, Innocenti P. Beneficial effects of Batimastat (BB-94), a matrix metalloproteinase inhibitor, in rat experimental colitis.
Digestion 63: 234-239 (2001).
-
Diav-Citrin O, Shechtman S, Gotteiner T, Arnon J, Ornoy A. Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study.
Teratology 63: 186-192 (2001).
-
Diefenbach A, Raulet DH. Strategies for target cell recognition by natural killer cells.
Immunol. Rev. 181: 170-184 (2001).
*
-
Diekman MJ, van der Put NM, Blom HJ, Tijssen JG, Wiersinga WM. Determinants of changes in plasma homocysteine in hyperthyroidism and hypothyroidism.
Clin. Endocrinol. (Oxf.) 54: 197-204 (2001).
*
-
Dietrich CG, Ottenhoff R, de Waart DR, Oude Elferink RP. Role of MRP2 and GSH in intrahepatic cycling of toxins.
Toxicology 167: 73-81 (2001).
*
-
Dignass AU. Mechanisms and modulation of intestinal epithelial repair.
Inflamm. Bowel Dis. 7: 68-77 (2001).
*
-
Diks SH, van Deventer SJ, Peppelenbosch MP. Lipopolysaccharide recognition, internalisation, signalling and other cellular effects.
J. Endotoxin Res. 7: 335-348 (2001).
*
-
DiMagno EP. Gene mutations and idiopathic chronic pancreatitis: clinical implications and testing.
Gastroenterology 121: 1508-1512 (2001).
-
Ding H, Cheng H, Fu Z, Yan L, Yang G. Relationship of large multifunctional proteasome 7 gene polymorphism with susceptibility to type 1 diabetes mellitus and DR3 gene.
Chin. Med. J. (Engl.) 114: 1263-1266 (2001).
-
Ding J, Woo JT, Nagai K. The effects of retinoic acid on reversing the adipocyte differentiation into an osteoblastic tendency in ST2 cells, a murine bone marrow-derived stromal cell line.
Cytotechnology 36: 125-136 (2001).
*
-
Diwakar V, Pearson L, Beath S. Liver disease in children with cystic fibrosis.
Paediatr. Respir. Rev. 2: 340-349 (2001).
-
Djilali-Saiah I, Ouellette P, Caillat-Zucman S, Debray D, Kohn JI, Alvarez F. CTLA-4/CD 28 region polymorphisms in children from families with autoimmune hepatitis.
Hum. Immunol. 62: 1356-1362 (2001).
-
Doffinger R, Smahi A, Bessia C, Geissmann F, Feinberg J, Durandy A, Bodemer C, Kenwrick S, Dupuis-Girod S, Blanche S, Wood P, Rabia SH, Headon DJ, Overbeek PA, Le Deist F, Holland SM, Belani K, Kumararatne DS, Fischer A, Shapiro R, Conley ME, et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling.
Nat. Genet. 27: 277-285 (2001).
*
-
Doherty DG, O'Farrelly C. Dendritic cells: regulators of hepatic immunity or tolerance?
J. Hepatol. 34: 156-160 (2001).
*
-
Dohmen K. Primary biliary cirrhosis and pernicious anemia.
J. Gastroenterol. Hepatol. 16: 1316-1318 (2001).
*
-
Domagk D, Bisping G, Poremba C, Fegeler W, Domschke W, Menzel J. Common bile duct obstruction due to candidiasis.
Scand. J. Gastroenterol. 36: 444-446 (2001).
-
Dominguez Ortega J, Trindade C, Alonso Llamazares A, Castellano Bravo A, Cimarra Alvarez-Lovel M, Martinez-Cocera C. Hypersensitivity to allopurinol. Efficacy of a desensitizing protocol in 3 cases.
An. Med. Interna. 18: 27-28 (2001).
-
Donaldson P, Agarwal K, Craggs A, Craig W, James O, Jones D. HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility.
Gut 48: 397-402 (2001).
*
-
Donaldson PT, Norris S. Immunogenetics in PSC.
Best Pract. Res. Clin. Gastroenterol. 15: 611-627 (2001).
*
-
Donner MG, Keppler D. Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver.
Hepatology 34: 351-359 (2001).
*
-
Dotan I, Hallak A, Arber N, Santo M, Alexandrowitz A, Knaani Y, Hershkoviz R, Brazowski E, Halpern Z. Low-dose low-molecular weight heparin (enoxaparin) is effective as adjuvant treatment in active ulcerative colitis: an open trial.
Dig. Dis. Sci. 46: 2239-2244 (2001).
*
-
Douglas JA, Erdos MR, Watanabe RM, Braun A, Johnston CL, Oeth P, Mohlke KL, Valle TT, Ehnholm C, Buchanan TA, Bergman RN, Collins FS, Boehnke M, Tuomilehto J. The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences.
Diabetes 50: 886-890 (2001).
*
-
Dourakis SP, Michael AE, Papanikolaou IS, Nomikou E, Thalassinou P, Hadziyannis SJ. Autoimmune hepatitis associated with the antiphospholipid syndrome.
Eur. J. Gastroenterol. Hepatol. 13: 591-593 (2001).
-
Dove-Edwin I, Thomas HJ. Review article: the prevention of colorectal cancer.
Aliment. Pharmacol. Ther. 15: 323-336 (2001).
*
-
Doyle DF, Braasch DA, Jackson LK, Weiss HE, Boehm MF, Mangelsdorf DJ, Corey DR. Engineering orthogonal ligand-receptor pairs from "near drugs".
J. Am. Chem. Soc. 123: 11367-11371 (2001).
*
-
Drent M, van den Berg R, Haenen GR, van den Berg H, Wouters EF, Bast A. NF-kappaB activation in sarcoidosis.
Sarcoidosis Vasc. Diffuse Lung Dis. 18: 50-56 (2001).
-
Drouin SM, Kildsgaard J, Haviland J, Zabner J, Jia HP, McCray PB Jr, Tack BF, Wetsel RA. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma.
J. Immunol. 166: 2025-2032 (2001).
*
-
Du W, Sun H, Wang H, Qiang B, Shen Y, Yao Z, Gu J, Xiong M, Huang W, Chen Z, Zuo J, Hua X, Gao W, Sun Q, Fang F. Confirmation of susceptibility gene loci on chromosome 1 in Northern China Han families with type 2 diabetes.
Chin. Med. J. (Engl.) 114: 876-878 (2001).
-
Dubinsky MC, Hassard PV, Seidman EG, Kam LY, Abreu MT, Targan SR, Vasiliauskas EA. An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy.
Inflamm. Bowel Dis. 7: 181-189 (2001).
*
-
Dubois RN. Nonsteroidal antiinflammatory drugs, cyclooxygenase-2, and colorectal cancer prevention.
Curr. Opin. Gastroenterol. 17: 65-71 (2001).
-
Duchini A, Hendry RM, Nyberg LM, Viernes ME, Pockros PJ. Immune response to influenza vaccine in adult liver transplant recipients.
Liver Transpl. 7: 311-313 (2001).
*
-
Duez H, Fruchart JC, Staels B. PPARS in inflammation, atherosclerosis and thrombosis.
J. Cardiovasc. Risk 8: 187-194 (2001).
-
Dumoutier L, Leemans C, Lejeune D, Kotenko SV, Renauld JC. Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types.
J. Immunol. 167: 3545-3549 (2001).
*
-
Dumoutier L, Lejeune D, Colau D, Renauld JC. Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22.
J. Immunol. 166: 7090-7095 (2001).
*
-
Dunne C. Adaptation of bacteria to the intestinal niche: probiotics and gut disorder.
Inflamm. Bowel Dis. 7: 136-145 (2001).
*
-
Dunstan SJ, Ho VA, Duc CM, Lanh MN, Phuong CX, Luxemburger C, Wain J, Dudbridge F, Peacock CS, House D, Parry C, Hien TT, Dougan G, Farrar J, Blackwell JM. Typhoid fever and genetic polymorphisms at the natural resistance-associated macrophage protein 1.
J. Infect. Dis. 183: 1156-1160 (2001).
*
-
Dunstan SJ, Stephens HA, Blackwell JM, Duc CM, Lanh MN, Dudbridge F, Phuong CX, Luxemburger C, Wain J, Ho VA, Hien TT, Farrar J, Dougan G. Genes of the class II and class III major histocompatibility complex are associated with typhoid fever in Vietnam.
J. Infect. Dis. 183: 261-268 (2001).
*
-
Durand F, Bernuau J, Giostra E, Mentha G, Shouval D, Degott C, Benhamou JP, Valla D. Wilson's disease with severe hepatic insufficiency: beneficial effects of early administration of D-penicillamine.
Gut 48: 849-852 (2001).
*
-
Durand V, Pers JO, Renaudineau Y, Saraux A, Youinou P, Jamin C. Differential effects of anti-Fc gamma RIIIb autoantibodies on polymorphonuclear neutrophil apoptosis and function.
J. Leukoc. Biol. 69: 233-240 (2001).
*
-
Durandy A. Terminal defects of B lymphocyte differentiation.
Curr. Opin. Allergy Clin. Immunol. 1: 519-524 (2001).
-
Durazzo M, Bresso F, Premoli A, Rabbione L. Variant syndromes in autoimmune hepatic diseases.
Minerva Gastroenterol. Dietol. 47: 27-38 (2001).
-
Durieu I. Cystic fibrosis in adulthood.
Rev. Med. Interne. 22 Suppl. 3: 367s-373s (2001).
-
Duseja A, Chawla YK. What is rifampicin doing in pruritus of cholestasis?
Trop. Gastroenterol. 22: 123-124 (2001).
-
Dussault I, Lin M, Hollister K, Wang EH, Synold TW, Forman BM. Peptide mimetic HIV protease inhibitors are ligands for the orphan receptor SXR.
J. Biol. Chem. 276: 33309-33312 (2001).
*
-
Dwinell MB, Lugering N, Eckmann L, Kagnoff MF. Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells.
Gastroenterology 120: 49-59 (2001).
*
-
Dyment DA, Willer CJ, Scott B, Armstrong H, Ligers A, Hillert J, Paty DW, Hashimoto S, Devonshire V, Hooge J, Kastrukoff L, Oger J, Metz L, Warren S, Hader W, Power C, Auty A, Nath A, Nelson R, Freedman M, Brunet D, et al. Genetic susceptibility to MS: a second stage analysis in Canadian MS families.
Neurogenetics 3: 145-151 (2001).
*
-
Dziarski R, Wang Q, Miyake K, Kirschning CJ, Gupta D. MD-2 enables Toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to Gram-positive and Gram-negative bacteria and their cell wall components.
J. Immunol. 166: 1938-1944 (2001).
*
-
Eaden J, Abrams K, McKay H, Denley H, Mayberry J. Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis.
J. Pathol. 194: 152-157 (2001).
*
-
Eaden J, Mayberry MK, Sherr A, Mayberry JF. Screening: the legal view.
Public Health 115: 218-221 (2001).
-
Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis.
Gut 48: 526-535 (2001).
*
-
Echard BW, Talpur NA, Fan AY, Bagchi D, Preuss HG. Hepatoprotective ability of a novel botanical formulation on mild liver injury in rats produced by acute acetaminophen and/or alcohol ingestion.
Res. Commun. Mol. Pathol. Pharmacol. 110: 73-85 (2001).
-
Edwards EB, Harper AM. Application of a continuous disease severity score to the OPTN liver waiting list.
Clin. Transpl. 2001: 19-24 (2001).
-
Eerens I, Vanbeckevoort D, Vansteenbergen W, Van Hoe L. Autoimmune pancreatitis associated with primary sclerosing cholangitis: MR imaging findings.
Eur. Radiol. 11: 1401-1404 (2001).
*
-
Efferth T. The human ATP-binding cassette transporter genes: from the bench to the bedside.
Curr. Mol. Med. 1: 45-65 (2001).
*
-
Egea PF, Rochel N, Birck C, Vachette P, Timmins PA, Moras D. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
J. Mol. Biol. 307: 557-576 (2001).
*
-
Eidelman O, Srivastava M, Zhang J, Leighton X, Murtie J, Jozwik C, Jacobson K, Weinstein DL, Metcalf EL, Pollard HB. Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-alphaR/NFkappaB pathway.
Mol. Med. 7: 523-534 (2001).
*
-
Eidelman O, Zhang J, Srivastava M, Pollard HB. Cystic fibrosis and the use of pharmacogenomics to determine surrogate endpoints for drug discovery.
Am. J. Pharmacogenomics 1: 223-238 (2001).
-
Eisen GM, Dominitz JA, Faigel DO, Goldstein JL, Kalloo AN, Petersen BT, Raddawi HM, Ryan ME, Vargo JJ, Young HS, Fanelli RD, Hyman NH, Wheeler-Harbaugh J. Enteroscopy.
Gastrointest. Endosc. 53: 871-873 (2001).
*
-
Eisen HN. Specificity and degeneracy in antigen recognition: yin and yang in the immune system.
Annu. Rev. Immunol. 19: 1-21 (2001).
*
-
Ek J, Andersen G, Urhammer SA, Gaede PH, Drivsholm T, Borch-Johnsen K, Hansen T, Pedersen O. Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to type II diabetes mellitus.
Diabetologia 44: 2220-2226 (2001).
*
-
El-Magadmi M, Alansari A, Teh LS, Ordi J, Gul A, Inanc M, Bruce I, Hajeer A. Association of the A561C E-selectin polymorphism with systemic lupus erythematosus in 2 independent populations.
J. Rheumatol. 28: 2650-2652 (2001).
-
El-Zaatari FA, Osato MS, Graham DY. Etiology of Crohn's disease: the role of Mycobacterium avium paratuberculosis.
Trends Mol. Med. 7: 247-252 (2001).
*
-
Elangbam CS, Tyler RD, Lightfoot RM. Peroxisome proliferator-activated receptors in atherosclerosis and inflammation - an update.
Toxicol. Pathol. 29: 224-231 (2001).
*
-
Elder JT, Nair RP, Henseler T, Jenisch S, Stuart P, Chia N, Christophers E, Voorhees JJ. The genetics of psoriasis 2001: the odyssey continues.
Arch. Dermatol. 137: 1447-1454 (2001).
*
-
Elholm M, Dam I, Jorgensen C, Krogsdam AM, Holst D, Kratchmarova I, Gottlicher M, Gustafsson JA, Berge R, Flatmark T, Knudsen J, Mandrup S, Kristiansen K. Acyl-CoA esters antagonize the effects of ligands on peroxisome proliferator-activated receptor alpha conformation, DNA binding, and interaction with co-factors.
J. Biol. Chem. 276: 21410-21416 (2001).
*
-
Ellis HJ, Ciclitira PJ. In vivo gluten challenge in celiac disease.
Can. J. Gastroenterol. 15: 243-247 (2001).
*
-
Ellis JA, Stebbing M, Harrap SB. Polymorphism of the androgen receptor gene is associated with male pattern baldness.
J. Invest. Dermatol. 116: 452-455 (2001).
*
-
Ellman MH, Hanauer S, Sitrin M, Cohen R. Crohn's disease arthritis treated with infliximab: an open trial in four patients.
J. Clin. Rheumatol. 7: 67-71 (2001).
-
Elson CO, Cong Y, Iqbal N, Weaver CT. Immuno-bacterial homeostasis in the gut: new insights into an old enigma.
Semin. Immunol. 13: 187-194 (2001).
*
-
Embry AF. Multiple sclerosis and antecedent infections: a case-control study.
Neurology 56: 282-283 (2001).
-
Eng FJ, Friedman SL. Transcriptional regulation in hepatic stellate cells.
Semin. Liver Dis. 21: 385-395 (2001).
-
Engel I, Murre C. The function of E- and Id proteins in lymphocyte development.
Nat. Rev. Immunol. 1: 193-199 (2001).
*
-
Engel T, Lorkowski S, Lueken A, Rust S, Schluter B, Berger G, Cullen P, Assmann G. The human ABCG4 gene is regulated by oxysterols and retinoids in monocyte-derived macrophages.
Biochem. Biophys. Res. Commun. 288: 483-488 (2001).
*
-
Engler J, Paul H, Gamardo J, Rodriguez MA. Acute synovitis, fever and rash possibly caused by metallic debris from a loosened knee prosthesis in a patient with rheumatoid arthritis.
J. Clin. Rheumatol. 7: 257-260 (2001).
-
Enns R, Baillie J. Recurrent cholangitis following "successful" treatment for gallbladder cancer.
Endoscopy 33: 167-171 (2001).
-
Ermann J, Fathman CG. Autoimmune diseases: genes, bugs and failed regulation.
Nat. Immunol. 2: 759-761 (2001).
*
-
Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments.
Gastroenterology 120: 682-707 (2001).
*
-
Evans AK, Fitzgerald DA, McKay KO. The impact of meconium ileus on the clinical course of children with cystic fibrosis.
Eur. Respir. J. 18: 784-789 (2001).
*
-
Evans D, Aberle J, Wendt D, Wolf A, Beisiegel U, Mann WA. A polymorphism, L162V, in the peroxisome proliferator-activated receptor alpha (PPARalpha) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus.
J. Mol. Med. 79: 198-204 (2001).
*
-
Evelyn CM, Kim JW, Wong AL. HELLP-like syndrome associated with hepatic necrosis in a patient with systemic lupus erythematosus.
J. Clin. Rheumatol. 7: 179-183 (2001).
-
Facchini S, Candusso M, Martelossi S, Liubich M, Panfili E, Ventura A. Efficacy of long-term treatment with thalidomide in children and young adults with Crohn disease: preliminary results.
J. Pediatr. Gastroenterol. Nutr. 32: 178-181 (2001).
*
-
Faeh M, Hauser SP, Nydegger UE. Transient thrombopoietin peak after liver transplantation for end-stage liver disease.
Br. J. Haematol. 112: 493-498 (2001).
*
-
Fagan C, Phelan D. Severe convulsant hypomagnesaemia and short bowel syndrome.
Anaesth. Intensive Care 29: 281-283 (2001).
-
Fagarasan S, Kinoshita K, Muramatsu M, Ikuta K, Honjo T. In situ class switching and differentiation to IgA-producing cells in the gut lamina propria.
Nature 413: 639-643 (2001).
*
-
Fagenholz PJ, Warren SM, Greenwald JA, Bouletreau PJ, Spector JA, Crisera FE, Longaker MT. Osteoblast gene expression is differentially regulated by TGF-beta isoforms.
J. Craniofac. Surg. 12: 183-190 (2001).
-
Faint JM, Annels NE, Curnow SJ, Shields P, Pilling D, Hislop AD, Wu L, Akbar AN, Buckley CD, Moss PA, Adams DH, Rickinson AB, Salmon M. Memory T cells constitute a subset of the human CD8+CD45RA+ pool with distinct phenotypic and migratory characteristics.
J. Immunol. 167: 212-220 (2001).
*
-
Fairbrother WJ, Gordon NC, Humke EW, O'Rourke KM, Starovasnik MA, Yin JP, Dixit VM. The PYRIN domain: a member of the death domain-fold superfamily.
Protein Sci. 10: 1911-1918 (2001).
*
-
Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes.
Semin. Liver Dis. 21: 17-26 (2001).
-
Falkner KC, Pinaire JA, Xiao GH, Geoghegan TE, Prough RA. Regulation of the rat glutathione S-transferase A2 gene by glucocorticoids: involvement of both the glucocorticoid and pregnane X receptors.
Mol. Pharmacol. 60: 611-619 (2001).
*
-
Faller G, Kirchner T. Helicobacter pylori and antigastric autoimmunity.
Pathologe 22: 25-30 (2001).
-
Fam AG. Difficult gout and new approaches for control of hyperuricemia in the allopurinol-allergic patient.
Curr. Rheumatol. Rep. 3: 29-35 (2001).
-
Fam AG, Dunne SM, Iazzetta J, Paton TW. Efficacy and safety of desensitization to allopurinol following cutaneous reactions.
Arthritis Rheum. 44: 231-238 (2001).
*
-
Fang WH, Yao YM, Shi ZG, Yu Y, Wu Y, Lu LR, Sheng ZY. Effect of recombinant bactericidal/permeability-increasing protein on endotoxin translocation and lipopolysaccharide-binding protein/CD14 expression in rats after thermal injury.
Crit. Care Med. 29: 1452-1459 (2001).
-
Faouzi S, Burckhardt BE, Hanson JC, Campe CB, Schrum LW, Rippe RA, Maher JJ. Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-kappa B-independent, caspase-3-dependent pathway.
J. Biol. Chem. 276: 49077-49082 (2001).
*
-
Fardel O, Payen L, Courtois A, Vernhet L, Lecureur V. Regulation of biliary drug efflux pump expression by hormones and xenobiotics.
Toxicology 167: 37-46 (2001).
*
-
Fargion S, Mattioli M, Fracanzani AL, Sampietro M, Tavazzi D, Fociani P, Taioli E, Valenti L, Fiorelli G. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis.
Am. J. Gastroenterol. 96: 2448-2455 (2001).
*
-
Fargion S, Valenti L, Dongiovanni P, Scaccabarozzi A, Fracanzani AL, Taioli E, Mattioli M, Sampietro M, Fiorelli G. Tumor necrosis factor alpha promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis.
Blood 97: 3707-3712 (2001).
*
-
Farmer M, Hunt L, Eichenberger MR, Petras RE, Janosky JE, Galandiuk S. Association of susceptibility locus for inflammatory bowel disease on chromosome 16 with both ulcerative colitis and Crohn's disease.
Dig. Dis. Sci. 46: 632-636 (2001).
*
-
Farmer MA, Sundberg JP, Bristol IJ, Churchill GA, Li R, Elson CO, Leiter EH. A major quantitative trait locus on chromosome 3 controls colitis severity in IL-10-deficient mice.
Proc. Natl. Acad. Sci. U.S.A. 98: 13820-13825 (2001).
*
-
Farrell PM, Kosorok MR, Rock MJ, Laxova A, Zeng L, Lai HC, Hoffman G, Laessig RH, Splaingard ML. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.
Pediatrics 107: 1-13 (2001).
*
-
Farrokhyar F, Swarbrick ET, Grace RH, Hellier MD, Gent AE, Irvine EJ. Low mortality in ulcerative colitis and Crohn's disease in three regional centers in England.
Am. J. Gastroenterol. 96: 501-507 (2001).
*
-
Farrokhyar F, Swarbrick ET, Irvine EJ. A critical review of epidemiological studies in inflammatory bowel disease.
Scand. J. Gastroenterol. 36: 2-15 (2001).
*
-
Farup PG, Hinterleitner TA, Lukas M, Hebuterne X, Rachmilewitz D, Campieri M, Meier R, Keller R, Rathbone B, Oddsson E. Mesalazine 4 g daily given as prolonged-release granules twice daily and four times daily is at least as effective as prolonged-release tablets four times daily in patients with ulcerative colitis.
Inflamm. Bowel Dis. 7: 237-242 (2001).
*
-
Fasano A. Intestinal zonulin: open sesame!
Gut 49: 159-162 (2001).
*
-
Fattinger K, Funk C, Pantze M, Weber C, Reichen J, Stieger B, Meier PJ. The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions.
Clin. Pharmacol. Ther. 69: 223-231 (2001).
*
-
Faubion WA Jr, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study.
Gastroenterology 121: 255-260 (2001).
*
-
Faubion WA Jr, Loftus EV, Sandborn WJ, Freese DK, Perrault J. Pediatric "PSC-IBD": a descriptive report of associated inflammatory bowel disease among pediatric patients with PSC.
J. Pediatr. Gastroenterol. Nutr. 33: 296-300 (2001).
*
-
Faurschou M, Hasselbalch HC, Nielsen OJ. Sustained remission of platelet counts following monoclonal anti-CD20 antibody therapy in two cases of idiopathic autoimmune thrombocytopenia and neutropenia.
Eur. J. Haematol. 66: 408-411 (2001).
*
-
Faust TW. Recurrent primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis after transplantation.
Liver Transpl. 7: S99-S108 (2001).
*
-
Fava M. Augmentation and combination strategies in treatment-resistant depression.
J. Clin. Psychiatry 62 Suppl. 18: 4-11 (2001).
-
Favrbo K. Can sclerosis be inhibited by vitamin D?
Ugeskr. Laeger. 163: 4887-4889 (2001).
-
Fayard E, Schoonjans K, Auwerx J. Xol INXS: role of the liver X and the farnesol X receptors.
Curr. Opin. Lipidol. 12: 113-120 (2001).
-
Feagan BG, Enns R, Fedorak RN, Panaccione R, Pare P, Steinhart AH, Wild G. Infliximab for the treatment of Crohn's disease: efficacy, safety and pharmacoeconomics.
Can. J. Clin. Pharmacol. 8: 188-198 (2001).
-
Federico P, Zochodne DW. Reversible Parkinsonism and hyperammonemia associated with portal vein thrombosis.
Acta Neurol. Scand. 103: 198-200 (2001).
*
-
Federle MP, Blachar A. CT evaluation of the liver: principles and techniques.
Semin. Liver Dis. 21: 135-145 (2001).
-
Federle MP, Brancatelli G. Imaging of benign hepatic masses.
Semin. Liver Dis. 21: 237-249 (2001).
-
Fedorak RN; Canadian Association of Gastroenterology. Canadian Association of Gastroenterology Clinical Practice Guidelines: the use of infliximab in Crohn's disease.
Can. J. Gastroenterol. 15: 367-370 (2001).
*
-
Feix A, Fritsche-Polanz R, Kletzmayr J, Vychytil A, Horl WH, Sunder-Plassmann G, Fodinger M. Increased prevalence of combined MTR and MTHFR genotypes among individuals with severely elevated total homocysteine plasma levels.
Am. J. Kidney Dis. 38: 956-964 (2001).
-
Feldmann G. Liver transplantation of hepatic stem cells: potential use for treating liver diseases.
Cell Biol. Toxicol. 17: 77-85 (2001).
*
-
Feldmann M, Maini RN. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
Annu. Rev. Immunol. 19: 163-196 (2001).
*
-
Fellermann K, Stange EF. Defensins - innate immunity at the epithelial frontier.
Eur. J. Gastroenterol. Hepatol. 13: 771-776 (2001).
*
-
Feranchak AP, Sokol RJ. Cholangiocyte biology and cystic fibrosis liver disease.
Semin. Liver Dis. 21: 471-488 (2001).
-
Fernandez-Esparrach G, Sanchez-Fueyo A, Gines P, Uriz J, Quinto L, Ventura PJ, Cardenas A, Guevara M, Sort P, Jimenez W, Bataller R, Arroyo V, Rodes J. A prognostic model for predicting survival in cirrhosis with ascites.
J. Hepatol. 34: 46-52 (2001).
*
-
Ferret PJ, Hammoud R, Tulliez M, Tran A, Trebeden H, Jaffray P, Malassagne B, Calmus Y, Weill B, Batteux F. Detoxification of reactive oxygen species by a nonpeptidyl mimic of superoxide dismutase cures acetaminophen-induced acute liver failure in the mouse.
Hepatology 33: 1173-1180 (2001).
*
-
Fickert P, Zollner G, Fuchsbichler A, Stumptner C, Pojer C, Zenz R, Lammert F, Stieger B, Meier PJ, Zatloukal K, Denk H, Trauner M. Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver.
Gastroenterology 121: 170-183 (2001).
*
-
Field CJ, Clandinin MT, Van Aerde JE. Polyunsaturated fatty acids and T-cell function: implications for the neonate.
Lipids 36: 1025-1032 (2001).
-
Fierro IM, Serhan CN. Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins.
Braz. J. Med. Biol. Res. 34: 555-566 (2001).
*
-
Figer A, Irmin L, Geva R, Flex D, Sulkes J, Sulkes A, Friedman E. The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in Israel.
Br. J. Cancer 84: 478-481 (2001).
*
-
Filteau SM, Rollins NC, Coutsoudis A, Sullivan KR, Willumsen JF, Tomkins AM. The effect of antenatal vitamin A and beta-carotene supplementation on gut integrity of infants of HIV-infected South African women.
J. Pediatr. Gastroenterol. Nutr. 32: 464-470 (2001).
*
-
Finkelman FD, Urban JF. The other side of the coin: the protective role of the TH2 cytokines.
J. Allergy Clin. Immunol. 107: 772-780 (2001).
*
-
Fiocchi C. Multifaceted progress in mechanisms and therapy of inflammatory bowel disease.
Curr. Opin. Gastroenterol. 17: 305-306 (2001).
-
Fiocchi C. TGF-beta/Smad signaling defects in inflammatory bowel disease: mechanisms and possible novel therapies for chronic inflammation.
J. Clin. Invest. 108: 523-526 (2001).
*
-
Fiorucci S, Mencarelli A, Palazzetti B, Del Soldato P, Morelli A, Ignarro LJ. An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity.
Proc. Natl. Acad. Sci. U.S.A. 98: 2652-2657 (2001).
*
-
Fischer GF, Mayr WR. Molecular genetics of the HLA complex.
Wien. Klin. Wochenschr. 113: 814-824 (2001).
-
Fischler B, Papadogiannakis N, Nemeth A. Aetiological factors in neonatal cholestasis.
Acta Paediatr. 90: 88-92 (2001).
-
Fischler B, Papadogiannakis N, Nemeth A. Clinical aspects on neonatal cholestasis based on observations at a Swedish tertiary referral centre.
Acta Paediatr. 90: 171-178 (2001).
-
Fisher JR, Ostrov BE. Coexistent lyme disease and parvovirus infection in a child.
J. Clin. Rheumatol. 7: 350-353 (2001).
-
Fisher MA, Eklund SA, James SA, Lin X. Adverse events associated with hepatitis B vaccine in U.S. children less than six years of age, 1993 and 1994.
Ann. Epidemiol. 11: 13-21 (2001).
-
Fitzgerald KA, Palsson-McDermott EM, Bowie AG, Jefferies CA, Mansell AS, Brady G, Brint E, Dunne A, Gray P, Harte MT, McMurray D, Smith DE, Sims JE, Bird TA, O'Neill LA. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
Nature 413: 78-83 (2001).
*
-
Flaitz CM. Chronic sclerosing sialadenitis of the sublingual gland.
Am. J. Dent. 14: 335-336 (2001).
-
Fleming KA, Boberg KM, Glaumann H, Bergquist A, Smith D, Clausen OP. Biliary dysplasia as a marker of cholangiocarcinoma in primary sclerosing cholangitis.
J. Hepatol. 34: 360-365 (2001).
*
-
Fleming RE, Sly WS. Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease.
Proc. Natl. Acad. Sci. U.S.A. 98: 8160-8162 (2001).
*
-
Flemstrom G, Isenberg JI. Gastroduodenal mucosal alkaline secretion and mucosal protection.
News Physiol. Sci. 16: 23-28 (2001).
*
-
Fleshner PR, Vasiliauskas EA, Kam LY, Fleshner NE, Gaiennie J, Abreu-Martin MT, Targan SR. High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis.
Gut 49: 671-677 (2001).
*
-
Flood L, Lofberg R, Stierna P, Wikstrom AC. Glucocorticoid receptor mRNA in patients with ulcerative colitis: a study of responders and nonresponders to glucocorticosteroid therapy.
Inflamm. Bowel Dis. 7: 202-209 (2001).
*
-
Floreani A, Guido M, Bortolami M, Della Zentil G, Venturi C, Pennelli N, Naccarato R. Relationship between apoptosis, tumour necrosis factor, and cell proliferation in chronic cholestasis.
Dig. Liver Dis. 33: 570-575 (2001).
-
Flores-Suarez LF. ANCAS, one, two or three fates?
Rev. Invest. Clin. 53: 159-173 (2001).
*
-
Flores-Villanueva PO, Yunis EJ, Delgado JC, Vittinghoff E, Buchbinder S, Leung JY, Uglialoro AM, Clavijo OP, Rosenberg ES, Kalams SA, Braun JD, Boswell SL, Walker BD, Goldfeld AE. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity.
Proc. Natl. Acad. Sci. U.S.A. 98: 5140-5145 (2001).
*
-
Flotte TR, Laube BL. Gene therapy in cystic fibrosis.
Chest 120: 124S-131S (2001).
*
-
Foley PJ, McGrath DS, Puscinska E, Petrek M, Kolek V, Drabek J, Lympany PA, Pantelidis P, Welsh KI, Zielinski J, du Bois RM. Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis.
Am. J. Respir. Cell. Mol. Biol. 25: 272-277 (2001).
*
-
Folzenlogen D. A case of atorvastatin combined toxic myopathy and inflammatory myositis.
J. Clin. Rheumatol. 7: 340-345 (2001).
-
Fonollosa V, Simeon CP, Castells L, Garcia F, Castro A, Solans R, Lima J, Vargas V, Guardia J, Vilardell M. Morphologic capillary changes and manifestations of connective tissue diseases in patients with primary biliary cirrhosis.
Lupus 10: 628-631 (2001).
*
-
Fontan Casariego G. Primary immunodeficiencies. Clinical features and variant forms.
Allergol. Immunopathol (Madr.) 29: 101-107 (2001).
-
Fornaciari G, Salvarani C, Beltrami M, Macchioni P, Stockbrugger RW, Russel MG. Muscoloskeletal manifestations in inflammatory bowel disease.
Can. J. Gastroenterol. 15: 399-403 (2001).
*
-
Forsthuber TG, Shive CL, Wienhold W, de Graaf K, Spack EG, Sublett R, Melms A, Kort J, Racke MK, Weissert R. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells.
J. Immunol. 167: 7119-7125 (2001).
*
-
Fourcade S, Savary S, Albet S, Gauthe D, Gondcaille C, Pineau T, Bellenger J, Bentejac M, Holzinger A, Berger J, Bugaut M. Fibrate induction of the adrenoleukodystrophy-related gene (ABCD2): promoter analysis and role of the peroxisome proliferator-activated receptor PPARalpha.
Eur. J. Biochem. 268: 3490-3500 (2001).
*
-
Fowler E, Moyer M, Krishna RG, Chin CC, Wold F. Removal of N-terminal blocking groups from proteins.
Curr. Protoc. Protein Sci. Chapter 11: Unit 11.7 (2001).
-
Fowler R, Imrie K. Thalidomide-associated hepatitis: a case report.
Am. J. Hematol. 66: 300-302 (2001).
-
Fox CK, Furtwaengler A, Nepomuceno RR, Martinez OM, Krams SM. Apoptotic pathways in primary biliary cirrhosis and autoimmune hepatitis.
Liver 21: 272-279 (2001).
-
Fox JG, Handt L, Sheppard BJ, Xu S, Dewhirst FE, Motzel S, Klein H. Isolation of Helicobacter cinaedi from the colon, liver, and mesenteric lymph node of a rhesus monkey with chronic colitis and hepatitis.
J. Clin. Microbiol. 39: 1580-1585 (2001).
*
-
Fracanzani AL, Burdick L, Borzio M, Roncalli M, Bonelli N, Borzio F, Maraschi A, Fiorelli G, Fargion S. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis.
Hepatology 34: 1109-1112 (2001).
*
-
Fracasso PM, Brady MF, Moore DH, Walker JL, Rose PG, Letvak L, Grogan TM, McGuire WP. Phase II study of paclitaxel and valspodar (PSC 833) in refractory ovarian carcinoma: a gynecologic oncology group study.
J. Clin. Oncol. 19: 2975-2982 (2001).
*
-
Franciotta D, Cuccia M, Dondi E, Piccolo G, Cosi V. Polymorphic markers in MHC class II/III region: a study on Italian patients with myasthenia gravis.
J. Neurol. Sci. 190: 11-16 (2001).
*
-
Francke S, Manraj M, Lacquemant C, Lecoeur C, Lepretre F, Passa P, Hebe A, Corset L, Yan SL, Lahmidi S, Jankee S, Gunness TK, Ramjuttun US, Balgobin V, Dina C, Froguel P. A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27.
Hum. Mol. Genet. 10: 2751-2765 (2001).
*
-
Franklin CL, Gorelick PL, Riley LK, Dewhirst FE, Livingston RS, Ward JM, Beckwith CS, Fox JG. Helicobacter typhlonius sp. nov., a novel murine urease-negative Helicobacter species.
J. Clin. Microbiol. 39: 3920-3926 (2001).
*
-
Fraticelli P, Sironi M, Bianchi G, D'Ambrosio D, Albanesi C, Stoppacciaro A, Chieppa M, Allavena P, Ruco L, Girolomoni G, Sinigaglia F, Vecchi A, Mantovani A. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses.
J. Clin. Invest. 107: 1173-1181 (2001).
*
-
Freedman SD, Kern HF, Scheele GA. Pancreatic acinar cell dysfunction in CFTR(-/-) mice is associated with impairments in luminal pH and endocytosis.
Gastroenterology 121: 950-957 (2001).
*
-
Freeman HJ. Colorectal cancer complicating Crohn's disease.
Can. J. Gastroenterol. 15: 231-236 (2001).
*
-
Freeman ML, Cass OW, Dailey J. Dilation of high-grade pancreatic and biliary ductal strictures with small-caliber angioplasty balloons.
Gastrointest. Endosc. 54: 89-92 (2001).
*
-
Freeman ML, DiSario JA, Nelson DB, Fennerty MB, Lee JG, Bjorkman DJ, Overby CS, Aas J, Ryan ME, Bochna GS, Shaw MJ, Snady HW, Erickson RV, Moore JP, Roel JP. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study.
Gastrointest. Endosc. 54: 425-434 (2001).
*
-
Freeman ML, Hawes RH, Vakil N, Camilleri M, Hanauer SB. Best of DDW 2001. Highlights from the 2001 Digestive Disease Week. May 20-23, 2001, Atlanta, GA.
Rev. Gastroenterol. Disord. 1: 100-110 (2001).
*
-
Freeman RB, Rohrer RJ, Katz E, Lewis WD, Jenkins R, Cosimi AB, Delmonico F, Friedman A, Lorber M, O'Connor K, Bradley J. Preliminary results of a liver allocation plan using a continuous medical severity score that de-emphasizes waiting time.
Liver Transpl. 7: 173-178 (2001).
*
-
Freeze HH. Congenital disorders of glycosylation and the pediatric liver.
Semin. Liver Dis. 21: 501-515 (2001).
-
Freiberger T, Litzman J, Vondruskova E. Role of aspartic acid at position 57 of the HLA-DQ beta chain in sporadic and familial forms of selective IgA deficiency.
Cas. Lek. Cesk. 140: 770-773 (2001).
-
Friedman JD, Dello Buono FA. Opioid antagonists in the treatment of opioid-induced constipation and pruritus.
Ann. Pharmacother. 35: 85-91 (2001).
-
Friedman S. Management of inflammatory bowel disease during pregnancy and nursing.
Semin. Gastrointest. Dis. 12: 245-252 (2001).
-
Friedman S, Marion JF, Scherl E, Rubin PH, Present DH. Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease.
Inflamm. Bowel Dis. 7: 1-7 (2001).
*
-
Friess H, Holzinger F, Liao Q, Buchler MW. Surveillance of pre-malignant disease of the pancreatico-biliary system.
Best Pract. Res. Clin. Gastroenterol. 15: 285-300 (2001).
*
-
Fruchart JC, Staels B, Duriez P. PPARS, metabolic disease and atherosclerosis.
Pharmacol. Res. 44: 345-352 (2001).
*
-
Fu HL, Hsu TC, Chang CC, Tsay GJ. Antigenic specificity of anti-neutrophil cytoplasmic antibody.
J. Formos. Med. Assoc. 100: 35-39 (2001).
-
Fu X, Menke JG, Chen Y, Zhou G, MacNaul KL, Wright SD, Sparrow CP, Lund EG. 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells.
J. Biol. Chem. 276: 38378-38387 (2001).
*
-
Fuchs M, Stange EF. Cholesterol and cholestasis: a lesson from the Mdr2 (-/-) mouse.
J. Hepatol. 34: 339-341 (2001).
*
-
Fujiie S, Hieshima K, Izawa D, Nakayama T, Fujisawa R, Ohyanagi H, Yoshie O. Proinflammatory cytokines induce liver and activation-regulated chemokine/macrophage inflammatory protein-3alpha/CCL20 in mucosal epithelial cells through NF-kappaB.
Int. Immunol. 13: 1255-1263 (2001).
*
-
Fujinami RS. Viruses and autoimmune disease - two sides of the same coin?
Trends Microbiol. 9: 377-381 (2001).
*
-
Fukagawa NK, Liang P, Li M, Ashikaga T, Reddy KR, Krawitt EL. Glutathione-S-transferase M1 null genotype in autoimmune hepatitis.
Dig. Dis. Sci. 46: 2080-2083 (2001).
*
-
Fuleihan RL. The hyper IgM syndrome.
Curr. Allergy Asthma Rep. 1: 445-450 (2001).
-
Fuleihan RL. Hyper IgM syndrome: the other side of the coin.
Curr. Opin. Pediatr. 13: 528-532 (2001).
-
Fumagalli A, Ferrari M, Soriani N, Gessi A, Foglieni B, Martina E, Manitto MP, Brancato R, Dean M, Allikmets R, Cremonesi L. Mutational scanning of the ABCR gene with double-gradient denaturing-gradient gel electrophoresis (DG-DGGE) in Italian Stargardt disease patients.
Hum. Genet. 109: 326-338 (2001).
*
-
Fung Y, Yee J, Simpson WL, Glajchen N, Harpaz N. CT appearance of gastric involvement in multifocal idiopathic fibrosclerosis.
J. Comput. Assist. Tomogr. 25: 239-241 (2001).
-
Funk C, Ponelle C, Scheuermann G, Pantze M. Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat.
Mol. Pharmacol. 59: 627-635 (2001).
*
-
Furlano RI, Anthony A, Day R, Brown A, McGarvey L, Thomson MA, Davies SE, Berelowitz M, Forbes A, Wakefield AJ, Walker-Smith JA, Murch SH. Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism.
J. Pediatr. 138: 366-372 (2001).
*
-
Furuse M, Furuse K, Sasaki H, Tsukita S. Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells.
J. Cell Biol. 153: 263-272 (2001).
*
-
Furuya T, Joe B, Salstrom JL, Hashiramoto A, Dobbins DE, Wilder RL, Remmers EF. Polymorphisms of the tumor necrosis factor alpha locus among autoimmune disease susceptible and resistant inbred rat strains.
Genes Immun. 2: 229-232 (2001).
*
-
Gabolde M, Hubert D, Guilloud-Bataille M, Lenaerts C, Feingold J, Besmond C. The mannose binding lectin gene influences the severity of chronic liver disease in cystic fibrosis.
J. Med. Genet. 38: 310-311 (2001).
*
-
Gadjeva M, Thiel S, Jensenius JC. The mannan-binding-lectin pathway of the innate immune response.
Curr. Opin. Immunol. 13: 74-78 (2001).
-
Galli A, Pinaire J, Fischer M, Dorris R, Crabb DW. The transcriptional and DNA binding activity of peroxisome proliferator-activated receptor alpha is inhibited by ethanol metabolism. A novel mechanism for the development of ethanol-induced fatty liver.
J. Biol. Chem. 276: 68-75 (2001).
*
-
Gambelunghe G, Ghaderi M, Tortoioli C, Falorni A, Santeusanio F, Brunetti P, Sanjeevi CB, Falorni A; Umbria Type 1 Diabetes Registry. Two distinct MICA gene markers discriminate major autoimmune diabetes types.
J. Clin. Endocrinol. Metab. 86: 3754-3760 (2001).
*
-
Garcia CE, Garcia RF, Mayer AD, Neuberger J. Liver transplantation in patients over sixty years of age.
Transplantation 72: 679-684 (2001).
-
Garcia-Consuegra Molina J, Tapia Moreno R, Abelairas Gomez J, Peralta Calvo J, Merino Munoz R. Uveitis and juvenile idiopathic arthritis.
An. Esp. Pediatr. 54: 255-259 (2001).
-
Garcia-Lozano JR, Gonzalez-Escribano MF, Valenzuela A, Garcia A, Nunez-Roldan A. Association of vitamin D receptor genotypes with early onset rheumatoid arthritis.
Eur. J. Immunogenet. 28: 89-93 (2001).
*
-
Garcia-Tevijano ER, Berasain C, Rodriguez JA, Corrales FJ, Arias R, Martin-Duce A, Caballeria J, Mato JM, Avila MA. Hyperhomocysteinemia in liver cirrhosis: mechanisms and role in vascular and hepatic fibrosis.
Hypertension 38: 1217-1221 (2001).
*
-
Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis.
Gastroenterology 120: 726-748 (2001).
*
-
Garcia-Tsao G. Bacterial translocation: cause or consequence of decompensation in cirrhosis?
J. Hepatol. 34: 150-155 (2001).
*
-
Garnett WR, Yunker N. Treatment of Crohn's disease with infliximab.
Am. J. Health Syst. Pharm. 58: 307-316 (2001).
-
Garred P, Voss A, Madsen HO, Junker P. Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients.
Genes Immun. 2: 442-450 (2001).
*
-
Gassull MA, Cabre E. Nutrition in inflammatory bowel disease.
Curr. Opin. Clin. Nutr. Metab. Care 4: 561-569 (2001).
-
Gaudet R, Wiley DC. Structure of the ABC ATPase domain of human TAP1, the transporter associated with antigen processing.
EMBO J. 20: 4964-4972 (2001).
*
-
Gaughan DJ, Kluijtmans LA, Barbaux S, McMaster D, Young IS, Yarnell JW, Evans A, Whitehead AS. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations.
Atherosclerosis 157: 451-456 (2001).
-
Ge Z, Doig P, Fox JG. Characterization of proteins in the outer membrane preparation of a murine pathogen, Helicobacter bilis.
Infect. Immun. 69: 3502-3506 (2001).
*
-
Ge Z, White DA, Whary MT, Fox JG. Fluorogenic PCR-based quantitative detection of a murine pathogen, Helicobacter hepaticus.
J. Clin. Microbiol. 39: 2598-2602 (2001).
*
-
Gearhart PJ, Wood RD. Emerging links between hypermutation of antibody genes and DNA polymerases.
Nat. Rev. Immunol. 1: 187-192 (2001).
*
-
Geboes K. Biological therapies in IBD: an international course.
IDrugs 4: 265-267 (2001).
-
Geerts A. History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells.
Semin. Liver Dis. 21: 311-335 (2001).
-
Geick A, Eichelbaum M, Burk O. Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin.
J. Biol. Chem. 276: 14581-14587 (2001).
*
-
Georges RN, Lipman S, Silvestri F, Sussman B, Dardik H. Endovascular treatment of mycotic hepatic artery aneurysm in the hostile abdomen - a case report.
Vasc. Surg. 35: 477-481 (2001).
-
Geourjon C, Orelle C, Steinfels E, Blanchet C, Deleage G, Di Pietro A, Jault JM. A common mechanism for ATP hydrolysis in ABC transporter and helicase superfamilies.
Trends Biochem. Sci. 26: 539-544 (2001).
*
-
Gershon ES, Kelsoe JR, Kendler KS, Watson JD. A scientific opportunity.
Science 294: 957 (2001).
*
-
Gershwin ME. The natural history of primary biliary cirrhosis: of genes and cooperation.
J. Hepatol. 35: 412-415 (2001).
*
-
Gershwin ME, Van de Water J. Cholangiocytes and primary biliary cirrhosis: prediction and predication.
J. Clin. Invest. 108: 187-188 (2001).
*
-
Ghezzi A, Zaffaroni M. Neurological manifestations of gastrointestinal disorders, with particular reference to the differential diagnosis of multiple sclerosis.
Neurol. Sci. 22 Suppl. 2: S117-S122 (2001).
-
Ghilardi G, Biondi ML, Mangoni J, Leviti S, DeMonti M, Guagnellini E, Scorza R. Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness.
Clin. Cancer Res. 7: 2344-2346 (2001).
*
-
Ghosh S, Armitage E, Wilson D, Minor PD, Afzal MA. Detection of persistent measles virus infection in Crohn's disease: current status of experimental work.
Gut 48: 748-752 (2001).
*
-
Gibson AW, Edberg JC, Wu J, Westendorp RG, Huizinga TW, Kimberly RP. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus.
J. Immunol. 166: 3915-3922 (2001).
*
-
Giercksky KE. COX-2 inhibition and prevention of cancer.
Best Pract. Res. Clin. Gastroenterol. 15: 821-833 (2001).
*
-
Giese LA. Milk thistle and the treatment of hepatitis.
Gastroenterol. Nurs. 24: 95-97 (2001).
-
Gilchrist FC, Bunn C, Foley PJ, Lympany PA, Black CM, Welsh KI, du Bois RM. Class II HLA associations with autoantibodies in scleroderma: a highly significant role for HLA-DP.
Genes Immun. 2: 76-81 (2001).
*
-
Gillam EM. The PXR ligand-binding domain: how to be picky and promiscuous at the same time.
Trends Pharmacol. Sci. 22: 448 (2001).
*
-
Gilliland WR, Tsokos GC. The clinical spectrum of anti-insulin receptor antibodies and autoimmune disease.
J. Clin. Rheumatol. 7: 361-362 (2001).
-
Ginsburg PM, Dassopoulos T, Ehrenpreis ED. Thalidomide treatment for refractory Crohn's disease: a review of the history, pharmacological mechanisms and clinical literature.
Ann. Med. 33: 516-525 (2001).
-
Gionchetti P, Rizzello F. CBP-1011 (InKine Pharmaceutical Co).
IDrugs 4: 935-938 (2001).
-
Gionchetti P, Rizzello F, Campieri M. Probiotics and antibiotics in inflammatory bowel disease.
Curr. Opin. Gastroenterol. 17: 331-335 (2001).
-
Girardin SE, Tournebize R, Mavris M, Page AL, Li X, Stark GR, Bertin J, DiStefano PS, Yaniv M, Sansonetti PJ, Philpott DJ. CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri.
EMBO Rep. 2: 736-742 (2001).
*
-
Gish RG, Mason A. Autoimmune liver disease. Current standards, future directions.
Clin. Liver Dis. 5: 287-314 (2001).
-
Gisler SM, Stagljar I, Traebert M, Bacic D, Biber J, Murer H. Interaction of the type IIa Na/Pi cotransporter with PDZ proteins.
J. Biol. Chem. 276: 9206-9213 (2001).
*
-
Glas J, Martin K, Brunnler G, Kopp R, Folwaczny C, Weiss EH, Albert ED. MICA, MICB and C1_4_1 polymorphism in Crohn's disease and ulcerative colitis.
Tissue Antigens 58: 243-249 (2001).
*
-
Glas J, Werner AI, Brunnler G, Witter K, Scholz S, Weiss EH, Albert ED. Linkage disequilibria between HLA-B, C1_4_1, MICA and MICB.
Tissue Antigens 58: 411-418 (2001).
*
-
Gluud C, Christensen E. Ursodeoxycholic acid for primary biliary cirrhosis: lesson for the future?
J. Hepatol. 34: 787-788 (2001).
*
-
Goggins MG, Goh J, O'Connell MA, Weir DG, Kelleher D, Mahmud N. Soluble adhesion molecules in inflammatory bowel disease.
Ir. J. Med. Sci. 170: 107-111 (2001).
-
Goggins MG, Shah SA, Goh J, Cherukuri A, Weir DG, Kelleher D, Mahmud N. Increased urinary nitrite, a marker of nitric oxide, in active inflammatory bowel disease.
Mediators Inflamm. 10: 69-73 (2001).
*
-
Goh SK, Gull SE, Alexander GJ. Pregnancy in primary biliary cirrhosis complicated by portal hypertension: report of a case and review of the literature.
BJOG 108: 760-762 (2001).
*
-
Goischke HK, Ochsendorf FR. Acne inversa in Crohn's disease.
Z. Gastroenterol. 39: 965-969 (2001).
-
Goldberg AC, Bittencourt PL, Mougin B, Cancado EL, Porta G, Carrilho F, Kalil J. Analysis of HLA haplotypes in autoimmune hepatitis type 1: identifying the major susceptibility locus.
Hum. Immunol. 62: 165-169 (2001).
-
Goldstein F. Look out for toxic effects of mesalamines!
J. Clin. Gastroenterol. 32: 98 (2001).
-
Goldstein NS, Soman A, Gordon SC. Portal tract eosinophils and hepatocyte cytokeratin 7 immunoreactivity helps distinguish early-stage, mildly active primary biliary cirrhosis and autoimmune hepatitis.
Am. J. Clin. Pathol. 116: 846-853 (2001).
*
-
Gollnick HP, Graupe K, Zaumseil RP. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne.
Eur. J. Dermatol. 11: 538-544 (2001).
-
Gomez Lira M, Patuzzo C, Castellani C, Bovo P, Cavallini G, Mastella G, Pignatti PF. CFTR and cationic trypsinogen mutations in idiopathic pancreatitis and neonatal hypertrypsinemia.
Pancreatology 1: 538-542 (2001).
-
Goncalves NS, Ghaem-Maghami M, Monteleone G, Frankel G, Dougan G, Lewis DJ, Simmons CP, MacDonald TT. Critical role for tumor necrosis factor alpha in controlling the number of lumenal pathogenic bacteria and immunopathology in infectious colitis.
Infect. Immun. 69: 6651-6659 (2001).
*
-
Gonzalez E, Dhanda R, Bamshad M, Mummidi S, Geevarghese R, Catano G, Anderson SA, Walter EA, Stephan KT, Hammer MF, Mangano A, Sen L, Clark RA, Ahuja SS, Dolan MJ, Ahuja SK. Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic.
Proc. Natl. Acad. Sci. U.S.A. 98: 5199-5204 (2001).
*
-
Gonzalez P, Alvarez R, Batalla A, Reguero JR, Alvarez V, Astudillo A, Cubero GI, Cortina A, Coto E. Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction.
Genes Immun. 2: 191-195 (2001).
*
-
Gonzalez S, Brautbar C, Martinez-Borra J, Lopez-Vazquez A, Segal R, Blanco-Gelaz MA, Enk CD, Safriman C, Lopez-Larrea C. Polymorphism in MICA rather than HLA-B/C genes is associated with psoriatic arthritis in the Jewish population.
Hum. Immunol. 62: 632-638 (2001).
-
Gonzalez-Gay MA, Hajeer AH, Dababneh A, Makki R, Garcia-Porrua C, Thomson W, Ollier W. Seronegative rheumatoid arthritis in elderly and polymyalgia rheumatica have similar patterns of HLA association.
J. Rheumatol. 28: 122-125 (2001).
-
Gonzalez-Koch A, Czaja AJ, Carpenter HA, Roberts SK, Charlton MR, Porayko MK, Rosen CB, Wiesner RH. Recurrent autoimmune hepatitis after orthotopic liver transplantation.
Liver Transpl. 7: 302-310 (2001).
*
-
Good MF. Towards a blood-stage vaccine for malaria: are we following all the leads?
Nat. Rev. Immunol. 1: 117-125 (2001).
*
-
Goodgame RW, Kimball K, Akram S, Ike E, Ou CN, Sutton F, Graham D. Randomized controlled trial of clarithromycin and ethambutol in the treatment of Crohn's disease.
Aliment. Pharmacol. Ther. 15: 1861-1866 (2001).
*
-
Goodwin B, Moore LB, Stoltz CM, McKee DD, Kliewer SA. Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor.
Mol. Pharmacol. 60: 427-431 (2001).
*
-
Goolamali SI, Taylor-Robinson SD. Endoscopic retrograde cholangiopancreatography appearances of early primary sclerosing cholangitis.
J. Clin. Gastroenterol. 32: 460-461 (2001).
-
Gordon FH, Lai CW, Hamilton MI, Allison MC, Srivastava ED, Fouweather MG, Donoghue S, Greenlees C, Subhani J, Amlot PL, Pounder RE. A randomized placebo-controlled trial of a humanized monoclonal antibody to alpha4 integrin in active Crohn's disease.
Gastroenterology 121: 268-274 (2001).
*
-
Goreti Catorze M, Pereira F, Fonseca F, Morbey A, Assis Pacheco F. Pyoderma gangrenosum associated with sclerosing cholangitis, type 1 diabetes mellitus and ulcerative colitis.
J. Eur. Acad. Dermatol. Venereol. 15: 257-259 (2001).
-
Goto M, Okamoto Y, Yamamoto M, Aki H. Anti-inflammatory effects of 5-aminosalicylic acid conjugates with chenodeoxycholic acid and ursodeoxycholic acid on carrageenan-induced colitis in guinea-pigs.
J. Pharm. Pharmacol. 53: 1711-1720 (2001).
*
-
Gottesman MM, Ambudkar SV. Overview: ABC transporters and human disease.
J. Bioenerg. Biomembr. 33: 453-458 (2001).
*
-
Goudet P, Dozois RR, Kelly KA, Ilstrup DM, Phillips SF. Characteristics and evolution of extraintestinal manifestations associated with ulcerative colitis after proctocolectomy.
Dig. Surg. 18: 51-55 (2001).
*
-
Gould Rothberg BE, Sundseth SS, DiPippo VA, Brown PJ, Winegar DA, Gottshalk WK, Shenoy SG, Rothberg JM. The characterization of PPAR alpha ligand drug action in an in vivo model by comprehensive differential gene expression profiling.
Funct. Integr. Genomics 1: 294-304 (2001).
*
-
Gow PJ, Fleming KA, Chapman RW. Primary sclerosing cholangitis associated with rheumatoid arthritis and HLA DR4: is the association a marker of patients with progressive liver disease?
J. Hepatol. 34: 631-635 (2001).
*
-
Gow PJ, Peacock SE, Chapman RW. Wilson's disease presenting with rapidly progressive visual loss: another neurologic manifestation of Wilson's disease?
J. Gastroenterol. Hepatol. 16: 699-701 (2001).
*
-
Grabczynska SA, Carey BS, McGregor JM, Hawk JL, Vaughan RW. Tumour necrosis factor alpha promoter polymorphism at position -308 is not associated with actinic prurigo.
Clin. Exp. Dermatol. 26: 700-704 (2001).
*
-
Graham RR, Langefeld CD, Gaffney PM, Ortmann WA, Selby SA, Baechler EC, Shark KB, Ockenden TC, Rohlf KE, Moser KL, Brown WM, Gabriel SE, Messner RP, King RA, Horak P, Elder JT, Stuart PE, Rich SS, Behrens TW. Genetic linkage and transmission disequilibrium of marker haplotypes at chromosome 1q41 in human systemic lupus erythematosus.
Arthritis Res. 3: 299-305 (2001).
*
-
Grand RJ. Section editor's commentary. Anti-TNF therapies have eliminated the need for steroids in pediatric Crohn's disease.
Inflamm. Bowel Dis. 7: 345-346 (2001).
*
-
Granstein RD. New treatments for psoriasis.
N. Engl. J. Med. 345: 284-287 (2001).
*
-
Grant AJ, Lalor PF, Hubscher SG, Briskin M, Adams DH. MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease).
Hepatology 33: 1065-1072 (2001).
*
-
Gratwohl A, Passweg J, Gerber I, Tyndall A; International Stem Cell Project for Autoimmune Diseases. Stem cell transplantation for autoimmune diseases.
Best Pract. Res. Clin. Haematol. 14: 755-776 (2001).
-
Grau J, Ribera JM, Tormo M, Indiano JM, Vercher J, Sandoval V, Ramirez G, Sastre A, Flores E, Garcia-Conde J. Results of treatment with 2-chlorodeoxyadenosine in refractory or relapsed Langerhans cell histiocytosis. Study of 9 patients.
Med. Clin. (Barc.) 116: 339-342 (2001).
-
Gray MA, O'Reilly C, Winpenny J, Argent B. Functional interactions of HCO3- with cystic fibrosis transmembrane conductance regulator.
JOP 2: S207-S211 (2001).
*
-
Greco L. The father figure in coeliac disease.
Gut 49: 163-164 (2001).
*
-
Greco L, Babron MC, Corazza GR, Percopo S, Sica R, Clot F, Fulchignoni-Lataud MC, Zavattari P, Momigliano-Richiardi P, Casari G, Gasparini P, Tosi R, Mantovani V, De Virgiliis S, Iacono G, D'Alfonso A, Selinger-Leneman H, Lemainque A, Serre JL, et al. Existence of a genetic risk factor on chromosome 5q in Italian coeliac disease families.
Ann. Hum. Genet. 65: 35-41 (2001).
*
-
Greeley T, Shumaker H, Wang Z, Schweinfest CW, Soleimani M. Downregulated in adenoma and putative anion transporter are regulated by CFTR in cultured pancreatic duct cells.
Am. J. Physiol. Gastrointest. Liver Physiol. 281: G1301-G1308 (2001).
*
-
Green AJ, Barcellos LF, Rimmler JB, Garcia ME, Caillier S, Lincoln RR, Bucher P, Pericak-Vance MA, Haines JL, Hauser SL, Oksenberg JR; Multiple Sclerosis Genetics Group. Sequence variation in the transforming growth factor-beta1 (TGFB1) gene and multiple sclerosis susceptibility.
J. Neuroimmunol. 116: 116-124 (2001).
-
Greenberg LE, Nguyen T, Miller SM. Suspected allopurinol-induced aseptic meningitis.
Pharmacotherapy 21: 1007-1009 (2001).
-
Greger R, Schreiber R, Mall M, Wissner A, Hopf A, Briel M, Bleich M, Warth R, Kunzelmann K. Cystic fibrosis and CFTR.
Pflugers Arch. 443 Suppl. 1: S3-S7 (2001).
*
-
Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance.
J. Immunol. 167: 1945-1953 (2001).
*
-
Gregorio GV, Portmann B, Karani J, Harrison P, Donaldson PT, Vergani D, Mieli-Vergani G. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study.
Hepatology 33: 544-553 (2001).
*
-
Gresser U. Amoxicillin-clavulanic acid therapy may be associated with severe side effects - review of the literature.
Eur. J. Med. Res. 6: 139-149 (2001).
*
-
Grewal HP, Shokouh-Amiri MH, Vera S, Stratta R, Bagous W, Gaber AO. Surgical technique for right lobe adult living donor liver transplantation without venovenous bypass or portocaval shunting and with duct-to-duct biliary reconstruction.
Ann. Surg. 233: 502-508 (2001).
*
-
Griffiths AM. Anti-TNF therapies have eliminated the need for steroids in pediatric Crohn's disease: con. Why use a drug with an unknown long-term safety profile if more established therapies will be effective?
Inflamm. Bowel Dis. 7: 342-344 (2001).
*
-
Griffiths DJ. Endogenous retroviruses in the human genome sequence.
Genome Biol. 2: REVIEWS1017 (2001).
*
-
Griffiths MM, Remmers EF. Genetic analysis of collagen-induced arthritis in rats: a polygenic model for rheumatoid arthritis predicts a common framework of cross-species inflammatory/autoimmune disease loci.
Immunol. Rev. 184: 172-183 (2001).
*
-
Grigorenko EL, Wood FB, Meyer MS, Pauls JE, Hart LA, Pauls DL. Linkage studies suggest a possible locus for developmental dyslexia on chromosome 1p.
Am. J. Med. Genet. 105: 120-129 (2001).
-
Grimble RF. Nutritional modulation of immune function.
Proc. Nutr. Soc. 60: 389-397 (2001).
*
-
Grismer LE, Gill SA, Harris MD. Liver biopsy in psoriatic arthritis to detect methotrexate hepatotoxicity.
J. Clin. Rheumatol. 7: 224-227 (2001).
-
Gritti A, Di Sarno AM, Comito M, De Vincenzo A, De Paola P, Vajro P. Psychological impact of liver transplantation on children's inner worlds.
Pediatr. Transplant. 5: 37-43 (2001).
-
Groen AK. The pros and cons of gene expression analysis by microarrays.
J. Hepatol. 35: 295-296 (2001).
*
-
Groeneveld AB, Beishuizen A, Appelmelk BJ, Girbes AR. Adjuvant therapies for sepsis and shock: which are more effective?
Ned. Tijdschr. Geneeskd. 145: 1718-1722 (2001).
-
Grompe M. The pathophysiology and treatment of hereditary tyrosinemia type 1.
Semin. Liver Dis. 21: 563-571 (2001).
-
Grompe M. Liver repopulation for the treatment of metabolic diseases.
J. Inherit. Metab. Dis. 24: 231-244 (2001).
*
-
Groux H. An overview of regulatory T cells.
Microbes Infect. 3: 883-889 (2001).
*
-
Guan Y, Breyer MD. Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease.
Kidney Int. 60: 14-30 (2001).
*
-
Guandalini S, Gokhale R. Update on immunologic basis of celiac disease.
Curr. Opin. Gastroenterol. 17: 545-550 (2001).
-
Gudmundsson KG, Arngrimsson R, Jonsson T. Eighteen years follow-up study of the clinical manifestations and progression of Dupuytren's disease.
Scand. J. Rheumatol. 30: 31-34 (2001).
*
-
Guerre-Millo M, Rouault C, Poulain P, Andre J, Poitout V, Peters JM, Gonzalez FJ, Fruchart JC, Reach G, Staels B. PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance.
Diabetes 50: 2809-2814 (2001).
*
-
Guerrero M, Gall E, Tilahun E, Garon J. Wegener's granulomatosis presenting as subglottic stenosis.
J. Clin. Rheumatol. 7: 91-96 (2001).
-
Guerrin M, Vincent C, Simon M, Tazi Ahnini R, Fort M, Serre G. Identification of six novel polymorphisms in the human corneodesmosin gene.
Tissue Antigens 57: 32-38 (2001).
*
-
Guo X, Nanus DM, Ruiz A, Rando RR, Bok D, Gudas LJ. Reduced levels of retinyl esters and vitamin A in human renal cancers.
Cancer Res. 61: 2774-2781 (2001).
*
-
Gupta P, Gokhale R, Kirschner BS. 6-Mercaptopurine metabolite levels in children with inflammatory bowel disease.
J. Pediatr. Gastroenterol. Nutr. 33: 450-454 (2001).
*
-
Gupta R, Agarwal SR, Jain M, Malhotra V, Sarin SK. Autoimmune hepatitis in the Indian subcontinent: 7 years experience.
J. Gastroenterol. Hepatol. 16: 1144-1148 (2001).
*
-
Gupta RA, Dubois RN. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.
Nat. Rev. Cancer 1: 11-21 (2001).
*
-
Gupta S, Stravitz RT, Dent P, Hylemon PB. Down-regulation of cholesterol 7alpha-hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-Jun N-terminal kinase pathway.
J. Biol. Chem. 276: 15816-15822 (2001).
*
-
Gursoy S, Erdal E, Herken H, Madenci E, Alasehirli B. Association of T102C polymorphism of the 5-HT2A receptor gene with psychiatric status in fibromyalgia syndrome.
Rheumatol. Int. 21: 58-61 (2001).
*
-
Guslandi M. Probiotics in Crohn's disease.
Gut 49: 873-874 (2001).
*
-
Gyomorey K, Garami E, Galley K, Rommens JM, Bear CE. Non-CFTR chloride channels likely contribute to secretion in the murine small intestine.
Pflugers Arch. 443 Suppl. 1: S103-S106 (2001).
*
-
Habu Y, Seki S, Takayama E, Ohkawa T, Koike Y, Ami K, Majima T, Hiraide H. The mechanism of a defective IFN-gamma response to bacterial toxins in an atopic dermatitis model, NC/Nga mice, and the therapeutic effect of IFN-gamma, IL-12, or IL-18 on dermatitis.
J. Immunol. 166: 5439-5447 (2001).
*
-
Hadj Kacem H, Bellassoued M, Bougacha-Elleuch N, Abid M, Ayadi H. CTLA-4 gene polymorphisms in Tunisian patients with Graves' disease.
Clin. Immunol. 101: 361-365 (2001).
*
-
Hadj Kacem H, Kaddour N, Adyel FZ, Bahloul Z, Ayadi H. HLA-DQB1 CAR1/CAR2, TNFa IR2/IR4 and CTLA-4 polymorphisms in Tunisian patients with rheumatoid arthritis and Sjogren's syndrome.
Rheumatology (Oxford) 40: 1370-1374 (2001).
*
-
Hagenbuch N, Reichel C, Stieger B, Cattori V, Fattinger KE, Landmann L, Meier PJ, Kullak-Ublick GA. Effect of phenobarbital on the expression of bile salt and organic anion transporters of rat liver.
J. Hepatol. 34: 881-887 (2001).
*
-
Hahm KB, Im YH, Parks TW, Park SH, Markowitz S, Jung HY, Green J, Kim SJ. Loss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel disease.
Gut 49: 190-198 (2001).
*
-
Hahn JS, Kim C, Min YH, Ko YW, Suh CO, Park YY. Non-Hodgkin's lymphoma and primary biliary cirrhosis with Sjogren's syndrome.
Yonsei. Med. J. 42: 258-263 (2001).
*
-
Hakim F, Fowler DH, Shearer GM, Gress RE. Animal models of acute and chronic graft-versus-host disease.
Curr. Protoc. Immunol. Chapter 4: Unit 4.3 (2001).
-
Halliwell B. Free radicals and other reactive species in disease.
ENCYCLOPEDIA OF LIFE SCIENCES Nature Publishing Group www.els.net (2001). *
-
Halonen M, Pelto-Huikko M, Eskelin P, Peltonen L, Ulmanen I, Kolmer M. Subcellular location and expression pattern of autoimmune regulator (Aire), the mouse orthologue for human gene defective in autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED).
J. Histochem. Cytochem. 49: 197-208 (2001).
*
-
Halsey NA, Hyman SL; Conference Writing Panel. Measles-mumps-rubella vaccine and autistic spectrum disorder: report from the New Challenges in Childhood Immunizations Conference convened in Oak Brook, Illinois, June 12-13, 2000.
Pediatrics 107: e84 (2001).
*
-
Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, Fukushima M, Nikaido T, Nakayama K, Usuda N, Kiyosawa K. High serum IgG4 concentrations in patients with sclerosing pancreatitis.
N. Engl. J. Med. 344: 732-738 (2001).
*
-
Hamera-Slynarska M, Slynarski K. The undesirable side-effects of non-steroidal anti-inflammatory drugs.
Ortop. Traumatol. Rehabil. 3: 126-128 (2001).
-
Hammel P, Couvelard A, O'Toole D, Ratouis A, Sauvanet A, Flejou JF, Degott C, Belghiti J, Bernades P, Valla D, Ruszniewski P, Levy P. Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct.
N. Engl. J. Med. 344: 418-423 (2001).
*
-
Hammer B, Link A, Wagner A, Bohm M. Hypersensitivity syndrome during therapy with allopurinol in asymptomatic hyperuricemia with a fatal outcome.
Dtsch. Med. Wochenschr. 126: 1331-1334 (2001).
-
Hammond CL, Lee TK, Ballatori N. Novel roles for glutathione in gene expression, cell death, and membrane transport of organic solutes.
J. Hepatol. 34: 946-954 (2001).
*
-
Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, Frenzel H, King K, Hasselmeyer A, MacPherson AJ, Bridger S, van Deventer S, Forbes A, Nikolaus S, Lennard-Jones JE, Foelsch UR, Krawczak M, Lewis C, Schreiber S, Mathew CG. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations.
Lancet 357: 1925-1928 (2001).
*
-
Hampe J, Lynch NJ, Daniels S, Bridger S, Macpherson AJ, Stokkers P, Forbes A, Lennard-Jones JE, Mathew CG, Curran ME, Schreiber S. Fine mapping of the chromosome 3p susceptibility locus in inflammatory bowel disease.
Gut 48: 191-197 (2001).
*
-
Han Y, Zhang W, Chen J, Zhou H, Wang L. Clinical and pathological study of autoimmune hepatopathy.
Zhonghua Gan Zang Bing Za Zhi 9: 82S-84S (2001).
-
Hanauer SB. Biologics in peri-operative management of Crohn's disease.
Acta Gastroenterol. Belg. 64: 191-192 (2001).
-
Hanauer SB. Crohn's disease therapy: step up or top down therapy.
Acta Gastroenterol. Belg. 64: 189-190 (2001).
-
Hanauer SB. Update on medical management of inflammatory bowel disease: ulcerative colitis.
Rev. Gastroenterol. Disord. 1: 169-176 (2001).
*
-
Hanauer SB, Dassopoulos T. Evolving treatment strategies for inflammatory bowel disease.
Annu. Rev. Med. 52: 299-318 (2001).
*
-
Hanauer SB, Sandborn W; Practice Parameters Committee of the American College of Gastroenterology. Management of Crohn's disease in adults.
Am. J. Gastroenterol. 96: 635-643 (2001).
*
-
Hanck C, Manigold T, Bocker U, Kurimoto M, Kolbel CB, Singer MV, Rossol S. Gene expression of interleukin 18 in unstimulated peripheral blood mononuclear cells of patients with alcoholic cirrhosis.
Gut 49: 106-111 (2001).
*
-
Handschin C, Podvinec M, Looser R, Amherd R, Meyer UA. Multiple enhancer units mediate drug induction of CYP2H1 by xenobiotic-sensing orphan nuclear receptor chicken xenobiotic receptor.
Mol. Pharmacol. 60: 681-689 (2001).
*
-
Handschin C, Podvinec M, Stockli J, Hoffmann K, Meyer UA. Conservation of signaling pathways of xenobiotic-sensing orphan nuclear receptors, chicken xenobiotic receptor, constitutive androstane receptor, and pregnane X receptor, from birds to humans.
Mol. Endocrinol. 15: 1571-1585 (2001).
*
-
Hanson NQ, Aras O, Yang F, Tsai MY. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease.
Clin. Chem. 47: 661-666 (2001).
*
-
Harada K, Furubo S, Ozaki S, Hiramatsu K, Sudo Y, Nakanuma Y. Increased expression of WAF1 in intrahepatic bile ducts in primary biliary cirrhosis relates to apoptosis.
J. Hepatol. 34: 500-506 (2001).
*
-
Harada K, Ozaki S, Kono N, Tsuneyama K, Katayanagi K, Hiramatsu K, Nakanuma Y. Frequent molecular identification of Campylobacter but not Helicobacter genus in bile and biliary epithelium in hepatolithiasis.
J. Pathol. 193: 218-223 (2001).
*
-
Harada K, Tsuneyama K, Sudo Y, Masuda S, Nakanuma Y. Molecular identification of bacterial 16S ribosomal RNA gene in liver tissue of primary biliary cirrhosis: is Propionibacterium acnes involved in granuloma formation?
Hepatology 33: 530-536 (2001).
*
-
Harada K, Yasoshima M, Ozaki S, Sanzen T, Nakanuma Y. PCR and in situ hybridization studies of telomerase subunits in human non-neoplastic livers.
J. Pathol. 193: 210-217 (2001).
*
-
Harada M, Sakisaka S, Terada K, Kimura R, Kawaguchi T, Koga H, Kim M, Taniguchi E, Hanada S, Suganuma T, Furuta K, Sugiyama T, Sata M. A mutation of the Wilson disease protein, ATP7B, is degraded in the proteasomes and forms protein aggregates.
Gastroenterology 120: 967-974 (2001).
*
-
Harats D, Yodfat O, Doolman R, Gavendo S, Marko D, Shaish A, Sela BA. Homocysteine elevation with fibrates: is it a class effect?
Isr. Med. Assoc. J. 3: 243-246 (2001).
*
-
Hardcastle J, Hardcastle PT, Chapman J, Taylor CJ. Taurocholic acid-induced secretion in normal and cystic fibrosis mouse ileum.
J. Pharm. Pharmacol. 53: 711-719 (2001).
-
Hardcastle J, Hardcastle PT, Chapman J, Taylor CJ. Ursodeoxycholic acid action on the transport function of the small intestine in normal and cystic fibrosis mice.
J. Pharm. Pharmacol. 53: 1457-1467 (2001).
*
-
Harding G, McKenna R, Minuk G. The immune response to alkaline phosphatase and other immunogens in patients with primary biliary cirrhosis.
Hepatogastroenterology 48: 66-70 (2001).
-
Hardy RR, Hayakawa K. B cell development pathways.
Annu. Rev. Immunol. 19: 595-621 (2001).
*
-
Harnois DM, Angulo P, Jorgensen RA, LaRusso NF, Lindor KD. High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis.
Am. J. Gastroenterol. 96: 1558-1562 (2001).
*
-
Harper L, Cockwell P, Adu D, Savage CO. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
Kidney Int. 59: 1729-1738 (2001).
*
-
Harper L, Radford D, Plant T, Drayson M, Adu D, Savage CO. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
Arthritis Rheum. 44: 921-930 (2001).
*
-
Harris JE, Lammerding AM. Crohn's disease and Mycobacterium avium subsp. paratuberculosis: current issues.
J. Food Prot. 64: 2103-2110 (2001).
-
Hartley P, Petruckevitch A, Reeves B, Rolles K. The National Liver Transplantation audit: an overview of patients presenting for liver transplantation from 1994 to 1998. On behalf of the Steering Group of the UK Liver Transplantation Audit.
Br. J. Surg. 88: 52-58 (2001).
-
Hartmann G, Kim H, Piquette-Miller M. Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice.
Int. Immunopharmacol. 1: 189-199 (2001).
-
Hashimoto E, Obata H, Tanikawa K, Ichida F. Selection and timing of liver transplantation in primary biliary cirrhosis.
Hepatol. Res. 20: 271-278 (2001).
-
Hashimoto E, Shimada M, Noguchi S, Taniai M, Tokushige K, Hayashi N, Takasaki K, Fuchinoue S, Ludwig J. Disease recurrence after living liver transplantation for primary biliary cirrhosis: a clinical and histological follow-up study.
Liver Transpl. 7: 588-595 (2001).
*
-
Hasko G, Szabo C, Nemeth ZH, Deitch EA. Sulphasalazine inhibits macrophage activation: inhibitory effects on inducible nitric oxide synthase expression, interleukin-12 production and major histocompatibility complex II expression.
Immunology 103: 473-478 (2001).
*
-
Haslam N, Standen GR, Probert CS. An investigation of the association of the prothrombin G20210A gene mutation and inflammatory bowel disease: factor II and IBD.
Inflamm. Bowel Dis. 7: 133-135 (2001).
*
-
Hasler P, Zouali M. B cell receptor signaling and autoimmunity.
FASEB J. 15: 2085-2098 (2001).
*
-
Hassanein T. Cholestasis.
Z. Gastroenterol. 39 (Suppl. 2): 36 (2001).
-
Hattar K, Sibelius U, Bickenbach A, Csernok E, Seeger W, Grimminger F. Subthreshold concentrations of anti-proteinase 3 antibodies (c-ANCA) specifically prime human neutrophils for fMLP-induced leukotriene synthesis and chemotaxis.
J. Leukoc. Biol. 69: 89-97 (2001).
*
-
Hatzis GS, Vassiliou VA, Delladetsima JK. Overlap syndrome of primary sclerosing cholangitis and autoimmune hepatitis.
Eur. J. Gastroenterol. Hepatol. 13: 203-206 (2001).
-
Hausmann M, Spottl T, Andus T, Rothe G, Falk W, Scholmerich J, Herfarth H, Rogler G. Subtractive screening reveals up-regulation of NADPH oxidase expression in Crohn's disease intestinal macrophages.
Clin. Exp. Immunol. 125: 48-55 (2001).
*
-
Havrda DE, Rathbun S, Scheid D. A case report of warfarin resistance due to azathioprine and review of the literature.
Pharmacotherapy 21: 355-357 (2001).
-
Hawk ET, Viner JL. Chemoprevention in ulcerative colitis: narrowing the gap between clinical practice and research.
Ann. Intern. Med. 134: 158-160 (2001).
*
-
Hawkes ND, Mutimer D, Thomas GA. Intermittent jaundice and rigors in a patient with longstanding ulcerative colitis.
Postgrad. Med. J. 77: 406-407 (2001).
*
-
Hawkey GM, Cole AT, McIntyre AS, Long RG, Hawkey CJ. Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points.
Gut 49: 372-379 (2001).
*
-
Hawthorne AB. Methotrexate: a useful alternative in Crohn's disease?
Gut 49: 9-10 (2001).
*
-
Hay JE, Malinchoc M, Dickson ER. A controlled trial of calcitonin therapy for the prevention of post-liver transplantation atraumatic fractures in patients with primary biliary cirrhosis and primary sclerosing cholangitis.
J. Hepatol. 34: 292-298 (2001).
*
-
Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, Eng JK, Akira S, Underhill DM, Aderem A. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5.
Nature 410: 1099-1103 (2001).
*
-
Hayashi N, Yamamoto H, Hiraoka N, Dono K, Ito Y, Okami J, Kondo M, Nagano H, Umeshita K, Sakon M, Matsuura N, Nakamori S, Monden M. Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm.
Hepatology 34: 638-650 (2001).
*
-
Hayashi T, Takahashi T, Minami T, Akaike J, Kasahara K, Adachi M, Hinoda Y, Takahashi S, Hirayama T, Imai K. Fatal acute hepatic failure induced by danazol in a patient with endometriosis and aplastic anemia.
J. Gastroenterol. 36: 783-786 (2001).
*
-
Hayhurst GP, Lee YH, Lambert G, Ward JM, Gonzalez FJ. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis.
Mol. Cell. Biol. 21: 1393-1403 (2001).
*
-
He XS, Ansari AA, Gershwin ME. Xenobiotic considerations for the development of autoimmune liver diseases: bad genes and bad luck.
Rev. Environ. Health 16: 191-202 (2001).
-
Heath WR, Carbone FR. Cross-presentation, dendritic cells, tolerance and immunity.
Annu. Rev. Immunol. 19: 47-64 (2001).
*
-
Heath WR, Carbone FR. Cross-presentation in viral immunity and self-tolerance.
Nat. Rev. Immunol. 1: 126-134 (2001).
*
-
Heathcote J. Primary biliary cirrhosis with features of autoimmune hepatitis.
Curr. Gastroenterol. Rep. 3: 60-64 (2001).
-
Heding PE, Karlsen AE, Veijola R, Nerup J, Pociot F. No evidence of a functionally significant polymorphism of the BCL2 gene in Danish, Finnish and Basque type 1 diabetes families.
Genes Immun. 2: 398-400 (2001).
*
-
Heemskerk MH, de Paus RA, Lurvink EG, Koning F, Mulder A, Willemze R, van Rood JJ, Falkenburg JH. Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex.
Proc. Natl. Acad. Sci. U.S.A. 98: 6806-6811 (2001).
*
-
Heeringa P, Bijl M, de Jager-Krikken A, Zandvoort A, Dijkstra G, Moshage H, Tervaert JW, Tiebosch AT, Kallenberg CG, van Goor H. Renal expression of endothelial and inducible nitric oxide synthase, and formation of peroxynitrite-modified proteins and reactive oxygen species in Wegener's granulomatosis.
J. Pathol. 193: 224-232 (2001).
*
-
Hegazy DM, O'Reilly DA, Yang BM, Hodgkinson AD, Millward BA, Demaine AG. NFkappaB polymorphisms and susceptibility to type 1 diabetes.
Genes Immun. 2: 304-308 (2001).
*
-
Hegele RA, Cao H. Single nucleotide polymorphisms of RXRA encoding retinoid X receptor alpha.
J. Hum. Genet. 46: 423-425 (2001).
*
-
Heiss E, Herhaus C, Klimo K, Bartsch H, Gerhauser C. Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms.
J. Biol. Chem. 276: 32008-32015 (2001).
*
-
Hellier JP, Eliaou JF, Daures JP, Sany J, Combe B. HLA-DRB1 genes and patients with late onset rheumatoid arthritis.
Ann. Rheum. Dis. 60: 531-533 (2001).
*
-
Helton WS, Espat NJ. Cholecystitis and cholangitis.
Curr. Treat. Opt. Infect. Dis. 3: 387-400 (2001). *
-
Hendriks HJ, van Kreel B, Forget PP. Effects of therapy with lansoprazole on intestinal permeability and inflammation in young cystic fibrosis patients.
J. Pediatr. Gastroenterol. Nutr. 33: 260-265 (2001).
*
-
Heneghan MA, Norris SM, O'Grady JG, Harrison PM, McFarlane IG. Management and outcome of pregnancy in autoimmune hepatitis.
Gut 48: 97-102 (2001).
*
-
Heneghan MA, Portmann BC, Norris SM, Williams R, Muiesan P, Rela M, Heaton ND, O'Grady JG. Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults.
Hepatology 34: 464-470 (2001).
*
-
Heneghan MA, Sylvestre PB. Cholestatic diseases of liver transplantation.
Semin. Gastrointest. Dis. 12: 133-147 (2001).
-
Henry MT, Cave S, Rendall J, O'Connor CM, Morgan K, FitzGerald MX, Kalsheker N. An alpha1-antitrypsin enhancer polymorphism is a genetic modifier of pulmonary outcome in cystic fibrosis.
Eur. J. Hum. Genet. 9: 273-278 (2001).
*
-
Herfarth H, Pollok-Kopp B, Goke M, Press A, Oppermann M. Polymorphism of CC chemokine receptors CCR2 and CCR5 in Crohn's disease.
Immunol. Lett. 77: 113-117 (2001).
-
Hermon-Taylor J. Protagonist. Mycobacterium avium subspecies paratuberculosis is a cause of Crohn's disease.
Gut 49: 755-756 (2001).
*
-
Hernan MA, Olek MJ, Ascherio A. Cigarette smoking and incidence of multiple sclerosis.
Am. J. Epidemiol. 154: 69-74 (2001).
*
-
Hernan MA, Zhang SM, Lipworth L, Olek MJ, Ascherio A. Multiple sclerosis and age at infection with common viruses.
Epidemiology 12: 301-306 (2001).
-
Hernandez HM, Kovarik P, Whitington PF, Alonso EM. Autoimmune hepatitis as a late complication of liver transplantation.
J. Pediatr. Gastroenterol. Nutr. 32: 131-136 (2001).
*
-
Herzog ED, Tosini G. The mammalian circadian clock shop.
Semin. Cell. Dev. Biol. 12: 295-303 (2001).
*
-
Heuschen UA, Hinz U, Allemeyer EH, Stern J, Lucas M, Autschbach F, Herfarth C, Heuschen G. Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis.
Gastroenterology 120: 841-847 (2001).
*
-
Heward JM, Nithiyananthan R, Allahabadia A, Gibson S, Franklyn JA, Gough SC. No association of an interleukin 4 gene promoter polymorphism with Graves' disease in the United Kingdom.
J. Clin. Endocrinol. Metab. 86: 3861-3863 (2001).
*
-
Heyman M. Symposium on 'dietary influences on mucosal immunity'. How dietary antigens access the mucosal immune system.
Proc. Nutr. Soc. 60: 419-426 (2001).
-
Hiatt KK, Ingram DA, Zhang Y, Bollag G, Clapp DW. Neurofibromin GTPase-activating protein-related domains restore normal growth in Nf1-/- cells.
J. Biol. Chem. 276: 7240-7245 (2001).
*
-
Hibbs AM, Bznik-Cizman B, Guttenberg M, Goldberg B, Meyers K. Ulcerative colitis in a renal transplant patient with previous Goodpasture disease.
Pediatr. Nephrol. 16: 543-546 (2001).
*
-
Higgins CF. ABC transporters: physiology, structure and mechanism - an overview.
Res. Microbiol. 152: 205-210 (2001).
-
Higgins CF, Linton KJ. Structural biology. The xyz of ABC transporters.
Science 293: 1782-1784 (2001).
*
-
Higuchi H, Miyoshi H, Bronk SF, Zhang H, Dean N, Gores GJ. Bid antisense attenuates bile acid-induced apoptosis and cholestatic liver injury.
J. Pharmacol. Exp. Ther. 299: 866-873 (2001).
*
-
Hill AV. Immunogenetics and genomics.
Lancet 357: 2037-2041 (2001).
*
-
Hirai I, Ishiyama S, Fuse A, Kuzu H, Sakurai F, Kimura S, Kimura W. Primary sclerosing cholangitis successfully treated by resection of the confluence of the hepatic duct.
J. Hepatobiliary Pancreat. Surg. 8: 169-173 (2001).
-
Hiraki T, Kanazawa S, Mimura H, Yasui K, Tanaka A, Dendo S, Yoshimura K, Hiraki Y. Altered hepatic hemodynamics caused by temporary occlusion of the right hepatic vein: evaluation with Doppler US in 14 patients.
Radiology 220: 357-364 (2001).
*
-
Hirano F, Kobayashi A, Hirano Y, Nomura Y, Fukawa E, Makino I. Bile acids regulate RANTES gene expression through its cognate NF-kappaB binding sites.
Biochem. Biophys. Res. Commun. 288: 1095-1101 (2001).
*
-
Hiraoka A, Kojima N, Yamauchi Y, Ninomiya T, Masumoto T, Michitaka K, Horiike N, Onji M. An autopsy case of primary biliary cirrhosis with severe interstitial pneumonia.
Intern. Med. 40: 1104-1108 (2001).
*
-
Hirata K, Nathanson MH. Bile duct epithelia regulate biliary bicarbonate excretion in normal rat liver.
Gastroenterology 121: 396-406 (2001).
*
-
Hiratani H, Akamizu T. Association study on candidate loci of susceptible genes of autoimmune thyroid diseases in a Japanese population.
Rinsho Byori 49: 1151-1156 (2001).
-
Hirotani M, Tsukamoto T, Bourdeaux J, Sadano H, Osumi T. Stabilization of peroxisome proliferator-activated receptor alpha by the ligand.
Biochem. Biophys. Res. Commun. 288: 106-110 (2001).
*
-
Hizawa N, Yamaguchi E, Jinushi E, Konno S, Kawakami Y, Nishimura M. Increased total serum IgE levels in patients with asthma and promoter polymorphisms at CTLA4 and FCER1B.
J. Allergy Clin. Immunol. 108: 74-79 (2001).
*
-
Hlaing T, Guo RF, Dilley KA, Loussia JM, Morrish TA, Shi MM, Vincenz C, Ward PA. Molecular cloning and characterization of DEFCAP-L and -S, two isoforms of a novel member of the mammalian Ced-4 family of apoptosis proteins.
J. Biol. Chem. 276: 9230-9238 (2001).
*
-
Hocking LJ, Herbert CA, Nicholls RK, Williams F, Bennett ST, Cundy T, Nicholson GC, Wuyts W, Van Hul W, Ralston SH. Genomewide search in familial Paget disease of bone shows evidence of genetic heterogeneity with candidate loci on chromosomes 2q36, 10p13, and 5q35.
Am. J. Hum. Genet. 69: 1055-1061 (2001).
*
-
Hodak E, Lapidoth M, Kohn K, David D, Brautbar B, Kfir K, Narinski N, Safirman S, Maron M, Klein K. Mycosis fungoides: HLA class II associations among Ashkenazi and non-Ashkenazi Jewish patients.
Br. J. Dermatol. 145: 974-980 (2001).
*
-
Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome.
Nat. Genet. 29: 301-305 (2001).
*
-
Hofmann AF. Bile secretion in mice and men.
Hepatology 34: 848-850 (2001).
*
-
Hogan MM, Vogel SN. Measurement of tumor necrosis factor alpha and beta.
Curr. Protoc. Immunol. Chapter 6: Unit 6.10 (2001).
-
Hoglen NC, Hirakawa BP, Fisher CD, Weeks S, Srinivasan A, Wong AM, Valentino KL, Tomaselli KJ, Bai X, Karanewsky DS, Contreras PC. Characterization of the caspase inhibitor IDN-1965 in a model of apoptosis-associated liver injury.
J. Pharmacol. Exp. Ther. 297: 811-818 (2001).
*
-
Hoglund P, Sormaala M, Haila S, Socha J, Rajaram U, Scheurlen W, Sinaasappel M, de Jonge H, Holmberg C, Yoshikawa H, Kere J. Identification of seven novel mutations including the first two genomic rearrangements in SLC26A3 mutated in congenital chloride diarrhea.
Hum. Mutat. 18: 233-242 (2001).
-
Hokari R, Miura S, Nagata H, Fujimori H, Koseki S, Kato S, Kurose I, Sekizuka E, Granger DN, Ishii H. Intercellular cell adhesion molecule-1 regulates lymphocyte movement into intestinal microlymphatics of rat Peyer's patches.
J. Leukoc. Biol. 70: 896-902 (2001).
*
-
Holloway JW, Lonjou C, Beghe B, Peng Q, Gaunt TR, Gomes I, Hall IP, Dewar JC, Wilkinson J, Thomas NS, Holgate ST, Morton NE. Linkage analysis of the 5q31-33 candidate region for asthma in 240 UK families.
Genes Immun. 2: 20-24 (2001).
*
-
Holopainen P, Mustalahti K, Uimari P, Collin P, Maki M, Partanen J. Candidate gene regions and genetic heterogeneity in gluten sensitivity.
Gut 48: 696-701 (2001).
*
-
Holopainen PM, Partanen JA. Technical note: linkage disequilibrium and disease-associated CTLA4 gene polymorphisms.
J. Immunol. 167: 2457-2458 (2001).
*
-
Holscher C, Atkinson RA, Arendse B, Brown N, Myburgh E, Alber G, Brombacher F. A protective and agonistic function of IL-12p40 in mycobacterial infection.
J. Immunol. 167: 6957-6966 (2001).
*
-
Holtmann MH, Galle PR, Neurath MF. Immunotherapeutic approaches to inflammatory bowel diseases.
Expert Opin. Biol. Ther. 1: 455-466 (2001).
-
Holtmeier J, Leuschner U. Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.
Digestion 64: 137-150 (2001).
*
-
Holzmann K, Klump B, Borchard F, Gregor M, Porschen R. Flow cytometric and histologic evaluation in a large cohort of patients with ulcerative colitis: correlation with clinical characteristics and impact on surveillance.
Dis. Colon Rectum 44: 1446-1455 (2001).
-
Honjo S, Kono S, Coleman MP, Shinchi K, Sakurai Y, Todoroki I, Umeda T, Wakabayashi K, Imanishi K, Nishikawa H, Ogawa S, Katsurada M, Nakagawa K, Yoshizawa N. Coffee consumption and serum aminotransferases in middle-aged Japanese men.
J. Clin. Epidemiol. 54: 823-829 (2001).
-
Honma J, Mitomi H, Murakami K, Igarashi M, Saigenji K, Toyama K. Nodular duodenitis involving CD8+ cell infiltration in patients with ulcerative colitis.
Hepatogastroenterology 48: 1604-1610 (2001).
-
Honorati MC, Meliconi R, Pulsatelli L, Cane S, Frizziero L, Facchini A. High in vivo expression of interleukin-17 receptor in synovial endothelial cells and chondrocytes from arthritis patients.
Rheumatology (Oxford) 40: 522-527 (2001).
*
-
Hooiveld GJ, van Montfoort JE, Meijer DK, Muller M. Function and regulation of ATP-binding cassette transport proteins involved in hepatobiliary transport.
Eur. J. Pharm. Sci. 12: 525-543 (2001).
*
-
Horiuchi A, Kawa S, Hamano H, Ochi Y, Kiyosawa K. Sclerosing pancreato-cholangitis responsive to corticosteroid therapy: report of 2 case reports and review.
Gastrointest. Endosc. 53: 518-522 (2001).
*
-
Horiuchi Y. Lichenoid eruptions due to ursodeoxycholic acid administration.
Gastroenterology 121: 501-502 (2001).
*
-
Horn MP, Pachlopnik JM, Vogel M, Dahinden M, Wurm F, Stadler BM, Miescher SM. Conditional autoimmunity mediated by human natural anti-Fc(epsilon)RIalpha autoantibodies?
FASEB J. 15: 2268-2274 (2001).
*
-
Horng T, Barton GM, Medzhitov R. TIRAP: an adapter molecule in the Toll signaling pathway.
Nat. Immunol. 2: 835-841 (2001).
*
-
Hou G, Liang X, Chen R, Yang C, Huang F, Yan Z, Xu P, Wang Y. A study of Wilson's disease gene encoded products and gene mutations.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi 18: 165-168 (2001).
-
Houlston RS, Tomlinson IP. Polymorphisms and colorectal tumor risk.
Gastroenterology 121: 282-301 (2001).
*
-
Howard LA, Micu AL, Sellers EM, Tyndale RF. Low doses of nicotine and ethanol induce CYP2E1 and chlorzoxazone metabolism in rat liver.
J. Pharmacol. Exp. Ther. 299: 542-550 (2001).
*
-
Howard TD, Whittaker PA, Zaiman AL, Koppelman GH, Xu J, Hanley MT, Meyers DA, Postma DS, Bleecker ER. Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population.
Am. J. Respir. Cell. Mol. Biol. 25: 377-384 (2001).
*
-
Howes N, Greenhalf W, Rutherford S, O'Donnell M, Mountford R, Ellis I, Whitcomb D, Imrie C, Drumm B, Neoptolemos JP. A new polymorphism for the RI22H mutation in hereditary pancreatitis.
Gut 48: 247-250 (2001).
*
-
Hrobjartsson A, Gotzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment.
N. Engl. J. Med. 344: 1594-1602 (2001).
*
-
Hsiao GR, Wolf RE, Kimpel DL. Intravenous immunoglobulin to prevent recurrent thrombosis in the antiphospholipid syndrome.
J. Clin. Rheumatol. 7: 336-339 (2001).
-
Hsieh CS, Huang CC, Wu JJ, Chaung HC, Wu CL, Chang NK, Chang YM, Chou MH, Chuang JH. Ascending cholangitis provokes IL-8 and MCP-1 expression and promotes inflammatory cell infiltration in the cholestatic rat liver.
J. Pediatr. Surg. 36: 1623-1628 (2001).
-
Hsu MH, Savas U, Griffin KJ, Johnson EF. Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor alpha in HepG2 cells.
J. Biol. Chem. 276: 27950-27958 (2001).
*
-
Hsu PN, Wolf Bryant P, Sutkowski N, McLellan B, Ploegh HL, Huber BT. Association of mouse mammary tumor virus superantigen with MHC class II during biosynthesis.
J. Immunol. 166: 3309-3314 (2001).
*
-
Hu FB. The role of n-3 polyunsaturated fatty acids in the prevention and treatment of cardiovascular disease.
Drugs Today (Barc.) 37: 49-56 (2001).
-
Hu Y, Baud V, Oga T, Kim KI, Yoshida K, Karin M. IKKalpha controls formation of the epidermis independently of NF-kappaB.
Nature 410: 710-714 (2001).
*
-
Huang BB, Bonish BK, Chaturvedi V, Qin JZ, Nickoloff BJ. Keratinocyte CDw60 expression is modulated by both a Th-1 type cytokine IFN-gamma and Th-2 cytokines IL-4 and IL-13: relevance to psoriasis.
J. Invest. Dermatol. 116: 305-312 (2001).
*
-
Huang L, Vore M. Multidrug resistance P-glycoprotein 2 is essential for the biliary excretion of indocyanine green.
Drug Metab. Dispos. 29: 634-637 (2001).
*
-
Hubacek JA, Berge KE, Cohen JC, Hobbs HH. Mutations in ATP-cassette binding proteins G5 (ABCG5) and G8 (ABCG8) causing sitosterolemia.
Hum. Mutat. 18: 359-360 (2001).
*
-
Hubacek JA, Stuber F, Frohlich D, Book M, Wetegrove S, Ritter M, Rothe G, Schmitz G. Gene variants of the bactericidal/permeability increasing protein and lipopolysaccharide binding protein in sepsis patients: gender-specific genetic predisposition to sepsis.
Crit. Care Med. 29: 557-561 (2001).
-
Hudson VM. Rethinking cystic fibrosis pathology: the critical role of abnormal reduced glutathione (GSH) transport caused by CFTR mutation.
Free Radic. Biol. Med. 30: 1440-1461 (2001).
-
Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.
Nature 411: 599-603 (2001).
*
-
Hui T, Rozga J, Demetriou AA. Bioartificial liver support.
J. Hepatobiliary Pancreat. Surg. 8: 1-15 (2001).
*
-
Hulkkonen J, Pertovaara M, Antonen J, Lahdenpohja N, Pasternack A, Hurme M. Genetic association between interleukin-10 promoter region polymorphisms and primary Sjogren's syndrome.
Arthritis Rheum. 44: 176-179 (2001).
*
-
Hulkkonen J, Pertovaara M, Antonen J, Pasternack A, Hurme M. Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjogren's syndrome and correlate with the clinical manifestations of the disease.
Rheumatology (Oxford) 40: 656-661 (2001).
*
-
Hulten K, El-Zimaity HM, Karttunen TJ, Almashhrawi A, Schwartz MR, Graham DY, El-Zaatari FA. Detection of Mycobacterium avium subspecies paratuberculosis in Crohn's diseased tissues by in situ hybridization.
Am. J. Gastroenterol. 96: 1529-1535 (2001).
*
-
Humar B, D'Orazio D, Albrecht C, Bauerfeind P, Muller H, Dobbie Z, Bendik I. Expression of putative anticancer targets in familial adenomatous polyposis and its association with the APC mutation status.
Int. J. Oncol. 19: 1179-1186 (2001).
-
Hunt PJ, Marshall SE, Weetman AP, Bunce M, Bell JI, Wass JA, Welsh KI. Histocompatibility leucocyte antigens and closely linked immunomodulatory genes in autoimmune thyroid disease.
Clin. Endocrinol. (Oxf.) 55: 491-499 (2001).
*
-
Huppert FA, Van Niekerk JK. Dehydroepiandrosterone (DHEA) supplementation for cognitive function.
Cochrane Database Syst. Rev. 2: CD000304 (2001).
-
Huster D, Schubert C, Achenbach H, Caca K, Mossner J, Berr F. Successful clinical application of extracorporal albumin dialysis in a patient with benign recurrent intrahepatic cholestasis (BRIC).
Z. Gastroenterol. 39 (Suppl. 2): 13-14 (2001).
-
Hustert E, Zibat A, Presecan-Siedel E, Eiselt R, Mueller R, Fuss C, Brehm I, Brinkmann U, Eichelbaum M, Wojnowski L, Burk O. Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4.
Drug Metab. Dispos. 29: 1454-1459 (2001).
*
-
Hutson DG, Russell E, Levi JU, Jeffers LJ, Reddy KR, Yrizarry JM, Scagnelli T, Sleeman D, Schiff ER, Livingstone AS. Dilatation of biliary strictures through the afferent limb of a Roux-en-Y choledochojejunostomy in patients with sclerosing cholangitis.
World J. Surg. 25: 1251-1253 (2001).
*
-
Hymowitz SG, Filvaroff EH, Yin JP, Lee J, Cai L, Risser P, Maruoka M, Mao W, Foster J, Kelley RF, Pan G, Gurney AL, de Vos AM, Starovasnik MA. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding.
EMBO J. 20: 5332-5341 (2001).
*
-
Hyogo H, Tazuma S, Nishioka T, Ochi H, Yamaguchi A, Numata Y, Kanno K, Sakomoto M, Asamoto Y, Tsuboi K, Nakai K, Yasumiba S, Sunami Y, Kajiyama G. Phospholipid alterations in hepatocyte membranes and transporter protein changes in cholestatic rat model.
Dig. Dis. Sci. 46: 2089-2097 (2001).
*
-
Hytonen M, Patjas M, Vento SI, Kauppi P, Malmberg H, Ylikoski J, Kere J. Cystic fibrosis gene mutations deltaF508 and 394delTT in patients with chronic sinusitis in Finland.
Acta Otolaryngol. 121: 945-947 (2001).
*
-
Iglesias Alzueta J, Matamoros Florí N. Common variable immunodeficiency. Review.
Allergol. Immunopathol. (Madr.) 29: 113-118 (2001).
-
Ihara K, Ahmed S, Nakao F, Kinukawa N, Kuromaru R, Matsuura N, Iwata I, Nagafuchi S, Kohno H, Miyako K, Hara T. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with type 1 diabetes in the Japanese population.
Immunogenetics 53: 447-454 (2001).
-
Iijima H, Takahashi I, Kiyono H. Mucosal immune network in the gut for the control of infectious diseases.
Rev. Med. Virol. 11: 117-133 (2001).
-
Iizuka M, Saito H, Yukawa M, Itou H, Shirasaka T, Chiba M, Fukushima T, Watanabe S. No evidence of persistent mumps virus infection in inflammatory bowel disease.
Gut 48: 637-641 (2001).
*
-
Ikeda F, Yamamoto K, Fujioka S, Okamoto R, Yabushita K, Miyake M, Shimada N, Kono H, Nakamura M, Terada R, Miyake Y, Tsuji T. Laparoscopic findings in primary sclerosing cholangitis.
Endoscopy 33: 267-270 (2001).
-
Ikeda Y, Akbar F, Matsui H, Onji M. Characterization of antigen-presenting dendritic cells in the peripheral blood and colonic mucosa of patients with ulcerative colitis.
Eur. J. Gastroenterol. Hepatol. 13: 841-850 (2001).
-
Ikuno N, Mackay IR, Jois J, Omagari K, Rowley MJ. Antimitochondrial autoantibodies in saliva and sera from patients with primary biliary cirrhosis.
J. Gastroenterol. Hepatol. 16: 1390-1394 (2001).
*
-
Ikuno N, Scealy M, Davies JM, Whittingham SF, Omagari K, Mackay IR, Rowley MJ. A comparative study of antibody expressions in primary biliary cirrhosis and autoimmune cholangitis using phage display.
Hepatology 34: 478-486 (2001).
*
-
Imada A, Ina K, Shimada M, Yokoyama T, Yokoyama Y, Nishio Y, Yamaguchi T, Ando T, Kusugami K. Coordinate upregulation of interleukin-8 and growth-related gene product-alpha is present in the colonic mucosa of inflammatory bowel.
Scand. J. Gastroenterol. 36: 854-864 (2001).
-
Imai T, Jiang M, Chambon P, Metzger D. Impaired adipogenesis and lipolysis in the mouse upon selective ablation of the retinoid X receptor alpha mediated by a tamoxifen-inducible chimeric Cre recombinase (Cre-ERT2) in adipocytes.
Proc. Natl. Acad. Sci. U.S.A. 98: 224-228 (2001).
*
-
Imai T, Jiang M, Kastner P, Chambon P, Metzger D. Selective ablation of retinoid X receptor alpha in hepatocytes impairs their lifespan and regenerative capacity.
Proc. Natl. Acad. Sci. U.S.A. 98: 4581-4856 (2001).
*
-
Immervoll T, Loesgen S, Dutsch G, Gohlke H, Herbon N, Klugbauer S, Dempfle A, Bickeboller H, Becker-Follmann J, Ruschendorf F, Saar K, Reis A, Wichmann HE, Wjst M. Fine mapping and single nucleotide polymorphism association results of candidate genes for asthma and related phenotypes.
Hum. Mutat. 18: 327-336 (2001).
*
-
Imrie H, Vaidya B, Perros P, Kelly WF, Toft AD, Young ET, Kendall-Taylor P, Pearce SH. Evidence for a Graves' disease susceptibility locus at chromosome Xp11 in a United Kingdom population.
J. Clin. Endocrinol. Metab. 86: 626-630 (2001).
*
-
in t' Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T, Breteler MM, Stricker BH. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease.
N. Engl. J. Med. 345: 1515-1521 (2001).
*
-
Inamadar AC, Sampagavi VV, Athanikar SB, Patil MN, Deshmukh NS. Vitiligo and psoriasis: coexistence with colocalization.
Indian J. Dermatol. Venereol. Leprol. 67: 214-215 (2001).
*
-
Ingram DA, Hiatt K, King AJ, Fisher L, Shivakumar R, Derstine C, Wenning MJ, Diaz B, Travers JB, Hood A, Marshall M, Williams DA, Clapp DW. Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro.
J. Exp. Med. 194: 57-69 (2001).
*
-
Inohara N, Nunez G. The NOD: a signaling module that regulates apoptosis and host defense against pathogens.
Oncogene 20: 6473-6481 (2001).
*
-
Inohara N, Ogura Y, Chen FF, Muto A, Nunez G. Human Nod1 confers responsiveness to bacterial lipopolysaccharides.
J. Biol. Chem. 276: 2551-2554 (2001).
*
-
Inokuchi A, Hinoshita E, Iwamoto Y, Kohno K, Kuwano M, Uchiumi T. Enhanced expression of the human multidrug resistance protein 3 by bile salt in human enterocytes. A transcriptional control of a plausible bile acid transporter.
J. Biol. Chem. 276: 46822-46829 (2001).
*
-
Inomata Y, Nakamura T, Uemoto S, Tanaka K, Wakabayashi G, Shimazu M. Domino split-liver transplantation from a living donor: case reports of in situ and ex situ splitting.
Liver Transpl. 7: 150-153 (2001).
*
-
Inoue I, Goto S, Matsunaga T, Nakajima T, Awata T, Hokari S, Komoda T, Katayama S. The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells.
Metabolism 50: 3-11 (2001).
*
-
Inoue N, Watanabe M, Sato T, Okazawa A, Yamazaki M, Kanai T, Ogata H, Iwao Y, Ishii H, Hibi T. Restricted V(H) gene usage in lamina propria B cells producing anticolon antibody from patients with ulcerative colitis.
Gastroenterology 121: 15-23 (2001).
*
-
Invernizzi P, Podda M, Battezzati PM, Crosignani A, Zuin M, Hitchman E, Maggioni M, Meroni PL, Penner E, Wesierska-Gadek J. Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis.
J. Hepatol. 34: 366-372 (2001).
*
-
Ionescu-Tirgoviste C, Guja C, Herr M, Cucca E, Welsh K, Bunce M, Marshall S, Todd JA. Low frequency of HLA DRB1*03 - DQB1*02 and DQB1*0302 haplotypes in Romania is consistent with the country's low incidence of type I diabetes.
Diabetologia 44 Suppl. 3: B60-B66 (2001).
-
Iredale JP. Hepatic stellate cell behavior during resolution of liver injury.
Semin. Liver Dis. 21: 427-436 (2001).
-
Ishaq S, Green JR. Tolerability of aminosalicylates in inflammatory bowel disease.
BioDrugs 15: 339-349 (2001).
-
Ishibashi H. Are primary biliary cirrhosis and autoimmune cholangitis reflective of the pendulum of a clock and therefore represent a 'phase' of the same disease?
J. Gastroenterol. Hepatol. 16: 121-123 (2001).
-
Ishigami F, Naka S, Takeshita K, Kurumi Y, Hanasawa K, Tani T. Bile salt tauroursodeoxycholic acid modulation of Bax translocation to mitochondria protects the liver from warm ischemia-reperfusion injury in the rat.
Transplantation 72: 1803-1807 (2001).
-
Ishiguro H, Naruse S, San Román JI, Case M, Steward MC. Pancreatic ductal bicarbonate secretion: past, present and future.
JOP 2: S192-S197 (2001).
*
-
Ishikawa N, Imamura T, Nakajima K, Yamaga J, Yuchi H, Ootsuka M, Inatsu H, Aoki T, Eto T. Acute pericarditis associated with 5-aminosalicylic acid (5-ASA) treatment for severe active ulcerative colitis.
Intern. Med. 40: 901-904 (2001).
*
-
Ishitsuka T, Kashiwagi H, Konishi F. Microsatellite instability in inflamed and neoplastic epithelium in ulcerative colitis.
J. Clin. Pathol. 54: 526-532 (2001).
*
-
Ishizuka K, Sugimura K, Homma T, Matsuzawa J, Mochizuki T, Kobayashi M, Suzuki K, Otsuka K, Tashiro K, Yamaguchi O, Asakura H. Influence of interleukin-10 on the interleukin-1 receptor antagonist/interleukin-1 beta ratio in the colonic mucosa of ulcerative colitis.
Digestion 63 Suppl. 1: 22-27 (2001).
-
Isolauri E. Probiotics in human disease.
Am. J. Clin. Nutr. 73: 1142S-1146S (2001).
*
-
Isolauri E, Sutas Y, Kankaanpaa P, Arvilommi H, Salminen S. Probiotics: effects on immunity.
Am. J. Clin. Nutr. 73: 444S-450S (2001).
*
-
Issa LL, Leong GM, Barry JB, Sutherland RL, Eisman JA. Glucocorticoid receptor-interacting protein-1 and receptor-associated coactivator-3 differentially interact with the vitamin D receptor (VDR) and regulate VDR-retinoid X receptor transcriptional cross-talk.
Endocrinology 142: 1606-1615 (2001).
*
-
Itai T, Tanaka M, Nagata S. Processing of tumor necrosis factor by the membrane-bound TNF-alpha-converting enzyme, but not its truncated soluble form.
Eur. J. Biochem. 268: 2074-2082 (2001).
*
-
Ito K, Olsen SL, Qiu W, Deeley RG, Cole SP. Mutation of a single conserved tryptophan in multidrug resistance protein 1 (MRP1/ABCC1) results in loss of drug resistance and selective loss of organic anion transport.
J. Biol. Chem. 276: 15616-15624 (2001).
*
-
Ito M, Uchida Y, Kamano S, Kawabata H, Nishioka M. Clinical comparisons between two subsets of gastric antral vascular ectasia.
Gastrointest. Endosc. 53: 764-770 (2001).
*
-
Ito S, Ieiri I, Tanabe M, Suzuki A, Higuchi S, Otsubo K. Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects.
Pharmacogenetics 11: 175-184 (2001).
-
Itoh J, de La Motte C, Strong SA, Levine AD, Fiocchi C. Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease.
Gut 49: 35-41 (2001).
*
-
Iverson SL, Uetrecht JP. Identification of a reactive metabolite of terbinafine: insights into terbinafine-induced hepatotoxicity.
Chem. Res. Toxicol. 14: 175-181 (2001).
*
-
Izadpanah A, Dwinell MB, Eckmann L, Varki NM, Kagnoff MF. Regulated MIP-3alpha/CCL20 production by human intestinal epithelium: mechanism for modulating mucosal immunity.
Am. J. Physiol. Gastrointest. Liver Physiol. 280: G710-G719 (2001).
*
-
Jabiry-Zieniewicz Z, Wiczynska-Zajac A, Cyganek A, Marianowski L. Menstrual abnormalities in women with biliary cirrhosis treated with liver transplantation.
Ginekol. Pol. 72: 1513-1517 (2001).
-
Jack DL, Klein NJ, Turner MW. Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis.
Immunol. Rev. 180: 86-99 (2001).
*
-
Jackson WD. Pancreatitis: etiology, diagnosis, and management.
Curr. Opin. Pediatr. 13: 447-451 (2001).
-
Jacobsen S, Madsen HO, Klarlund M, Jensen T, Skjodt H, Jensen KE, Svejgaard A, Garred P; TIRA Group. The influence of mannose binding lectin polymorphisms on disease outcome in early polyarthritis.
J. Rheumatol. 28: 935-942 (2001).
-
Jacquemin E. Role of multidrug resistance 3 deficiency in pediatric and adult liver disease: one gene for three diseases.
Semin. Liver Dis. 21: 551-562 (2001).
*
-
Jacquemin E, De Vree JM, Cresteil D, Sokal EM, Sturm E, Dumont M, Scheffer GL, Paul M, Burdelski M, Bosma PJ, Bernard O, Hadchouel M, Oude Elferink RP. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood.
Gastroenterology 120: 1448-1458 (2001).
*
-
Jadoul M, Dode C, Cosyns JP, Abramowicz D, Georges B, Delpech M, Pirson Y. Autosomal-dominant periodic fever with AA amyloidosis: novel mutation in tumor necrosis factor receptor 1 gene.
Kidney Int. 59: 1677-1682 (2001).
*
-
Jain A, Demetris AJ, Kashyap R, Blakomer K, Ruppert K, Khan A, Rohal S, Starzl TE, Fung JJ. Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years.
Liver Transpl. 7: 623-630 (2001).
*
-
Jain A, Kashyap R, Marsh W, Rohal S, Khanna A, Fung JJ. Reasons for long-term use of steroid in primary adult liver transplantation under tacrolimus.
Transplantation 71: 1102-1106 (2001).
*
-
Jain A, Ma CA, Liu S, Brown M, Cohen J, Strober W. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia.
Nat. Immunol. 2: 223-228 (2001).
*
-
Jaiswal M, LaRusso NF, Shapiro RA, Billiar TR, Gores GJ. Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes.
Gastroenterology 120: 190-199 (2001).
*
-
Jalan R, Williams R. The inflammatory basis of intracranial hypertension in acute liver failure.
J. Hepatol. 34: 940-942 (2001).
*
-
James DG. Sarcoidosis 2001.
Postgrad. Med. J. 77: 177-180 (2001).
*
-
Jang WH, Yang YI, Yea SS, Lee YJ, Chun JH, Kim HI, Kim MS, Paik KH. The -238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers.
Cancer Lett. 166: 41-46 (2001).
*
-
Janowitz HD, Bodian C. The placebo response and the "natural history" of inflammatory bowel disease.
Inflamm. Bowel Dis. 7: 64-66 (2001).
*
-
Jansen PL, Muller M, Sturm E. Genes and cholestasis.
Hepatology 34: 1067-1074 (2001).
*
-
Jansen PL, Roskams T. Why are patients with liver disease jaundiced? ATP-binding cassette transporter expression in human liver disease.
J. Hepatol. 35: 811-813 (2001).
*
-
Janssen HL, Wijnhoud A, Haagsma EB, van Uum SH, van Nieuwkerk CM, Adang RP, Chamuleau RA, van Hattum J, Vleggaar FP, Hansen BE, Rosendaal FR, van Hoek B. Extrahepatic portal vein thrombosis: aetiology and determinants of survival.
Gut 49: 720-724 (2001).
*
-
Jarvelainen HA, Orpana A, Perola M, Savolainen VT, Karhunen PJ, Lindros KO. Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease.
Hepatology 33: 1148-1153 (2001).
*
-
Javitt NB, Lee YC, Shimizu C, Fuda H, Strott CA. Cholesterol and hydroxycholesterol sulfotransferases: identification, distinction from dehydroepiandrosterone sulfotransferase, and differential tissue expression.
Endocrinology 142: 2978-2984 (2001).
*
-
Jawaheer D, Seldin MF, Amos CI, Chen WV, Shigeta R, Monteiro J, Kern M, Criswell LA, Albani S, Nelson JL, Clegg DO, Pope R, Schroeder HW Jr, Bridges SL Jr, Pisetsky DS, Ward R, Kastner DL, Wilder RL, Pincus T, Callahan LF, Flemming D, Wener MH, et al. A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases.
Am. J. Hum. Genet. 68: 927-936 (2001).
*
-
Jayaram H, Satsangi J, Chapman RW. Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction?
Gut 48: 430-434 (2001).
*
-
Jayawardene SA, Sheerin N, Pattison JM, Hartley B, Goldsmith DJ. Spontaneous abdominal hemorrhage with AA-amyloidosis and vasculitis in a patient with rheumatoid arthritis.
J. Clin. Rheumatol. 7: 86-90 (2001).
-
Jenkins MK, Khoruts A, Ingulli E, Mueller DL, McSorley SJ, Reinhardt RL, Itano A, Pape KA. In vivo activation of antigen-specific CD4 T cells.
Annu. Rev. Immunol. 19: 23-45 (2001).
*
-
Jennings JS, Howdle PD. Celiac disease.
Curr. Opin. Gastroenterol. 17: 118-126 (2001).
-
Jensen-Jarolim E, Neumann C, Oberhuber G, Gscheidlinger R, Neuchrist C, Reinisch W, Zuberi RI, Penner E, Liu FT, Boltz-Nitulescu G. Anti-Galectin-3 IgG autoantibodies in patients with Crohn's disease characterized by means of phage display peptide libraries.
J. Clin. Immunol. 21: 348-356 (2001).
*
-
Jeon BR, Lee SM. S-Adenosylmethionine protects post-ischemic mitochondrial injury in rat liver.
J. Hepatol. 34: 395-401 (2001).
-
Jetten AM, Kurebayashi S, Ueda E. The ROR nuclear orphan receptor subfamily: critical regulators of multiple biological processes.
Prog. Nucleic Acid Res. Mol. Biol. 69: 205-247 (2001).
-
Jeziorska M, Haboubi N, Schofield P, Woolley DE. Distribution and activation of eosinophils in inflammatory bowel disease using an improved immunohistochemical technique.
J. Pathol. 194: 484-492 (2001).
*
-
Jia JD, Bauer M, Cho JJ, Ruehl M, Milani S, Boigk G, Riecken EO, Schuppan D. Antifibrotic effect of silymarin in rat secondary biliary fibrosis is mediated by downregulation of procollagen alpha1(I) and TIMP-1.
J. Hepatol. 35: 392-398 (2001).
*
-
Jiang HQ, Bos NA, Cebra JJ. Timing, localization, and persistence of colonization by segmented filamentous bacteria in the neonatal mouse gut depend on immune status of mothers and pups.
Infect. Immun. 69: 3611-3617 (2001).
*
-
Jin Y, Nonoyama S, Morio T, Imai K, Ochs HD, Mizutani S. Characterization of soluble CD40 ligand released from human activated platelets.
J. Med. Dent. Sci. 48: 23-27 (2001).
-
Jin Z, Ji Z, Hu J. Mannose-binding lectin gene site mutations and the susceptibility of rheumatic heart disease.
Zhonghua Yi Xue Za Zhi 81: 1284-1286 (2001).
-
Joergensen GH, Luovíksson BR. The current concept of primary IgA deficiency and its prevalence in Iceland.
Laeknabladid. 87: 873-879 (2001).
-
Johanneson B, Alarcon-Riquelme ME. An update on the genetics of systemic lupus erythematosus.
Isr. Med. Assoc. J. 3: 88-93 (2001).
*
-
Johansen FE, Braathen R, Brandtzaeg P. The J chain is essential for polymeric Ig receptor-mediated epithelial transport of IgA.
J. Immunol. 167: 5185-5192 (2001).
*
-
Johansson C, Smedh C, Partonen T, Pekkarinen P, Paunio T, Ekholm J, Peltonen L, Lichtermann D, Palmgren J, Adolfsson R, Schalling M. Seasonal affective disorder and serotonin-related polymorphisms.
Neurobiol. Dis. 8: 351-357 (2001).
-
John S, Eyre S, Myerscough A, Barrett J, Silman A, Ollier W, Worthington J. Linkage and association analysis of candidate genes in rheumatoid arthritis.
J. Rheumatol. 28: 1752-1755 (2001).
-
John S, Worthington J. Genetic epidemiology. Approaches to the genetic analysis of rheumatoid arthritis.
Arthritis Res. 3: 216-220 (2001).
*
-
Johnson CD. ABC of the upper gastrointestinal tract. Upper abdominal pain: gall bladder.
BMJ 323: 1170-1173 (2001).
*
-
Johnson DR, Finch RA, Lin ZP, Zeiss CJ, Sartorelli AC. The pharmacological phenotype of combined multidrug-resistance mdr1a/1b- and mrp1-deficient mice.
Cancer Res. 61: 1469-1476 (2001).
*
-
Johnson RW, Reveille JD, McNearney T, Fischbach M, Friedman AW, Ahn C, Arnett FC, Tan FK. Lack of association of a functionally relevant single nucleotide polymorphism of matrix metalloproteinase-1 promoter with systemic sclerosis (scleroderma).
Genes Immun. 2: 273-275 (2001).
*
-
Johnston JB, Silva C, Gonzalez G, Holden J, Warren KG, Metz LM, Power C. Diminished adenosine A1 receptor expression on macrophages in brain and blood of patients with multiple sclerosis.
Ann. Neurol. 49: 650-658 (2001).
-
Johnston JB, Silva C, Holden J, Warren KG, Clark AW, Power C. Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases.
Ann. Neurol. 50: 434-442 (2001).
-
Jonas E, Hultcrantz R, Slezak P, Blomqvist L, Schnell PO, Jacobsson H. Dynamic 99Tcm-HIDA SPET: non-invasive measuring of intrahepatic bile flow. Description of the method and a study in primary sclerosing cholangitis.
Nucl. Med. Commun. 22: 127-134 (2001).
*
-
Jones SA, Horiuchi S, Topley N, Yamamoto N, Fuller GM. The soluble interleukin 6 receptor: mechanisms of production and implications in disease.
FASEB J. 15: 43-58 (2001).
*
-
Jong-Hon K, Yajima R, Karino Y, Yoshida J, Tsuji K, Watanabe S, Horada K, Itoh Y, Sekiguchi K, Toyoda S, Maekubo H. Development of a new enzyme-linked immunosorbent assay for the detection of anti-M2 in primary biliary cirrhosis.
Hepatol. Res. 21: 1-7 (2001).
-
Joo NS, Krouse ME, Wu JV, Saenz Y, Jayaraman S, Verkman AS, Wine JJ. HCO3- transport in relation to mucus secretion from submucosal glands.
JOP 2: S280-S284 (2001).
*
-
Jorgensen J, Mortensen PB. Hydrogen sulfide and colonic epithelial metabolism: implications for ulcerative colitis.
Dig. Dis. Sci. 46: 1722-1732 (2001).
*
-
Jostock T, Mullberg J, Ozbek S, Atreya R, Blinn G, Voltz N, Fischer M, Neurath MF, Rose-John S. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.
Eur. J. Biochem. 268: 160-167 (2001).
*
-
Jovanovic DV, Di Battista JA, Martel-Pelletier J, Reboul P, He Y, Jolicoeur FC, Pelletier JP. Modulation of TIMP-1 synthesis by antiinflammatory cytokines and prostaglandin E2 in interleukin 17 stimulated human monocytes/macrophages.
J. Rheumatol. 28: 712-718 (2001).
-
Jowsey SG, Taylor ML, Schneekloth TD, Clark MM. Psychosocial challenges in transplantation.
J. Psychiatr. Pract. 7: 404-414 (2001).
-
Jun ES, Kim YS, Yoo , Roh HJ, Jung JS. Changes in expression of ion channels and aquaporins mRNA during differentiation in normal human nasal epithelial cells.
Life Sci. 68: 827-840 (2001).
*
-
Jun TY, Pae CU, Chae JH, Bahk WM, Kim KS. Polymorphism of CTLA-4 gene for major depression in the Korean population.
Psychiatry Clin. Neurosci. 55: 533-537 (2001).
-
Jung D, Hagenbuch B, Gresh L, Pontoglio M, Meier PJ, Kullak-Ublick GA. Characterization of the human OATP-C (SLC21A6) gene promoter and regulation of liver-specific OATP genes by hepatocyte nuclear factor 1 alpha.
J. Biol. Chem. 276: 37206-37214 (2001).
*
-
Junge U, Wienke J, Schuler A. Acute Budd-Chiari syndrome, portal and splenic vein thrombosis in a patient with ulcerative colitis associated with antiphospholipid antibodies and protein C deficiency.
Z. Gastroenterol. 39: 845-852 (2001).
-
Kadry Z, Malekkiani N, Clavien PA. Treatment of primary and secondary liver malignancy.
Swiss. Med. Wkly. 131: 338-345 (2001).
*
-
Kagawa H, Nomura S, Nagahama M, Ozaki Y, Fukuhara S. Effect of bezafibrate on soluble adhesion molecules and platelet activation markers in patients with connective tissue diseases and secondary hyperlipidemia.
Clin. Appl. Thromb. Hemost. 7: 153-157 (2001).
-
Kahn K, Sharp H, Hunter D, Kerzner B, Jessurun J, Blaese M. Primary sclerosing cholangitis in Wiskott-Aldrich syndrome.
J. Pediatr. Gastroenterol. Nutr. 32: 95-99 (2001).
*
-
Kaido T, Imamura M. Hepatocyte growth factor: clinical implications in hepatobiliary pancreatic surgery.
J. Hepatobiliary Pancreat. Surg. 8: 65-75 (2001).
*
-
Kaijzel EL, Bayley JP, van Krugten MV, Smith L, van de Linde P, Bakker AM, Breedveld FC, Huizinga TW, Verweij CL. Allele-specific quantification of tumor necrosis factor alpha (TNF) transcription and the role of promoter polymorphisms in rheumatoid arthritis patients and healthy individuals.
Genes Immun. 2: 135-144 (2001).
*
-
Kaiserling E. Newly-formed lymph nodes in the submucosa in chronic inflammatory bowel disease.
Lymphology 34: 22-29 (2001).
*
-
Kajander EO, Ciftcioglu N, Miller-Hjelle MA, Hjelle JT. Nanobacteria: controversial pathogens in nephrolithiasis and polycystic kidney disease.
Curr. Opin. Nephrol. Hypertens. 10: 445-452 (2001).
-
Kalinski P, Vieira PL, Schuitemaker JH, de Jong EC, Kapsenberg ML. Prostaglandin E(2) is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer.
Blood 97: 3466-3469 (2001).
*
-
Kamal A, Bhan A, Murray PI. Uveitis with autoimmune hepatic disorders.
Ocul. Immunol. Inflamm. 9: 267-272 (2001).
-
Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR. A model to predict survival in patients with end-stage liver disease.
Hepatology 33: 464-470 (2001).
*
-
Kamel IR, Kruskal JB, Raptopoulos V. Imaging for right lobe living donor liver transplantation.
Semin. Liver Dis. 21: 271-282 (2001).
-
Kanaan N, Sawaya R. Nocturnal leg cramps. Clinically mysterious and painful - but manageable.
Geriatrics 56: 34, 39-42 (2001).
-
Kanai T, Watanabe M, Okazawa A, Sato T, Hibi T. Interleukin-18 and Crohn's disease.
Digestion 63 Suppl. 1: 37-42 (2001).
-
Kane KP, Silver ET, Hazes B. Specificity and function of activating Ly-49 receptors.
Immunol. Rev. 181: 104-114 (2001).
*
-
Kane SV, Cohen RD, Aikens JE, Hanauer SB. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis.
Am. J. Gastroenterol. 96: 2929-2933 (2001).
*
-
Kaneko K, Nagasaki Y, Furukawa T, Mizutamari H, Sato A, Masamune A, Shimosegawa T, Horii A. Analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene mutations in Japanese patients with chronic pancreatitis.
J. Hum. Genet. 46: 293-297 (2001).
-
Kang BY, Chung SW, Kim TS. Inhibition of interleukin-12 production in lipopolysaccharide-activated mouse macrophages by parthenolide, a predominant sesquiterpene lactone in Tanacetum parthenium: involvement of nuclear factor-kappaB.
Immunol. Lett. 77: 159-163 (2001).
-
Kanno N, LeSage G, Glaser S, Alpini G. Regulation of cholangiocyte bicarbonate secretion.
Am. J. Physiol. Gastrointest. Liver Physiol. 281: G612-G625 (2001).
*
-
Kanzler S, Bozkurt S, Herkel J, Galle PR, Dienes HP, Lohse AW. Presence of SLA/LP autoantibodies in patients with primary biliary cirrhosis as a marker for secondary autoimmune hepatitis (overlap syndrome).
Dtsch. Med. Wochenschr. 126: 450-456 (2001).
-
Kaplan M. Genetic interactions in the pathogenesis of neonatal hyperbilirubinemia: Gilbert's Syndrome and glucose-6-phosphate dehydrogenase deficiency.
J. Perinatol. 21 Suppl. 1: S30-S34 (2001).
-
Kapsoritakis AN, Koukourakis MI, Sfiridaki A, Potamianos SP, Kosmadaki MG, Koutroubakis IE, Kouroumalis EA. Mean platelet volume: a useful marker of inflammatory bowel disease activity.
Am. J. Gastroenterol. 96: 776-781 (2001).
*
-
Kasof GM, Lu JJ, Liu D, Speer B, Mongan KN, Gomes BC, Lorenzi MV. Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB.
Oncogene 20: 7965-7975 (2001).
*
-
Kast HR, Nguyen CM, Sinal CJ, Jones SA, Laffitte BA, Reue K, Gonzalez FJ, Willson TM, Edwards PA. Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids.
Mol. Endocrinol. 15: 1720-1728 (2001).
*
-
Kast RE, Altschuler EL. Remission of Crohn's disease on bupropion.
Gastroenterology 121: 1260-1261 (2001).
*
-
Kastner DL, O'Shea JJ. A fever gene comes in from the cold.
Nat. Genet. 29: 241-242 (2001).
*
-
Katsuta Y, Zhang XJ, Aramaki T. Pulmonary hypertension complicating portal hypertension: portopulmonary hypertension.
Nippon Rinsho 59: 1186-1192 (2001).
-
Katz JA, Pore G. Inflammatory bowel disease and pregnancy.
Inflamm. Bowel Dis. 7: 146-157 (2001).
*
-
Katz Y, Nadiv O, Beer Y. Interleukin-17 enhances tumor necrosis factor alpha-induced synthesis of interleukins 1,6, and 8 in skin and synovial fibroblasts: a possible role as a "fine-tuning cytokine" in inflammation processes.
Arthritis Rheum. 44: 2176-2184 (2001).
*
-
Kaufmann SH. How can immunology contribute to the control of tuberculosis?
Nat. Rev. Immunol. 1: 20-30 (2001).
*
-
Kauppi M, Kankaanpaa E, Kautiainen H. Exocrine dysfunction of the pancreas in patients with chronic polyarthritis.
J. Clin. Rheumatol. 7: 166-169 (2001).
-
Kauppi P, Lindblad-Toh K, Sevon P, Toivonen HT, Rioux JD, Villapakkam A, Laitinen LA, Hudson TJ, Kere J, Laitinen T. A second-generation association study of the 5q31 cytokine gene cluster and the interleukin-4 receptor in asthma.
Genomics 77: 35-42 (2001).
*
-
Kawaguchi M, Kokubu F, Kuga H, Matsukura S, Hoshino H, Ieki K, Imai T, Adachi M, Huang SK. Modulation of bronchial epithelial cells by IL-17.
J. Allergy Clin. Immunol. 108: 804-809 (2001).
*
-
Kawaguchi T, Sakisaka S, Harada M, Hanada S, Taniguchi E, Koga H, Sasatomi K, Tanikawa K, Sata M. Endotoxin increases paracellular permeability of isolated rat hepatocyte couplets.
Hepatol. Res. 20: 144-154 (2001).
-
Kawahara T, Ichikawa A, Katakura Y, Teruya K, Yoshida T, Kikuchi M, Kamei M, Hashizume S, Shirahata S. Establishment of hybridomas producing cancer specific human antibodies from B cell line derived from PBL of a patient with adult T cell leukemia.
Cytotechnology 36: 171-177 (2001).
*
-
Kawasaki A, Tsuchiya N, Fukazawa T, Hashimoto H, Tokunaga K. Presence of four major haplotypes in human BCMA gene: lack of association with systemic lupus erythematosus and rheumatoid arthritis.
Genes Immun. 2: 276-279 (2001).
*
-
Kawasaki T, Ueo T, Itani T, Shibatohge M, Mimura J, Komori H, Todo A, Okuno T, Kudo M. A case of localized primary sclerosing cholangitis mimicking intrahepatic bile duct cancer.
Hepatol. Res. 20: 259-264 (2001).
-
Kaya M, de Groen PC, Angulo P, Nagorney DM, Gunderson LL, Gores GJ, Haddock MG, Lindor KD. Treatment of cholangiocarcinoma complicating primary sclerosing cholangitis: the Mayo Clinic experience.
Am. J. Gastroenterol. 96: 1164-1169 (2001).
*
-
Kaya M, Petersen BT, Angulo P, Baron TH, Andrews JC, Gostout CJ, Lindor KD. Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis.
Am. J. Gastroenterol. 96: 1059-1066 (2001).
*
-
Kazumori H, Hashimoto T, Akagi S, Adachi K, Watanabe M, Kinoshita Y. Sclerosing cholangitis and systemic lymphadenopathy.
J. Gastroenterol. 36: 429-432 (2001).
*
-
Ke S, Rabson AB, Germino JF, Gallo MA, Tian Y. Mechanism of suppression of cytochrome P-450 1A1 expression by tumor necrosis factor-alpha and lipopolysaccharide.
J. Biol. Chem. 276: 39638-39644 (2001).
*
-
Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.
N. Engl. J. Med. 345: 1098-1104 (2001).
*
-
Keates AC, Keates S, Kwon JH, Arseneau KO, Law DJ, Bai L, Merchant JL, Wang TC, Kelly CP. ZBP-89, Sp1, and nuclear factor-kappa B regulate epithelial neutrophil-activating peptide-78 gene expression in Caco-2 human colonic epithelial cells.
J. Biol. Chem. 276: 43713-43722 (2001).
*
-
Kedzierska A, Turowski G. Histocompatibility HLA system of man. Consideration in the light of current concepts. I. Organization and polymorphism.
Przegl. Lek. 58: 459-462 (2001).
-
Kedzierska A, Turowski G. Histocompatibility HLA system in man. Considerations in the light of current concept. Part III. The relationship between HLA antigens and disease susceptibility.
Przegl. Lek. 58: 814-817 (2001).
-
Keim V. Mutations of the pancreatic secretory trypsin inhibitor. Is the cause of chronic pancreatitis now known?
Z. Gastroenterol. 39: 765-768 (2001).
-
Kelley DS. Modulation of human immune and inflammatory responses by dietary fatty acids.
Nutrition 17: 669-673 (2001).
-
Kelley JT 3rd, Agudelo CA, Sharma V, Holland NW. Fever with acute arthritis in calcium pyrophosphate dihydrate deposition disease: a missed explanation for altered mental status in elderly patients?
J. Clin. Rheumatol. 7: 322-325 (2001).
-
Kelley MR, Tritt R, Xu Y, New S, Freie B, Clapp DW, Deutsch WA. The Drosophila S3 multifunctional DNA repair/ribosomal protein protects Fanconi anemia cells against oxidative DNA damaging agents.
Mutat. Res. 485: 107-119 (2001).
-
Kelley TJ, Elmer HL, Corey DA. Reduced Smad3 protein expression and altered transforming growth factor-beta1-mediated signaling in cystic fibrosis epithelial cells.
Am. J. Respir. Cell. Mol. Biol. 25: 732-738 (2001).
*
-
Kelly D, Conway S. Genomics at work: the global gene response to enteric bacteria.
Gut 49: 612-613 (2001).
*
-
Kempton CL, Bagby G, Collins JF. Ulcerative colitis presenting as purpura fulminans.
Inflamm. Bowel Dis. 7: 319-322 (2001).
*
-
Kennedy MA, Venkateswaran A, Tarr PT, Xenarios I, Kudoh J, Shimizu N, Edwards PA. Characterization of the human ABCG1 gene: liver X receptor activates an internal promoter that produces a novel transcript encoding an alternative form of the protein.
J. Biol. Chem. 276: 39438-39447 (2001).
*
-
Keogan MT, Edelman RR. Technologic advances in abdominal MR imaging.
Radiology 220: 310-320 (2001).
*
-
Kerb R, Hoffmeyer S, Brinkmann U. ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2.
Pharmacogenomics 2: 51-64 (2001).
-
Kersten S. Mechanisms of nutritional and hormonal regulation of lipogenesis.
EMBO Rep. 2: 282-286 (2001).
*
-
Kersten S, Mandard S, Escher P, Gonzalez FJ, Tafuri S, Desvergne B, Wahli W. The peroxisome proliferator-activated receptor alpha regulates amino acid metabolism.
FASEB J. 15: 1971-1978 (2001).
*
-
Keshavarzian A, Choudhary S, Holmes EW, Yong S, Banan A, Jakate S, Fields JZ. Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats.
J. Pharmacol. Exp. Ther. 299: 442-448 (2001).
*
-
Kessova IG, Leo MA, Lieber CS. Effect of beta-carotene on hepatic cytochrome P-450 in ethanol-fed rats.
Alcohol Clin. Exp. Res. 25: 1368-1372 (2001).
*
-
Keung YK, Morgan D, Hodges D, Blann M, Cobos E. Myelodysplasia-like syndrome and end-stage liver disease: report of 2 cases.
Acta Haematol. 105: 100-102 (2001).
-
Khan N, Maheshwari V, Trivedi I, Kalam A. Immunopathology of skin lesions.
Indian J. Dermatol. Venereol. Leprol. 67: 234-237 (2001).
*
-
Khawaja K, Gennery AR, Flood TJ, Abinun M, Cant AJ. Bone marrow transplantation for CD40 ligand deficiency: a single centre experience.
Arch. Dis. Child. 84: 508-511 (2001).
*
-
Kho YH, Pool MO, Jansman FG, Harting JW. Pharmacotherapeutic options in inflammatory bowel disease: an update.
Pharm. World Sci. 23: 17-21 (2001).
*
-
Khush RS, Leulier F, Lemaitre B. Drosophila immunity: two paths to NF-kappaB.
Trends Immunol. 22: 260-264 (2001).
*
-
Kidd PM. Multiple sclerosis, an autoimmune inflammatory disease: prospects for its integrative management.
Altern. Med. Rev. 6: 540-566 (2001).
*
-
Kiefer C, Hessel S, Lampert JM, Vogt K, Lederer MO, Breithaupt DE, von Lintig J. Identification and characterization of a mammalian enzyme catalyzing the asymmetric oxidative cleavage of provitamin A.
J. Biol. Chem. 276: 14110-14116 (2001).
*
-
Kiesslich R, Holfelder M, Will D, Hahn M, Nafe B, Genitsariotis R, Daniello S, Maeurer M, Jung M. Interventional ERCP in patients with cholestasis. Degree of biliary bacterial colonization and antibiotic resistance.
Z. Gastroenterol. 39: 985-992 (2001).
-
Kikuoka N, Sugihara S, Yanagawa T, Ikezaki A, Kim HS, Matsuoka H, Kobayashi Y, Wataki K, Konda S, Sato H, Miyamoto S, Sasaki N, Sakamaki T, Niimi H, Murata M. Cytotoxic T lymphocyte antigen 4 gene polymorphism confers susceptibility to type 1 diabetes in Japanese children: analysis of association with HLA genotypes and autoantibodies.
Clin. Endocrinol. (Oxf.) 55: 597-603 (2001).
*
-
Kilhamn J, Brevinge H, Quiding-Jarbrink M, Svennerholm AM, Jertborn M. Induction and distribution of intestinal immune responses after administration of recombinant cholera toxin B subunit in the ileal pouches of colectomized patients.
Infect. Immun. 69: 3466-3471 (2001).
*
-
Kim HS. Prevention of colon cancer with ursodiol in ulcerative colitis.
Inflamm. Bowel Dis. 7: 279-280 (2001).
*
-
Kim HS, Lund GB, Venbrux AC. Advanced percutaneous transhepatic biliary access.
Tech. Vasc. Interv. Radiol. 4: 153-171 (2001).
-
Kim IS, Lee IH, Lee JH, Lee SY. Induction of haptoglobin by all-trans retinoic acid in THP-1 human monocytic cell line.
Biochem. Biophys. Res. Commun. 284: 738-742 (2001).
*
-
Kim J, Min G, Kemper B. Chromatin assembly enhances binding to the CYP2B1 phenobarbital-responsive unit (PBRU) of nuclear factor-1, which binds simultaneously with constitutive androstane receptor (CAR)/retinoid X receptor (RXR) and enhances CAR/RXR-mediated activation …
J. Biol. Chem. 276: 7559-7567 (2001).
*
-
Kim JS, Kim JM, Jung HC, Song IS. Caspase-3 activity and expression of Bcl-2 family in human neutrophils by Helicobacter pylori water-soluble proteins.
Helicobacter 6: 207-215 (2001).
*
-
Kim KE, Brasitus TA. The role of vitamin D in normal and pathologic processes in the colon.
Curr. Opin. Gastroenterol. 17: 72-77 (2001).
-
Kim MH, Yasuda K. Percutaneous transhepatic cholangioscopic examination: a necessity for the biliary endoscopist.
Gastrointest. Endosc. 53: 695-697 (2001).
*
-
Kim MJ, Deplewski D, Ciletti N, Michel S, Reichert U, Rosenfield RL. Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development.
Mol. Genet. Metab. 74: 362-369 (2001).
*
-
Kim TI, Lee YC, Lee KH, Han JH, Chon CY, Moon YM, Kang JK, Park IS. Effects of nonsteroidal anti-inflammatory drugs on Helicobacter pylori-infected gastric mucosae of mice: apoptosis, cell proliferation, and inflammatory activity.
Infect. Immun. 69: 5056-5063 (2001).
*
-
Kim WR, Gross JB Jr, Poterucha JJ, Locke GR 3rd, Dickson ER. Outcome of hospital care of liver disease associated with hepatitis C in the United States.
Hepatology 33: 201-206 (2001).
*
-
Kim WR, Poterucha JJ. Is it time for mass screening for hepatitis C?
Am. J. Med. 111: 667-668 (2001).
*
-
Kimbrell DA, Beutler B. The evolution and genetics of innate immunity.
Nat. Rev. Genet. 2: 256-267 (2001).
*
-
King AL, Fraser JS, Moodie SJ, Curtis D, Dearlove AM, Ellis HJ, Rosen-Bronson S, Ciclitira PJ. Coeliac disease: follow-up linkage study provides further support for existence of a susceptibility locus on chromosome 11p11.
Ann. Hum. Genet. 65: 377-386 (2001).
*
-
Kingwell BA, Medley TL, Waddell TK, Cole TJ, Dart AM, Jennings GL. Large artery stiffness: structural and genetic aspects.
Clin. Exp. Pharmacol. Physiol. 28: 1040-1043 (2001).
*
-
Kinnman N, Goria O, Wendum D, Gendron MC, Rey C, Poupon R, Housset C. Hepatic stellate cell proliferation is an early platelet-derived growth factor-mediated cellular event in rat cholestatic liver injury.
Lab. Invest. 81: 1709-1716 (2001).
-
Kirov G, Lowry CA, Stephens M, Oldfield S, O'Donovan MC, Lightman SL, Owen MJ. Screening ABCG1, the human homologue of the Drosophila white gene, for polymorphisms and association with bipolar affective disorder.
Mol. Psychiatry 6: 671-677 (2001).
-
Kirschning CJ, Bauer S. Toll-like receptors: cellular signal transducers for exogenous molecular patterns causing immune responses.
Int. J. Med. Microbiol. 291: 251-260 (2001).
-
Kisand KE, Metskula K, Kisand KV, Kivik T, Gershwin ME, Uibo R. The follow-up of asymptomatic persons with antibodies to pyruvate dehydrogenase in adult population samples.
J. Gastroenterol. 36: 248-254 (2001).
*
-
Kissler S, Anderton SM, Wraith DC. Antigen-presenting cell activation: a link between infection and autoimmunity?
J. Autoimmun. 16: 303-308 (2001).
-
Kita H, Mackay IR, Van De Water J, Gershwin ME. The lymphoid liver: considerations on pathways to autoimmune injury.
Gastroenterology 120: 1485-1501 (2001).
*
-
Kitada T, Seki S, Iwai S, Yamada T, Sakaguchi H, Wakasa K. In situ detection of oxidative DNA damage, 8-hydroxydeoxyguanosine, in chronic human liver disease.
J. Hepatol. 35: 613-618 (2001).
*
-
Kitchen P, Forbes A. Intravenous nutrition in critical illness.
Curr. Opin. Gastroenterol. 17: 150-153 (2001).
-
Kitchen PA, Walters JR. Molecular and cellular biology of small-bowel mucosa.
Curr. Opin. Gastroenterol. 17: 104-109 (2001).
-
Kiyono H, Kweon MN, Hiroi T, Takahashi I. The mucosal immune system: from specialized immune defense to inflammation and allergy.
Acta Odontol. Scand. 59: 145-153 (2001).
-
Klebl FH, Olsen JE, Jain S, Doe WF. Expression of macrophage-colony stimulating factor in normal and inflammatory bowel disease intestine.
J. Pathol. 195: 609-615 (2001).
*
-
Klein AP, Hruban RH, Brune KA, Petersen GM, Goggins M. Familial pancreatic cancer.
Cancer J. 7: 266-273 (2001).
-
Klein W, Tromm A, Griga T, Fricke H, Folwaczny C, Hocke M, Eitner K, Marx M, Duerig N, Epplen JT. Interleukin-4 and interleukin-4 receptor gene polymorphisms in inflammatory bowel diseases.
Genes Immun. 2: 287-289 (2001).
*
-
Klein W, Tromm A, Griga T, Fricke H, Folwaczny C, Hocke M, Eitner K, Marx M, Epplen JT. The polymorphism at position -174 of the IL-6 gene is not associated with inflammatory bowel disease.
Eur. J. Gastroenterol. Hepatol. 13: 45-47 (2001).
-
Kliewer SA, Xu HE, Lambert MH, Willson TM. Peroxisome proliferator-activated receptors: from genes to physiology.
Recent Prog. Horm. Res. 56: 239-263 (2001).
*
-
Klinnert MD, Nelson HS, Price MR, Adinoff AD, Leung DY, Mrazek DA. Onset and persistence of childhood asthma: predictors from infancy.
Pediatrics 108: e69 (2001).
*
-
Klitz W, Brautbar C, Schito AM, Barcellos LF, Oksenberg JR. Evolution of the CCR5 Delta32 mutation based on haplotype variation in Jewish and Northern European population samples.
Hum. Immunol. 62: 530-538 (2001).
-
Kmiec Z. Cooperation of liver cells in health and disease.
Adv. Anat. Embryol. Cell. Biol. 161: III-XIII, 1-151 (2001).
-
Knauf F, Yang CL, Thomson RB, Mentone SA, Giebisch G, Aronson PS. Identification of a chloride-formate exchanger expressed on the brush border membrane of renal proximal tubule cells.
Proc. Natl. Acad. Sci. U.S.A. 98: 9425-9430 (2001).
*
-
Kobayashi H, Kimura S, Aoki N, Sato K, Celis E, Katagiri M. Existence of MHC class I-restricted alloreactive CD4+ T cells reacting with peptide transporter-deficient cells.
Immunogenetics 53: 626-633 (2001).
-
Kocak N, Saltik IN. The effect of ursodeoxycholic acid in children with prolonged hepatitis A virus infection that may be a trigger factor for autoimmune hepatitis.
Am. J. Gastroenterol. 96: 610-611 (2001).
*
-
Koch C, Cuppens H, Rainisio M, Madessani U, Harms H, Hodson M, Mastella G, Navarro J, Strandvik B, McKenzie S; Investigators of the ERCF. European Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations.
Pediatr. Pulmonol. 31: 1-12 (2001).
*
-
Kohout P. Small bowel permeability in diagnosis of celiac disease and monitoring of compliance of a gluten-free diet (gut permeability in celiac disease).
Acta Medica (Hradec. Kralove.) 44: 101-104 (2001).
-
Koike K, Kohda K, Kuga T, Nakazawa O, Ando M, Takayanagi N, Matsunaga T, Sakamaki S, Niitsu Y. Ulcerative colitis after autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
Bone Marrow Transplant 28: 619-621 (2001).
-
Kojima H, Sakurai S, Kuriyama S, Yoshiji H, Imazu H, Uemura M, Nakatani Y, Yamao J, Fukui H. Endothelin-1 plays a major role in portal hypertension of biliary cirrhotic rats through endothelin receptor subtype B together with subtype A in vivo.
J. Hepatol. 34: 805-811 (2001).
*
-
Kojima Y, Kinouchi Y, Takahashi S, Negoro K, Hiwatashi N, Shimosegawa T. Inflammatory bowel disease is associated with a novel promoter polymorphism of natural resistance-associated macrophage protein 1 (NRAMP1) gene.
Tissue Antigens 58: 379-384 (2001).
*
-
Kolan C, Ghuysen A, Lambermont B, D'Orio V. Clinical case of the month. Porto-pulmonary hypertension syndrome associated with severe hypoxemia.
Rev. Med. Liege. 56: 543-547 (2001).
-
Kolker O, Galun E, Melhem A, Ilan Y, Eid A, Jurim O, Ashun Y, Safadi R. Primary biliary cirrhosis and liver transplantation.
Transplant. Proc. 33: 2932 (2001).
*
-
Komatsu-Wakui M, Tokunaga K, Ishikawa Y, Leelayuwat C, Kashiwase K, Tanaka H, Moriyama S, Nakajima F, Park MH, Jia GJ, Chimge NO, Sideltseva EW, Juji T. Wide distribution of the MICA-MICB null haplotype in East Asians.
Tissue Antigens 57: 1-8 (2001).
*
-
Kondo H, Watanabe J, Iwasaki H. T-large granular lymphocyte leukemia accompanied by an increase of natural killer cells (CD3-) and associated with ulcerative colitis and autoimmune hepatitis.
Leuk. Lymphoma 41: 207-212 (2001).
-
Konenkov VI, Prokofiev VF, Shevchenko AV, Golovanova OV, Smolnikova MV. Polymorphism of immune response genes as a factor for predisposition to development of diseases.
Russ. J. Immunol. 6: 123-130 (2001).
-
Kong AN, Owuor E, Yu R, Hebbar V, Chen C, Hu R, Mandlekar S. Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE/EpRE).
Drug Metab. Rev. 33: 255-271 (2001).
-
Koniaris LG, Zimmers-Koniaris T, Hsiao EC, Chavin K, Sitzmann JV, Farber JM. Cytokine-responsive gene-2/IFN-inducible protein-10 expression in multiple models of liver and bile duct injury suggests a role in tissue regeneration.
J. Immunol. 167: 399-406 (2001).
*
-
Konig CW, Pfannenberg C, Trubenbach J, Remy C, Bohmer GM, Ruck P, Claussen CD. MR cholangiography in the diagnosis of sclerosing cholangitis in Langerhans' cell histiocytosis.
Eur. Radiol. 11: 2516-2520 (2001).
*
-
Konig J, Schreiber R, Voelcker T, Mall M, Kunzelmann K. The cystic fibrosis transmembrane conductance regulator (CFTR) inhibits ENaC through an increase in the intracellular Cl- concentration.
EMBO Rep. 2: 1047-1051 (2001).
*
-
Koretzky GA, Myung PS. Positive and negative regulation of T-cell activation by adaptor proteins.
Nat. Rev. Immunol. 1: 95-107 (2001).
*
-
Kornbluth A. What happened to drug trials in ulcerative colitis? Problems, PPARs, placebos, and (possible) progress.
Am. J. Gastroenterol. 96: 3232-3234 (2001).
*
-
Korzeniowska-Kowal A, Witkowska D, Gamian A. Molecular mimicry of bacterial polysaccharides and their role in etiology of infectious and autoimmune diseases.
Postepy. Hig. Med. Dosw. 55: 211-232 (2001).
-
Koteish A, Diehl AM. Animal models of steatosis.
Semin. Liver Dis. 21: 89-104 (2001).
-
Kotenko SV, Izotova LS, Mirochnitchenko OV, Esterova E, Dickensheets H, Donnelly RP, Pestka S. Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity.
J. Immunol. 166: 7096-7103 (2001).
*
-
Kotenko SV, Izotova LS, Mirochnitchenko OV, Esterova E, Dickensheets H, Donnelly RP, Pestka S. Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta ) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes.
J. Biol. Chem. 276: 2725-2732 (2001).
*
-
Kotter I, Gunaydin I, Stubiger N, Yazici H, Fresko I, Zouboulis CC, Adler Y, Steiert I, Kurz B, Wernet D, Braun B, Muller CA. Comparative analysis of the association of HLA-B*51 suballeles with Behcet's disease in patients of German and Turkish origin.
Tissue Antigens 58: 166-170 (2001).
*
-
Kotze MJ, de Villiers JN, Rooney RN, Grobbelaar JJ, Mansvelt EP, Bouwens CS, Carr J, Stander I, du Plessis L. Analysis of the NRAMP1 gene implicated in iron transport: association with multiple sclerosis and age effects.
Blood Cells Mol. Dis. 27: 44-53 (2001).
-
Koutkia P, Lu Z, Chen TC, Holick MF. Treatment of vitamin D deficiency due to Crohn's disease with tanning bed ultraviolet B radiation.
Gastroenterology 121: 1485-1488 (2001).
*
-
Koutroubakis IE, Petinaki E, Mouzas IA, Vlachonikolis IG, Anagnostopoulou E, Castanas E, Maniatis AN, Kouroumalis EA. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease.
Am. J. Gastroenterol. 96: 449-454 (2001).
*
-
Kovacs E. Investigation of interleukin-6 (IL-6), soluble IL-6 receptor (sIL-6R) and soluble gp130 (sgp130) in sera of cancer patients.
Biomed. Pharmacother. 55: 391-396 (2001).
-
Koyanagi T, Nakamuta M, Enjoji M, Iwamoto H, Motomura K, Sakai H, Nawata H. The selenoorganic compound ebselen suppresses liver injury induced by Propionibacterium acnes and lipopolysaccharide in rats.
Int. J. Mol. Med. 7: 321-327 (2001).
-
Krahenbuhl S. Mitochondria: important target for drug toxicity?
J. Hepatol. 34: 334-336 (2001).
*
-
Krasinskas AM, Ruchelli ED, Rand EB, Chittams JL, Furth EE. Central venulitis in pediatric liver allografts.
Hepatology 33: 1141-1147 (2001).
*
-
Krause WF, DuBois RN. The molecular basis for prevention of colorectal cancer.
Clin. Colorectal Cancer 1: 47-54 (2001).
*
-
Kreft B, Pauleit D, Bachmann R, Conrad R, Kramer A, Schild HH. Incidence and significance of small focal liver lesions in MRI.
Rofo. 173: 424-429 (2001).
-
Kreimer-Erlacher H, Seidl H, Back B, Kerl H, Wolf P. High mutation frequency at Ha-ras exons 1-4 in squamous cell carcinomas from PUVA-treated psoriasis patients.
Photochem. Photobiol. 74: 323-330 (2001).
-
Kren BT, Rodrigues CM, Setchell KD, Steer CJ. Modulation of steady-state messenger RNA levels in the regenerating rat liver with bile acid feeding.
Liver Transpl. 7: 321-334 (2001).
*
-
Krige JE, Beckingham IJ. ABC of diseases of liver, pancreas, and biliary system. Portal hypertension-2. Ascites, encephalopathy, and other conditions.
BMJ 322: 416-418 (2001).
*
-
Krige JE, Beckingham IJ. ABC of diseases of liver, pancreas, and biliary system. Portal hypertension-1: varices.
BMJ 322: 348-351 (2001).
*
-
Krige JE, Beckingham IJ. ABC of diseases of liver, pancreas, and biliary system. Liver abscesses and hydatid disease.
BMJ 322: 537-540 (2001).
*
-
Krinsky GA, Lee VS, Theise ND, Weinreb JC, Rofsky NM, Diflo T, Teperman LW. Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation.
Radiology 219: 445-454 (2001).
*
-
Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, Moestrup SK. Identification of the haemoglobin scavenger receptor.
Nature 409: 198-201 (2001).
*
-
Krowka MJ. Caveats concerning hepatopulmonary syndrome.
J. Hepatol. 34: 756-758 (2001).
*
-
Kruger A, Quack P, Schneider PM, Rittner C, Hohler T. Sequence analysis of the DRB1 promoter reveals limited polymorphism with no influence on gene expression.
Genes Immun. 2: 211-215 (2001).
*
-
Kruis W, Schreiber S, Theuer D, Brandes JW, Schutz E, Howaldt S, Krakamp B, Hamling J, Monnikes H, Koop I, Stolte M, Pallant D, Ewald U. Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses.
Gut 49: 783-789 (2001).
*
-
Krutzik SR, Sieling PA, Modlin RL. The role of Toll-like receptors in host defense against microbial infection.
Curr. Opin. Immunol. 13: 104-108 (2001).
-
Krystal JH, Cramer JA, Krol WF, Kirk GF, Rosenheck RA; Veterans Affairs Naltrexone Cooperative Study 425 Group. Naltrexone in the treatment of alcohol dependence.
N. Engl. J. Med. 345: 1734-1739 (2001).
*
-
Ku NO, Gish R, Wright TL, Omary MB. Keratin 8 mutations in patients with cryptogenic liver disease.
N. Engl. J. Med. 344: 1580-1587 (2001).
*
-
Kubicka S, Kuhnel F, Flemming P, Hain B, Kezmic N, Rudolph KL, Manns M, Meier PN. K-ras mutations in the bile of patients with primary sclerosing cholangitis.
Gut 48: 403-408 (2001).
*
-
Kubota H, Chiba H, Takakuwa Y, Osanai M, Tobioka H, Kohama G, Mori M, Sawada N. Retinoid X receptor alpha and retinoic acid receptor gamma mediate expression of genes encoding tight-junction proteins and barrier function in F9 cells during visceral endodermal differentiation.
Exp. Cell Res. 263: 163-172 (2001).
*
-
Kucharzik T, Walsh SV, Chen J, Parkos CA, Nusrat A. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins.
Am. J. Pathol. 159: 2001-2009 (2001).
*
-
Kudryavtseva M, Bezborodkina NN, Okovity SV, Kudryavtsev BN. Metabolic heterogeneity of glycogen in hepatocytes of patients with liver cirrhosis: the glycogen of the liver lobule zones in cirrhosis.
Eur. J. Gastroenterol. Hepatol. 13: 693-697 (2001).
-
Kugathasan S. MMR and IBD: the only thing we have to fear is...fear itself.
Inflamm. Bowel Dis. 7: 349-350 (2001).
*
-
Kugathasan S. Pediatric inflammatory bowel disease: clinical and therapeutic aspects.
Curr. Opin. Gastroenterol. 17: 350-355 (2001).
-
Kuhbacher T, Gionchetti P, Hampe J, Helwig U, Rosenstiel P, Campieri M, Buhr HJ, Schreiber S. Activation of signal-transducer and activator of transcription 1 (STAT1) in pouchitis.
Clin. Exp. Immunol. 123: 395-401 (2001).
*
-
Kuisma J, Nuutinen H, Luukkonen P, Jarvinen H, Kahri A, Farkkila M. Long term metabolic consequences of ileal pouch-anal anastomosis for ulcerative colitis.
Am. J. Gastroenterol. 96: 3110-3116 (2001).
*
-
Kula D, Jurecka-Tuleja B, Gubala E, Krawczyk A, Szpak S, Jarzab M. Association of polymorphism of LTalpha and TNF genes with Graves' disease.
Folia Histochem. Cytobiol. 39 Suppl. 2: 77-78 (2001).
-
Kullak-Ublick GA, Ismair MG, Stieger B, Landmann L, Huber R, Pizzagalli F, Fattinger K, Meier PJ, Hagenbuch B. Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver.
Gastroenterology 120: 525-533 (2001).
*
-
Kullberg MC, Rothfuchs AG, Jankovic D, Caspar P, Wynn TA, Gorelick PL, Cheever AW, Sher A. Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation.
Infect. Immun. 69: 4232-4241 (2001).
*
-
Kumanogoh A, Wang X, Lee I, Watanabe C, Kamanaka M, Shi W, Yoshida K, Sato T, Habu S, Itoh M, Sakaguchi N, Sakaguchi S, Kikutani H. Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: a role of CD40 in regulatory T cell development.
J. Immunol. 166: 353-360 (2001).
*
-
Kumar A, Bansal M, Srivastava DN, Pandhi A, Menon A, Mehra NK, Malaviya AN. Long-term outcome of undifferentiated spondylarthropathy.
Rheumatol. Int. 20: 221-224 (2001).
*
-
Kumar D, Tandon RK. Use of ursodeoxycholic acid in liver diseases.
J. Gastroenterol. Hepatol. 16: 3-14 (2001).
*
-
Kumar P, Prasad AK, Maji BK, Mani U, Dutta KK. Hepatoxic alterations induced by inhalation of trichlorethylene (TCE) in rats.
Biomed. Environ. Sci. 14: 325-332 (2001).
-
Kumar PG, Laloraya M, Wang CY, Ruan QG, Davoodi-Semiromi A, Kao KJ, She JX. The autoimmune regulator (AIRE) is a DNA-binding protein.
J. Biol. Chem. 276: 41357-41364 (2001).
*
-
Kundhal KK, Kundhal PS, Griffiths AM. Crohn’s disease in children.
University of Toronto Medical Journal 78: 200-204 (2001). *
-
Kunzelmann K, Mall M. Pharmacotherapy of the ion transport defect in cystic fibrosis.
Clin. Exp. Pharmacol. Physiol. 28: 857-867 (2001).
*
-
Kuon W, Holzhutter HG, Appel H, Grolms M, Kollnberger S, Traeder A, Henklein P, Weiss E, Thiel A, Lauster R, Bowness P, Radbruch A, Kloetzel PM, Sieper J. Identification of HLA-B27-restricted peptides from the Chlamydia trachomatis proteome with possible relevance to HLA-B27-associated diseases.
J. Immunol. 167: 4738-4746 (2001).
*
-
Kurahara K, Matsumoto T, Iida M, Honda K, Yao T, Fujishima M. Clinical and endoscopic features of nonsteroidal anti-inflammatory drug-induced colonic ulcerations.
Am. J. Gastroenterol. 96: 473-480 (2001).
*
-
Kurina LM, Goldacre MJ, Yeates D, Gill LE. Depression and anxiety in people with inflammatory bowel disease.
J. Epidemiol. Community Health 55: 716-720 (2001).
*
-
Kurtz CB, Cannon EP, Brezzani A, Pitruzzello M, Dinardo C, Rinard E, Acheson DW, Fitzpatrick R, Kelly P, Shackett K, Papoulis AT, Goddard PJ, Barker RH Jr, Palace GP, Klinger JD. GT160-246, a toxin binding polymer for treatment of Clostridium difficile colitis.
Antimicrob. Agents Chemother. 45: 2340-2347 (2001).
*
-
Kurz AK, Graf D, Schmitt M, Vom Dahl S, Haussinger D. Tauroursodesoxycholate-induced choleresis involves p38(MAPK) activation and translocation of the bile salt export pump in rats.
Gastroenterology 121: 407-419 (2001).
*
-
Kuwata K, Hirota M, Sugita H, Kai M, Hayashi N, Nakamura M, Matsuura T, Adachi N, Nishimori I, Ogawa M. Genetic mutations in exons 3 and 4 of the pancreatic secretory trypsin inhibitor in patients with pancreatitis.
J. Gastroenterol. 36: 612-618 (2001).
*
-
Kwon OJ, Brautbar C, Weintrob N, Sprecher E, Saphirman C, Bloch K, Pinhas-Hamiel O, Assah S, Vardi P, Israel S. Immunogenetics of HLA class II in Israeli Ashkenazi Jewish, Israeli non-Ashkenazi Jewish, and in Israeli Arab IDDM patients.
Hum. Immunol. 62: 85-91 (2001).
-
Kyne L, Kelly CP. Recurrent Clostridium difficile diarrhoea.
Gut 49: 152-153 (2001).
*
-
Kyo K, Muto T, Nagawa H, Lathrop GM, Nakamura Y. Associations of distinct variants of the intestinal mucin gene MUC3A with ulcerative colitis and Crohn's disease.
J. Hum. Genet. 46: 5-20 (2001).
-
Kyokane T, Norimizu S, Taniai H, Yamaguchi T, Takeoka S, Tsuchida E, Naito M, Nimura Y, Ishimura Y, Suematsu M. Carbon monoxide from heme catabolism protects against hepatobiliary dysfunction in endotoxin-treated rat liver.
Gastroenterology 120: 1227-1240 (2001).
*
-
Kyprianou A, Hanna J, Mullen KD. Focal neurological signs in cirrhotic patients with episodes of hepatic encephalopathy.
Am. J. Gastroenterol. 96: 273-274 (2001).
*
-
La Fontaine S, Theophilos MB, Firth SD, Gould R, Parton RG, Mercer JF. Effect of the toxic milk mutation (tx) on the function and intracellular localization of Wnd, the murine homologue of the Wilson copper ATPase.
Hum. Mol. Genet. 10: 361-370 (2001).
*
-
LaDuca JR, Gaspari AA. Targeting tumor necrosis factor alpha. New drugs used to modulate inflammatory diseases.
Dermatol. Clin. 19: 617-635 (2001).
-
Laffitte BA, Joseph SB, Walczak R, Pei L, Wilpitz DC, Collins JL, Tontonoz P. Autoregulation of the human liver X receptor alpha promoter.
Mol. Cell Biol. 21: 7558-7568 (2001).
*
-
Laffitte BA, Repa JJ, Joseph SB, Wilpitz DC, Kast HR, Mangelsdorf DJ, Tontonoz P. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes.
Proc. Natl. Acad. Sci. U.S.A. 98: 507-512 (2001).
*
-
Laflamme N, Soucy G, Rivest S. Circulating cell wall components derived from Gram-negative, not Gram-positive, bacteria cause a profound induction of the gene-encoding Toll-like receptor 2 in the CNS.
J. Neurochem. 79: 648-657 (2001).
*
-
Laharie D, Debeugny S, Peeters M, Van Gossum A, Gower-Rousseau C, Belaiche J, Fiasse R, Dupas JL, Lerebours E, Piotte S, Cortot A, Vermeire S, Grandbastien B, Colombel JF. Inflammatory bowel disease in spouses and their offspring.
Gastroenterology 120: 816-819 (2001).
*
-
Laifer SA, Stiller RJ, Siddiqui DS, Dunston-Boone G, Whetham JC. Ursodeoxycholic acid for the treatment of intrahepatic cholestasis of pregnancy.
J. Matern. Fetal. Med. 10: 131-135 (2001).
-
Lambert NC, Stevens AM, Tylee TS, Erickson TD, Furst DE, Nelson JL. From the simple detection of microchimerism in patients with autoimmune diseases to its implication in pathogenesis.
Ann. N. Y. Acad. Sci. 945: 164-171 (2001).
*
-
Lammert F, Carey MC, Paigen B. Chromosomal organization of candidate genes involved in cholesterol gallstone formation: a murine gallstone map.
Gastroenterology 120: 221-238 (2001).
*
-
Lampen A, Meyer S, Nau H. Phytanic acid and docosahexaenoic acid increase the metabolism of all-trans-retinoic acid and CYP26 gene expression in intestinal cells.
Biochim. Biophys. Acta 1521: 97-106 (2001).
*
-
Lamprecht A, Ubrich N, Yamamoto H, Schafer U, Takeuchi H, Maincent P, Kawashima Y, Lehr CM. Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease.
J. Pharmacol. Exp. Ther. 299: 775-781 (2001).
*
-
Lanas AA, Ferrandez AA. Should coronary patients chronically taking a low-dose of aspirin receive gastroprotective agents?
Rev. Esp. Cardiol. 54: 1361-1364 (2001).
-
Landau M, Mesterman R, Ophir J, Mevorah B, Alcalay J, Harel A, Nevo Y. Clinical significance of markedly elevated serum creatine kinase levels in patients with acne on isotretinoin.
Acta Derm. Venereol. 81: 350-352 (2001).
-
Langmead L, Rampton DS. Review article: herbal treatment in gastrointestinal and liver disease - benefits and dangers.
Aliment. Pharmacol. Ther. 15: 1239-1252 (2001).
*
-
Langner C, Denk H. Chronic cholangitis.
Pathologe 22: 375-387 (2001).
-
Lapidus A. The changing epidemiology of inflammatory bowel diseases.
Acta Gastroenterol. Belg. 64: 155-159 (2001).
-
Larriba S, Sumoy L, Ramos MD, Gimenez J, Estivill X, Casals T, Nunes V. ATB(0)/SLC1A5 gene. Fine localisation and exclusion of association with the intestinal phenotype of cystic fibrosis.
Eur. J. Hum. Genet. 9: 860-866 (2001).
*
-
Latham P, Lund EK, Brown JC, Johnson IT. Effects of cellular redox balance on induction of apoptosis by eicosapentaenoic acid in HT29 colorectal adenocarcinoma cells and rat colon in vivo.
Gut 49: 97-105 (2001).
*
-
Latruffe N, Cherkaoui Malki M, Nicolas-Frances V, Jannin B, Clemencet MC, Hansmannel F, Passilly-Degrace P, Berlot JP. Peroxisome-proliferator-activated receptors as physiological sensors of fatty acid metabolism: molecular regulation in peroxisomes.
Biochem. Soc. Trans. 29: 305-309 (2001).
*
-
Laval SH, Timms A, Edwards S, Bradbury L, Brophy S, Milicic A, Rubin L, Siminovitch KA, Weeks DE, Calin A, Wordsworth BP, Brown MA. Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci.
Am. J. Hum. Genet. 68: 918-926 (2001).
*
-
Lavy A, Broide E, Reif S, Keter D, Niv Y, Odes S, Eliakim R, Halak A, Ron Y, Patz J, Fich A, Villa Y, Arber N, Gilat T. Measles is more prevalent in Crohn's disease patients. A multicentre Israeli study.
Dig. Liver Dis. 33: 472-476 (2001).
-
Lawrance IC, Fiocchi C, Chakravarti S. Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes.
Hum. Mol. Genet. 10: 445-456 (2001).
*
-
Lawrance IC, Maxwell L, Doe W. Inflammation location, but not type, determines the increase in TGF-beta1 and IGF-1 expression and collagen deposition in IBD intestine.
Inflamm. Bowel Dis. 7: 16-26 (2001).
*
-
Lawrance IC, Maxwell L, Doe W. Altered response of intestinal mucosal fibroblasts to profibrogenic cytokines in inflammatory bowel disease.
Inflamm. Bowel Dis. 7: 226-236 (2001).
*
-
Lawrence JW, Li Y, Chen S, DeLuca JG, Berger JP, Umbenhauer DR, Moller DE, Zhou G. Differential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) alpha.
J. Biol. Chem. 276: 31521-31527 (2001).
*
-
Lawrence JW, Wollenberg GK, DeLuca JG. Tumor necrosis factor alpha is not required for WY14,643-induced cell proliferation.
Carcinogenesis 22: 381-386 (2001).
*
-
Lawson TM, Amos N, Bulgen D, Williams BD. Minocycline-induced lupus: clinical features and response to rechallenge.
Rheumatology (Oxford) 40: 329-335 (2001).
*
-
Lazaridis KN, Gores GJ, Lindor KD. Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'.
J. Hepatol. 35: 134-146 (2001).
*
-
Lazaron V, Leslie DB, Wasiluk KR, Dunn DL. Accelerated internalization and detoxification of endotoxin by anti-lipopolysaccharide antibody is an Fc receptor-mediated process.
Surgery 130: 192-197 (2001).
-
Le Marechal C, Audrezet MP, Quere I, Raguenes O, Langonne S, Ferec C. Complete and rapid scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by denaturing high-performance liquid chromatography (D-HPLC): major implications for genetic counselling.
Hum. Genet. 108: 290-298 (2001).
-
Le Page C, Popescu O, Genin P, Lian J, Paquin A, Galipeau J, Hiscott J. Disruption of NF-kappa B signaling and chemokine gene activation by retroviral mediated expression of IKK gamma/NEMO mutants.
Virology 286: 422-433 (2001).
*
-
Le Saux O, Beck K, Sachsinger C, Silvestri C, Treiber C, Goring HH, Johnson EW, De Paepe A, Pope FM, Pasquali-Ronchetti I, Bercovitch L, Marais AS, Viljoen DL, Terry SF, Boyd CD. A spectrum of ABCC6 mutations is responsible for pseudoxanthoma elasticum.
Am. J. Hum. Genet. 69: 749-764 (2001).
*
-
Lebrec D. Drug therapy for portal hypertension.
Gut 49: 441-442 (2001).
*
-
Lebrec D. Life, death, and varices.
Gut 49: 607-608 (2001).
*
-
Lecanda J, Urtasun R, Recalde S, Prieto J, Medina JF. A novel polymorphism IVS2+843C>T in the alternate promoter b1 of the human AE2 anion exchanger gene.
Hum. Mutat. 17: 82 (2001).
*
-
Lechler R, Chai JG, Marelli-Berg F, Lombardi G. T-cell anergy and peripheral T-cell tolerance.
Philos. Trans. R. Soc. Lond. B. Biol. Sci. 356: 625-637 (2001).
*
-
Leclerc JC, Cannard L, Lefevre F, Debelle L, Beot S, Boccaccini H, Bazin C, Regent D. Imaging of the intrahepatic biliary tree with thick slice MR cholangiography.
J. Radiol. 82: 151-160 (2001).
*
-
LeCluyse EL. Pregnane X receptor: molecular basis for species differences in CYP3A induction by xenobiotics.
Chem. Biol. Interact. 134: 283-289 (2001).
*
-
Lee CK, Hong JS, Cho YS, Yoo B, Kim GS, Moon HB. Lack of relationship between vitamin D receptor polymorphism and bone erosion in rheumatoid arthritis.
J. Korean Med. Sci. 16: 188-192 (2001).
*
-
Lee CR, Kim WH, Cho YS, Kim MH, Kim JH, Park IS, Bang D. Colonoscopic findings in intestinal Behcet's disease.
Inflamm. Bowel Dis. 7: 243-249 (2001).
*
-
Lee J, Azzaroli F, Wang L, Soroka CJ, Gigliozzi A, Setchell KD, Kramer W, Boyer JL. Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat.
Gastroenterology 121: 1473-1484 (2001).
*
-
Lee J, Ho WH, Maruoka M, Corpuz RT, Baldwin DT, Foster JS, Goddard AD, Yansura DG, Vandlen RL, Wood WI, Gurney AL. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1.
J. Biol. Chem. 276: 1660-1664 (2001).
*
-
Lee JC, Gladman DD, Schentag CT, Cook RJ. The long-term use of azathioprine in patients with psoriatic arthritis.
J. Clin. Rheumatol. 7: 160-165 (2001).
-
Lee JY, Goldman D, Piliero LM, Petri M, Sullivan KE. Interferon-gamma polymorphisms in systemic lupus erythematosus.
Genes Immun. 2: 254-257 (2001).
*
-
Lee JY, Sohn KH, Rhee SH, Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4.
J. Biol. Chem. 276: 16683-16689 (2001).
*
-
Lee KT, Liu TS. Altered mucin gene expression in stone-containing intrahepatic bile ducts and cholangiocarcinomas.
Dig. Dis. Sci. 46: 2166-2172 (2001).
*
-
Lee MG, Ahn W, Lee JA, Kim JY, Choi JY, Moe OW, Milgram SL, Muallem S, Kim KH. Coordination of pancreatic HCO3- secretion by protein-protein interaction between membrane transporters.
JOP 2: S203-S206 (2001).
*
-
Lee SD, Surawicz CM. Ursodiol for all?
Am. J. Gastroenterol. 96: 3437-3438 (2001).
*
-
Lee SP, Ko CW. Pronucleating proteins in bile-a myth?
J. Hepatol. 35: 525-526 (2001).
*
-
Lee WJ, Lim HK, Jang KM, Kim SH, Lee SJ, Lim JH, Choo IW. Radiologic spectrum of cholangiocarcinoma: emphasis on unusual manifestations and differential diagnoses.
Radiographics 21: 97-116 (2001).
*
-
Lee YH, Ji JD, Sohn J, Song GG. Polymorphsims of CTLA-4 exon 1 +49, CTLA-4 promoter -318 and Fas promoter -670 in spondyloarthropathies.
Clin. Rheumatol. 20: 420-422 (2001).
*
-
Lee YH, Kim YR, Ji JD, Sohn J, Song GG. Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus.
J. Rheumatol. 28: 2008-2011 (2001).
-
Lee YH, Kim YR, Ji JD, Sohn J, Song GG. Polymorphisms of the CTLA-4 exon 1 and promoter gene in systemic lupus erythematosus.
Lupus 10: 601-605 (2001).
-
Lee YH, Kim YR, Ji JD, Sohn J, Song GG. p53 codon 72 polymorphism and rheumatoid arthritis.
J. Rheumatol. 28: 2392-2394 (2001).
-
Lee YM, Kim DJ. Primary sclerosing cholangitis.
Curr. Treat. Options Gastroenterol. 4: 469-477 (2001).
-
Lee YM, Teo EK, Ng TM, Khor C, Fock KM. Autoimmune hepatitis in Singapore: a rare syndrome affecting middle-aged women.
J. Gastroenterol. Hepatol. 16: 1384-1389 (2001).
*
-
Lefebvre P. Molecular basis for designing selective modulators of retinoic acid receptor transcriptional activities.
Curr. Drug Targets Immune Endocr. Metabol. Disord. 1: 153-164 (2001).
-
Legnani PE, Kornbluth A. Immunomodulator therapy in inflammatory bowel disease.
Curr. Treat. Options Gastroenterol. 4: 199-205 (2001).
-
LeGrand A, Fermor B, Fink C, Pisetsky DS, Weinberg JB, Vail TP, Guilak F. Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci.
Arthritis Rheum. 44: 2078-2083 (2001).
*
-
Lehmann J, Bellmann S, Werner C, Schroder R, Schutze N, Alber G. IL-12p40-dependent agonistic effects on the development of protective innate and adaptive immunity against Salmonella enteritidis.
J. Immunol. 167: 5304-5315 (2001).
*
-
Leidenius M, Hockersted K, Broome U, Ericzon BG, Friman S, Olausson M, Schrumpf E. Hepatobiliary carcinoma in primary sclerosing cholangitis: a case control study.
J. Hepatol. 34: 792-798 (2001).
*
-
Leiper K, Campbell BJ, Jenkinson MD, Milton J, Yu LG, Democratis J, Rhodes JM. Interaction between bacterial peptides, neutrophils and goblet cells: a possible mechanism for neutrophil recruitment and goblet cell depletion in colitis.
Clin. Sci. (Lond.) 101: 395-402 (2001).
*
-
Leiter EH. The NOD mouse: a model for insulin-dependent diabetes mellitus.
Curr. Protoc. Immunol. Chapter 15: Unit 15.9 (2001).
-
LeLeiko NS, Gribetz D. Pediatric gastroenterology at the Mount Sinai hospital.
Mt. Sinai J. Med. 68: 102-105 (2001).
*
-
Lengeling A, Pfeffer K, Balling R. The battle of two genomes: genetics of bacterial host/pathogen interactions in mice.
Mamm. Genome 12: 261-271 (2001).
*
-
Lenhard JM. PPAR gamma/RXR as a molecular target for diabetes.
Receptors Channels 7: 249-258 (2001).
-
Leonard WJ. Cytokines and immunodeficiency diseases.
Nat. Rev. Immunol. 1: 200-208 (2001).
*
-
Leslie EM, Deeley RG, Cole SP. Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters.
Toxicology 167: 3-23 (2001).
*
-
Leslie WD. All patients with inflammatory bowel disease should have bone density assessment: con.
Inflamm. Bowel Dis. 7: 163-167 (2001).
*
-
Lester LA, Rich SS, Blumenthal MN, Togias A, Murphy S, Malveaux F, Miller ME, Dunston GM, Solway J, Wolf RL, Samet JM, Marsh DG, Meyers DA, Ober C, Bleecker ER; Collaborative Study on the Genetics of Asthma. Ethnic differences in asthma and associated phenotypes: collaborative study on the genetics of asthma.
J. Allergy Clin. Immunol. 108: 357-362 (2001).
*
-
Leung TF, Tang NL, Chan IH, Li AM, Ha G, Lam CW. A polymorphism in the coding region of interleukin-13 gene is associated with atopy but not asthma in Chinese children.
Clin. Exp. Allergy 31: 1515-1521 (2001).
*
-
Levanon D, Glusman G, Bangsow T, Ben-Asher E, Male DA, Avidan N, Bangsow C, Hattori M, Taylor TD, Taudien S, Blechschmidt K, Shimizu N, Rosenthal A, Sakaki Y, Lancet D, Groner Y. Architecture and anatomy of the genomic locus encoding the human leukemia-associated transcription factor RUNX1/AML1.
Gene 262: 23-33 (2001).
*
-
Levels JH, Abraham PR, van den Ende A, van Deventer SJ. Distribution and kinetics of lipoprotein-bound endotoxin.
Infect. Immun. 69: 2821-2828 (2001).
*
-
Levings MK, Sangregorio R, Roncarolo MG. Human CD25(+)CD4(+) T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.
J. Exp. Med. 193: 1295-1302 (2001).
*
-
Levite M, Chowers Y. Nerve-driven immunity: neuropeptides regulate cytokine secretion of T cells and intestinal epithelial cells in a direct, powerful and contextual manner.
Ann. Oncol. 12 Suppl. 2: S19-S25 (2001).
-
Levy O, Elsbach P. Bactericidal/permeability-increasing protein in host defense and its efficacy in the treatment of bacterial sepsis.
Curr. Infect. Dis. Rep. 3: 407-412 (2001).
-
Lewis JD. How safe is immunomodulator therapy?
Inflamm. Bowel Dis. 7: 178-179 (2001).
*
-
Lewis JD. Ursodiol prevents UC-associated CRC.
Gastroenterology 121: 491-492 (2001).
*
-
Lewis JD, Bilker WB, Brensinger C, Deren JJ, Vaughn DJ, Strom BL. Inflammatory bowel disease is not associated with an increased risk of lymphoma.
Gastroenterology 121: 1080-1087 (2001).
*
-
Lewis JD, Lichtenstein GR, Stein RB, Deren JJ, Judge TA, Fogt F, Furth EE, Demissie EJ, Hurd LB, Su CG, Keilbaugh SA, Lazar MA, Wu GD. An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis.
Am. J. Gastroenterol. 96: 3323-3328 (2001).
*
-
Lewis RS. Calcium signaling mechanisms in T lymphocytes.
Annu. Rev. Immunol. 19: 497-521 (2001).
*
-
Leyendecker JR, Dodd GD 3rd. Minimally invasive techniques for the treatment of liver tumors.
Semin. Liver Dis. 21: 283-291 (2001).
-
Li J, Peet GW, Balzarano D, Li X, Massa P, Barton RW, Marcu KB. Novel NEMO/IkappaB kinase and NF-kappaB target genes at the pre-B to immature B cell transition.
J. Biol. Chem. 276: 18579-18590 (2001).
*
-
Li M, Chiba H, Warot X, Messaddeq N, Gerard C, Chambon P, Metzger D. RXR-alpha ablation in skin keratinocytes results in alopecia and epidermal alterations.
Development 128: 675-688 (2001).
*
-
Li P, Morris DL, Willcox BE, Steinle A, Spies T, Strong RK. Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA.
Nat. Immunol. 2: 443-451 (2001).
*
-
Li TK, Yin SJ, Crabb DW, O'Connor S, Ramchandani VA. Genetic and environmental influences on alcohol metabolism in humans.
Alcohol Clin. Exp. Res. 25: 136-144 (2001).
-
Li XD, Essayan DM, Liu MC, Beaty TH, Huang SK. Profiling of differential gene expression in activated, allergen-specific human Th2 cells.
Genes Immun. 2: 88-98 (2001).
*
-
Li-Masters T, Morgan ET. Effects of bacterial lipopolysaccharide on phenobarbital-induced CYP2B expression in mice.
Drug Metab. Dispos. 29: 252-257 (2001).
*
-
Liang CP, Tall AR. Transcriptional profiling reveals global defects in energy metabolism, lipoprotein, and bile acid synthesis and transport with reversal by leptin treatment in ob/ob mouse liver.
J. Biol. Chem. 276: 49066-49076 (2001).
*
-
Liang GC, Barr WG. Open trial of leflunomide for refractory psoriasis and psoriatic arthritis.
J. Clin. Rheumatol. 7: 366-370 (2001).
-
Liang X, Hou G, Chen R, Xu P, Huang F, Wang Y, Yan Z, Ou C. A study of gene products encoded by Wilson disease gene.
Zhonghua Gan Zang Bing Za Zhi 9: 86-88 (2001).
-
Lichtenstein GR. Management of bone loss in inflammatory bowel disease.
Semin. Gastrointest. Dis. 12: 275-283 (2001).
-
Lichtenstein GR. Approach to corticosteroid-dependent and corticosteroid-refractory Crohn's disease.
Inflamm. Bowel Dis. 7 Suppl. 1: S23-S29 (2001).
*
-
Lichtenstein GR. Is infliximab effective for induction of remission in patients with ulcerative colitis?
Inflamm. Bowel Dis. 7: 89-93 (2001).
*
-
Liden H, Norrby J, Gabel M, Friman S, Olausson M. Outcome after liver transplantation for primary sclerosing cholangitis.
Transplant. Proc. 33: 2452-2453 (2001).
*
-
Lieberman DA, Weiss DG; Veterans Affairs Cooperative Study Group 380. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
N. Engl. J. Med. 345: 555-560 (2001).
*
-
Liermann Garcia RF, Evangelista Garcia C, McMaster P, Neuberger J. Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center.
Hepatology 33: 22-27 (2001).
*
-
Ligers A, Dyment DA, Willer CJ, Sadovnick AD, Ebers G, Risch N, Hillert J; Canadian Collaborative Study Groups. Evidence of linkage with HLA-DR in DRB1*15-negative families with multiple sclerosis.
Am. J. Hum. Genet. 69: 900-903 (2001).
*
-
Ligers A, Teleshova N, Masterman T, Huang WX, Hillert J. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms.
Genes Immun. 2: 145-152 (2001).
*
-
Lim SS, Conn DL. The use of low-dose prednisone in the management of rheumatoid arthritis.
Bull. Rheum. Dis. 50: 1-4 (2001).
*
-
Lima LC, Matte U, Leistner S, Bopp AR, Scholl VC, Giugliani R, da Silveira TR. Molecular analysis of the Pi*Z allele in patients with liver disease.
Am. J. Med. Genet. 104: 287-290 (2001).
-
Lin CH, Hsieh SY, Sheen IS, Lee WC, Chen TC, Shyu WC, Liaw YF. Genome-wide hypomethylation in hepatocellular carcinogenesis.
Cancer Res. 61: 4238-4243 (2001).
*
-
Lin EC, Kuni CC. Radionuclide imaging of hepatic and biliary disease.
Semin. Liver Dis. 21: 179-194 (2001).
-
Lindberg BU, Broome U, Persson B. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study.
Dis. Colon Rectum 44: 77-85 (2001).
*
-
Linden A. Role of interleukin-17 and the neutrophil in asthma.
Int. Arch. Allergy Immunol. 126: 179-184 (2001).
-
Linder S, Soderlund C. Endoscopic therapy in primary sclerosing cholangitis: outcome of treatment and risk of cancer.
Hepatogastroenterology 48: 387-392 (2001).
-
Lindsay JO, Hodgson HJ. Review article: the immunoregulatory cytokine interleukin-10 - a therapy for Crohn's disease?
Aliment. Pharmacol. Ther. 15: 1709-1716 (2001).
*
-
Lindstedt R, Monk N, Lombardi G, Lechler R. Amino acid substitutions in the putative MHC class II "dimer of dimers" interface inhibit CD4+ T cell activation.
J. Immunol. 166: 800-808 (2001).
*
-
Link KH, Sunelaitis E, Kornmann M, Schatz M, Gansauge F, Leder G, Formentini A, Staib L, Pillasch J, Beger HG. Regional chemotherapy of nonresectable colorectal liver metastases with mitoxantrone, 5-fluorouracil, folinic acid, and mitomycin C may prolong survival.
Cancer 92: 2746-2753 (2001).
*
-
Linsdell P. Direct block of the cystic fibrosis transmembrane conductance regulator Cl(-) channel by butyrate and phenylbutyrate.
Eur. J. Pharmacol. 411: 255-260 (2001).
*
-
Linskens RK, Huijsdens XW, Savelkoul PH, Vandenbroucke-Grauls CM, Meuwissen SG. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics.
Scand. J. Gastroenterol. Suppl. 234: 29-40 (2001).
*
-
Linthoudt DV, Deruaz J, Gerster JC. Periostitis in a patient with ulcerative colitis.
J. Clin. Rheumatol. 7: 403-405 (2001).
-
Lio D, Candore G, Colombo A, Colonna Romano G, Gervasi F, Marino V, Scola L, Caruso C. A genetically determined high setting of TNF-alpha influences immunologic parameters of HLA-B8,DR3 positive subjects: implications for autoimmunity.
Hum. Immunol. 62: 705-713 (2001).
-
Liu B, Wang Y, Melana SM, Pelisson I, Najfeld V, Holland JF, Pogo BG. Identification of a proviral structure in human breast cancer.
Cancer Res. 61: 1754-1759 (2001).
*
-
Liu C, Xu Z, Gupta D, Dziarski R. Peptidoglycan recognition proteins: a novel family of four human innate immunity pattern recognition molecules.
J. Biol. Chem. 276: 34686-34694 (2001).
*
-
Liu MF, Wang CR, Lin LC, Wu CR. CTLA-4 gene polymorphism in promoter and exon-1 regions in Chinese patients with systemic lupus erythematosus.
Lupus 10: 647-649 (2001).
*
-
Liu W, Toyosawa S, Furuichi T, Kanatani N, Yoshida C, Liu Y, Himeno M, Narai S, Yamaguchi A, Komori T. Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures.
J. Cell Biol. 155: 157-166 (2001).
*
-
Liu Z, Geboes K, Hellings P, Maerten P, Heremans H, Vandenberghe P, Boon L, van Kooten P, Rutgeerts P, Ceuppens JL. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
J. Immunol. 167: 1830-1838 (2001).
*
-
Ljung T, Herulf M, Beijer E, Jacobsson H, Lundberg J, Finkel Y, Hellstrom PM. Rectal nitric oxide assessment in children with Crohn disease and ulcerative colitis. Indicator of ileocaecal and colorectal affection.
Scand. J. Gastroenterol. 36: 1073-1076 (2001).
*
-
Llewelyn M, Cohen J. Superantigen antagonist peptides.
Crit. Care 5: 53-55 (2001).
*
-
Lobaccaro JM, Repa JJ, Lu TT, Caira F, Henry-Berger J, Volle DH, Mangelsdorf DJ. Regulation of lipid metabolism by the orphan nuclear receptors.
Ann. Endocrinol. (Paris) 62: 239-247 (2001).
-
Loinaz C, Gonzalez EM, Jimenez C, Garcia I, Gomez R, Gonzalez-Pinto I, Colina F, Gimeno A. Long-term biliary complications after liver surgery leading to liver transplantation.
World J. Surg. 25: 1260-1263 (2001).
*
-
Loiseau P, Lepage V, Djelal F, Busson M, Tamouza R, Raffoux C, Menkes CJ, Meyer O, Charron D, Goldberg D. HLA class I and class II are both associated with the genetic predisposition to primary Sjogren syndrome.
Hum. Immunol. 62: 725-731 (2001).
-
Lombardi ML, Pirozzi G, Luongo V, Mercuro O, Pace E, Blanco Del Vecchio G, Cozzolino A, Errico S, Fusco C, Castiglione F. Crohn disease: susceptibility and disease heterogeneity revealed by HLA genotyping.
Hum. Immunol. 62: 701-704 (2001).
-
Londei M. The external world of gluten and autoimmunity.
Gut 49: 463-464 (2001).
*
-
Long SA, Quan C, Van de Water J, Nantz MH, Kurth MJ, Barsky D, Colvin ME, Lam KS, Coppel RL, Ansari A, Gershwin ME. Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis.
J. Immunol. 167: 2956-2963 (2001).
*
-
Longo M, Crosignani A, Podda M. Hyperlipidemia in chronic cholestatic liver disease.
Curr. Treat. Options Gastroenterol. 4: 111-114 (2001).
-
Lopez Ramos D, Gabriel R, Cantero Perona J, Moreno Otero R, Fernandez Bermejo M, Mate Jimenez J. Association of MALTectomy (appendectomy and tonsillectomy) and inflammatory bowel disease: a familial case-control study.
Rev. Esp. Enferm. Dig. 93: 303-314 (2001).
-
Lopez RR Jr, Cosenza CA, Lois J, Hoffman AL, Sher LS, Noguchi H, Pan SH, McMonigle M. Long-term results of metallic stents for benign biliary strictures.
Arch. Surg. 136: 664-669 (2001).
*
-
Lorenzi AR, Johnson AH, Davies G, Gough A. Gastric antral vascular ectasia in systemic sclerosis: complete resolution with methylprednisolone and cyclophosphamide.
Ann. Rheum. Dis. 60: 796-798 (2001).
*
-
Lorkowski S, Kratz M, Wenner C, Schmidt R, Weitkamp B, Fobker M, Reinhardt J, Rauterberg J, Galinski EA, Cullen P. Expression of the ATP-binding cassette transporter gene ABCG1 (ABC8) in Tangier disease.
Biochem. Biophys. Res. Commun. 283: 821-830 (2001).
*
-
Lorkowski S, Rust S, Engel T, Jung E, Tegelkamp K, Galinski EA, Assmann G, Cullen P. Genomic sequence and structure of the human ABCG1 (ABC8) gene.
Biochem. Biophys. Res. Commun. 280: 121-131 (2001).
*
-
Louthrenoo W, Aramsareewong T, Sukitawut W. Adult onset Still's disease: clinical features and outcome in 16 Thai patients.
J. Clin. Rheumatol. 7: 301-307 (2001).
-
Love MW, Craddock AL, Angelin B, Brunzell JD, Duane WC, Dawson PA. Analysis of the ileal bile acid transporter gene, SLC10A2, in subjects with familial hypertriglyceridemia.
Arterioscler. Thromb. Vasc. Biol. 21: 2039-2045 (2001).
*
-
Lowenfels A, Maisonneuve P, Palys B. Re: Ockenga et al. - mutations of cystic fibrosis gene in patients with pancreatitis.
Am. J. Gastroenterol. 96: 614-615 (2001).
*
-
Lowry PW, Franklin CL, Weaver AL, Pike MG, Mays DC, Tremaine WJ, Lipsky JJ, Sandborn WJ. Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease.
Gut 49: 665-670 (2001).
*
-
Lowry PW, Franklin CL, Weaver AL, Szumlanski CL, Mays DC, Loftus EV, Tremaine WJ, Lipsky JJ, Weinshilboum RM, Sandborn WJ. Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide.
Gut 49: 656-664 (2001).
*
-
Lu K, Lee MH, Hazard S, Brooks-Wilson A, Hidaka H, Kojima H, Ose L, Stalenhoef AF, Mietinnen T, Bjorkhem I, Bruckert E, Pandya A, Brewer HB Jr, Salen G, Dean M, Srivastava A, Patel SB. Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively.
Am. J. Hum. Genet. 69: 278-290 (2001).
*
-
Lu SC, Alvarez L, Huang ZZ, Chen L, An W, Corrales FJ, Avila MA, Kanel G, Mato JM. Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation.
Proc. Natl. Acad. Sci. U.S.A. 98: 5560-5565 (2001).
*
-
Lu TT, Repa JJ, Mangelsdorf DJ. Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism.
J. Biol. Chem. 276: 37735-37738 (2001).
*
-
Lu W, Sun G. Clinical characteristics of primary biliary cirrhosis with Sjogren's syndrome of 20 cases.
Zhonghua Nei Ke Za Zhi 40: 747-749 (2001).
-
Lubberts E, Joosten LA, Oppers B, van den Bersselaar L, Coenen-de Roo CJ, Kolls JK, Schwarzenberger P, van de Loo FA, van den Berg WB. IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis.
J. Immunol. 167: 1004-1013 (2001).
*
-
Lubberts E, van den Berg WB. Potential of modulatory cytokines in the rheumatoid arthritis process.
Drug News Perspect. 14: 517-522 (2001).
-
Lucero PF, Frey WC, Shaffer RT, Morris MJ. Granulomatous lung masses in an elderly patient with inactive Crohn's disease.
Inflamm. Bowel Dis. 7: 256-259 (2001).
*
-
Lucotte G. Distribution of the CCR5 gene 32-basepair deletion in West Europe. A hypothesis about the possible dispersion of the mutation by the Vikings in historical times.
Hum. Immunol. 62: 933-936 (2001).
-
Ludvigsson JF, Ludvigsson J. Coeliac disease in the father affects the newborn.
Gut 49: 169-175 (2001).
*
-
Lugering A, Schmidt M, Lugering N, Pauels HG, Domschke W, Kucharzik T. Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway.
Gastroenterology 121: 1145-1157 (2001).
*
-
Lukacs NW. Role of chemokines in the pathogenesis of asthma.
Nat. Rev. Immunol. 1: 108-116 (2001).
*
-
Lund JN, Scholefield JH, Grainge MJ, Smith SJ, Mangham C, Armitage NC, Robinson MH, Logan RF. Risks, costs, and compliance limit colorectal adenoma surveillance: lessons from a randomised trial.
Gut 49: 91-96 (2001).
*
-
Lund PK, Zuniga CC. Intestinal fibrosis in human and experimental inflammatory bowel disease.
Curr. Opin. Gastroenterol. 17: 318-323 (2001).
-
Luo TH, Zhao Y, Li G, Yuan WT, Zhao JJ, Chen JL, Huang W, Luo M. A genome-wide search for type II diabetes susceptibility genes in Chinese Hans.
Diabetologia 44: 501-506 (2001).
*
-
Luross JA, Williams NA. The genetic and immunopathological processes underlying collagen-induced arthritis.
Immunology 103: 407-416 (2001).
*
-
Luu L, Ramshaw H, Tahayato A, Stuart A, Jones G, White J, Petkovich M. Regulation of retinoic acid metabolism.
Adv. Enzyme Regul. 41: 159-175 (2001).
-
Lykavieris P, Hadchouel M, Chardot C, Bernard O. Outcome of liver disease in children with Alagille syndrome: a study of 163 patients.
Gut 49: 431-435 (2001).
*
-
Maalej A, Bougacha N, Rebai A, Bellassouad M, Ayadi-Makni F, Abid M, Jouida J, Makni H, Ayadi H. Lack of linkage and association between autoimmune thyroid diseases and the CTLA-4 gene in a large Tunisian family.
Hum. Immunol. 62: 1245-1250 (2001).
-
Maalej A, Makni H, Ayadi F, Bellassoued M, Jouida J, Bouguacha N, Abid M, Ayadi H. A full genome screening in a large Tunisian family affected with thyroid autoimmune disorders.
Genes Immun. 2: 71-75 (2001).
*
-
MacCoss MJ, Fukagawa NK, Matthews DE. Measurement of intracellular sulfur amino acid metabolism in humans.
Am. J. Physiol. Endocrinol. Metab. 280: E947-E955 (2001).
*
-
MacDonald PN, Baudino TA, Tokumaru H, Dowd DR, Zhang C. Vitamin D receptor and nuclear receptor coactivators: crucial interactions in vitamin D-mediated transcription.
Steroids 66: 171-176 (2001).
-
MacIntyre CR, McIntyre PB. MMR, autism and inflammatory bowel disease: responding to patient concerns using an evidence-based framework.
Med. J. Aust. 175: 127-128 (2001).
-
Mack M, Cihak J, Simonis C, Luckow B, Proudfoot AE, Plachy J, Bruhl H, Frink M, Anders HJ, Vielhauer V, Pfirstinger J, Stangassinger M, Schlondorff D. Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice.
J. Immunol. 166: 4697-4704 (2001).
*
-
Mack R, Chowdary D, Samaan P, Podolak I, Dermody J. Prevalence of CTLA-4 polymorphism A49G in Ashkenazi Jews.
Genet. Test. 5: 269-271 (2001).
-
MacLean G, Abu-Abed S, Dolle P, Tahayato A, Chambon P, Petkovich M. Cloning of a novel retinoic-acid metabolizing cytochrome P450, Cyp26B1, and comparative expression analysis with Cyp26A1 during early murine development.
Mech. Dev. 107: 195-201 (2001).
*
-
Macpherson AJ, Hunziker L, McCoy K, Lamarre A. IgA responses in the intestinal mucosa against pathogenic and non-pathogenic microorganisms.
Microbes Infect. 3: 1021-1035 (2001).
*
-
Madsen K, Cornish A, Soper P, McKaigney C, Jijon H, Yachimec C, Doyle J, Jewell L, De Simone C. Probiotic bacteria enhance murine and human intestinal epithelial barrier function.
Gastroenterology 121: 580-591 (2001).
*
-
Madsen KL. The use of probiotics in gastrointestinal disease.
Can. J. Gastroenterol. 15: 817-822 (2001).
*
-
Madsen KL. Inflammatory bowel disease: lessons from the IL-10 gene-deficient mouse.
Clin. Invest. Med. 24: 250-257 (2001).
-
Magnusson PK, Enroth H, Eriksson I, Held M, Nyren O, Engstrand L, Hansson LE, Gyllensten UB. Gastric cancer and human leukocyte antigen: distinct DQ and DR alleles are associated with development of gastric cancer and infection by Helicobacter pylori.
Cancer Res. 61: 2684-2689 (2001).
*
-
Magnusson V, Nakken B, Bolstad AI, Alarcon-Riquelme ME. Cytokine polymorphisms in systemic lupus erythematosus and Sjogren's syndrome.
Scand. J. Immunol. 54: 55-61 (2001).
*
-
Mahadevan U, Sandborn WJ. Evolving medical therapies for Crohn's disease.
Curr. Gastroenterol. Rep. 3: 471-476 (2001).
-
Mahadevan U, Sandborn WJ. Infliximab for the treatment of orofacial Crohn's disease.
Inflamm. Bowel Dis. 7: 38-42 (2001).
*
-
Maher JJ. Interactions between hepatic stellate cells and the immune system.
Semin. Liver Dis. 21: 417-426 (2001).
-
Mahmud N, Kamm MA, Dupas JL, Jewell DP, O'Morain CA, Weir DG, Kelleher D. Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study.
Gut 49: 552-556 (2001).
*
-
Mahmud N, Weir DG. The urban diet and Crohn's disease: is there a relationship?
Eur. J. Gastroenterol. Hepatol. 13: 93-95 (2001).
*
-
Mailleau C, Paul A, Colin M, Xing PX, Guernier C, Bernaudin JF, Capeau J, Brahimi-Horn MC. Glycoconjugate metabolism in a cystic fibrosis knockout mouse model.
Mol. Genet. Metab. 72: 122-131 (2001).
*
-
Maire F, Beaugerie L, Cohen M, Deschamps A, Cosnes J, Capeau J, Gendre JP. Factors associated with hyperhomocysteinemia in Crohn's disease.
Gastroenterol. Clin. Biol. 25: 745-748 (2001).
-
Maiuri L, Ciacci C, Vacca L, Ricciardelli I, Auricchio S, Quaratino S, Londei M. IL-15 drives the specific migration of CD94+ and TCR-gammadelta+ intraepithelial lymphocytes in organ cultures of treated celiac patients.
Am. J. Gastroenterol. 96: 150-156 (2001).
*
-
Mak TW, Penninger JM, Ohashi PS. Knockout mice: a paradigm shift in modern immunology.
Nat. Rev. Immunol. 1: 11-19 (2001).
*
-
Makita T, Hernandez-Hoyos G, Chen TH, Wu H, Rothenberg EV, Sucov HM. A developmental transition in definitive erythropoiesis: erythropoietin expression is sequentially regulated by retinoic acid receptors and HNF4.
Genes Dev. 15: 889-901 (2001).
*
-
Malats N. Gene-environment interactions in pancreatic cancer.
Pancreatology 1: 472-476 (2001).
-
Malats N, Casals T, Porta M, Guarner L, Estivill X, Real FX. Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group.
Gut 48: 70-74 (2001).
*
-
Malhi H, Gupta S. Hepatocyte transplantation: new horizons and challenges.
J. Hepatobiliary Pancreat. Surg. 8: 40-50 (2001).
-
Malloy PJ, Zhu W, Zhao XY, Pehling GB, Feldman D. A novel inborn error in the ligand-binding domain of the vitamin D receptor causes hereditary vitamin D-resistant rickets.
Mol. Genet. Metab. 73: 138-148 (2001).
*
-
Mandal A, Mayberry J. Magnetic resonance spectroscopy: a new test for differentiating ulcerative colitis from Crohn's disease?
Am. J. Gastroenterol. 96: 271-273 (2001).
*
-
Manfredi R, Chiodo F. Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate.
J. Infect. 42: 181-188 (2001).
-
Manns MP, Strassburg CP. Autoimmune hepatitis: clinical challenges.
Gastroenterology 120: 1502-1517 (2001).
*
-
Manolova I, Dancheva M, Halacheva K. Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus: prevalence, antigen specificity, and clinical associations.
Rheumatol. Int. 20: 197-204 (2001).
*
-
Marasini B, Casari S, Zeni S, Turri O, Biondi ML. Stromelysin promoter polymorphism is associated with systemic sclerosis.
Rheumatology (Oxford) 40: 475-476 (2001).
*
-
Marasini B, Gagetta M, Rossi V, Ferrari P. Rheumatic disorders and primary biliary cirrhosis: an appraisal of 170 Italian patients.
Ann. Rheum. Dis. 60: 1046-1049 (2001).
*
-
Marchesini G, Bianchi G, Amodio P, Salerno F, Merli M, Panella C, Loguercio C, Apolone G, Niero M, Abbiati R; Italian Study Group for quality of life in cirrhosis. Factors associated with poor health-related quality of life of patients with cirrhosis.
Gastroenterology 120: 170-178 (2001).
*
-
Margetts PJ, Churchill DN, Alexopoulou I. Interstitial nephritis in patients with inflammatory bowel disease treated with mesalamine.
J. Clin. Gastroenterol. 32: 176-178 (2001).
-
Marie I, Levesque H, Tranvouez JL, Francois A, Riachi G, Cailleux N, Courtois H. Autoimmune hepatitis and systemic sclerosis: a new overlap syndrome?
Rheumatology (Oxford) 40: 102-106 (2001).
*
-
Marinho R, Graca H, Ramalho F, Costa A, Batista A, De Moura MC. Autoimmune cholangiopathy.
Acta Med. Port. 14: 361-366 (2001).
-
Marion JF. Crohn's disease and ulcerative colitis: when is a diagnostic procedure necessary?
Minerva Gastroenterol. Dietol. 47: 9-16 (2001).
-
Markowitz JS, DeVane CL. The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).
Psychopharmacol. Bull. 35: 53-64 (2001).
-
Marmor M, Sheppard HW, Donnell D, Bozeman S, Celum C, Buchbinder S, Koblin B, Seage GR 3rd; HIV Network for Prevention Trials Vaccine Preparedness Protocol Team. Homozygous and heterozygous CCR5-Delta32 genotypes are associated with resistance to HIV infection.
J. Acquir. Immune Defic. Syndr. 27: 472-481 (2001).
-
Marrack P, Kappler J, Kotzin BL. Autoimmune disease: why and where it occurs.
Nat. Med. 7: 899-905 (2001).
*
-
Marrosu MG, Murru R, Murru MR, Costa G, Zavattari P, Whalen M, Cocco E, Mancosu C, Schirru L, Solla E, Fadda E, Melis C, Porru I, Rolesu M, Cucca F. Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia.
Hum. Mol. Genet. 10: 2907-2916 (2001).
*
-
Marschall HU, Broome U, Einarsson C, Alvelius G, Thomas HG, Matern S. Isoursodeoxycholic acid: metabolism and therapeutic effects in primary biliary cirrhosis.
J. Lipid Res. 42: 735-742 (2001).
*
-
Marsh SG, Bodmer JG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system, 2000.
Hum. Immunol. 62: 419-468 (2001).
-
Marsh SG, Bodmer JG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system, 2000.
Tissue Antigens 57: 236-283 (2001).
*
-
Marsh SG, Bodmer JG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, MacH B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system, 2000.
Eur. J. Immunogenet. 28: 377-424 (2001).
-
Marshak S, Ben-Shushan E, Shoshkes M, Havin L, Cerasi E, Melloul D. Regulatory elements involved in human pdx-1 gene expression.
Diabetes 50 Suppl. 1: S37-S38 (2001).
*
-
Marshall H. RANTES polymorphism affects susceptibility to HIV and asthma.
Trends Immunol. 22: 13 (2001).
*
-
Marshall SE, Welsh KI. The role of cytokine polymorphisms in rejection after solid organ transplantation.
Genes Immun. 2: 297-303 (2001).
*
-
Marteau P, Seksik P. Role of prebiotics and probiotics in therapeutic management of cryptogenetic inflammatory bowel disease.
Gastroenterol. Clin. Biol. 25: C94-C97 (2001).
-
Martignetti JA, Aqeel AA, Sewairi WA, Boumah CE, Kambouris M, Mayouf SA, Sheth KV, Eid WA, Dowling O, Harris J, Glucksman MJ, Bahabri S, Meyer BF, Desnick RJ. Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome.
Nat. Genet. 28: 261-265 (2001).
*
-
Martin K, Heinzlmann M, Borchers R, Mack M, Loeschke K, Folwaczny C. Delta 32 mutation of the chemokine-receptor 5 gene in inflammatory bowel disease.
Clin. Immunol. 98: 18-22 (2001).
*
-
Martin R, Sturzebecher CS, McFarland HF. Immunotherapy of multiple sclerosis: where are we? Where should we go?
Nat. Immunol. 2: 785-788 (2001).
*
-
Martinez A, Fernandez-Arquero M, Balsa A, Rubio A, Alves H, Pascual-Salcedo D, Martin-Mola E, de la Concha EG. Primary association of a MICA allele with protection against rheumatoid arthritis.
Arthritis Rheum. 44: 1261-1265 (2001).
*
-
Martinez F, Nos P, Benlloch S, Ponce J. Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab.
Inflamm. Bowel Dis. 7: 323-326 (2001).
*
-
Martínez Sobrepera HJ, Cabrera Gomez JA, Tuero Iglesias A. Exogenous factors in the aetiology of multiple sclerosis in Cuba. A study of cases and controls.
Rev. Neurol. 33: 931-937 (2001).
-
Martinon F, Hofmann K, Tschopp J. The pyrin domain: a possible member of the death domain-fold family implicated in apoptosis and inflammation.
Curr. Biol. 11: R118-R120 (2001).
*
-
Martins EB, Chapman RW. Sclerosing cholangitis.
Curr. Opin. Gastroenterol. 17: 458-462 (2001).
-
Marucci L, Ugili L, Macarri G, Feliciangeli G, Bendia E, Jezequel AM, Orlandi F, Benedetti A. Primary biliary cirrhosis: modalities of injury and death in biliary epithelium.
Dig. Liver Dis. 33: 576-583 (2001).
-
Marzioni M, Glaser SS, Alpini G, LeSage GD. Role of apoptosis in development of primary biliary cirrhosis.
Dig. Liver Dis. 33: 531-533 (2001).
-
Masci E, Toti G, Mariani A, Curioni S, Lomazzi A, Dinelli M, Minoli G, Crosta C, Comin U, Fertitta A, Prada A, Passoni GR, Testoni PA. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study.
Am. J. Gastroenterol. 96: 417-423 (2001).
*
-
Mascrez B, Mark M, Krezel W, Dupe V, LeMeur M, Ghyselinck NB, Chambon P. Differential contributions of AF-1 and AF-2 activities to the developmental functions of RXR alpha.
Development 128: 2049-2062 (2001).
*
-
Mason A. Viral induction of type 2 diabetes and autoimmune liver disease.
J. Nutr. 131: 2805S-2808S (2001).
*
-
Massei F, Palla G, Ughi C, Macchia P, Maggiore G. Cholestasis as a presenting feature of acute Epstein-Barr virus infection.
Pediatr. Infect. Dis. J. 20: 721-722 (2001).
-
Massie RJ, Poplawski N, Wilcken B, Goldblatt J, Byrnes C, Robertson C. Intron-8 polythymidine sequence in Australasian individuals with CF mutations R117H and R117C.
Eur. Respir. J. 17: 1195-1200 (2001).
*
-
Masson D, Jarry A, Baury B, Blanchardie P, Laboisse C, Lustenberger P, Denis MG. Overexpression of the CD155 gene in human colorectal carcinoma.
Gut 49: 236-240 (2001).
*
-
Masson-Bessiere C, Sebbag M, Girbal-Neuhauser E, Nogueira L, Vincent C, Senshu T, Serre G. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin.
J. Immunol. 166: 4177-4184 (2001).
*
-
Masuda J, Omagari K, Matsuo I, Kinoshita H, Sakimura K, Hazama H, Ohba K, Isomoto H, Murase K, Murata I, Kohno S. Changes in titers of antimitochondrial and antinuclear antibodies during the course of primary biliary cirrhosis.
J. Gastroenterol. Hepatol. 16: 239-243 (2001).
*
-
Masuyama H, Hiramatsu Y, Mizutani Y, Inoshita H, Kudo T. The expression of pregnane X receptor and its target gene, cytochrome P450 3A1, in perinatal mouse.
Mol. Cell. Endocrinol. 172: 47-56 (2001).
-
Matarese G, Di Giacomo A, Sanna V, Lord GM, Howard JK, Di Tuoro A, Bloom SR, Lechler RI, Zappacosta S, Fontana S. Requirement for leptin in the induction and progression of autoimmune encephalomyelitis.
J. Immunol. 166: 5909-5916 (2001).
*
-
Mathieu C, Van Etten E, Gysemans C, Decallonne B, Kato S, Laureys J, Depovere J, Valckx D, Verstuyf A, Bouillon R. In vitro and in vivo analysis of the immune system of vitamin D receptor knockout mice.
J. Bone Miner. Res. 16: 2057-2065 (2001).
-
Matricardi PM, Ronchetti R. Are infections protecting from atopy?
Curr. Opin. Allergy Clin. Immunol. 1: 413-419 (2001).
-
Matsuda T, Suzuki J, Furuya K, Masutani M, Kawakami Y. Serum angiotensin I-converting enzyme is reduced in Crohn's disease and ulcerative colitis irrespective of genotype.
Am. J. Gastroenterol. 96: 2705-2710 (2001).
*
-
Matsui T, Nishioka K, Kato T, Yamamoto K. Autoantibodies to CTLA-4 enhance T cell proliferation.
J. Rheumatol. 28: 220-221 (2001).
-
Matsui T, Otsuka M, Maenaka K, Furukawa H, Yabe T, Yamamoto K, Nishioka K, Kato T. Detection of autoantibodies to killer immunoglobulin-like receptors using recombinant fusion proteins for two killer immunoglobulin-like receptors in patients with systemic autoimmune diseases.
Arthritis Rheum. 44: 384-388 (2001).
*
-
Matsumoto T, Nakamura S, Jin-No Y, Sawa Y, Hara J, Oshitani N, Arakawa T, Otani H, Nagura H. Role of granuloma in the immunopathogenesis of Crohn's disease.
Digestion 63 Suppl. 1: 43-47 (2001).
-
Matsushima-Nishiwaki R, Okuno M, Adachi S, Sano T, Akita K, Moriwaki H, Friedman SL, Kojima S. Phosphorylation of retinoid X receptor alpha at serine 260 impairs its metabolism and function in human hepatocellular carcinoma.
Cancer Res. 61: 7675-7682 (2001).
*
-
Matsushita M, Miyakawa H, Tanaka A, Hijikata M, Kikuchi K, Fujikawa H, Arai J, Sainokami S, Hino K, Terai I, Mishiro S, Gershwin ME. Single nucleotide polymorphisms of the mannose-binding lectin are associated with susceptibility to primary biliary cirrhosis.
J. Autoimmun. 17: 251-257 (2001).
*
-
Matsuzaka Y, Makino S, Nakajima K, Tomizawa M, Oka A, Bahram S, Kulski JK, Tamiya G, Inoko H. New polymorphic microsatellite markers in the human MHC class III region.
Tissue Antigens 57: 397-404 (2001).
*
-
Mattey DL, Dawes PT, Gonzalez-Gay MA, Garcia-Porrua C, Thomson W, Hajeer AH, Ollier WE. HLA-DRB1 alleles encoding an aspartic acid at position 70 protect against development of rheumatoid arthritis.
J. Rheumatol. 28: 232-239 (2001).
-
Mattey DL, Hassell AB, Dawes PT, Cheung NT, Poulton KV, Thomson W, Hajeer AH, Ollier WE. Independent association of rheumatoid factor and the HLA-DRB1 shared epitope with radiographic outcome in rheumatoid arthritis.
Arthritis Rheum. 44: 1529-1533 (2001).
*
-
Mauras N. Growth hormone therapy in the glucocorticosteroid-dependent child: metabolic and linear growth effects.
Horm. Res. 56 Suppl. 1: 13-18 (2001).
-
Mazzella G, Rizzo N, Azzaroli F, Simoni P, Bovicelli L, Miracolo A, Simonazzi G, Colecchia A, Nigro G, Mwangemi C, Festi D, Roda E. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers.
Hepatology 33: 504-508 (2001).
*
-
Mbanya JC, Sobngwi E, Mbanya DN. HLA-DRB1, -DQA1, -DQB1 and DPB1 susceptibility alleles in Cameroonian type 1 diabetes patients and controls.
Eur. J. Immunogenet. 28: 459-462 (2001).
*
-
McAdam SN, Fleckenstein B, Rasmussen IB, Schmid DG, Sandlie I, Bogen B, Viner NJ, Sollid LM. T cell recognition of the dominant I-A(k)-restricted hen egg lysozyme epitope: critical role for asparagine deamidation.
J. Exp. Med. 193: 1239-1246 (2001).
*
-
McBee JK, Van Hooser JP, Jang GF, Palczewski K. Isomerization of 11-cis-retinoids to all-trans-retinoids in vitro and in vivo.
J. Biol. Chem. 276: 48483-48493 (2001).
*
-
McCallion K, Mitchell RM, Wilson RH, Kee F, Watson RG, Collins JS, Gardiner KR. Flexible sigmoidoscopy and the changing distribution of colorectal cancer: implications for screening.
Gut 48: 522-525 (2001).
*
-
McCormack G, Moriarty D, O'Donoghue DP, McCormick PA, Sheahan K, Baird AW. Tissue cytokine and chemokine expression in inflammatory bowel disease.
Inflamm. Res. 50: 491-495 (2001).
-
McCormack RM, Maxwell AP, Carson D, Patterson CC, Bingham A, Savage DA. Possible association between CTLA4 DNA polymorphisms and early onset type 1 diabetes in a UK population.
Genes Immun. 2: 233-235 (2001).
*
-
McCormick P, Manning D. Chronic inflammatory bowel disease and the 'over-clean' environment: rarity in the Irish 'traveller' community.
Ir. Med. J. 94: 203-204 (2001).
-
McCormick PA, O'Keefe C. Improving prognosis following a first variceal haemorrhage over four decades.
Gut 49: 682-685 (2001).
*
-
McDermott JR, Grencis RK, Else KJ. Leucocyte recruitment during enteric nematode infection.
Immunology 103: 505-510 (2001).
*
-
McDermott MF. TNF and TNFR biology in health and disease.
Cell. Mol. Biol. (Noisy-le-grand) 47: 619-635 (2001).
-
McDermott MF, Frenkel J. Hereditary periodic fever syndromes.
Neth. J. Med. 59: 118-125 (2001).
-
McDevitt H. Closing in on type 1 diabetes.
N. Engl. J. Med. 345: 1060-1061 (2001).
*
-
McDonald DE, Pethick DW, Mullan BP, Hampson DJ. Increasing viscosity of the intestinal contents alters small intestinal structure and intestinal growth, and stimulates proliferation of enterotoxigenic Escherichia coli in newly-weaned pigs.
Br. J. Nutr. 86: 487-498 (2001).
*
-
McFarlane IG. Autoimmune liver diseases.
Scand. J. Clin. Lab. Invest. 235: 53-60 (2001).
-
McGovern DP, van Heel DA, Ahmad T, Jewell DP. NOD2 (CARD15), the first susceptibility gene for Crohn's disease.
Gut 49: 752-754 (2001).
*
-
McKay DM. Bacterial superantigens: provocateurs of gut dysfunction and inflammation?
Trends Immunol. 22: 497-501 (2001).
*
-
McKenna F, Weaver A, Fiechtner JJ, Bello AE, Fort JG. COX-2 specific inhibitors in the management of osteoarthritis of the knee: a placebo-controlled, randomized, double-blind study.
J. Clin. Rheumatol. 7: 151-159 (2001).
-
McManus DP, Ross AG, Williams GM, Sleigh AC, Wiest P, Erlich H, Trachtenberg E, Guanling W, McGarvey ST, Li YS, Waine GJ. HLA class II antigens positively and negatively associated with hepatosplenic schistosomiasis in a Chinese population.
Int. J. Parasitol. 31: 674-680 (2001).
*
-
Mealey KL, Bentjen SA, Gay JM, Cantor GH. Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene.
Pharmacogenetics 11: 727-733 (2001).
-
Medico E, Gentile A, Lo Celso C, Williams TA, Gambarotta G, Trusolino L, Comoglio PM. Osteopontin is an autocrine mediator of hepatocyte growth factor-induced invasive growth.
Cancer Res. 61: 5861-5688 (2001).
*
-
Medina J, Jones EA, Garcia-Monzon C, Moreno-Otero R. Immunopathogenesis of cholestatic autoimmune liver diseases.
Eur. J. Clin. Invest. 31: 64-71 (2001).
-
Medlin J. New research group to target autoimmune disorders.
Environ. Health Perspect. 109: A311 (2001).
*
-
Medzhitov R. Toll-like receptors and innate immunity.
Nat. Rev. Immunol. 1: 135-145 (2001).
*
-
Mehal WZ, Azzaroli F, Crispe IN. Immunology of the healthy liver: old questions and new insights.
Gastroenterology 120: 250-260 (2001).
*
-
Meier PN, Manns MP. Medical and endoscopic treatment in primary sclerosing cholangitis.
Best Pract. Res. Clin. Gastroenterol. 15: 657-666 (2001).
*
-
Melamed-Frank M, Lache O, Enav BI, Szafranek T, Levy NS, Ricklis RM, Levy AP. Structure-function analysis of the antioxidant properties of haptoglobin.
Blood 98: 3693-3698 (2001).
*
-
Melichar B, Kohout P, Bratova M, Solichova D, Kralíckova P, Zadak Z. Intestinal permeability in patients with chemotherapy-induced stomatitis.
J. Cancer Res. Clin. Oncol. 127: 314-318 (2001).
-
Melki M, Pouderoux P, Pignodel C, Balmes JL. Granulomatous colitis likely induced by isotretinoin.
Gastroenterol. Clin. Biol. 25: 433-435 (2001).
-
Mellado M, Rodriguez-Frade JM, Manes S, Martinez-A C. Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation.
Annu. Rev. Immunol. 19: 397-421 (2001).
*
-
Meller S, Jagiello P, Borgmann S, Fricke H, Epplen JT, Gencik M. Novel SNPs in the CD18 gene validate the association with MPO-ANCA+ vasculitis.
Genes Immun. 2: 269-272 (2001).
*
-
Melnick RL. Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)?
Environ. Health Perspect. 109: 437-442 (2001).
*
-
Meloni I, Rubegni P, De Aloe G, Bruttini M, Pianigiani E, Cusano R, Seri M, Mondillo S, Federico A, Bardelli AM, Andreassi L, Fimiani M, Renieri A. Pseudoxanthoma elasticum: point mutations in the ABCC6 gene and a large deletion including also ABCC1 and MYH11.
Hum. Mutat. 18: 85 (2001).
*
-
Meltzer E, Dolev E. Inflammatory bowel disease and osteoporosis - an evidence-based connection.
Harefuah. 140: 590-593, 679 (2001).
-
Memon RA, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR. In vivo and in vitro regulation of sterol 27-hydroxylase in the liver during the acute phase response: potential role of hepatocyte nuclear factor-1.
J. Biol. Chem. 276: 30118-30126 (2001).
*
-
Mendelson DS, Simpson W, Yeh HC. Right upper quadrant pain and fever in a patient with pulmonary sarcoidosis.
Semin. Liver Dis. 21: 293-296 (2001).
-
Mendez-Sanchez N, Gonzalez V, Aguayo P, Sanchez JM, Tanimoto MA, Elizondo J, Uribe M. Fish oil (n-3) polyunsaturated fatty acids beneficially affect biliary cholesterol nucleation time in obese women losing weight.
J. Nutr. 131: 2300-2303 (2001).
*
-
Menghini VV, Arora AS. Infliximab-associated reversible cholestatic liver disease.
Mayo Clin. Proc. 76: 84-86 (2001).
*
-
Mennone A, Biemesderfer D, Negoianu D, Yang CL, Abbiati T, Schultheis PJ, Shull GE, Aronson PS, Boyer JL. Role of sodium/hydrogen exchanger isoform NHE3 in fluid secretion and absorption in mouse and rat cholangiocytes.
Am. J. Physiol. Gastrointest. Liver Physiol. 280: G247-G254 (2001).
*
-
Menon K, Romagnuolo J, Barkun AN. Expandable metal biliary stenting in patients with recurrent premature polyethylene stent occlusion.
Am. J. Gastroenterol. 96: 1435-1440 (2001).
*
-
Menon KV, Angulo P, Weston S, Dickson ER, Lindor KD. Bone disease in primary biliary cirrhosis: independent indicators and rate of progression.
J. Hepatol. 35: 316-323 (2001).
*
-
Menon KVN, Angulo P, Lindor KD. Severe cholestatic hepatitis from troglitazone in a patient with nonalcoholic steatohepatitis and diabetes mellitus.
Am. J. Gastroenterol. 96: 1631-1634 (2001).
*
-
Mercadante S, Villari P, Fulfaro F. Rifampicin in opioid-induced itching.
Support Care Cancer 9: 467-468 (2001).
*
-
Meriluoto T, Halonen M, Pelto-Huikko M, Kangas H, Korhonen J, Kolmer M, Ulmanen I, Eskelin P. The autoimmune regulator: a key toward understanding the molecular pathogenesis of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.
Keio. J. Med. 50: 225-239 (2001).
*
-
Merkel PA. Drug-induced vasculitis.
Rheum. Dis. Clin. North Am. 27: 849-862 (2001).
-
Merriman TR, Cordell HJ, Eaves IA, Danoy PA, Coraddu F, Barber R, Cucca F, Broadley S, Sawcer S, Compston A, Wordsworth P, Shatford J, Laval S, Jirholt J, Holmdahl R, Theofilopoulos AN, Kono DH, Tuomilehto J, et al. Suggestive evidence for association of human chromosome 18q12-q21 and its orthologue on rat and mouse chromosome 18 with several autoimmune diseases.
Diabetes 50: 184-194 (2001).
*
-
Meyer G, Donner H, Herwig J, Bohles H, Usadel KH, Badenhoop K. Screening for an AIRE-1 mutation in patients with Addison's disease, type 1 diabetes, Graves' disease and Hashimoto's thyroiditis as well as in APECED syndrome.
Clin. Endocrinol. (Oxf.) 54: 335-338 (2001).
*
-
Meyer JM, Han J, Moxley G. Tumor necrosis factor markers show sex-influenced association with rheumatoid arthritis.
Arthritis Rheum. 44: 286-295 (2001).
*
-
Miceli-Richard C, Lesage S, Rybojad M, Prieur AM, Manouvrier-Hanu S, Hafner R, Chamaillard M, Zouali H, Thomas G, Hugot JP. CARD15 mutations in Blau syndrome.
Nat. Genet. 29: 19-20 (2001).
*
-
Michalik L, Desvergne B, Tan NS, Basu-Modak S, Escher P, Rieusset J, Peters JM, Kaya G, Gonzalez FJ, Zakany J, Metzger D, Chambon P, Duboule D, Wahli W. Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice.
J. Cell Biol. 154: 799-814 (2001).
*
-
Michalska Z, Stalke P, Witczak-Malinowska K, Lakomy EA, Sikorska K, Radowska D, Stolarczyk J, Trocha H. Autoimmune reactions in HBV and HCV.
Med. Sci. Monit. 7 Suppl. 1: 175-180 (2001).
-
Michel M, Johanet C, Meyer O, Frances C, Wittke F, Michel C, Arfi S, Tournier-Lasserve E, Piette JC; Group for Research on Auto-Immune Disorders (GRAID). Familial lupus erythematosus. Clinical and immunologic features of 125 multiplex families.
Medicine (Baltimore) 80: 153-158 (2001).
-
Michel T, Reichhart JM, Hoffmann JA, Royet J. Drosophila Toll is activated by Gram-positive bacteria through a circulating peptidoglycan recognition protein.
Nature 414: 756-759 (2001).
*
-
Michell NP, Lalor P, Langman MJ. Heparin therapy for ulcerative colitis? Effects and mechanisms.
Eur. J. Gastroenterol. Hepatol. 13: 449-456 (2001).
-
Michelson D, Faries D, Wernicke J, Kelsey D, Kendrick K, Sallee FR, Spencer T; Atomoxetine ADHD Study Group. Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study.
Pediatrics 108: e83 (2001).
*
-
Middel P, Reich K, Polzien F, Blaschke V, Hemmerlein B, Herms J, Korabiowska M, Radzun HJ. Interleukin 16 expression and phenotype of interleukin 16 producing cells in Crohn's disease.
Gut 49: 795-803 (2001).
*
-
Miehsler W, Puspok A, Oberhuber T, Vogelsang H. Impact of different therapeutic regimens on the outcome of patients with Crohn's disease of the upper gastrointestinal tract.
Inflamm. Bowel Dis. 7: 99-105 (2001).
*
-
Mieli-Vergani G, Vergani D. Sclerosing cholangitis in the paediatric patient.
Best Pract. Res. Clin. Gastroenterol. 15: 681-690 (2001).
*
-
Miettinen M, Sareneva T, Julkunen I, Matikainen S. IFNs activate Toll-like receptor gene expression in viral infections.
Genes Immun. 2: 349-355 (2001).
*
-
Migliaccio C, Van de Water J, Ansari AA, Kaplan MM, Coppel RL, Lam KS, Thompson RK, Stevenson F, Gershwin ME. Heterogeneous response of antimitochondrial autoantibodies and bile duct apical staining monoclonal antibodies to pyruvate dehydrogenase complex E2: the molecule versus the mimic.
Hepatology 33: 792-801 (2001).
*
-
Mignot E, Lin L, Rogers W, Honda Y, Qiu X, Lin X, Okun M, Hohjoh H, Miki T, Hsu S, Leffell M, Grumet F, Fernandez-Vina M, Honda M, Risch N. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups.
Am. J. Hum. Genet. 68: 686-699 (2001).
*
-
Miki K, Xu M, Gupta A, Ba Y, Tan Y, Al-Refaie W, Bouvet M, Makuuchi M, Moossa AR, Hoffman RM. Methioninase cancer gene therapy with selenomethionine as suicide prodrug substrate.
Cancer Res. 61: 6805-6810 (2001).
*
-
Milicic A, Brown MA, Wordsworth BP. Polymorphism in codon 17 of the CTLA-4 gene (+49 A/G) is not associated with susceptibility to rheumatoid arthritis in British Caucasians.
Tissue Antigens 58: 50-54 (2001).
*
-
Milkiewicz P, Boron-Kaczmarska A. Autoimmune hepatitis: pathogenesis, clinical features and treatment.
Przegl. Lek. 58: 139-142 (2001).
-
Milkiewicz P, Mills CO, Hubscher SG, Cardenas R, Cardenas T, Williams A, Elias E. Visualization of the transport of primary and secondary bile acids across liver tissue in rats: in vivo study with fluorescent bile acids.
J. Hepatol. 34: 4-10 (2001).
*
-
Milkiewicz P, Roma MG, Cardenas R, Mills CO, Elias E, Coleman R. Effect of tauroursodeoxycholate and S-adenosyl-L-methionine on 17beta-estradiol glucuronide-induced cholestasis.
J. Hepatol. 34: 184-191 (2001).
*
-
Miller AL. The etiologies, pathophysiology, and alternative/complementary treatment of asthma.
Altern. Med. Rev. 6: 20-47 (2001).
*
-
Miller E, Waight P, Farrington CP, Andrews N, Stowe J, Taylor B. Idiopathic thrombocytopenic purpura and MMR vaccine.
Arch. Dis. Child. 84: 227-229 (2001).
*
-
Miller RT, Scappino LA, Long SM, Corton JC. Role of thyroid hormones in hepatic effects of peroxisome proliferators.
Toxicol. Pathol. 29: 149-155 (2001).
*
-
Miller RT, Willson TM. Regulation of xenobiotic metabolism by orphan nuclear receptors.
Toxicol. Pathol. 29: 3-5 (2001).
*
-
Min JK, Han NI, Kim JA, Lee YS, Cho CS, Kim HY. A case of cholestatic autoimmune hepatitis and acute liver failure: an unusual hepatic manifestation of mixed connective tissue disease and Sjogren's syndrome.
J. Korean Med. Sci. 16: 512-515 (2001).
*
-
Miossec P. Cytokines in rheumatoid arthritis: is it all TNF-alpha?
Cell. Mol. Biol. (Noisy-le-grand) 47: 675-678 (2001).
-
Miot-Noirault E, Faure L, Guichard Y, Montharu J, Le Pape A. Scintigraphic in vivo assessment of the development of pulmonary intravascular macrophages in liver disease: experimental study in rats with biliary cirrhosis.
Chest 120: 941-947 (2001).
*
-
Misner DL, Jacobs S, Shimizu Y, de Urquiza AM, Solomin L, Perlmann T, De Luca LM, Stevens CF, Evans RM. Vitamin A deprivation results in reversible loss of hippocampal long-term synaptic plasticity.
Proc. Natl. Acad. Sci. U.S.A. 98: 11714-11719 (2001).
*
-
Mitchell SA, Bansi DS, Hunt N, Von Bergmann K, Fleming KA, Chapman RW. A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis.
Gastroenterology 121: 900-907 (2001).
*
-
Mitchell SA, Grove J, Spurkland A, Boberg KM, Fleming KA, Day CP, Schrumpf E, Chapman RW; European Study Group of Primary Sclerosing Cholangitis. Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis.
Gut 49: 288-294 (2001).
*
-
Miura T, Ouchida R, Yoshikawa N, Okamoto K, Makino Y, Nakamura T, Morimoto C, Makino I, Tanaka H. Functional modulation of the glucocorticoid receptor and suppression of NF-kappaB-dependent transcription by ursodeoxycholic acid.
J. Biol. Chem. 276: 47371-47378 (2001).
*
-
Miyakawa H, Kawaguchi N, Kikuchi K, Fujikawa H, Kitazawa E, Matsushita M. Definition of antigen specificity for antimitochondrial proteins detected by Western blotting using native mitochondrial proteins in primary biliary cirrhosis.
Hepatol. Res. 21: 101-107 (2001).
-
Miyakawa H, Kawaguchi N, Kikuchi K, Kitazawa E, Kawashima Y, Yajima R, Itoh Y. False positive reaction in ELISA for IgM class anti-M2 antibody and its prevention.
Hepatol. Res. 20: 279-287 (2001).
-
Miyakawa H, Tanaka A, Kikuchi K, Matsushita M, Kitazawa E, Kawaguchi N, Fujikawa H, Gershwin ME. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens.
Hepatology 34: 243-248 (2001).
*
-
Miyamasu M, Sekiya T, Ohta K, Ra C, Yoshie O, Yamamoto K, Tsuchiya N, Tokunaga K, Hirai K. Variations in the human CC chemokine eotaxin gene.
Genes Immun. 2: 461-463 (2001).
*
-
Miyoshi H, Rust C, Guicciardi ME, Gores GJ. NF-kappaB is activated in cholestasis and functions to reduce liver injury.
Am. J. Pathol. 158: 967-975 (2001).
*
-
Mizejewski GJ, Pass KA. Fatty acids, alpha-fetoprotein, and cystic fibrosis.
Pediatrics 108: 1370-1373 (2001).
*
-
Mizuguchi H, Mizuno H, Yasukawa K, Ishiguro T, Fukui K, Imanaka T, Takagi M. Enhanced signal transduction by a directly fused protein of interleukin-6 and its receptor.
J. Biosci. Bioeng. 91: 299-304 (2001).
*
-
Mizuki N, Ota M, Katsuyama Y, Yabuki K, Ando H, Shiina T, Nomura E, Onari K, Ohno S, Inoko H. HLA-B*51 allele analysis by the PCR-SBT method and a strong association of HLA-B*5101 with Japanese patients with Behcet's disease.
Tissue Antigens 58: 181-184 (2001).
*
-
Mizuki N, Ota M, Katsuyama Y, Yabuki K, Ando H, Yoshida M, Onari K, Nikbin B, Davatchi F, Chams H, Ghaderi AA, Ohno S, Inoko H. HLA class I genotyping including HLA-B*51 allele typing in the Iranian patients with Behcet's disease.
Tissue Antigens 57: 457-462 (2001).
*
-
Mizuki N, Yabuki K, Ota M, Verity D, Katsuyama Y, Ando H, Onari K, Goto K, Imagawa Y, Mandanat W, Fayyad F, Stanford M, Ohno S, Inoko H. Microsatellite mapping of a susceptible locus within the HLA region for Behcet's disease using Jordanian patients.
Hum. Immunol. 62: 186-190 (2001).
-
Mochizuki K, Suruga K, Kitagawa M, Takase S, Goda T. Modulation of the expression of peroxisome proliferator-activated receptor-dependent genes through disproportional expression of two subtypes in the small intestine.
Arch. Biochem. Biophys. 389: 41-48 (2001).
*
-
Mochizuki K, Suruga K, Yagi E, Takase S, Goda T. The expression of PPAR-associated genes is modulated through postnatal development of PPAR subtypes in the small intestine.
Biochim. Biophys. Acta 1531: 68-76 (2001).
*
-
Modolell I, Alvarez A, Guarner L, De Gracia J, Malagelada JR. Gastrointestinal, liver, and pancreatic involvement in adult patients with cystic fibrosis.
Pancreas 22: 395-399 (2001).
-
Moffatt MF, Schou C, Faux JA, Abecasis GR, James A, Musk AW, Cookson WO. Association between quantitative traits underlying asthma and the HLA-DRB1 locus in a family-based population sample.
Eur. J. Hum. Genet. 9: 341-346 (2001).
*
-
Mohan C. Murine lupus genetics: lessons learned.
Curr. Opin. Rheumatol. 13: 352-360 (2001).
-
Mohan N, Edwards ET, Cupps TR, Oliverio PJ, Sandberg G, Crayton H, Richert JR, Siegel JN. Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides.
Arthritis Rheum. 44: 2862-2869 (2001).
-
Molberg O, McAdam S, Lundin KE, Kristiansen C, Arentz-Hansen H, Kett K, Sollid LM. T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase.
Eur. J. Immunol. 31: 1317-1323 (2001).
-
Moller S, Bendtsen F, Henriksen JH. Splanchnic and systemic hemodynamic derangement in decompensated cirrhosis.
Can. J. Gastroenterol. 15: 94-106 (2001).
*
-
Monev SD. How should hyperuricemia be treated in a patient with allopurinol hypersensitivity?
Cleve. Clin. J. Med. 68: 597-598 (2001).
*
-
Moniaux N, Escande F, Porchet N, Aubert JP, Batra SK. Structural organization and classification of the human mucin genes.
Front. Biosci. 6: D1192-D1206 (2001).
-
Montagnani M, Love MW, Rossel P, Dawson PA, Qvist P. Absence of dysfunctional ileal sodium-bile acid cotransporter gene mutations in patients with adult-onset idiopathic bile acid malabsorption.
Scand. J. Gastroenterol. 36: 1077-1080 (2001).
*
-
Monteleone G, Kumberova A, Croft NM, McKenzie C, Steer HW, MacDonald TT. Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease.
J. Clin. Invest. 108: 601-609 (2001).
*
-
Monteleone G, Pender SL, Alstead E, Hauer AC, Lionetti P, McKenzie C, MacDonald TT. Role of interferon alpha in promoting T helper cell type 1 responses in the small intestine in coeliac disease.
Gut 48: 425-429 (2001).
*
-
Montero-Julian FA. The soluble IL-6 receptors: serum levels and biological function.
Cell. Mol. Biol. (Noisy-le-grand) 47: 583-597 (2001).
-
Montrose MH. Choosing sides in the battle against gastric acid.
J. Clin. Invest. 108: 1743-1744 (2001).
*
-
Moore J, Tyndall A, Brooks P. Stem cells in the aetiopathogenesis and therapy of rheumatic disease.
Best Pract. Res. Clin. Rheumatol. 15: 711-726 (2001).
-
Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor.
Annu. Rev. Immunol. 19: 683-765 (2001).
*
-
Mor-Cohen R, Zivelin A, Rosenberg N, Shani M, Muallem S, Seligsohn U. Identification and functional analysis of two novel mutations in the multidrug resistance protein 2 gene in Israeli patients with Dubin-Johnson syndrome.
J. Biol. Chem. 276: 36923-36930 (2001).
*
-
Moran AP, Prendergast MM. Molecular mimicry in Campylobacter jejuni and Helicobacter pylori lipopolysaccharides: contribution of gastrointestinal infections to autoimmunity.
J. Autoimmun. 16: 241-256 (2001).
-
Moreau R. Heme oxygenase: protective enzyme or portal hypertensive molecule?
J. Hepatol. 34: 936-939 (2001).
*
-
Moretta A, Bottino C, Sivori S, Marcenaro E, Castriconi R, Della Chiesa M, Carlomagno S, Augugliaro R, Nanni M, Vitale M, Millo R. Natural killer lymphocytes: "null cells" no more.
Ital. J. Anat. Embryol. 106: 335-342 (2001).
-
Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.
Annu. Rev. Immunol. 19: 197-223 (2001).
*
-
Mori T, Ono K, Hakozaki M, Kasukawa R, Kochi H. Autoantibodies of sera from patients with primary biliary cirrhosis recognize the alpha subunit of the decarboxylase component of human branched-chain 2-oxo acid dehydrogenase complex.
J. Hepatol. 34: 799-804 (2001).
*
-
Morishita A, Murota M, Fujita J, Ohtsuki Y, Nishioka M. Helper T lymphocytes specific for cytokeratin 19 in patients with primary biliary cirrhosis.
Hepatol. Res. 21: 108-116 (2001).
-
Morra M, Howie D, Grande MS, Sayos J, Wang N, Wu C, Engel P, Terhorst C. X-linked lymphoproliferative disease: a progressive immunodeficiency.
Annu. Rev. Immunol. 19: 657-682 (2001).
*
-
Morris DL, Montgomery SM, Galloway ML, Pounder RE, Wakefield AJ. Inflammatory bowel disease and laterality: is left handedness a risk?
Gut 49: 199-202 (2001).
*
-
Mortele KJ, Ros PR. Imaging of diffuse liver disease.
Semin. Liver Dis. 21: 195-212 (2001).
-
Mortimore M, Gibson PR, Selby WS, Radford-Smith GL, Florin TH; Schering Plough (Australia). Early Australian experience with infliximab, a chimeric antibody against tumour necrosis factor-alpha, in the treatment of Crohn's disease: is its efficacy augmented by steroid-sparing immunosuppressive therapy? The Infliximab User Group.
Intern. Med. J. 31: 146-150 (2001).
-
Morton HC, Brandtzaeg P. CD89: the human myeloid IgA Fc receptor.
Arch. Immunol. Ther. Exp. (Warsz.) 49: 217-229 (2001).
-
Moss ML, White JM, Lambert MH, Andrews RC. TACE and other ADAM proteases as targets for drug discovery.
Drug Discov. Today. 6: 417-426 (2001).
-
Motomura K, Ohata M, Satre M, Tsukamoto H. Destabilization of TNF-alpha mRNA by retinoic acid in hepatic macrophages: implications for alcoholic liver disease.
Am. J. Physiol. Endocrinol. Metab. 281: E420-E429 (2001).
*
-
Motoo Y, Yamaguchi Y, Watanabe H, Okai T, Sawabu N. Hepatic peribiliary cysts diagnosed by magnetic resonance cholangiography.
J. Gastroenterol. 36: 271-275 (2001).
*
-
Moulin F, Copple BL, Ganey PE, Roth RA. Hepatic and extrahepatic factors critical for liver injury during lipopolysaccharide exposure.
Am. J. Physiol. Gastrointest. Liver Physiol. 281: G1423-G1431 (2001).
*
-
Mozsik G, Bodis B, Figler M, Kiraly A, Karadi O, Par A, Rumi G, Suto G, Toth G, Vincze A. Mechanisms of action of retinoids in gastrointestinal mucosal protection in animals, human healthy subjects and patients.
Life Sci. 69: 3103-3112 (2001).
-
Mozsik G, Nagy Z, Nagy A, Rumi G, Karadi O, Czimmer J, Matus Z, Toth G, Par A. Leiden mutation (as genetic) and environmental (retinoids) sequences in the acute and chronic inflammatory and premalignant colon disease in human gastrointestinal tract.
J. Physiol. Paris 95: 489-494 (2001).
-
Mozzato-Chamay N, Corbett EL, Bailey RL, Mabey DC, Raynes J, Conway DJ. Polymorphisms in the IkappaB-alpha promoter region and risk of diseases involving inflammation and fibrosis.
Genes Immun. 2: 153-155 (2001).
*
-
Muangmoonchai R, Smirlis D, Wong SC, Edwards M, Phillips IR, Shephard EA. Xenobiotic induction of cytochrome P450 2B1 (CYP2B1) is mediated by the orphan nuclear receptor constitutive androstane receptor (CAR) and requires steroid co-activator 1 (SRC-1) and the transcription factor Sp1.
Biochem. J. 355: 71-78 (2001).
*
-
Mudd SH, Cerone R, Schiaffino MC, Fantasia AR, Minniti G, Caruso U, Lorini R, Watkins D, Matiaszuk N, Rosenblatt DS, Schwahn B, Rozen R, LeGros L, Kotb M, Capdevila A, Luka Z, Finkelstein JD, Tangerman A, Stabler SP, Allen RH, Wagner C. Glycine N-methyltransferase deficiency: a novel inborn error causing persistent isolated hypermethioninaemia.
J. Inherit. Metab. Dis. 24: 448-464 (2001).
*
-
Muehlenberg K, Wiedmann KH. Secondary sclerosing cholangitis with gallstone (following longterm ventilation and treatment with catecholamines).
Dtsch. Med. Wochenschr. 132: 1273-1274 (2001).
-
Mugica F, Castiella A, Otazua P, Munagorri A, Recasens M, Barrio J, Elosegui E. Prevalence of coeliac disease in unexplained chronic hypertransaminasemia.
Rev. Esp. Enferm. Dig. 93: 707-714 (2001).
-
Mulder CJ, Wahab PJ, Meijer JW, Metselaar E. A pilot study of recombinant human interleukin-10 in adults with refractory coeliac disease.
Eur. J. Gastroenterol. Hepatol. 13: 1183-1188 (2001).
-
Murakami H, Akbar SM, Matsui H, Onji M. Macrophage migration inhibitory factor in the sera and at the colonic mucosa in patients with ulcerative colitis: clinical implications and pathogenic significance.
Eur. J. Clin. Invest. 31: 337-343 (2001).
*
-
Murakami T, Mochizuki K, Nakamura H. Imaging evaluation of the cirrhotic liver.
Semin. Liver Dis. 21: 213-224 (2001).
-
Murakozy G, Gaede KI, Ruprecht B, Gutzeit O, Schurmann M, Schnabel A, Schlaak M, Gross WL, Muller-Quernheim J. Gene polymorphisms of immunoregulatory cytokines and angiotensin-converting enzyme in Wegener's granulomatosis.
J. Mol. Med. 79: 665-670 (2001).
*
-
Murata M, Kaji H, Iida K, Okimura Y, Chihara K. Dual action of eicosapentaenoic acid in hepatoma cells: up-regulation of metabolic action of insulin and inhibition of cell proliferation.
J. Biol. Chem. 276: 31422-31428 (2001).
*
-
Muratori L, Muratori P, Zauli D, Grassi A, Pappas G, Rodrigo L, Cassani F, Lenzi M, Bianchi FB. Antilactoferrin antibodies in autoimmune liver disease.
Clin. Exp. Immunol. 124: 470-473 (2001).
*
-
Muratori L, Sztul E, Muratori P, Gao Y, Ripalti A, Ponti C, Lenzi M, Landini MP, Bianchi FB. Distinct epitopes on formiminotransferase cyclodeaminase induce autoimmune liver cytosol antibody type 1.
Hepatology 34: 494-501 (2001).
*
-
Murray IA, Pathmakanthan S, Heeley R, Donnelly MT. The future of ERCP training in the UK.
Gut 49: 739-740 (2001).
*
-
Musialik J, Petelenz M, Jastrzebski D, Ziora D, Kondera-Anasz Z, Mertas A, Oklek K, Gonciarz Z. Lymphocyte subsets in peripheral blood and bronchoalveolar lavage in patients with primary biliary cirrhosis.
Med. Sci. Monit. 7 Suppl. 1: 311-315 (2001).
-
Musso M, Porretto F, Crescimanno A, Bondi F, Polizzi V, Scalone R. Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease.
Am. J. Hematol. 66: 75-79 (2001).
-
Mwantembe O, Gaillard MC, Barkhuizen M, Pillay V, Berry SD, Dewar JB, Song E. Ethnic differences in allelic associations of the interleukin-1 gene cluster in South African patients with inflammatory bowel disease (IBD) and in control individuals.
Immunogenetics 52: 249-254 (2001).
-
Mylonakis E, Ryan ET, Calderwood SB. Clostridium difficile-associated diarrhea: a review.
Arch. Intern. Med. 161: 525-533 (2001).
*
-
Nadashkevich ON. Autoimmune theory of pathogenesis of systemic scleroderma.
Lik. Sprava. 2001: 15-17 (2001).
-
Nadeau JH. Modifier genes in mice and humans.
Nat. Rev. Genet. 2: 165-174 (2001).
*
-
Naganuma M, Iwao Y, Ogata H, Inoue N, Funakoshi S, Yamamoto S, Nakamura Y, Ishii H, Hibi T. Measurement of colonic mucosal concentrations of 5-aminosalicylic acid is useful for estimating its therapeutic efficacy in distal ulcerative colitis: comparison of orally administered mesalamine and sulfasalazine.
Inflamm. Bowel Dis. 7: 221-225 (2001).
*
-
Nagaoka I, Hirota S, Niyonsaba F, Hirata M, Adachi Y, Tamura H, Heumann D. Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells.
J. Immunol. 167: 3329-3338 (2001).
*
-
Nagase I, Yoshida T, Saito M. Up-regulation of uncoupling proteins by beta-adrenergic stimulation in L6 myotubes.
FEBS Lett. 494: 175-180 (2001).
*
-
Nagler-Anderson C. Man the barrier! Strategic defences in the intestinal mucosa.
Nat. Rev. Immunol. 1: 59-67 (2001).
*
-
Nagura H, Ohtani H, Sasano H, Matsumoto T. The immuno-inflammatory mechanism for tissue injury in inflammatory bowel disease and Helicobacter pylori-infected chronic active gastritis. Roles of the mucosal immune system.
Digestion 63 Suppl. 1: 12-21 (2001).
-
Nagy Z, Nagy A, Karadi O, Figler M, Rumi G Jr, Suto G, Vincze A, Par A, Mozsik G. Prevalence of the factor V Leiden mutation in human inflammatory bowel disease with different activity.
J. Physiol. Paris 95: 483-487 (2001).
-
Naik S, Kelly EJ, Meijer L, Pettersson S, Sanderson IR. Absence of Toll-like receptor 4 explains endotoxin hyporesponsiveness in human intestinal epithelium.
J. Pediatr. Gastroenterol. Nutr. 32: 449-453 (2001).
*
-
Naimeh LG, Muller BA. Chronic urticaria in a 17-year-old patient with a past history of bowel disease.
Ann. Allergy Asthma Immunol. 86: 511-516 (2001).
-
Nakamaru Y, Fukuda S, Maguchi S, Ryu T, Inuyama Y. Relapsing polychondritis: a report of eight cases.
Auris. Nasus. Larynx 28: S107-S110 (2001).
-
Nakamura H, Tanaka E, Kaneko M, Iwakawa M, Hori T, Ikebukuro K, Amagai T, Ohkawa H. The clinical importance of the trimethadione tolerance test as a method for quantitative assessment of hepatic functional reserve in patients with biliary atresia.
J. Clin. Pharm. Ther. 26: 417-424 (2001).
*
-
Nakamura M, Fuchinoue S, Nakajima I, Kitajima K, Tojimbara T, Takasaki K, Shiraga H, Ito K, Tanaka K, Agishi T. Three cases of sequential liver-kidney transplantation from living-related donors.
Nephrol. Dial. Transplant. 16: 166-168 (2001).
*
-
Nakamura RM, Barry M. Serologic markers in inflammatory bowel disease (IBD).
MLO Med. Lab. Obs. 33: 8-15; quiz 16-19 (2001).
-
Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 regulates both Th1 and Th2 responses.
Annu. Rev. Immunol. 19: 423-474 (2001).
*
-
Nakanuma Y, Kouda W, Harada K, Hiramatsu K. Hepatic sarcoidosis with vanishing bile duct syndrome, cirrhosis, and portal phlebosclerosis. Report of an autopsy case.
J. Clin. Gastroenterol. 32: 181-184 (2001).
-
Nakanuma Y, Ohba K. Autoimmune liver diseases and their borderline lesions from pathologic standpoint of view.
Nippon Shokakibyo Gakkai Zasshi 98: 1247-1256 (2001).
-
Nakanuma Y, Tsuneyama K, Harada K. Pathology and pathogenesis of intrahepatic bile duct loss.
J. Hepatobiliary Pancreat. Surg. 8: 303-315 (2001).
-
Nakashima T, Yoh T, Sumida Y, Kakisaka Y, Mitsuyoshi H. Differences in the efficacy of ursodeoxycholic acid and bile acid metabolism between viral liver diseases and primary biliary cirrhosis.
J. Gastroenterol. Hepatol. 16: 541-547 (2001).
*
-
Nakayama M, Tsuji H, Shimono J, Azuma K, Ogata H, Matsumoto T, Aoyagi K, Fujishima M, Iida M. Primary biliary cirrhosis associated with ulcerative colitis.
Fukuoka Igaku Zasshi 92: 354-359 (2001).
-
Nakazawa T, Ohara H, Yamada T, Ando H, Sano H, Kajino S, Hashimoto T, Nakamura S, Ando T, Nomura T, Joh T, Itoh M. Atypical primary sclerosing cholangitis cases associated with unusual pancreatitis.
Hepatogastroenterology 48: 625-630 (2001).
-
Nakken B, Jonsson R, Bolstad AI. Polymorphisms of the Ro52 gene associated with anti-Ro 52-kd autoantibodies in patients with primary Sjogren's syndrome.
Arthritis Rheum. 44: 638-646 (2001).
*
-
Nakken B, Jonsson R, Brokstad KA, Omholt K, Nerland AH, Haga HJ, Halse AK. Associations of MHC class II alleles in Norwegian primary Sjogren's syndrome patients: implications for development of autoantibodies to the Ro52 autoantigen.
Scand. J. Immunol. 54: 428-433 (2001).
*
-
Naluai AT, Nilsson S, Gudjonsdottir AH, Louka AS, Ascher H, Ek J, Hallberg B, Samuelsson L, Kristiansson B, Martinsson T, Nerman O, Sollid LM, Wahlstrom J. Genome-wide linkage analysis of Scandinavian affected sib-pairs supports presence of susceptibility loci for celiac disease on chromosomes 5 and 11.
Eur. J. Hum. Genet. 9: 938-944 (2001).
*
-
Narayanan BA, Narayanan NK, Reddy BS. Docosahexaenoic acid regulated genes and transcription factors inducing apoptosis in human colon cancer cells.
Int. J. Oncol. 19: 1255-1262 (2001).
*
-
Narkewicz MR. Markers of cystic fibrosis-associated liver disease.
J. Pediatr. Gastroenterol. Nutr. 32: 421-422 (2001).
*
-
Narravula S, Colgan SP. Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor alpha expression during hypoxia.
J. Immunol. 166: 7543-7548 (2001).
*
-
Naser SA, Ghobrial G, Miles H. Effect of nicotine on inflammatory bowel disease.
Am. J. Gastroenterol. 96: 3455-3457 (2001).
*
-
Nash CL, Sutherland LR. Medical management of inflammatory bowel disease: old and new perspectives.
Curr. Opin. Gastroenterol. 17: 336-341 (2001).
-
Nataraj C, Thomas DW, Tilley SL, Nguyen MT, Mannon R, Koller BH, Coffman TM. Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse.
J. Clin. Invest. 108: 1229-1235 (2001).
*
-
Nathanson MH, Burgstahler AD, Masyuk A, LaRusso NF. Stimulation of ATP secretion in the liver by therapeutic bile acids.
Biochem. J. 358: 1-5 (2001).
*
-
Nau H. Teratogenicity of isotretinoin revisited: species variation and the role of all-trans-retinoic acid.
J. Am. Acad. Dermatol. 45: S183-S187 (2001).
-
Naumann A, Hempel JM, Schorn K. Detection of humoral immune response to inner ear proteins in patients with sensorineural hearing loss.
Laryngorhinootologie 80: 237-244 (2001).
-
Navarra SV, Saavedra SC, Cayco AV. Renal microtophi in a patient with lupus nephritis and tophaceous gout.
J. Clin. Rheumatol. 7: 268-272 (2001).
-
Nedergaard J, Golozoubova V, Matthias A, Asadi A, Jacobsson A, Cannon B. UCP1: the only protein able to mediate adaptive non-shivering thermogenesis and metabolic inefficiency.
Biochim. Biophys. Acta 1504: 82-106 (2001).
*
-
Nehra V, Angulo P, Buchman AL, Lindor KD. Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis.
Dig. Dis. Sci. 46: 2347-2352 (2001).
*
-
Nelson JL. HLA relationships of pregnancy, microchimerism and autoimmune disease.
J. Reprod. Immunol. 52: 77-84 (2001).
-
Nemetz A, Toth M, Garcia-Gonzalez MA, Zagoni T, Feher J, Pena AS, Tulassay Z. Allelic variation at the interleukin 1beta gene is associated with decreased bone mass in patients with inflammatory bowel diseases.
Gut 49: 644-649 (2001).
*
-
Nepom GT. The role of the DR4 shared epitope in selection and commitment of autoreactive T cells in rheumatoid arthritis.
Rheum. Dis. Clin. North Am. 27: 305-315 (2001).
-
Neuberger J. Hope or efficacy in donor liver allocation?
Transplantation 72: 1173-1176 (2001).
-
Neuberger J. Recurrent primary biliary cirrhosis.
Liver Transpl. 7: 596-599 (2001).
*
-
Neuberger J, Jones EA. Liver transplantation for intractable pruritus is contraindicated before an adequate trial of opiate antagonist therapy.
Eur. J. Gastroenterol. Hepatol. 13: 1393-1394 (2001).
-
Neufang G, Furstenberger G, Heidt M, Marks F, Muller-Decker K. Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin.
Proc. Natl. Acad. Sci. U.S.A. 98: 7629-7634 (2001).
*
-
Neuhausen SL, Feolo M, Farnham J, Book L, Zone JJ. Linkage analysis of HLA and candidate genes for celiac disease in a North American family-based study.
BMC Med. Genet. 2: 12 (2001).
*
-
Neurath MF. Signals on the immune tract.
Gut 49: 164-165 (2001).
*
-
Neuschwander-Tetri BA. Fatty liver and nonalcoholic steatohepatitis.
Clin. Cornerstone 3: 47-57 (2001).
-
Neuschwander-Tetri BA. Betaine: an old therapy for a new scourge.
Am. J. Gastroenterol. 96: 2534-2536 (2001).
*
-
Neuschwander-Tetri BA. A resistance movement in NASH.
Am. J. Gastroenterol. 96: 2813-2814 (2001).
*
-
Neve BP, Corseaux D, Chinetti G, Zawadzki C, Fruchart JC, Duriez P, Staels B, Jude B. PPARalpha agonists inhibit tissue factor expression in human monocytes and macrophages.
Circulation 103: 207-212 (2001).
*
-
Newton J, Francis R, Prince M, James O, Bassendine M, Rawlings D, Jones D. Osteoporosis in primary biliary cirrhosis revisited.
Gut 49: 282-287 (2001).
*
-
Ng CH, Tam MM, Hook SJ. Acne, isotretinoin treatment and acute depression.
World J. Biol. Psychiatry 2: 159-161 (2001).
-
Nguyen JT, Evans DP, Galvan M, Pace KE, Leitenberg D, Bui TN, Baum LG. CD45 modulates galectin-1-induced T cell death: regulation by expression of core 2 O-glycans.
J. Immunol. 167: 5697-5707 (2001).
*
-
Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, Vaulont S. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice.
Proc. Natl. Acad. Sci. U.S.A. 98: 8780-8785 (2001).
*
-
Nielsen OH, Vainer B, Rask-Madsen J. Review article: the treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine.
Aliment. Pharmacol. Ther. 15: 1699-1708 (2001).
*
-
Niesor EJ, Flach J, Lopes-Antoni I, Perez A, Bentzen CL. The nuclear receptors FXR and LXRalpha: potential targets for the development of drugs affecting lipid metabolism and neoplastic diseases.
Curr. Pharm. Des. 7: 231-259 (2001).
*
-
Nigro G, Angelini G, Grosso SB, Caula G, Sategna-Guidetti C. Psychiatric predictors of noncompliance in inflammatory bowel disease: psychiatry and compliance.
J. Clin. Gastroenterol. 32: 66-68 (2001).
*
-
Nijjar SS, Crosby HA, Wallace L, Hubscher SG, Strain AJ. Notch receptor expression in adult human liver: a possible role in bile duct formation and hepatic neovascularization.
Hepatology 34: 1184-1192 (2001).
*
-
Nikawa T, Ikemoto M, Kano M, Tokuoka K, Hirasaka K, Uehara S, Takatsu K, Rokutan K, Kishi K. Impaired vitamin A-mediated mucosal IgA response in IL-5 receptor-knockout mice.
Biochem. Biophys. Res. Commun. 285: 546-549 (2001).
*
-
Nikawa T, Ikemoto M, Tokuoka K, Teshima S, Alpers DH, Masui Y, Kishi K, Rokutan K. Interleukin-1beta enhances retinoic acid-mediated expression of bone-type alkaline phosphatase in rat IEC-6 cells.
Am. J. Physiol. Gastrointest. Liver Physiol. 280: G510-G517 (2001).
*
-
Nilsson HO, Mulchandani R, Tranberg KG, Wadstrom T. Helicobacter species identified in liver from patients with cholangiocarcinoma and hepatocellular carcinoma.
Gastroenterology 120: 323-324 (2001).
*
-
Nilubol N, Taub PJ, Venturero M, Lichtiger S, Bauer JJ. Ulcerative colitis and sarcoidosis.
Mt. Sinai J. Med. 68: 400-402 (2001).
*
-
Nishiguchi S, Shimoi S, Kurooka H, Tamori A, Habu D, Takeda T, Kubo S. Randomized pilot trial of vitamin K2 for bone loss in patients with primary biliary cirrhosis.
J. Hepatol. 35: 543-545 (2001).
*
-
Nishimagi E, Kawaguchi Y, Terai C, Kajiyama H, Hara M, Kamatani N. Progressive interstitial renal fibrosis due to Chinese herbs in a patient with calcinosis Raynaud esophageal sclerodactyly telangiectasia (CREST) syndrome.
Intern. Med. 40: 1059-1063 (2001).
*
-
Nishimori I, Onishi S. Hereditary pancreatitis in Japan: a review of pancreatitis-associated gene mutations.
Pancreatology 1: 444-447 (2001).
-
Nishimura H, Gogami A, Miyagawa Y, Nanbo A, Murakami Y, Baba T, Nagasawa S. Bactericidal/permeability-increasing protein promotes complement activation for neutrophil-mediated phagocytosis on bacterial surface.
Immunology 103: 519-525 (2001).
*
-
Nishio A, Bass NM, Luketic VA, Coppel RL, Gershwin ME. Primary biliary cirrhosis: from induction to destruction.
Semin. Gastrointest. Dis. 12: 89-102 (2001).
-
Nishio A, Keeffe EB, Gershwin ME. Primary biliary cirrhosis: lessons learned from an organ-specific disease.
Clin. Exp. Med. 1: 165-178 (2001).
*
-
Nishioji K, Okanoue T, Itoh Y, Narumi S, Sakamoto M, Nakamura H, Morita A, Kashima K. Increase of chemokine interferon-inducible protein-10 (IP-10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes.
Clin. Exp. Immunol. 123: 271-279 (2001).
*
-
No authors listed. Proceedings of the International Symposium on HCO3- and Cystic Fibrosis. San Diego, California, USA. March 3-5, 2001.
JOP 2: S150-S300 (2001).
*
-
Noe J, Hagenbuch B, Meier PJ, St-Pierre MV. Characterization of the mouse bile salt export pump overexpressed in the baculovirus system.
Hepatology 33: 1223-1231 (2001).
*
-
Noguchi E, Shibasaki M, Inudou M, Kamioka M, Yokouchi Y, Yamakawa-Kobayashi K, Hamaguchi H, Matsui A, Arinami T. Association between a new polymorphism in the activation-induced cytidine deaminase gene and atopic asthma and the regulation of total serum IgE levels.
J. Allergy Clin. Immunol. 108: 382-386 (2001).
*
-
Noguchi E, Yokouchi Y, Shibasaki M, Kamioka M, Yamakawa-Kobayashi K, Matsui A, Arinami T. Identification of missense mutation in the IL12B gene: lack of association between IL12B polymorphisms and asthma and allergic rhinitis in the Japanese population.
Genes Immun. 2: 401-403 (2001).
*
-
Noguchi H, Hanai T, Honda H, Harrison LC, Kobayashi T. Fuzzy neural network-based prediction of the motif for MHC class II binding peptides.
J. Biosci. Bioeng. 92: 227-231 (2001).
*
-
Noh JY, Asari T, Hamada N, Makino F, Ishikawa N, Abe Y, Ito K, Ito K. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.
Clin. Endocrinol. (Oxf.) 54: 651-654 (2001).
*
-
Nohara A, Mabuchi H. Nuclear receptor regulation of cholesterol metabolism.
Nippon Rinsho 59 Suppl. 2: 468-471 (2001).
-
Noone PG, Knowles MR. 'CFTR-opathies': disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations.
Respir. Res. 2: 328-332 (2001).
*
-
Noone PG, Zhou Z, Silverman LM, Jowell PS, Knowles MR, Cohn JA. Cystic fibrosis gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutations.
Gastroenterology 121: 1310-1319 (2001).
*
-
Nopola-Hemmi J, Myllyluoma B, Haltia T, Taipale M, Ollikainen V, Ahonen T, Voutilainen A, Kere J, Widen E. A dominant gene for developmental dyslexia on chromosome 3.
J. Med. Genet. 38: 658-664 (2001).
*
-
Norris S, Kondeatis E, Collins R, Satsangi J, Clare M, Chapman R, Stephens H, Harrison P, Vaughan R, Donaldson P. Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: the role of MICA polymorphism.
Gastroenterology 120: 1475-1482 (2001).
*
-
Nousia-Arvanitakis S, Fotoulaki M, Economou H, Xefteri M, Galli-Tsinopoulou A. Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-related liver disease.
J. Clin. Gastroenterol. 32: 324-328 (2001).
-
Novak K, Birmingham K, Pulverer B. Research news. At last, a ligand for RXR.
Nat. Med. 7: 31 (2001).
*
-
Nowack R, Grab I, Flores-Suarez LF, Schnulle P, Yard B, van der Woude FJ. ANCA titres, even of IgG subclasses, and soluble CD14 fail to predict relapses in patients with ANCA-associated vasculitis.
Nephrol. Dial. Transplant. 16: 1631-1637 (2001).
*
-
Nugent SG, Kumar D, Rampton DS, Evans DF. Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs.
Gut 48: 571-577 (2001).
*
-
Nunes AC, Amaro P, Mac as F, Cipriano A, Martins I, Rosa A, Pimenta I, Donato A, Freitas D. Fosinopril-induced prolonged cholestatic jaundice and pruritus: first case report.
Eur. J. Gastroenterol. Hepatol. 13: 279-282 (2001).
-
O'Brien KP, Holm SJ, Nilsson S, Carlen L, Rosenmuller T, Enerback C, Inerot A, Stahle-Backdahl M. The HCR gene on 6p21 is unlikely to be a psoriasis susceptibility gene.
J. Invest. Dermatol. 116: 750-754 (2001).
*
-
O'Brien ML, Twaroski TP, Cunningham ML, Glauert HP, Spear BT. Effects of peroxisome proliferators on antioxidant enzymes and antioxidant vitamins in rats and hamsters.
Toxicol. Sci. 60: 271-278 (2001).
*
-
O’Connell J. Role of Fas–FasL in inflammatory diseases.
Expert Rev. Mol. Med. 3: 1-18 (2001). *
-
O'Loughlin EV, Pang GP, Noltorp R, Koina C, Batey R, Clancy R. Interleukin 2 modulates ion secretion and cell proliferation in cultured human small intestinal enterocytes.
Gut 49: 636-643 (2001).
*
-
O'Reilly DA, Kingsnorth AN. A brief history of pancreatitis.
J. R. Soc. Med. 94: 130-132 (2001).
*
-
O'Reilly DA, Yang BM, Creighton JE, Demaine AG, Kingsnorth AN. Mutations of the cationic trypsinogen gene in hereditary and non-hereditary pancreatitis.
Digestion 64: 54-60 (2001).
-
O'Rourke JL, Grehan M, Lee A. Non-pylori Helicobacter species in humans.
Gut 49: 601-606 (2001).
*
-
O'Sullivan M, O'Morain C. Liquid diets for Crohn's disease.
Gut 48: 757 (2001).
*
-
Obermayer-Straub P, Manns MP. Hepatitis C and D, retroviruses and autoimmune manifestations.
J. Autoimmun. 16: 275-285 (2001).
*
-
Ochoa ER, Harris NL, Pilch BZ. Marginal zone B-cell lymphoma of the salivary gland arising in chronic sclerosing sialadenitis (Kuttner tumor).
Am. J. Surg. Pathol. 25: 1546-1550 (2001).
-
Ockenga J, Dork T, Stuhrmann M. Low prevalence of SPINK1 gene mutations in adult patients with chronic idiopathic pancreatitis.
J. Med. Genet. 38: 243-244 (2001).
-
Ockenga J, Stuhrmann M, Manns MP. Evaluation of the role of CFTR in alcohol related pancreatic disease.
Gut 49: 312-313 (2001).
*
-
Oda S, Sugai T, Ohta H. Preparation of methyl ursodeoxycholate via microbial reduction of methyl 7-ketolithocholate in an anaerobic interface bioreactor.
J. Biosci. Bioeng. 91: 202-207 (2001).
*
-
Odin JA, Huebert RC, Casciola-Rosen L, LaRusso NF, Rosen A. Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis.
J. Clin. Invest. 108: 223-232 (2001).
*
-
Oertel M, Kohlhaw K, Diepolder HM, Schroder S, Schwarz R, Tannapfel A, Mossner J, Hauss J, Berr F. Alloreactivity of natural killer cells in allogeneic liver transplantation.
Transplantation 72: 116-122 (2001).
-
Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.
Nature 411: 603-606 (2001).
*
-
Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB.
J. Biol. Chem. 276: 4812-4818 (2001).
*
-
Ohashi R, Tamai I, Nezu Ji J, Nikaido H, Hashimoto N, Oku A, Sai Y, Shimane M, Tsuji A. Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2.
Mol. Pharmacol. 59: 358-366 (2001).
*
-
Ohata M, Toda G. Gamma-glutamyltranspeptidase (gamma-GT).
Rinsho Byori 116: S62-S71 (2001).
-
Ohba K, Omagari K, Kinoshita H, Soda H, Masuda J, Hazama H, Tagawa M, Hata T, Nakamura H, Murata I, Kohno S. Primary biliary cirrhosis among atomic bomb survivors in Nagasaki, Japan.
J. Clin. Epidemiol. 54: 845-850 (2001).
-
Ohlsson S, Ljungkrantz I, Ohlsson K, Segelmark M, Wieslander J. Novel distribution of the secretory leucocyte proteinase inhibitor in kidney.
Mediators Inflamm. 10: 347-350 (2001).
*
-
Ohmoto K, Mitsui Y, Yamamoto S. Effect of bezafibrate in primary biliary cirrhosis: a pilot study.
Liver 21: 223-224 (2001).
-
Ohta S, Harigai M, Tanaka M, Kawaguchi Y, Sugiura T, Takagi K, Fukasawa C, Hara M, Kamatani N. Tumor necrosis factor-alpha (TNF-alpha) converting enzyme contributes to production of TNF-alpha in synovial tissues from patients with rheumatoid arthritis.
J. Rheumatol. 28: 1756-1763 (2001).
-
Ohtami S, Kobayashi O, Ohtami H. Analysis of intractable factors in chronic airway infections: role of the autoimmunity induced by BPI-ANCA.
J. Infect. Chemother. 7: 228-238 (2001).
*
-
Oikarinen H. Imaging of biliary carcinoma, fistula and primary sclerosing cholangitis and percutaneous metallic stenting in malignant biliary obstruction.
Department of Diagnostic Radiology, University of Oulu, Oulu Finland ISBN 951-42-5917-3 (http://herkules.oulu.fi/isbn9514259173/isbn9514259173.pdf) (2001). *
-
Oikarinen H, Paakko E, Suramo I, Paivansalo M, Tervonen O, Lehtola J, Aukee J. Imaging and estimation of the prognostic features of primary sclerosing cholangitis by ultrasonography and MR cholangiography.
Acta Radiol. 42: 403-408 (2001).
*
-
Okamoto R, Yamamoto K, Yabushita K, Okano N, Shimada N, Matsumura S, Mizuno M, Higashi T, Tsuji T. T cell repertoire in primary biliary cirrhosis: a common T cell clone and repertoire change after treatment.
J. Clin. Immunol. 21: 278-285 (2001).
*
-
Oketani K, Nagakura N, Harada K, Inoue T. In vitro effects of E3040, a dual inhibitor of 5-lipoxygenase and thromboxane A(2) synthetase, on eicosanoid production.
Eur. J. Pharmacol. 422: 209-216 (2001).
*
-
Olausson M, Mjornstedt L, Backman L, Lindner P, Olsson R, Krantz M, Karlsen KL, Stenqvist O, Henriksson BA, Friman S. Liver transplantation - from experiment to routine care. Experiences from the first 500 liver transplantations in Gothenburg.
Lakartidningen 98: 4556-4562 (2001).
-
Olin J, Schneider L. Galantamine for Alzheimer's disease.
Cochrane Database Syst. Rev. 1: CD001747 (2001).
-
Oliver WR Jr, Shenk JL, Snaith MR, Russell CS, Plunket KD, Bodkin NL, Lewis MC, Winegar DA, Sznaidman ML, Lambert MH, Xu HE, Sternbach DD, Kliewer SA, Hansen BC, Willson TM. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport.
Proc. Natl. Acad. Sci. U.S.A. 98: 5306-5311 (2001).
*
-
Ollier WE, Harrison B, Symmons D. What is the natural history of rheumatoid arthritis?
Best Pract. Res. Clin. Rheumatol. 15: 27-48 (2001).
-
Ollier WE, Kennedy LJ, Thomson W, Barnes AN, Bell SC, Bennett D, Angles JM, Innes JF, Carter SD. Dog MHC alleles containing the human RA shared epitope confer susceptibility to canine rheumatoid arthritis.
Immunogenetics 53: 669-673 (2001).
-
Olsen I, Wiker HG, Johnson E, Langeggen H, Reitan LJ. Elevated antibody responses in patients with Crohn's disease against a 14-kDa secreted protein purified from Mycobacterium avium subsp. paratuberculosis.
Scand. J. Immunol. 53: 198-203 (2001).
*
-
Olsen NJ, Park JH, King LE Jr. Amyopathic dermatomyositis.
Curr. Rheumatol. Rep. 3: 346-351 (2001).
-
Olson JK, Croxford JL, Miller SD. Virus-induced autoimmunity: potential role of viruses in initiation, perpetuation, and progression of T-cell-mediated autoimmune disease.
Viral Immunol. 14: 227-250 (2001).
-
Omata F, Birkenbach M, Matsuzaki S, Christ AD, Blumberg RS. The expression of IL-12 p40 and its homologue, Epstein-Barr virus-induced gene 3, in inflammatory bowel disease.
Inflamm. Bowel Dis. 7: 215-220 (2001).
*
-
Onori P, Franchitto A, Alvaro D, Gaudio E. Immunohistochemical features of bile duct epithelial cells in normal and experimental liver conditions.
Ital. J. Anat. Embryol. 106 (2 Suppl. 1): 371-378 (2001).
-
Oram JF, Vaughan AM, Stocker R. ATP-binding cassette transporter A1 mediates cellular secretion of alpha-tocopherol.
J. Biol. Chem. 276: 39898-39902 (2001).
*
-
Orchard TR, Dhar A, Simmons JD, Vaughan R, Welsh KI, Jewell DP. MHC class I chain-like gene A (MICA) and its associations with inflammatory bowel disease and peripheral arthropathy.
Clin. Exp. Immunol. 126: 437-440 (2001).
*
-
Orgad S, Neumann S, Loewenthal R, Netanelov-Shapira I, Gazit E. Prevalence of cystic fibrosis mutations in Israeli Jews.
Genet. Test. 5: 47-52 (2001).
-
Ortiz D, Arias IM. MDR3 mutations: a glimpse into pandora's box and the future of canalicular pathophysiology.
Gastroenterology 120: 1549-1552 (2001).
*
-
Osangthamnont C, Manatsathit S, Pongprasopchai S, Viriyataveekul R, Chaihirunkarn S, Leelakusolvong S, Boonyapisit S. Antibodies to neutrophil cytoplasma in patients with ulcerative colitis and their first-degree relatives in Thailand.
J. Gastroenterol. Hepatol. 16: 866-871 (2001).
*
-
Oshima T, Pavlick K, Grisham MB, Jordan P, Manas K, Joh T, Itoh M, Alexander JS. Glucocorticoids and IL-10, but not 6-MP, 5-ASA or sulfasalazine block endothelial expression of MAdCAM-1: implications for inflammatory bowel disease therapy.
Aliment. Pharmacol. Ther. 15: 1211-1218 (2001).
*
-
Ostedgaard LS, Baldursson O, Welsh MJ. Regulation of the cystic fibrosis transmembrane conductance regulator Cl- channel by its R domain.
J. Biol. Chem. 276: 7689-7692 (2001).
*
-
Ostrow JD, Tiribelli C. New concepts in bilirubin neurotoxicity and the need for studies at clinically relevant bilirubin concentrations.
J. Hepatol. 34: 467-470 (2001).
*
-
Ostrow JD, Tiribelli C. Variation in UGT1A1 activity in Gilbert's syndrome.
J. Hepatol. 34: 636-639 (2001).
-
Oswald M, Kullak-Ublick GA, Paumgartner G, Beuers U. Expression of hepatic transporters OATP-C and MRP2 in primary sclerosing cholangitis.
Liver 21: 247-253 (2001).
*
-
Ota M, Katsuyama Y, Kimura A, Tsuchiya K, Kondo M, Naruse T, Mizuki N, Itoh K, Sasazuki T, Inoko H. A second susceptibility gene for developing rheumatoid arthritis in the human MHC is localized within a 70-kb interval telomeric of the TNF genes in the HLA class III region.
Genomics 71: 263-270 (2001).
*
-
Ouellette AJ, Bevins CL. Paneth cell defensins and innate immunity of the small bowel.
Inflamm. Bowel Dis. 7: 43-50 (2001).
*
-
Ovetchkine P. Secondary effects of vaccinations.
Arch. Pediatr. 8: 316-320 (2001).
-
Ozen H, Kocak N, Saltik IN, Yuce A, Gurakan F. Autoimmune hepatitis.
Indian J. Pediatr. 68: 725-728 (2001).
-
Paavola P, Helio T, Kiuru M, Halme L, Turunen U, Terwilliger J, Karvonen AL, Julkunen R, Niemela S, Nurmi H, Farkkila M, Kontula K. Genetic analysis in Finnish families with inflammatory bowel disease supports linkage to chromosome 3p21.
Eur. J. Hum. Genet. 9: 328-334 (2001).
*
-
Pahan K, Sheikh FG, Liu X, Hilger S, McKinney M, Petro TM. Induction of nitric-oxide synthase and activation of NF-kappaB by interleukin-12 p40 in microglial cells.
J. Biol. Chem. 276: 7899-7905 (2001).
*
-
Paik J, During A, Harrison EH, Mendelsohn CL, Lai K, Blaner WS. Expression and characterization of a murine enzyme able to cleave beta-carotene. The formation of retinoids.
J. Biol. Chem. 276: 32160-32168 (2001).
*
-
Paine P, Hobday C, Keating JJ, Brown CM, Morris JA. Ulcerative pan-colitis and primary sclerosing cholangitis with hyposplenism complicated by fatal pneumococcal meningitis.
CME Gastroenterology 4: 95-96 (2001). *
-
Painter P, Krasnoff J, Paul SM, Ascher NL. Physical activity and health-related quality of life in liver transplant recipients.
Liver Transpl. 7: 213-219 (2001).
*
-
Pallone F, Monteleone G. Mechanisms of tissue damage in inflammatory bowel disease.
Curr. Opin. Gastroenterol. 17: 307-312 (2001).
-
Palmer LJ, Cookson WO, James AL, Musk AW, Burton PR. Gibbs sampling-based segregation analysis of asthma-associated quantitative traits in a population-based sample of nuclear families.
Genet. Epidemiol. 20: 356-372 (2001).
-
Palomero J, Galan AI, Munoz ME, Tunon MJ, Gonzalez-Gallego J, Jimenez R. Effects of aging on the susceptibility to the toxic effects of cyclosporin A in rats. Changes in liver glutathione and antioxidant enzymes.
Free Radic. Biol. Med. 30: 836-845 (2001).
-
Palsson R, Jonasson JG, Kristjansson M, Bodvarsson A, Goldin RD, Cox DW, Olafsson S. Genotype-phenotype interactions in Wilson's disease: insight from an Icelandic mutation.
Eur. J. Gastroenterol. Hepatol. 13: 433-436 (2001).
-
Pan Q, Petit-Frere C, Dai S, Huang P, Morton HC, Brandtzaeg P, Hammarstrom L. Regulation of switching and production of IgA in human B cells in donors with duplicated alpha1 genes.
Eur. J. Immunol. 31: 3622-3630 (2001).
*
-
Panaccione R; Canadian Consensus Group on the use of infliximab in Crohn's disease. Infliximab for the treatment of Crohn's disease: review and indications for clinical use in Canada.
Can. J. Gastroenterol. 15: 371-375 (2001).
*
-
Panasiuk A, Prokopowicz D, Zak J. Peripheral blood T, B lymphocytes and NK cells in primary biliary cirrhosis.
Rocz. Akad. Med. Bialymst. 46: 231-239 (2001).
-
Pandak WM, Bohdan P, Franklund C, Mallonee DH, Eggertsen G, Bjorkhem I, Gil G, Vlahcevic ZR, Hylemon PB. Expression of sterol 12alpha-hydroxylase alters bile acid pool composition in primary rat hepatocytes and in vivo.
Gastroenterology 120: 1801-1809 (2001).
*
-
Pandey JP, Nietert PJ, Silver RM. Cytochrome P2 polymorphisms and susceptibility to scleroderma: comment on the article by Povey et al.
Arthritis Rheum. 44: 2705-2706 (2001).
-
Panes J. Inflammatory bowel disease: pathogenesis and targets for therapeutic interventions.
Acta Physiol. Scand. 173: 159-165 (2001).
*
-
Panoutsakopoulou V, Sanchirico ME, Huster KM, Jansson M, Granucci F, Shim DJ, Wucherpfennig KW, Cantor H. Analysis of the relationship between viral infection and autoimmune disease.
Immunity 15: 137-147 (2001).
*
-
Pantelidis P, Fanning GC, Wells AU, Welsh KI, Du Bois RM. Analysis of tumor necrosis factor-alpha, lymphotoxin-alpha, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis.
Am. J. Respir. Crit. Care Med. 163: 1432-1436 (2001).
*
-
Papa A, De Stefano V, Danese S, Chiusolo P, Persichilli S, Casorelli I, Zappacosta B, Giardina B, Gasbarrini A, Leone G, Gasbarrini G. Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease.
Am. J. Gastroenterol. 96: 2677-2682 (2001).
*
-
Papadakis KA, Prehn J, Moreno ST, Cheng L, Kouroumalis EA, Deem R, Breaverman T, Ponath PD, Andrew DP, Green PH, Hodge MR, Binder SW, Targan SR. CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn's disease.
Gastroenterology 121: 246-254 (2001).
*
-
Papadakis KA, Tung JK, Binder SW, Kam LY, Abreu MT, Targan SR, Vasiliauskas EA. Outcome of cytomegalovirus infections in patients with inflammatory bowel disease.
Am. J. Gastroenterol. 96: 2137-2142 (2001).
*
-
Papaioannou A, Ferko NC, Adachi JD. All patients with inflammatory bowel disease should have bone density assessment: pro.
Inflamm. Bowel Dis. 7: 158-162 (2001).
*
-
Papiernik M. Natural CD4+ CD25+ regulatory T cells. Their role in the control of superantigen responses.
Immunol. Rev. 182: 180-189 (2001).
*
-
Par A. Gastrointestinal immunology.
Orv. Hetil. 142: 2357-2367 (2001).
-
Parc YR, Olschwang S, Desaint B, Schmitt G, Parc RG, Tiret E. Familial adenomatous polyposis: prevalence of adenomas in the ileal pouch after restorative proctocolectomy.
Ann. Surg. 233: 360-364 (2001).
*
-
Pares A, Guanabens N, Alvarez L, De Osaba MJ, Oriola J, Pons F, Caballeria L, Monegal A, Salvador G, Jo J, Peris P, Rivera F, Ballesta AM, Rodes J. Collagen type Ialpha1 and vitamin D receptor gene polymorphisms and bone mass in primary biliary cirrhosis.
Hepatology 33: 554-560 (2001).
*
-
Parikh-Patel A, Gold EB, Worman H, Krivy KE, Gershwin ME. Risk factors for primary biliary cirrhosis in a cohort of patients from the United States.
Hepatology 33: 16-21 (2001).
*
-
Park SH, Waxman DJ. Inhibitory cross-talk between STAT5b and liver nuclear factor HNF3beta: impact on the regulation of growth hormone pulse-stimulated, male-specific liver cytochrome P-450 gene expression.
J. Biol. Chem. 276: 43031-43039 (2001).
*
-
Park Y, Eisenbarth GS. Genetic susceptibility factors of type 1 diabetes in Asians.
Diabetes Metab. Res. Rev. 17: 2-11 (2001).
-
Park Y, Lee H, Sanjeevi CB, Eisenbarth GS. MICA polymorphism is associated with type 1 diabetes in the Korean population.
Diabetes Care 24: 33-38 (2001).
*
-
Parkes M, Booth JC, Pillai G, Mee AS. Do steroids help jaundice caused by primary sclerosing cholangitis?
J. Clin. Gastroenterol. 33: 319-322 (2001).
-
Parkes M, Jewell D. Ulcerative colitis and Crohns disease: molecular genetics and clinical implications.
Expert Rev. Mol. Med. 3: 1-18 (2001).
*
-
Parkes M, Satsangi J, Jewell DP, Weeks DE, Barmada MM, Duerr RH. Ulcerative colitis is more strongly linked to chromosome 12 than Crohn's disease.
Gut 49: 311 (2001).
*
-
Parkkila S, Niemela O, Britton RS, Fleming RE, Waheed A, Bacon BR, Sly WS. Molecular aspects of iron absorption and HFE expression.
Gastroenterology 121: 1489-1496 (2001).
*
-
Parlak E, Kosar Y, Ulker A, Dagli U, Alkim C, Sahin B. Primary sclerosing cholangitis in patients with inflammatory bowel disease in Turkey.
J. Clin. Gastroenterol. 33: 299-301 (2001).
-
Parola M, Robino G. Oxidative stress-related molecules and liver fibrosis.
J. Hepatol. 35: 297-306 (2001).
*
-
Parolin MB, Coelho JC, Costa PB, Pimentel SK, dos Santos-Neto LE, Vayego SA. Return to work of adults after liver transplantation.
Arq. Gastroenterol. 38: 172-175 (2001).
-
Parrado A, Despouy G, Kraiba R, Le Pogam C, Dupas S, Choquette M, Robledo M, Larghero J, Bui H, Le Gall I, Rochette-Egly C, Chomienne C, Padua RA. Retinoic acid receptor alpha1 variants, RARalpha1DeltaB and RARalpha1DeltaBC, define a new class of nuclear receptor isoforms.
Nucleic Acids Res. 29: 4901-4908 (2001).
*
-
Pasare C, Mukherjee P, Verhoef A, Bansal P, Mendiratta SK, George A, Lamb JR, Rath S, Bal V. T cells in mice expressing a transgenic human TCR beta chain get positively selected but cannot be activated in the periphery by signaling through TCR.
Int. Immunol. 13: 53-62 (2001).
*
-
Pascual M, Martin J, Nieto A, Giphart MJ, van der Slik AR, de Vries RR, Zanelli E. Distribution of HERV-LTR elements in the 5'-flanking region of HLA-DQB1 and association with autoimmunity.
Immunogenetics 53: 114-118 (2001).
-
Pascual M, Nieto A, Lopez-Nevot MA, Ramal L, Mataran L, Caballero A, Alonso A, Martin J, Zanelli E. Rheumatoid arthritis in southern Spain: toward elucidation of a unifying role of the HLA class II region in disease predisposition.
Arthritis Rheum. 44: 307-314 (2001).
*
-
Pascussi JM, Drocourt L, Gerbal-Chaloin S, Fabre JM, Maurel P, Vilarem MJ. Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. Sequential role of glucocorticoid receptor and pregnane X receptor.
Eur. J. Biochem. 268: 6346-6358 (2001).
*
-
Patel DD, Knight BL, Wiggins D, Humphreys SM, Gibbons GF. Disturbances in the normal regulation of SREBP-sensitive genes in PPAR alpha-deficient mice.
J. Lipid Res. 42: 328-337 (2001).
*
-
Patel GK, Anstey AV. Rifampicin-induced lupus erythematosus.
Clin. Exp. Dermatol. 26: 260-262 (2001).
-
Paterson JR, Lawrence JR. Salicylic acid: a link between aspirin, diet and the prevention of colorectal cancer.
QJM 94: 445-458 (2001).
*
-
Pathan N, Marusawa H, Krajewska M, Matsuzawa S, Kim H, Okada K, Torii S, Kitada S, Krajewski S, Welsh K, Pio F, Godzik A, Reed JC. TUCAN, an antiapoptotic caspase-associated recruitment domain family protein overexpressed in cancer.
J. Biol. Chem. 276: 32220-32229 (2001).
*
-
Patil NS, Pashine A, Belmares MP, Liu W, Kaneshiro B, Rabinowitz J, McConnell H, Mellins ED. Rheumatoid arthritis (RA)-associated HLA-DR alleles form less stable complexes with class II-associated invariant chain peptide than non-RA-associated HLA-DR alleles.
J. Immunol. 167: 7157-7168 (2001).
*
-
Patja A, Paunio M, Kinnunen E, Junttila O, Hovi T, Peltola H. Risk of Guillain-Barre syndrome after measles-mumps-rubella vaccination.
J. Pediatr. 138: 250-254 (2001).
*
-
Paul M, Klein T, Krause I, Molad Y, Narinsky R, Weinberger A. Allelic distribution of HLA-B*5 in HLA-B5-positive Israeli patients with Behcet's disease.
Tissue Antigens 58: 185-186 (2001).
*
-
Pauli-Magnus C, Murdter T, Godel A, Mettang T, Eichelbaum M, Klotz U, Fromm MF. P-glycoprotein-mediated transport of digitoxin, alpha-methyldigoxin and beta-acetyldigoxin.
Naunyn. Schmiedebergs. Arch. Pharmacol. 363: 337-343 (2001).
*
-
Pauli-Magnus C, Rekersbrink S, Klotz U, Fromm MF. Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein.
Naunyn. Schmiedebergs. Arch. Pharmacol. 364: 551-557 (2001).
*
-
Paulson EK. Evaluation of the liver for metastatic disease.
Semin. Liver Dis. 21: 225-236 (2001).
-
Pavletic SZ, Odell JR, Pirruccello SJ, Ursick MM, Haire CE, Sharp JG, Kessinger A, Klassen LW. Intensive immunoablation and autologous blood stem cell transplantation in patients with refractory rheumatoid arthritis: the University of Nebraska experience.
J. Rheumatol. Suppl. 64: 13-20 (2001).
-
Payne DN, Adcock IM. Molecular mechanisms of corticosteroid actions.
Paediatr. Respir. Rev. 2: 145-150 (2001).
-
Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
Am. J. Gastroenterol. 96: 730-734 (2001).
*
-
Pegram AA, Kennedy LD. Prevention and treatment of veno-occlusive disease.
Ann. Pharmacother. 35: 935-942 (2001).
-
Perdigon G, Fuller R, Raya R. Lactic acid bacteria and their effect on the immune system.
Curr. Issues Intest. Microbiol. 2: 27-42 (2001).
-
Perdriger A. Do the HLA-DQ and DP genes play a role in rheumatoid arthritis?
Joint Bone Spine 68: 12-18 (2001).
-
Perdu J, Germain DP. Identification of novel polymorphisms in the pM5 and MRP1 (ABCC1) genes at locus 16p13.1 and exclusion of both genes as responsible for pseudoxanthoma elasticum.
Hum. Mutat. 17: 74-75 (2001).
*
-
Perez-Aguilar F, Martinez-Sanjuan V, Montoliu G, Lloret M, Ferrer-Calvete J, Ponce J, Berenguer J. Usefulness of magnetic cholangioresonance in the study of hepatobiliary disease in patients adults with cystic fibrosis.
Gastroenterol. Hepatol. 24: 122-126 (2001).
-
Pericak-Vance MA, Rimmler JB, Martin ER, Haines JL, Garcia ME, Oksenberg JR, Barcellos LF, Lincoln R, Goodkin DE, Hauser SL. Linkage and association analysis of chromosome 19q13 in multiple sclerosis.
Neurogenetics 3: 195-201 (2001).
*
-
Perl A. Endogenous retroviruses in pathogenesis of autoimmunity.
J. Rheumatol. 28: 461-464 (2001).
-
Permutt MA, Wasson JC, Suarez BK, Lin J, Thomas J, Meyer J, Lewitzky S, Rennich JS, Parker A, DuPrat L, Maruti S, Chayen S, Glaser B. A genome scan for type 2 diabetes susceptibility loci in a genetically isolated population.
Diabetes 50: 681-685 (2001).
*
-
Perner A, Andresen L, Normark M, Fischer-Hansen B, Sorensen S, Eugen-Olsen J, Rask-Madsen J. Expression of nitric oxide synthases and effects of L-arginine and L-NMMA on nitric oxide production and fluid transport in collagenous colitis.
Gut 49: 387-394 (2001).
*
-
Perron H, Jouvin-Marche E, Michel M, Ounanian-Paraz A, Camelo S, Dumon A, Jolivet-Reynaud C, Marcel F, Souillet Y, Borel E, Gebuhrer L, Santoro L, Marcel S, Seigneurin JM, Marche PN, Lafon M. Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation.
Virology 287: 321-332 (2001).
*
-
Perry A, Roth KA, Banerjee R, Fuller CE, Gutmann DH. NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors.
Am. J. Pathol. 159: 57-61 (2001).
*
-
Pertwee RG. Cannabinoids and the gastrointestinal tract.
Gut 48: 859-867 (2001).
*
-
Pessayre D, Berson A, Fromenty B, Mansouri A. Mitochondria in steatohepatitis.
Semin. Liver Dis. 21: 57-69 (2001).
-
Peters JM, Park Y, Gonzalez FJ, Pariza MW. Influence of conjugated linoleic acid on body composition and target gene expression in peroxisome proliferator-activated receptor alpha-null mice.
Biochim. Biophys. Acta 1533: 233-242 (2001).
*
-
Petersen J, Ott M, von Weizsacker F. Current status of cell-based therapies in liver diseases.
Z. Gastroenterol. 39: 975-980 (2001).
-
Petersen SV, Thiel S, Jensenius JC. The mannan-binding lectin pathway of complement activation: biology and disease association.
Mol. Immunol. 38: 133-149 (2001).
*
-
Petrone A, Bugawan TL, Mesturino CA, Nistico L, Galgani A, Giorgi G, Cascino I, Erlich HA, Di Mario U, Buzzetti R. The distribution of HLA class II susceptible/protective haplotypes could partially explain the low incidence of type 1 diabetes in continental Italy (Lazio region).
Tissue Antigens 58: 385-394 (2001).
*
-
Petrone A, Giorgi G, Mesturino CA, Capizzi M, Cascino I, Nistico L, Osborn J, Di Mario U, Buzzetti R. Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto's thyroiditis in an Italian population.
Thyroid 11: 171-175 (2001).
-
Petryshen TL, Kaplan BJ, Fu Liu M, de French NS, Tobias R, Hughes ML, Field LL. Evidence for a susceptibility locus on chromosome 6q influencing phonological coding dyslexia.
Am. J. Med. Genet. 105: 507-517 (2001).
-
Pfutzer RH, Whitcomb DC. SPINK1 mutations are associated with multiple phenotypes.
Pancreatology 1: 457-460 (2001).
-
Phillips C. Serum antibody responses to Clostridium difficile toxin A: predictive and protective?
Gut 49: 167-168 (2001).
*
-
Phillips JR, Angulo P, Petterson T, Lindor KD. Fat-soluble vitamin levels in patients with primary biliary cirrhosis.
Am. J. Gastroenterol. 96: 2745-2750 (2001).
*
-
Piccoli DA, Spinner NB. Alagille syndrome and the Jagged1 gene.
Semin. Liver Dis. 21: 525-534 (2001).
-
Pimtanothai N, Hurley CK, Leke R, Klitz W, Johnson AH. HLA-DR and -DQ polymorphism in Cameroon.
Tissue Antigens 58: 1-8 (2001).
*
-
Pinero-Pilona A, Litonjua P, Aviles-Santa L, Raskin P. Idiopathic type 1 diabetes in Dallas, Texas: a 5-year experience.
Diabetes Care 24: 1014-1018 (2001).
*
-
Pinzani M, Marra F. Cytokine receptors and signaling in hepatic stellate cells.
Semin. Liver Dis. 21: 397-416 (2001).
-
Pinzani M, Romanelli RG, Magli S. Progression of fibrosis in chronic liver diseases: time to tally the score.
J. Hepatol. 34: 764-767 (2001).
*
-
Pitkanen J, Vahamurto P, Krohn K, Peterson P. Subcellular localization of the autoimmune regulator protein. Characterization of nuclear targeting and transcriptional activation domain.
J. Biol. Chem. 276: 19597-19602 (2001).
*
-
Pittock S, Drumm B, Fleming P, McDermott M, Imrie C, Flint S, Bourke B. The oral cavity in Crohn's disease.
J. Pediatr. 138: 767-771 (2001).
*
-
Plendl H, Siebert R, Steinemann D, Grote W. High frequency of the N34S mutation in the SPINK1 gene in chronic pancreatitis detected by a new PCR-RFLP assay.
Am. J. Med. Genet. 100: 252-253 (2001).
-
Poddar U, Thapa BR, Bhasin DK, Prasad A, Nagi B, Singh K. Endoscopic retrograde cholangiopancreatography in the management of pancreaticobiliary disorders in children.
J. Gastroenterol. Hepatol. 16: 927-931 (2001).
*
-
Poirier H, Niot I, Monnot MC, Braissant O, Meunier-Durmort C, Costet P, Pineau T, Wahli W, Willson TM, Besnard P. Differential involvement of peroxisome-proliferator-activated receptors alpha and delta in fibrate and fatty-acid-mediated inductions of the gene encoding liver fatty-acid-binding protein in the liver and the small intestine.
Biochem. J. 355: 481-488 (2001).
*
-
Pomfret EA, Pomposelli JJ, Jenkins RL. Live donor liver transplantation.
J. Hepatol. 34: 613-624 (2001).
*
-
Ponsioen CY, Stokkers PC, vd Horst AR, Tytgat GN, van Deventer SJ. A patient with hereditary hemochromatosis, ulcerative colitis, and primary sclerosing cholangitis: genetic aspects.
Eur. J. Intern. Med. 12: 518-521 (2001).
*
-
Popat S, Hogberg L, McGuire S, Green H, Bevan S, Stenhammar L, Houlston RS. Germline mutations in TGM2 do not contribute to coeliac disease susceptibility in the Swedish population.
Eur. J. Gastroenterol. Hepatol. 13: 1477-1479 (2001).
-
Porakishvili N, Mageed R, Jamin C, Pers JO, Kulikova N, Renaudineau Y, Lydyard PM, Youinou P. Recent progress in the understanding of B-cell functions in autoimmunity.
Scand. J. Immunol. 54: 30-38 (2001).
*
-
Porsch-Ozcurumez M, Langmann T, Heimerl S, Borsukova H, Kaminski WE, Drobnik W, Honer C, Schumacher C, Schmitz G. The zinc finger protein 202 (ZNF202) is a transcriptional repressor of ATP binding cassette transporter A1 (ABCA1) and ABCG1 gene expression and a modulator of cellular lipid efflux.
J. Biol. Chem. 276: 12427-12433 (2001).
*
-
Posnett DN, Yarilina AA. Sleeping with the enemy - endogenous superantigens in humans.
Immunity 15: 503-506 (2001).
*
-
Post SM, Duez H, Gervois PP, Staels B, Kuipers F, Princen HM. Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase expression.
Arterioscler. Thromb. Vasc. Biol. 21: 1840-1845 (2001).
*
-
Potter KN, Thomson RK, Hamblin A, Richards SD, Lindsay JG, Stevenson FK. Immunogenetic analysis reveals that epitope shifting occurs during B-cell affinity maturation in primary biliary cirrhosis.
J. Mol. Biol. 306: 37-46 (2001).
*
-
Poupon R. "Overlap" syndromes. Autoimmune hepatitis-primary biliary liver cirrhosis; autoimmune hepatitis-primary sclerosing cholangitis.
Presse. Med. 30: 25-27 (2001).
-
Povey A, Guppy MJ, Wood M, Knight C, Black CM, Silman AJ. Cytochrome P2 polymorphisms and susceptibility to scleroderma following exposure to organic solvents.
Arthritis Rheum. 44: 662-665 (2001).
*
-
Power TE, Adams PC. Psychosocial impact of C282Y mutation testing for hemochromatosis.
Genet. Test. 5: 107-110 (2001).
-
Prabhudesai A, Kumar D. Surgery of the small bowel.
Curr. Opin. Gastroenterol. 17: 127-131 (2001).
-
Prasad KN, Hovland AR, Nahreini P, Cole WC, Hovland P, Kumar B, Prasad KC. Differentiation genes: are they primary targets for human carcinogenesis?
Exp. Biol. Med. (Maywood) 226: 805-813 (2001).
*
-
Prella M, Baccala R, Horisberger JD, Belin D, Di Raimondo F, Invernizzi R, Garozzo R, Schapira M. Haemolytic onset of Wilson disease in a patient with homozygous truncation of ATP7B at Arg1319.
Br. J. Haematol. 114: 230-232 (2001).
*
-
Press RD. Crohn's disease is caused by mutations in the bacterial response protein NOD2.
Mol. Diagn. 6: 347-348 (2001).
-
Prete PE, Majlessi A, Gilman S, Hamideh F. Systemic lupus erythematosus in men: a retrospective analysis in a veterans administration healthcare system population.
J. Clin. Rheumatol. 7: 142-150 (2001).
-
Price P, Cheong KY, Boodhoo A, Witt CS, McCann V, Christiansen FT, Allcock RJ. Can MHC class II genes mediate resistance to type 1 diabetes?
Immunol. Cell Biol. 79: 602-606 (2001).
*
-
Prince MI, Chetwynd A, Diggle P, Jarner M, Metcalf JV, James OF. The geographical distribution of primary biliary cirrhosis in a well-defined cohort.
Hepatology 34: 1083-1088 (2001).
*
-
Prinz-Langenohl R, Fohr I, Pietrzik K. Beneficial role for folate in the prevention of colorectal and breast cancer.
Eur. J. Nutr. 40: 98-105 (2001).
*
-
Probst A, Scheubel R, Wienbeck M. Treatment of watermelon stomach (GAVE syndrome) by means of endoscopic argon plasma coagulation (APC): long-term outcome.
Z. Gastroenterol. 39: 447-452 (2001).
-
Puchner TC, Kugathasan S, Kelly KJ, Binion DG. Successful desensitization and therapeutic use of infliximab in adult and pediatric Crohn's disease patients with prior anaphylactic reaction.
Inflamm. Bowel Dis. 7: 34-37 (2001).
*
-
Pulkkinen L, Nakano A, Ringpfeil F, Uitto J. Identification of ABCC6 pseudogenes on human chromosome 16p: implications for mutation detection in pseudoxanthoma elasticum.
Hum. Genet. 109: 356-265 (2001).
*
-
Pummi K, Malminen M, Aho H, Karvonen SL, Peltonen J, Peltonen S. Epidermal tight junctions: ZO-1 and occludin are expressed in mature, developing, and affected skin and in vitro differentiating keratinocytes.
J. Invest. Dermatol. 117: 1050-1058 (2001).
*
-
Puri AS, Kumar N, Gondal R, Lamba GS, Jain M. Primary biliary cirrhosis: an Indian experience.
Indian J. Gastroenterol. 20: 28-29 (2001).
-
Purucker E, Marschall HU, Winograd R, Matern S. Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats.
Biochim. Biophys. Acta 1526: 44-52 (2001).
*
-
Qasim A, Seery J, Morain CA. Osteoporosis in newly diagnosed inflammatory bowel disease.
Gastroenterology 121: 504-506 (2001).
*
-
Qasim A, Seery J, O'Morain CA. Aminosalicylate as prophylaxis for Crohn's disease.
Gut 49: 873 (2001).
*
-
Qian BF, Hammarstrom ML, Danielsson A. Differential expression of vasoactive intestinal polypeptide receptor 1 and 2 mRNA in murine intestinal T lymphocyte subtypes.
J. Neuroendocrinol. 13: 818-825 (2001).
*
-
Qiao D, Gaitonde SV, Qi W, Martinez JD. Deoxycholic acid suppresses p53 by stimulating proteasome-mediated p53 protein degradation.
Carcinogenesis 22: 957-964 (2001).
*
-
Quallich LG, Greenson J, Haftel HM, Fontana RJ. Is it Crohn's disease? A severe systemic granulomatous reaction to sulfasalazine in patient with rheumatoid arthritis.
BMC Gastroenterol. 1: 8 (2001).
*
-
Quarsten H, McAdam SN, Jensen T, Arentz-Hansen H, Molberg O, Lundin KE, Sollid LM. Staining of celiac disease-relevant T cells by peptide-DQ2 multimers.
J. Immunol. 167: 4861-4868 (2001).
*
-
Quezada A, Norambuena X, Bravo A, Castro-Rodriguez JA. Recurrent pneumonia as warning manifestation for suspecting primary immunodeficiencies in children.
J. Investig. Allergol. Clin. Immunol. 11: 295-299 (2001).
-
Quiding-Jarbrink M, Ahlstedt I, Lindholm C, Johansson EL, Lonroth H. Homing commitment of lymphocytes activated in the human gastric and intestinal mucosa.
Gut 49: 519-525 (2001).
*
-
Quinton PM. The neglected ion: HCO3-.
Nat. Med. 7: 292-293 (2001).
*
-
Quirke P. Antagonist. Mycobacterium avium subspecies paratuberculosis is a cause of Crohn's disease.
Gut 49: 757-760 (2001).
*
-
Quiroga S, Sebastia MC, Margarit C, Castells L, Boye R, Alvarez-Castells A. Complications of orthotopic liver transplantation: spectrum of findings with helical CT.
Radiographics 21: 1085-1102 (2001).
*
-
Racke MK. Experimental autoimmune encephalomyelitis (EAE).
Curr. Protoc. Neurosci. Chapter 9: Unit 9.7 (2001).
-
Rademaker M. Do women have more adverse drug reactions?
Am. J. Clin. Dermatol. 2: 349-351 (2001).
-
Radford DJ, Luu NT, Hewins P, Nash GB, Savage CO. Antineutrophil cytoplasmic antibodies stabilize adhesion and promote migration of flowing neutrophils on endothelial cells.
Arthritis Rheum. 44: 2851-2861 (2001).
-
Radivojevic D, Guc-Scekic M, Djurisic M, Lalic T, Minic P, Kanavakis E. Relation between gene mutations and pancreatic exocrine function in patients with cystic fibrosis.
Srp. Arh. Celok. Lek. 129 Suppl. 1: 6-9 (2001).
-
Raggers RJ, Vogels I, van Meer G. Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor.
Biochem. J. 357: 859-865 (2001).
*
-
Ragunath K, Williams JG. Review article: balsalazide therapy in ulcerative colitis.
Aliment. Pharmacol. Ther. 15: 1549-1554 (2001).
*
-
Rai RM, Boitnott J, Klein AS, Thuluvath PJ. Features of recurrent primary sclerosing cholangitis in two consecutive liver allografts after liver transplantation.
J. Clin. Gastroenterol. 32: 151-154 (2001).
-
Rajapakse R, Korelitz BI. Inflammatory bowel disease during pregnancy.
Curr. Treat. Options Gastroenterol. 4: 245-251 (2001).
-
Rajaram R, Ponsioen CY, Majoie CB, Reeders JW, Lameris JS. Evaluation of a modified cholangiographic classification system for primary sclerosing cholangitis.
Abdom. Imaging 26: 43-47 (2001).
*
-
Rajsbaum R, Fici D, Fraser PA, Flores-Villanueva PO, Awdeh ZL. Polymorphism of the human retinoid X receptor beta and linkage disequilibrium with HLA-DPB1.
Tissue Antigens 58: 24-29 (2001).
*
-
Rambaldi A, Gluud C. S-Adenosyl-L-methionine for alcoholic liver diseases.
Cochrane Database Syst. Rev. 4: CD002235 (2001).
*
-
Rambaldi A, Gluud C. Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis.
Cochrane Database Syst. Rev. 3: CD002148 (2001).
*
-
Ramos-Arroyo MA, Feijoo E, Sanchez-Valverde F, Aranburu E, Irisarri N, Olivera JE, Valiente A. Heat-shock protein 70-1 and HLA class II gene polymorphisms associated with celiac disease susceptibility in Navarra (Spain).
Hum. Immunol. 62: 821-825 (2001).
-
Rampton DS. Methotrexate in Crohn's disease.
Gut 48: 790-791 (2001).
*
-
Rannala B. Finding genes influencing susceptibility to complex diseases in the post-genome era.
Am. J. Pharmacogenomics 1: 203-221 (2001).
-
Rao CV, Hirose Y, Indranie C, Reddy BS. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids.
Cancer Res. 61: 1927-1933 (2001).
*
-
Rao MS, Reddy JK. Peroxisomal beta-oxidation and steatohepatitis.
Semin. Liver Dis. 21: 43-55 (2001).
-
Rapalus L, Minegishi Y, Lavoie A, Cunningham-Rundles C, Conley ME. Analysis of SWAP-70 as a candidate gene for non-X-linked hyper IgM syndrome and common variable immunodeficiency.
Clin. Immunol. 101: 270-275 (2001).
*
-
Rasmussen HB, Kelly MA, Clausen J. Genetic susceptibility to multiple sclerosis: detection of polymorphic nucleotides and an intron in the 3' untranslated region of the major histocompatibility complex class II transactivator gene.
Hum. Immunol. 62: 371-377 (2001).
-
Rasmussen HB, Kelly MA, Francis DA, Clausen J. CTLA4 in multiple sclerosis. Lack of genetic association in a European Caucasian population but evidence of interaction with HLA-DR2 among Shanghai Chinese.
J. Neurol. Sci. 184: 143-147 (2001).
*
-
Raty S, Sand J, Pulkkinen M, Matikainen M, Nordback I. Post-ERCP pancreatitis: reduction by routine antibiotics.
J. Gastrointest. Surg. 5: 339-345 (2001).
-
Rau H, Braun J, Donner H, Seissler J, Siegmund T, Usadel KH, Badenhoop K. The codon 17 polymorphism of the CTLA4 gene in type 2 diabetes mellitus.
J. Clin. Endocrinol. Metab. 86: 653-655 (2001).
*
-
Raulet DH, Vance RE, McMahon CW. Regulation of the natural killer cell receptor repertoire.
Annu. Rev. Immunol. 19: 291-330 (2001).
*
-
Rayhorn N. Treatment of inflammatory bowel disease in the adolescent.
J. Infus. Nurs. 24: 255-262 (2001).
-
Re F, Strominger JL. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells.
J. Biol. Chem. 276: 37692-37699 (2001).
*
-
Read RC, Wyllie DH. Toll receptors and sepsis.
Curr. Opin. Crit. Care 7: 371-375 (2001).
-
Read S, Powrie F. Induction of inflammatory bowel disease in immunodeficient mice by depletion of regulatory T cells.
Curr. Protoc. Immunol. Chapter 15: Unit 15.13 (2001).
-
Rebmann V, van der Ven K, Passler M, Pfeiffer K, Krebs D, Grosse-Wilde H. Association of soluble HLA-G plasma levels with HLA-G alleles.
Tissue Antigens 57: 15-21 (2001).
*
-
Rector A, Lemey P, Laffut W, Keyaerts E, Struyf F, Wollants E, Vermeire S, Rutgeerts P, Van Ranst M. Mannan-binding lectin (MBL) gene polymorphisms in ulcerative colitis and Crohn's disease.
Genes Immun. 2: 323-328 (2001).
*
-
Rector A, Vermeire S, Thoelen I, Keyaerts E, Struyf F, Vlietinck R, Rutgeerts P, Van Ranst M. Analysis of the CC chemokine receptor 5 (CCR5) delta-32 polymorphism in inflammatory bowel disease.
Hum. Genet. 108: 190-193 (2001).
*
-
Reddy JA, Clapp DW, Low PS. Retargeting of viral vectors to the folate receptor endocytic pathway.
J. Control Release 74: 77-82 (2001).
-
Reddy JK, Hashimoto T. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system.
Annu. Rev. Nutr. 21: 193-230 (2001).
*
-
Reddy KR, Colombel JF, Poulain D, Krawitt EL. Anti-Saccharomyces cerevisiae antibodies in autoimmune liver disease.
Am. J. Gastroenterol. 96: 252-253 (2001).
*
-
Reddy MM, Quinton PM. Selective activation of cystic fibrosis transmembrane conductance regulator Cl- and HCO3- conductances.
JOP 2: S212-S218 (2001).
*
-
Redmond TM, Gentleman S, Duncan T, Yu S, Wiggert B, Gantt E, Cunningham FX Jr. Identification, expression, and substrate specificity of a mammalian beta-carotene 15,15'-dioxygenase.
J. Biol. Chem. 276: 6560-6565 (2001).
*
-
Redondo MJ, Fain PR, Eisenbarth GS. Genetics of type 1A diabetes.
Recent Prog. Horm. Res. 56: 69-89 (2001).
*
-
Redondo-Cerezo E, Cabello MJ, Gonzalez Y, Gomez M, Garcia-Montero M, de Teresa J. Eosinophilic gastroenteritis: our recent experience: one-year experience of atypical onset of an uncommon disease.
Scand. J. Gastroenterol. 36: 1358-1360 (2001).
*
-
Redonnet A, Groubet R, Noel-Suberville C, Bonilla S, Martinez A, Higueret P. Exposure to an obesity-inducing diet early affects the pattern of expression of peroxisome proliferator, retinoic acid, and triiodothyronine nuclear receptors in the rat.
Metabolism 50: 1161-1167 (2001).
*
-
Reich K, Garbe C, Blaschke V, Maurer C, Middel P, Westphal G, Lippert U, Neumann C. Response of psoriasis to interleukin-10 is associated with suppression of cutaneous type 1 inflammation, downregulation of the epidermal interleukin-8/CXCR2 pathway and normalization of keratinocyte maturation.
J. Invest. Dermatol. 116: 319-329 (2001).
*
-
Reid AE. Nonalcoholic steatohepatitis.
Gastroenterology 121: 710-723 (2001).
*
-
Reid KC, Cockerill III FR, Patel R. Clinical and epidemiological features of Enterococcus casseliflavus/flavescens and Enterococcus gallinarum bacteremia: a report of 20 cases.
Clin. Infect. Dis. 32: 1540-1546 (2001).
*
-
Reiss AB, Awadallah NW, Malhotra S, Montesinos MC, Chan ES, Javitt NB, Cronstein BN. Immune complexes and IFN-gamma decrease cholesterol 27-hydroxylase in human arterial endothelium and macrophages.
J. Lipid Res. 42: 1913-1922 (2001).
*
-
Reiss Y, Proudfoot AE, Power CA, Campbell JJ, Butcher EC. CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin.
J. Exp. Med. 194: 1541-1547 (2001).
*
-
Reniers DE, Howard JM. Isotretinoin-induced inflammatory bowel disease in an adolescent.
Ann. Pharmacother. 35: 1214-1216 (2001).
-
Rerknimitr R, Kullavanijaya P. Endoscopy in HIV infected patients.
J. Med. Assoc. Thai. 84 Suppl. 1: S26-S31 (2001).
-
Reshetnyak VI, Sharafanova TI, Ilchenko LU, Golovanova EV, Poroshenko GG. Peripheral blood lymphocytes DNA in patients with chronic liver diseases.
World J. Gastroenterol. 7: 235-237 (2001).
*
-
Resta-Lenert S, Truong F, Barrett KE, Eckmann L. Inhibition of epithelial chloride secretion by butyrate: role of reduced adenylyl cyclase expression and activity.
Am. J. Physiol. Cell Physiol. 281: C1837-C1849 (2001).
*
-
Reus K, Mayer J, Sauter M, Scherer D, Muller-Lantzsch N, Meese E. Genomic organization of the human endogenous retrovirus HERV-K(HML-2.HOM) (ERVK6) on chromosome 7.
Genomics 72: 314-320 (2001).
*
-
Reveille JD, Ball EJ, Khan MA. HLA-B27 and genetic predisposing factors in spondyloarthropathies.
Curr. Opin. Rheumatol. 13: 265-272 (2001).
-
Reviron D, Foutrier C, Guis S, Mercier P, Roudier J. DRB1 alleles in polymyalgia rheumatica and rheumatoid arthritis in southern France.
Eur. J. Immunogenet. 28: 83-87 (2001).
*
-
Reviron D, Perdriger A, Toussirot E, Wendling D, Balandraud N, Guis S, Semana G, Tiberghien P, Mercier P, Roudier J. Influence of shared epitope-negative HLA-DRB1 alleles on genetic susceptibility to rheumatoid arthritis.
Arthritis Rheum. 44: 535-540 (2001).
*
-
Rex DK. Colorectal cancer screening and surveillance: the present and the future.
Rev. Gastroenterol. Disord. 1: 18-31 (2001).
*
-
Reynaert H, Chavez M, Geerts A. Vascular endothelial growth factor and liver regeneration.
J. Hepatol. 34: 759-761 (2001).
*
-
Rhodes AI, Shorvon PJ. Recent advances in small-bowel imaging: a review.
Curr. Opin. Gastroenterol. 17: 132-139 (2001).
-
Rhodes DA, Stammers M, Malcherek G, Beck S, Trowsdale J. The cluster of BTN genes in the extended major histocompatibility complex.
Genomics 71: 351-362 (2001).
*
-
Rhodes JM. Ulcerative colitis extent varies with time but endoscopic appearances may be deceptive.
Gut 49: 322-323 (2001).
*
-
Ribeiro RC, Feng W, Wagner RL, Costa CH, Pereira AC, Apriletti JW, Fletterick RJ, Baxter JD. Definition of the surface in the thyroid hormone receptor ligand binding domain for association as homodimers and heterodimers with retinoid X receptor.
J. Biol. Chem. 276: 14987-14995 (2001).
*
-
Ribot J, Felipe F, Bonet ML, Palou A. Changes of adiposity in response to vitamin A status correlate with changes of PPAR gamma 2 expression.
Obes. Res. 9: 500-509 (2001).
*
-
Ricart E, Panaccione R, Loftus EV, Tremaine WJ, Sandborn WJ. Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients.
Am. J. Gastroenterol. 96: 722-729 (2001).
*
-
Ricci CA. Dysfunctional defecation. "Why 'Jane' can't poop!".
AWHONN Lifelines 5: 50-55 (2001).
*
-
Richard-Miceli C, Dougados M. Tumour necrosis factor-alpha blockers in rheumatoid arthritis: review of the clinical experience.
BioDrugs 15: 251-259 (2001).
-
Richter M, Weiss M, Weinberger I, Furstenberger G, Marian B. Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors.
Carcinogenesis 22: 17-25 (2001).
*
-
Rinaldo P. Fatty acid transport and mitochondrial oxidation disorders.
Semin. Liver Dis. 21: 489-500 (2001).
-
Ringel Y, Drossman DA. Psychosocial aspects of Crohn's disease.
Surg. Clin. North Am. 81: 231-252, x (2001).
-
Ringpfeil F, Nakano A, Uitto J, Pulkkinen L. Compound heterozygosity for a recurrent 16.5-kb Alu-mediated deletion mutation and single-base-pair substitutions in the ABCC6 gene results in pseudoxanthoma elasticum.
Am. J. Hum. Genet. 68: 642-652 (2001).
*
-
Ringpfeil F, Pulkkinen L, Uitto J. Molecular genetics of pseudoxanthoma elasticum.
Exp. Dermatol. 10: 221-228 (2001).
*
-
Riordan SM, McIver CJ, Wakefield D, Duncombe VM, Thomas MC, Bolin TD. Small intestinal mucosal immunity and morphometry in luminal overgrowth of indigenous gut flora.
Am. J. Gastroenterol. 96: 494-500 (2001).
*
-
Riordan SM, Williams R. The Wilson's disease gene and phenotypic diversity.
J. Hepatol. 34: 165-171 (2001).
*
-
Rioux JD, Daly MJ, Silverberg MS, Lindblad K, Steinhart H, Cohen Z, Delmonte T, Kocher K, Miller K, Guschwan S, Kulbokas EJ, O'Leary S, Winchester E, Dewar K, Green T, Stone V, Chow C, Cohen A, Langelier D et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease.
Nat. Genet. 29: 223-228 (2001).
*
-
Rippin SJ, Hagenbuch B, Meier PJ, Stieger B. Cholestatic expression pattern of sinusoidal and canalicular organic anion transport systems in primary cultured rat hepatocytes.
Hepatology 33: 776-782 (2001).
*
-
Ritz MA, Jost R. Severe pneumococcal pneumonia following treatment with infliximab for Crohn's disease.
Inflamm. Bowel Dis. 7: 327 (2001).
*
-
Rivas Gonzalez P, Calvo Hernandez R, Molinelli Barranco M, Diaz Curiel M. Allopurinol hypersensitivity syndrome.
Rev. Clin. Esp. 201: 493 (2001).
-
Roberts AB, Piek E, Bottinger EP, Ashcroft G, Mitchell JB, Flanders KC. Is Smad3 a major player in signal transduction pathways leading to fibrogenesis?
Chest 120: 43S-47S (2001).
*
-
Roberts PJ, Morgan K, Miller R, Hunter JO, Middleton SJ. Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease.
Gut 48: 468-472 (2001).
*
-
Robertson BR, O'Rourke JL, Vandamme P, On SL, Lee A. Helicobacter ganmani sp. nov., a urease-negative anaerobe isolated from the intestines of laboratory mice.
Int. J. Syst. Evol. Microbiol. 51: 1881-1889 (2001).
*
-
Robertson DJ, Sandler RS. Measles virus and Crohn's disease: a critical appraisal of the current literature.
Inflamm. Bowel Dis. 7: 51-57 (2001).
*
-
Robertson G, Leclercq I, Farrell GC. Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress.
Am. J. Physiol. Gastrointest. Liver Physiol. 281: G1135-G1139 (2001).
*
-
Robinson J, Waller MJ, Parham P, Bodmer JG, Marsh SG. IMGT/HLA database - a sequence database for the human major histocompatibility complex.
Nucleic Acids Res. 29: 210-213 (2001).
*
-
Robinson PD, Schutz CK, Macciardi F, White BN, Holden JJ. Genetically determined low maternal serum dopamine beta-hydroxylase levels and the etiology of autism spectrum disorders.
Am. J. Med. Genet. 100: 30-36 (2001).
-
Robinson RC, Turbedsky K, Kaiser DA, Marchand JB, Higgs HN, Choe S, Pollard TD. Crystal structure of Arp2/3 complex.
Science 294: 1679-1684 (2001).
*
-
Roche HM, Terres AM, Black IB, Gibney MJ, Kelleher D. Fatty acids and epithelial permeability: effect of conjugated linoleic acid in Caco-2 cells.
Gut 48: 797-802 (2001).
*
-
Rockey DC. Hepatic blood flow regulation by stellate cells in normal and injured liver.
Semin. Liver Dis. 21: 337-349 (2001).
-
Rodgers GL, Mortensen JE, Goldsmith DP. Pyogenic arthritis caused by Capnocytophaga gingivalis in an immunocompetent three-year-old male.
J. Clin. Rheumatol. 7: 265-267 (2001).
-
Rodonezhskaia EV, Kharchenko NV. Correction of metabolic disturbances in patients with cholestasis.
Lik. Sprava. 2001: 148-149 (2001).
-
Rodrigues CM, Steer CJ. The therapeutic effects of ursodeoxycholic acid as an anti-apoptotic agent.
Expert Opin. Investig. Drugs 10: 1243-1253 (2001).
-
Rogler G, Gelbmann CM, Vogl D, Brunner M, Scholmerich J, Falk W, Andus T, Brand K. Differential activation of cytokine secretion in primary human colonic fibroblast/myofibroblast cultures.
Scand. J. Gastroenterol. 36: 389-398 (2001).
-
Rolfs A, Hediger MA. Intestinal metal ion absorption: an update.
Curr. Opin. Gastroenterol. 17: 177-183 (2001).
-
Rolston RK, Kant JA. Genetic testing in acute and chronic pancreatitis.
Curr. Gastroenterol. Rep. 3: 115-120 (2001).
-
Romagnuolo J, Fedorak RN, Dias VC, Bamforth F, Teltscher M. Hyperhomocysteinemia and inflammatory bowel disease: prevalence and predictors in a cross-sectional study.
Am. J. Gastroenterol. 96: 2143-2149 (2001).
*
-
Romphruk AV, Naruse TK, Romphruk A, Kawata H, Puapairoj C, Kulski JK, Leelayuwat C, Inoko H. Diversity of MICA (PERB11.1) and HLA haplotypes in Northeastern Thais.
Tissue Antigens 58: 83-89 (2001).
*
-
Rondanelli M, Cestaro B, Cazzola R, Trotti R, Opizzi A, Ioannou A, Magnani B, Migliavacca A, Ferrari E. Dietary restriction and oral administration of antioxidant and omega-3. What are the effects on the clinical variables in a group of obese women?
Minerva Gastroenterol. Dietol. 47: 195-204 (2001).
-
Rooney CP, Taggart C, Coakley R, McElvaney NG, O'Neill SJ. Anti-proteinase 3 antibody activation of neutrophils can be inhibited by alpha1-antitrypsin.
Am. J. Respir. Cell. Mol. Biol. 24: 747-754 (2001).
*
-
Ros JE, Schuetz JD, Geuken M, Streetz K, Moshage H, Kuipers F, Manns MP, Jansen PL, Trautwein C, Muller M. Induction of Mdr1b expression by tumor necrosis factor-alpha in rat liver cells is independent of p53 but requires NF-kappaB signaling.
Hepatology 33: 1425-1431 (2001).
*
-
Rosen-Wolff A, Kreth HW, Hofmann S, Hohne K, Heubner G, Mobius D, Zintl F, Gahr M, Roesler J. Periodic fever (TRAPS) caused by mutations in the TNFalpha receptor 1 (TNFRSF1A) gene of three German patients.
Eur. J. Haematol. 67: 105-109 (2001).
*
-
Rosenstein ED, Advani S, Reitz RE, Kramer N. The prevalence of insulin receptor antibodies in patients with systemic lupus erythematosus and related conditions.
J. Clin. Rheumatol. 7: 371-373 (2001).
-
Rosloniec EF, Cremer M, Kang A, Myers LK. Collagen-induced arthritis.
Curr. Protoc. Immunol. Chapter 15: Unit 15.5 (2001).
-
Rosmorduc O, Hermelin B, Poupon R. MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis.
Gastroenterology 120: 1459-1467 (2001).
*
-
Ross AC, Zolfaghari R, Weisz J. Vitamin A: recent advances in the biotransformation, transport, and metabolism of retinoids.
Curr. Opin. Gastroenterol. 17: 184-192 (2001).
-
Rossi L, Pfutzer RH, Parvin S, Ali L, Sattar S, Kahn AK, Gyr N, Whitcomb DC. SPINK1/PSTI mutations are associated with tropical pancreatitis in Bangladesh. A preliminary report.
Pancreatology 1: 242-245 (2001).
-
Rossmann H, Bachmann O, Wang Z, Shull GE, Obermaier B, Stuart-Tilley A, Alper SL, Seidler U. Differential expression and regulation of AE2 anion exchanger subtypes in rabbit parietal and mucous cells.
J. Physiol. 534: 837-848 (2001).
*
-
Roth MD, Marques-Magallanes JA, Yuan M, Sun W, Tashkin DP, Hankinson O. Induction and regulation of the carcinogen-metabolizing enzyme CYP1A1 by marijuana smoke and delta (9)-tetrahydrocannabinol.
Am. J. Respir. Cell. Mol. Biol. 24: 339-344 (2001).
*
-
Rothenberg ME, Mishra A, Brandt EB, Hogan SP. Gastrointestinal eosinophils.
Immunol. Rev. 179: 139-155 (2001).
*
-
Rouzier R, Robine S. The subtleties of intestinal metaplasia.
Gut 49: 8 (2001).
*
-
Rowling MJ, Schalinske KL. Retinoid compounds activate and induce hepatic glycine N-methyltransferase in rats.
J. Nutr. 131: 1914-1917 (2001).
*
-
Roy H. Chemoprevention adds up.
Am. J. Gastroenterol. 96: 278 (2001). *
-
Roy HK, Karolski WJ, Ratashak A. Distal bowel selectivity in the chemoprevention of experimental colon carcinogenesis by the non-steroidal anti-inflammatory drug nabumetone.
Int. J. Cancer 92: 609-615 (2001).
*
-
Roy P, Washizu J, Tilles AW, Yarmush ML, Toner M. Effect of flow on the detoxification function of rat hepatocytes in a bioartificial liver reactor.
Cell Transplant. 10: 609-614 (2001).
-
Rudwaleit M, Hohler T. Cytokine gene polymorphisms relevant for the spondyloarthropathies.
Curr. Opin. Rheumatol. 13: 250-254 (2001).
-
Ruhl R, Plum C, Elmazar MM, Nau H. Embryonic subcellular distribution of 13-cis- and all-trans-retinoic acid indicates differential cytosolic/nuclear localization.
Toxicol. Sci. 63: 82-89 (2001).
*
-
Ruiz del Prado MY, Olivares Lopez JL, Lazaro Almarza A, Lasierra Diaz MP. Two loci HLA haplotypes in celiac children. Linkage imbalance and haplotype frequencies. Comparative study with a control population.
An. Esp. Pediatr. 54: 7-12 (2001).
-
Ruiz MY, Olivares JL. Three-loci HLA haplotypes in Spanish celiac children and healthy subjects: estimation of linkage disequilibrium and haplotype frequencies.
Am. J. Gastroenterol. 96: 1455-1459 (2001).
*
-
Rulyak SJ, Brentnall TA. Inherited pancreatic cancer: surveillance and treatment strategies for affected families.
Pancreatology 1: 477-485 (2001).
-
Rumalla A, Baron TH, Leontovich O, Burgart LJ, Yacavone RF, Therneau TM, de Groen PC, Sebo TJ. Improved diagnostic yield of endoscopic biliary brush cytology by digital image analysis.
Mayo Clin. Proc. 76: 29-33 (2001).
*
-
Russell KA, Fass DN, Specks U. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.
Arthritis Rheum. 44: 463-468 (2001).
*
-
Russmann S, Zimmermann A, Krahenbuhl S, Kern B, Reichen J. Veno-occlusive disease, nodular regenerative hyperplasia and hepatocellular carcinoma after azathioprine treatment in a patient with ulcerative colitis.
Eur. J. Gastroenterol. Hepatol. 13: 287-290 (2001).
-
Rutgeerts P. The use of budesonide in the treatment of active Crohn's disease is good clinical practice.
Inflamm. Bowel Dis. 7: 60-61 (2001).
-
Rutgeerts P, Geboes K. Understanding inflammatory bowel disease - the clinician's perspective.
Eur. J. Surg. Suppl. 586: 66-72 (2001).
-
Rutgeerts PJ. Conventional treatment of Crohn's disease: objectives and outcomes.
Inflamm. Bowel Dis. 7 Suppl. 1: S2-S8 (2001).
*
-
Ryan BM, Weir DG. Relevance of folate metabolism in the pathogenesis of colorectal cancer.
J. Lab. Clin. Med. 138: 164-176 (2001).
*
-
Ryder SD, Beckingham IJ. ABC of diseases of liver, pancreas, and biliary system. Other causes of parenchymal liver disease.
BMJ 322: 290-292 (2001).
*
-
Ryder SD, Beckingham IJ. ABC of diseases of liver, pancreas, and biliary system: chronic viral hepatitis.
BMJ 322: 219-221 (2001).
*
-
Ryder SD, Beckingham IJ. ABC of diseases of liver, pancreas, and biliary system: acute hepatitis.
BMJ 322: 151-153 (2001).
*
-
Saadah OI, Smith AL, Hardikar W. Long-term outcome of autoimmune hepatitis in children.
J. Gastroenterol. Hepatol. 16: 1297-1302 (2001).
*
-
Sadowski T, Steinmeyer J. Minocycline inhibits the production of inducible nitric oxide synthase in articular chondrocytes.
J. Rheumatol. 28: 336-340 (2001).
-
Saiman L, Tabibi S, Starner TD, San Gabriel P, Winokur PL, Jia HP, McCray PB Jr, Tack BF. Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis.
Antimicrob. Agents Chemother. 45: 2838-2844 (2001).
*
-
Sairam S, Goel N, Lisse J, McNearney T. Pericardial effusion and cardiomyopathy following arthritis with parvovirus B19 infection: response to intravenous immunoglobulin.
J. Clin. Rheumatol. 7: 346-349 (2001).
-
Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, Kuniyasu Y, Nomura T, Toda M, Takahashi T. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance.
Immunol. Rev. 182: 18-32 (2001).
*
-
Sakaguchi T, Brand S, Reinecker HC. Mucosal barrier and immune mediators.
Curr. Opin. Gastroenterol. 17: 573-577 (2001).
-
Sakai K, Shirasawa S, Ishikawa N, Ito K, Tamai H, Kuma K, Akamizu T, Tanimura M, Furugaki K, Yamamoto K, Sasazuki T. Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese.
Hum. Mol. Genet. 10: 1379-1386 (2001).
*
-
Sakai M, Egawa N, Sakamaki H, Sanaka M, Yuyang T, Kamisawa T, Sakaki N, Funata N, Nakazawa Y, Ikegami T, Hashikura Y, Kawasaki S. Primary sclerosing cholangitis complicated with idiopathic thrombocytopenic purpura.
Intern. Med. 40: 1209-1214 (2001).
*
-
Sakisaka S, Kawaguchi T, Taniguchi E, Hanada S, Sasatomi K, Koga H, Harada M, Kimura R, Sata M, Sawada N, Mori M, Todo S, Kurohiji T. Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis.
Hepatology 33: 1460-1468 (2001).
*
-
Sakisaka S, Takeyama Y. Primary sclerosing cholangitis.
Nippon Naika Gakkai Zasshi 90: 29-34 (2001).
-
Salomon B, Bluestone JA. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.
Annu. Rev. Immunol. 19: 225-252 (2001).
*
-
Salvarani C, Boiardi L, Mantovani V, Olivieri I, Ciancio G, Cantini F, Salvi F, Malatesta R, Molinotti C, Govoni M, Trotta F, Filippini D, Paolazzi G, Viggiani M. Association of MICA alleles and HLA-B51 in Italian patients with Behcet's disease.
J. Rheumatol. 28: 1867-1870 (2001).
-
Salvarani C, Vlachonikolis IG, van der Heijde DM, Fornaciari G, Macchioni P, Beltrami M, Olivieri I, Di Gennaro F, Politi P, Stockbrugger RW, Russel MG; European Collaborative IBD Study Group. Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients.
Scand. J. Gastroenterol. 36: 1307-1313 (2001).
*
-
Salvati VM, Bajaj-Elliott M, Poulsom R, Mazzarella G, Lundin KE, Nilsen EM, Troncone R, MacDonald TT. Keratinocyte growth factor and coeliac disease.
Gut 49: 176-181 (2001).
*
-
Samstein B, Emond J. Liver transplants from living related donors.
Annu. Rev. Med. 52: 147-160 (2001).
*
-
Sanchez-Velasco P, Karadsheh NS, Garcia-Martin A, Ruiz de Alegria C, Leyva-Cobian F. Molecular analysis of HLA allelic frequencies and haplotypes in Jordanians and comparison with other related populations.
Hum. Immunol. 62: 901-909 (2001).
-
Sanchez-Velasco P, Leyva-Cobian F. The HLA class I and class II allele frequencies studied at the DNA level in the Svanetian population (Upper Caucasus) and their relationships to Western European populations.
Tissue Antigens 58: 223-233 (2001).
*
-
Sandborn WJ. Transcending conventional therapies: the role of biologic and other novel therapies.
Inflamm. Bowel Dis. 7 Suppl. 1: S9-S16 (2001).
*
-
Sandborn WJ. Strategies targeting tumor necrosis factor in Crohn's disease.
Acta Gastroenterol. Belg. 64: 170-172 (2001).
-
Sandborn WJ, Feagan BG, Hanauer SB, Present DH, Sutherland LR, Kamm MA, Wolf DC, Baker JP, Hawkey C, Archambault A, Bernstein CN, Novak C, Heath PK, Targan SR; CDP571 Crohn's Disease Study Group. An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial.
Gastroenterology 120: 1330-1338 (2001).
*
-
Sandborn WJ, Hanauer SB, Katz S, Safdi M, Wolf DG, Baerg RD, Tremaine WJ, Johnson T, Diehl NN, Zinsmeister AR. Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial.
Gastroenterology 121: 1088-1094 (2001).
*
-
Sandborn WJ, Loftus EV Jr, Colombel JF, Fleming KA, Seibold F, Homburger HA, Sendid B, Chapman RW, Tremaine WJ, Kaul DK, Wallace J, Harmsen WS, Zinsmeister AR, Targan SR. Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease.
Inflamm. Bowel Dis. 7: 192-201 (2001).
*
-
Sandford AJ, Zhu S, Bai TR, Fitzgerald JM, Pare PD. The role of the C-C chemokine receptor-5 Delta32 polymorphism in asthma and in the production of regulated on activation, normal T cells expressed and secreted.
J. Allergy Clin. Immunol. 108: 69-73 (2001).
*
-
Sands BE. Biologicals: principles, techniques and mechanisms of action.
Acta Gastroenterol. Belg. 64: 165-169 (2001).
-
Sands BE. Biological therapies for ulcerative colitis.
Acta Gastroenterol. Belg. 64: 205-209 (2001).
-
Sands BE, Tremaine WJ, Sandborn WJ, Rutgeerts PJ, Hanauer SB, Mayer L, Targan SR, Podolsky DK. Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study.
Inflamm. Bowel Dis. 7: 83-88 (2001).
*
-
Sandusky H, Cilluffo M, Braun J, Gordon LK. Ocular pANCA antigens are expressed in nonpigmented ciliary body epithelium and are conserved in multiple mammalian species.
Ocul. Immunol. Inflamm. 9: 25-34 (2001).
-
Santamaria P. Autoimmune disease: genetics.
ENCYCLOPEDIA OF LIFE SCIENCES Nature Publishing Group www.els.net (2001). *
-
Sanyal A. Treatment of cholestasis and cholestatic disorders.
Indian J. Gastroenterol. 20 Suppl. 1: C88-C89 (2001).
-
Sanyal AJ. Insulin resistance and nonalcoholic steatohepatitis: fat or fiction?
Am. J. Gastroenterol. 96: 274-276 (2001).
*
-
Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.
Gastroenterology 120: 1183-1192 (2001).
*
-
Sargent DJ, Goldberg RM, Jacobson SD, Macdonald JS, Labianca R, Haller DG, Shepherd LE, Seitz JF, Francini G. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients.
N. Engl. J. Med. 345: 1091-1097 (2001).
*
-
Sartor RB. Intestinal microflora in human and experimental inflammatory bowel disease.
Curr. Opin. Gastroenterol. 17: 324-330 (2001).
-
Sartor RB. Induction of mucosal immune responses by bacteria and bacterial components.
Curr. Opin. Gastroenterol. 17: 555-561 (2001).
-
Sasaki M, Van De Water J, Kenny TP, Gallo ML, Leung PS, Nakanuma Y, Ansari AA, Coppel RL, Neuberger J, Gershwin ME. Immunoglobulin gene usage and immunohistochemical characteristics of human monoclonal antibodies to the mitochondrial autoantigens of primary biliary cirrhosis induced in the XenoMouse.
Hepatology 34: 631-637 (2001).
*
-
Sategna Guidetti C, Solerio E, Scaglione N, Aimo G, Mengozzi G. Duration of gluten exposure in adult coeliac disease does not correlate with the risk for autoimmune disorders.
Gut 49: 502-505 (2001).
*
-
Satsangi J. Genetics of inflammatory bowel disease: from bench to bedside?
Acta Odontol. Scand. 59: 187-192 (2001).
*
-
Satsangi J, Chapman RW, Haldar N, Donaldson P, Mitchell S, Simmons J, Norris S, Marshall SE, Bell JI, Jewell DP, Welsh KI. A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis.
Gastroenterology 121: 124-130 (2001).
*
-
Satsangi J, Vermeire S. Chromosome 3p and inflammatory bowel disease.
Gut 49: 455 (2001).
*
-
Saugier-Veber P, Drouot N, Wolf LM, Kuhn JM, Frebourg T, Lefebvre H. Identification of a novel mutation in the autoimmune regulator (AIRE-1) gene in a French family with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.
Eur. J. Endocrinol. 144: 347-351 (2001).
*
-
Sauvant P, Sapin V, Alexandre-Gouabau MC, Dodeman I, Delpal S, Quadro L, Partier A, Abergel A, Colantuoni V, Rock E, Azais-Braesco V. Retinol mobilization from cultured rat hepatic stellate cells does not require retinol binding protein synthesis and secretion.
Int. J. Biochem. Cell Biol. 33: 1000-1012 (2001).
*
-
Saxena R, Shetty K, Berk PD. A 37-year-old male with hepatomegaly, neurologic and skin involvement associated with elevated urinary porphyrin excretion.
Semin. Liver Dis. 21: 119-128 (2001).
-
Scheffer H, van den Ouweland AM, Veeze HJ. From gene to disease; from defective chloride ion transport to cystic fibrosis.
Ned. Tijdschr. Geneeskd. 145: 686-687 (2001).
-
Scheidler MD, Giannella RA. Practical management of acute diarrhea.
Hosp. Pract. (Off. Ed.) 36: 49-56 (2001).
-
Scheinfeld N, Libkind M, Freilich S. New-onset ichthyosis and diabetes in a 14-year-old.
Pediatr. Dermatol. 18: 501-503 (2001).
-
Scheinfeld NS, Teplitz E, McClain SA. Crohn's disease and lichen nitidus: a case report and comparison of common histopathologic features.
Inflamm. Bowel Dis. 7: 314-318 (2001).
*
-
Schepke M, Sauerbruch T. Transjugular portosystemic stent shunt in treatment of liver diseases.
World J. Gastroenterol. 7: 170-174 (2001).
*
-
Scheppach W, Druge G, Wittenberg G, Mueller JG, Gassel AM, Gassel HJ, Richter F. Sclerosing cholangitis and liver cirrhosis after extrabiliary infections: report on three cases.
Crit. Care Med. 29: 438-441 (2001).
-
Scherr B, Tromm A, Voigt E, Muller KM, Griga T. Association of primary sclerosing cholangitis and sarcoidosis.
Med. Klin. 96: 550-554 (2001).
-
Schibler A, Bolt I, Gallati S, Schoni MH, Kraemer R. High morbidity and mortality in cystic fibrosis patients compound heterozygous for 3905insT and deltaF508.
Eur. Respir. J. 17: 1181-1186 (2001).
*
-
Schlichting J, Leuschner U. Drug therapy of primary biliary diseases: classical and modern strategies.
J. Cell. Mol. Med. 5: 98-115 (2001).
*
-
Schliess F, Haussinger D. Hepatic encephalopathy and nitric oxide.
J. Hepatol. 34: 610-612 (2001).
*
-
Schmidt H, Martindale R. The gastrointestinal tract in critical illness.
Curr. Opin. Clin. Nutr. Metab. Care 4: 547-551 (2001).
-
Schmiedlin-Ren P, Thummel KE, Fisher JM, Paine MF, Watkins PB. Induction of CYP3A4 by 1 alpha,25-dihydroxyvitamin D3 is human cell line-specific and is unlikely to involve pregnane X receptor.
Drug Metab. Dispos. 29: 1446-1453 (2001).
*
-
Schmitt M, Kubitz R, Lizun S, Wettstein M, Haussinger D. Regulation of the dynamic localization of the rat Bsep gene-encoded bile salt export pump by anisoosmolarity.
Hepatology 33: 509-518 (2001).
*
-
Schmitt-Egenolf M, Windemuth C, Hennies HC, Albis-Camps M, von Engelhardt B, Wienker T, Reis A, Traupe H, Blasczyk R. Comparative association analysis reveals that corneodesmosin is more closely associated with psoriasis than HLA-Cw*0602-B*5701 in German families.
Tissue Antigens 57: 440-446 (2001).
*
-
Schmitz G, Kaminski WE. ABC transporters and cholesterol metabolism.
Front. Biosci. 6: D505-D514 (2001).
-
Schmitz G, Langmann T, Heimerl S. Role of ABCG1 and other ABCG family members in lipid metabolism.
J. Lipid Res. 42: 1513-1520 (2001).
*
-
Schofl R. Diagnostic endoscopic retrograde cholangiopancreatography.
Endoscopy 33: 147-157 (2001).
-
Schoon EJ, Muller MC, Vermeer C, Schurgers LJ, Brummer RJ, Stockbrugger RW. Low serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor of osteoporosis in Crohn's disease?
Gut 48: 473-477 (2001).
*
-
Schreiber S. Monocytes or T cells in Crohn's disease: does IL-16 allow both to play at that game?
Gut 49: 747-748 (2001).
*
-
Schreiber S, Campieri M, Colombel JF, van Deventer SJ, Feagan B, Fedorak R, Forbes A, Gassull M, Gendre JP, van Hogezand RA, Lofberg R, Modigliani R, Pallone F, Petritsch W, Prantera C, Rampton D, Seibold F, Vatn M, Zeitz M, Rutgeerts P. Use of anti-tumour necrosis factor agents in inflammatory bowel disease. European guidelines for 2001-2003.
Int. J. Colorectal Dis. 16: 1-11 (2001).
*
-
Schreiber S, Nikolaus S, Malchow H, Kruis W, Lochs H, Raedler A, Hahn EG, Krummenerl T, Steinmann G; German ICAM-1 Study Group. Absence of efficacy of subcutaneous antisense ICAM-1 treatment of chronic active Crohn's disease.
Gastroenterology 120: 1339-1346 (2001).
*
-
Schreiber S, Sternon J. Anti-TNF alpha in rheumatoid arthritis.
Rev. Med. Brux. 22: 174-180 (2001).
-
Schreiber S; German Society of Digestive and Metabolic Diseases. Guidelines of the DGVS. Extraintestinal manifestations. German Society of Digestive and Metabolic Diseases.
Z. Gastroenterol. 39: 63-65 (2001).
-
Schreuder GM, Hurley CK, Marsh SG, Lau M, Maiers M, Kollman C, Noreen HJ. The HLA dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens.
Tissue Antigens 58: 109-140 (2001).
*
-
Schreuder GM, Hurley CK, Marsh SG, Lau M, Maiers M, Kollman C, Noreen HJ. The HLA dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens.
Eur. J. Immunogenet. 28: 565-596 (2001).
*
-
Schreuder GM, Hurley CK, Marsh SG, Lau M, Maiers M, Kollman C, Noreen HJ. The HLA dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens.
Hum. Immunol. 62: 826-849 (2001).
-
Schrumpf E, Boberg KM. Epidemiology of primary sclerosing cholangitis.
Best Pract. Res. Clin. Gastroenterol. 15: 553-562 (2001).
*
-
Schubert LA, Jeffery E, Zhang Y, Ramsdell F, Ziegler SF. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation.
J. Biol. Chem. 276: 37672-37679 (2001).
*
-
Schuetz E, Strom S. Promiscuous regulator of xenobiotic removal.
Nat. Med. 7: 536-537 (2001).
*
-
Schuetz EG. Induction of cytochromes P450.
Curr. Drug Metab. 2: 139-147 (2001).
-
Schuetz EG, Strom S, Yasuda K, Lecureur V, Assem M, Brimer C, Lamba J, Kim RB, Ramachandran V, Komoroski BJ, Venkataramanan R, Cai H, Sinal CJ, Gonzalez FJ, Schuetz JD. Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450.
J. Biol. Chem. 276: 39411-39418 (2001).
*
-
Schulte CM, Goebell H, Roher HD, Schulte KM. C-509T polymorphism in the TGFB1 gene promoter: impact on Crohn's disease susceptibility and clinical course?
Immunogenetics 53: 178-182 (2001).
-
Schultz H, Weiss J, Carroll SF, Gross WL. The endotoxin-binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodies.
J. Leukoc. Biol. 69: 505-512 (2001).
*
-
Schuppan D, Hahn EG. Clinical studies with silymarin: fibrosis progression is the end point.
Hepatology 33: 483-484 (2001).
*
-
Schuppan D, Ruehl M, Somasundaram R, Hahn EG. Matrix as a modulator of hepatic fibrogenesis.
Semin. Liver Dis. 21: 351-372 (2001).
-
Schwabe RF, Schnabl B, Kweon YO, Brenner DA. CD40 activates NF-kappaB and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells.
J. Immunol. 166: 6812-6819 (2001).
*
-
Schwartz DA, Pardi DS, Murray JA. Use of montelukast as steroid-sparing agent for recurrent eosinophilic gastroenteritis.
Dig. Dis. Sci. 46: 1787-1790 (2001).
*
-
Schwarz M, Russell DW, Dietschy JM, Turley SD. Alternate pathways of bile acid synthesis in the cholesterol 7alpha-hydroxylase knockout mouse are not upregulated by either cholesterol or cholestyramine feeding.
J. Lipid Res. 42: 1594-1603 (2001).
*
-
Schwetz BA. From the Food and Drug Administration.
JAMA 285: 1146 (2001).
*
-
Scolapio JS, Gostout CJ, Schroeder KW, Mahoney DW, Lindor KD. Dysphagia without endoscopically evident disease: to dilate or not?
Am. J. Gastroenterol. 96: 327-330 (2001).
*
-
Scroggie D, Harris MD, Abel M, Sakai L, Arroyo R. Vasculitis following treatment of rheumatoid arthritis with extracorporeal staphylococcal protein a immunoadsorption column (prosorba).
J. Clin. Rheumatol. 7: 238-241 (2001).
-
Sdepanian VL, de Morais MB, Fagundes-Neto U. Celiac disease: evaluation of compliance to gluten-free diet and knowledge of disease in patients registered at the Brazilian Celiac Association (ACA).
Arq. Gastroenterol. 38: 232-239 (2001).
-
Sechi LA, Mura M, Tanda F, Lissia A, Solinas A, Fadda G, Zanetti S, Manuela M, Francesco T, Amelia L, Antonello S, Giovanni F, Stefania Z. Identification of Mycobacterium avium subsp. paratuberculosis in biopsy specimens from patients with Crohn's disease identified by in situ hybridization.
J. Clin. Microbiol. 39: 4514-4517 (2001).
*
-
Sediva A, Lischke R, Simonek J, Tkaczyk J, Vavrova V, Bartosova J, Pohunek P, Bartunkova J, Pafko P. Lung transplantation for cystic fibrosis: immune system and autoimmunity.
Med. Sci. Monit. 7: 1219-1223 (2001).
*
-
Sedlaczek N, Jia JD, Bauer M, Herbst H, Ruehl M, Hahn EG, Schuppan D. Proliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat biliary fibrosis.
Am. J. Pathol. 158: 1239-1244 (2001).
*
-
Seegert D, Rosenstiel P, Pfahler H, Pfefferkorn P, Nikolaus S, Schreiber S. Increased expression of IL-16 in inflammatory bowel disease.
Gut 48: 326-332 (2001).
*
-
Seeliger M, Biesalski HK. Vitamin A metabolism and retinal degeneration.
Ophthalmologe 98: 520-525 (2001).
-
Seibold F, Stich O, Hufnagl R, Kamil S, Scheurlen M. Anti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease: a family study.
Scand. J. Gastroenterol. 36: 196-201 (2001).
*
-
Seidel J, Caca K, Schwab SG, Berr F, Wildenauer DB, Mentzel HJ, Horn N, Kauf E. Disturbed copper transport in humans. Part 2: mutations of the ATP7B gene lead to Wilson disease (WD).
Cell. Mol. Biol. (Noisy-le-grand) 47: OL149-157 (2001).
-
Seidl C, Korbitzer J, Badenhoop K, Seifried E, Hoelzer D, Zanelli E, Kaltwasser JP. Protection against severe disease is conferred by DERAA-bearing HLA-DRB1 alleles among HLA-DQ3 and HLA-DQ5 positive rheumatoid arthritis patients.
Hum. Immunol. 62: 523-529 (2001).
-
Seidl H, Kreimer-Erlacher H, Back B, Soyer HP, Hofler G, Kerl H, Wolf P. Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis.
J. Invest. Dermatol. 117: 365-370 (2001).
*
-
Seidler U, Bachmann O, Jacob P, Christiani S, Blumenstein I, Rossmann H. Na+/HCO3- cotransport in normal and cystic fibrosis intestine.
JOP 2: S247-S256 (2001).
*
-
Seki SS, Sugimura K, Ota M, Matsuzawa J, Katsuyama Y, Ishizuka K, Mochizuki T, Suzuki K, Yoneyama O, Mizuki N, Honma T, Inoko H, Asakura H. Stratification analysis of MICA triplet repeat polymorphisms and HLA antigens associated with ulcerative colitis in Japanese.
Tissue Antigens 58: 71-76 (2001).
*
-
Sekigawa I, Ogasawara H, Kaneko H, Hishikawa T, Hashimoto H. Retroviruses and autoimmunity.
Intern. Med. 40: 80-86 (2001).
*
-
Sell S. The role of progenitor cells in repair of liver injury and in liver transplantation.
Wound Repair Regen. 9: 467-482 (2001).
-
Sellami MK, Zitouni M, Zouiten F, Laadhar L, Ben Chaabane T, Makni S. Tuberculosis, primary biliary cirrhosis and autoimmunity (apropos of a case in Tunisia).
Bull. Soc. Pathol. Exot. 94: 330-331 (2001).
-
Selzner M, Clavien PA. Fatty liver in liver transplantation and surgery.
Semin. Liver Dis. 21: 105-113 (2001).
-
Sergeeva TV, Chistiakov DA, Kobalava ZhD, Moiseev VS. Polymorphism of catalase and glutathione peroxidase genes in macrovascular complications in patients with non-insulin-dependent diabetes mellitus and hypertension.
Genetika 37: 418-421 (2001).
-
Serrano MS, Schmidt-Sommerfeld E, Kilbaugh TJ, Brown RF, Udall JN Jr, Mannick EE. Use of infliximab in pediatric patients with inflammatory bowel disease.
Ann. Pharmacother. 35: 823-828 (2001).
-
Setterfield J, Theron J, Vaughan RW, Welsh KI, Mallon E, Wojnarowska F, Challacombe SJ, Black MM. Mucous membrane pemphigoid: HLA-DQB1*0301 is associated with all clinical sites of involvement and may be linked to antibasement membrane IgG production.
Br. J. Dermatol. 145: 406-414 (2001).
*
-
Severus WE, Littman AB, Stoll AL. Omega-3 fatty acids, homocysteine, and the increased risk of cardiovascular mortality in major depressive disorder.
Harv. Rev. Psychiatry 9: 280-293 (2001).
-
Shackel NA, McGuinness PH, Abbott CA, Gorrell MD, McCaughan GW. Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression.
Gut 49: 565-576 (2001).
*
-
Shafran I, Decker JW. Bacteria and Crohn's disease.
Am. J. Gastroenterol. 96: 3222-3224 (2001).
*
-
Shanahan F. Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics.
Gastroenterology 120: 622-635 (2001).
*
-
Sharma M, Benharouga M, Hu W, Lukacs GL. Conformational and temperature-sensitive stability defects of the delta F508 cystic fibrosis transmembrane conductance regulator in post-endoplasmic reticulum compartments.
J. Biol. Chem. 276: 8942-8950 (2001).
*
-
Sharma RA, Gescher AJ, O'Byrne KJ, Steward WP. Familiar drugs may prevent cancer.
Postgrad. Med. J. 77: 492-497 (2001).
*
-
Shaw MA, Donaldson IJ, Collins A, Peacock CS, Lins-Lainson Z, Shaw JJ, Ramos F, Silveira F, Blackwell JM. Association and linkage of leprosy phenotypes with HLA class II and tumour necrosis factor genes.
Genes Immun. 2: 196-204 (2001).
*
-
Shawcross DL, Jalan R. Delayed opioid withdrawal-like reaction in primary biliary cirrhosis following naloxone therapy.
Gastroenterology 121: 743-744 (2001).
*
-
Shek LP, Tay AH, Chew FT, Goh DL, Lee BW. Genetic susceptibility to asthma and atopy among Chinese in Singapore - linkage to markers on chromosome 5q31-33.
Allergy 56: 749-753 (2001).
*
-
Shen B, Achkar JP, Lashner BA, Ormsby AH, Remzi FH, Brzezinski A, Bevins CL, Bambrick ML, Seidner DL, Fazio VW. A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Inflamm. Bowel Dis. 7: 301-305 (2001).
*
-
Shen W, Scearce LM, Brestelli JE, Sund NJ, Kaestner KH. Foxa3 (hepatocyte nuclear factor 3gamma) is required for the regulation of hepatic GLUT2 expression and the maintenance of glucose homeostasis during a prolonged fast.
J. Biol. Chem. 276: 42812-42817 (2001).
*
-
Shen Z, Feng Y, Dewhirst FE, Fox JG. Coinfection of enteric Helicobacter spp. and Campylobacter spp. in cats.
J. Clin. Microbiol. 39: 2166-2172 (2001).
*
-
Sherman M. Alphafetoprotein: an obituary.
J. Hepatol. 34: 603-605 (2001).
*
-
Sherwood P, Lyburn I, Brown S, Ryder S. How are abnormal results for liver function tests dealt with in primary care? Audit of yield and impact.
BMJ 322: 276-278 (2001).
*
-
Shi X, Bai S, Li L, Cao X. Hoxa-9 represses transforming growth factor-beta-induced osteopontin gene transcription.
J. Biol. Chem. 276: 850-855 (2001).
*
-
Shiau AK, Coward P, Schwarz M, Lehmann JM. Orphan nuclear receptors: from new ligand discovery technologies to novel signaling pathways.
Curr. Opin. Drug Discov. Devel. 4: 575-590 (2001).
-
Shibata M, Morizane T, Tanaka A, Onozuka Y, Uchida T, Gershwin ME, Mitamura K. A case of autoimmune hepatitis with a high titer of antimitochondrial antibody and normal gamma-globulinemia.
J. Gastroenterol. Hepatol. 16: 830-835 (2001).
*
-
Shibata M, Wang RY, Yoshiba M, Shih JW, Alter HJ, Mitamura K. The presence of a newly identified infectious agent (SEN virus) in patients with liver diseases and in blood donors in Japan.
J. Infect. Dis. 184: 400-404 (2001).
*
-
Shibuya A. Hepatocellular carcinoma accompanied with primary biliary cirrhosis.
Nippon Rinsho 59 Suppl. 6: 465-468 (2001).
-
Shibuya A, Satomich A, Nagaba S, Endoh H, Kuwao S, Saigenji K. Thrombotic thrombocytopenic purpura in autoimmune hepatitis.
J. Gastroenterol. 36: 569-573 (2001).
*
-
Shih DQ, Bussen M, Sehayek E, Ananthanarayanan M, Shneider BL, Suchy FJ, Shefer S, Bollileni JS, Gonzalez FJ, Breslow JL, Stoffel M. Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism.
Nat. Genet. 27: 375-382 (2001).
*
-
Shimizu Y, Murata H, Kashii Y, Hirano K, Kunitani H, Higuchi K, Watanabe A. CC-chemokine receptor 6 and its ligand macrophage inflammatory protein 3alpha might be involved in the amplification of local necroinflammatory response in the liver.
Hepatology 34: 311-319 (2001).
*
-
Shimosegawa T. Do point mutations in the PSTI (SPINK1) gene truly contribute to the pathogenesis of chronic pancreatitis?
J. Gastroenterol. 36: 645-647 (2001).
*
-
Shinohara T, Yanai H, Hidaka T, Suzuki K, Ohsuzu F. Acute congestive heart failure associated with a limited form of systemic sclerosis and primary biliary cirrhosis.
Intern. Med. 40: 73-76 (2001).
*
-
Shinohara Y, Iwasaki H, Ota N, Nakajima T, Kodaira M, Kajita M, Shiba T, Emi M. Novel single nucleotide polymorphisms of the human nuclear factor kappa-B 2 gene identified by sequencing the entire gene.
J. Hum. Genet. 46: 50-51 (2001).
-
Shito M, Balis UJ, Tompkins RG, Yarmush ML, Toner M. A fulminant hepatic failure model in the rat: involvement of interleukin-1beta and tumor necrosis factor-alpha.
Dig. Dis. Sci. 46: 1700-1708 (2001).
*
-
Shlomchik MJ, Craft JE, Mamula MJ. From T to B and back again: positive feedback in systemic autoimmune disease.
Nat. Rev. Immunol. 1: 147-153 (2001).
*
-
Shneider BL. Intestinal bile acid transport: biology, physiology, and pathophysiology.
J. Pediatr. Gastroenterol. Nutr. 32: 407-417 (2001).
*
-
Shoda J, Kano M, Oda K, Kamiya J, Nimura Y, Suzuki H, Sugiyama Y, Miyazaki H, Todoroki T, Stengelin S, Kramer W, Matsuzaki Y, Tanaka N. The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function.
Am. J. Gastroenterol. 96: 3368-3378 (2001).
*
-
Shomer NH, Dangler CA, Schrenzel MD, Whary MT, Xu S, Feng Y, Paster BJ, Dewhirst FE, Fox JG. Cholangiohepatitis and inflammatory bowel disease induced by a novel urease-negative Helicobacter species in A/J and Tac:ICR:HascidfRF mice.
Exp. Biol. Med. (Maywood) 226: 420-428 (2001).
*
-
Shrestha R, Lasch H. Endoscopic therapy for biliary tract disease before orthotopic liver transplantation.
Gastrointest. Endosc. Clin. N. Am. 11: 45-64 (2001).
-
Shtoyerman-Chen R, Friedman E, Figer A, Carmel M, Patael Y, Rath P, Fidder HH, Bar-Meir S, Theodor L. The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect.
Genet. Test. 5: 141-146 (2001).
-
Shulenin S, Schriml LM, Remaley AT, Fojo S, Brewer B, Allikmets R, Dean M. An ATP-binding cassette gene (ABCG5) from the ABCG (White) gene subfamily maps to human chromosome 2p21 in the region of the Sitosterolemia locus.
Cytogenet. Cell. Genet. 92: 204-208 (2001).
-
Sicilia B, Lopez Miguel C, Arribas F, Lopez Zaborras J, Sierra E, Gomollon F. Environmental risk factors and Crohn's disease: a population-based, case-control study in Spain.
Dig. Liver Dis. 33: 762-767 (2001).
-
Siddiqi SA, Kumar NS, Nutting DF, Mansbach II CM. Nutrient absorption.
Curr. Opin. Gastroenterol. 17: 110-117 (2001).
-
Siegel JH. Has the endoscopic treatment of sclerosing cholangitis been rediscovered? Not likely, just old news recycled.
Gastrointest. Endosc. 54: 675-676 (2001).
-
Siegel MJ. Pediatric liver imaging.
Semin. Liver Dis. 21: 251-269 (2001).
-
Siegelman ES, Rosen MA. Imaging of hepatic steatosis.
Semin. Liver Dis. 21: 71-80 (2001).
-
Siegmund B, Fantuzzi G, Rieder F, Gamboni-Robertson F, Lehr HA, Hartmann G, Dinarello CA, Endres S, Eigler A. Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 281: R1264-R1273 (2001).
*
-
Siegmund D, Hausser A, Peters N, Scheurich P, Wajant H. Tumor necrosis factor (TNF) and phorbol ester induce TNF-related apoptosis-inducing ligand (TRAIL) under critical involvement of NF-kappa B essential modulator (NEMO)/IKKgamma.
J. Biol. Chem. 276: 43708-43712 (2001).
*
-
Sierra Santos L, Sendino Revuelta A, Pacheco Cuadros R, Aparicio Jabalquinto G, Barbado Hernandez FJ. Hashimoto's thyroiditis and Sjogren syndrome. Association or autoimmune multiple syndrome?
An. Med. Interna 18: 86-87 (2001).
-
Sieving PA, Chaudhry P, Kondo M, Provenzano M, Wu D, Carlson TJ, Bush RA, Thompson DA. Inhibition of the visual cycle in vivo by 13-cis retinoic acid protects from light damage and provides a mechanism for night blindness in isotretinoin therapy.
Proc. Natl. Acad. Sci. U.S.A. 98: 1835-1840 (2001).
*
-
Silva RF, Rodrigues CM, Brites D. Bilirubin-induced apoptosis in cultured rat neural cells is aggravated by chenodeoxycholic acid but prevented by ursodeoxycholic acid.
J. Hepatol. 34: 402-408 (2001).
*
-
Silveira ER, Naves MM, Vannucchi H, Jordao Junior AA, Dagli ML, Moreno FS. Vitamin A and all-trans and 9-cis retinoic acids inhibit cell proliferation during the progression phase of hepatocarcinogenesis in Wistar rats.
Nutr. Cancer 39: 244-251 (2001).
-
Silverberg MS, Clelland C, Murphy JE, Steinhart AH, McLeod RS, Greenberg GR, Cohen Z, Siminovitch KA. Carrier rate of APC I1307K is not increased in inflammatory bowel disease patients of Ashkenazi Jewish origin.
Hum. Genet. 108: 205-210 (2001).
*
-
Silverberg MS, Daly MJ, Moskovitz DN, Rioux JD, McLeod RS, Cohen Z, Greenberg GR, Hudson TJ, Siminovitch KA, Steinhart AH. Diagnostic misclassification reduces the ability to detect linkage in inflammatory bowel disease genetic studies.
Gut 49: 773-776 (2001).
*
-
Simmonds S, Mason D. Induction of autoimmune disease by depletion of regulatory T cells.
Curr. Protoc. Immunol. Chapter 15: Unit 15.12 (2001).
-
Simmons J. Crohn disease and ulcerative colitis.
ENCYCLOPEDIA OF LIFE SCIENCES Nature Publishing Group www.els.net (2001). *
-
Simms L, Steinhart AH. Budesonide for maintenance of remission in Crohn's disease.
Cochrane Database Syst. Rev. 1: CD002913 (2001).
*
-
Simon A, Dode C, van der Meer JW, Drenth JP. Familial periodic fever and amyloidosis due to a new mutation in the TNFRSF1A gene.
Am. J. Med. 110: 313-316 (2001).
*
-
Simon A, Drenth JP, van der Meer JW. From gene to disease; tumor necrosis factor receptor and a syndrome of familial periodic fever.
Ned. Tijdschr. Geneeskd. 145: 77-78 (2001).
-
Simon A, van Deuren M, Tighe PJ, van der Meer JW, Drenth JP. Genetic analysis as a valuable key to diagnosis and treatment of periodic fever.
Arch. Intern. Med. 161: 2491-2493 (2001).
*
-
Simoni D, Tolomeo M. Retinoids, apoptosis and cancer.
Curr. Pharm. Des. 7: 1823-1837 (2001).
-
Sinal CJ, Yoon M, Gonzalez FJ. Antagonism of the actions of peroxisome proliferator-activated receptor-alpha by bile acids.
J. Biol. Chem. 276: 47154-47162 (2001).
*
-
Singh AK, Wilson MT, Hong S, Olivares-Villagomez D, Du C, Stanic AK, Joyce S, Sriram S, Koezuka Y, Van Kaer L. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis.
J. Exp. Med. 194: 1801-1811 (2001).
*
-
Singh B, Powrie F, Mortensen NJ. Immune therapy in inflammatory bowel disease and models of colitis.
Br. J. Surg. 88: 1558-1569 (2001).
-
Singh SK, Mennone A, Gigliozzi A, Fraioli F, Boyer JL. Cl(-)-dependent secretory mechanisms in isolated rat bile duct epithelial units.
Am. J. Physiol. Gastrointest. Liver Physiol. 281: G438-G446 (2001).
*
-
Siordia-Reyes AG, Ferman-Cano F, Garcia GR, Rodriguez-Velasco A. Wilson disease. Report of a case of autopsy with copper tissue quantification and electronic microscopy.
Rev. Gastroenterol. Mex. 66: 38-41 (2001).
-
Siringo S, Piscaglia F, Zironi G, Sofia S, Gaiani S, Zammataro M, Bolondi L. Influence of esophageal varices and spontaneous portal-systemic shunts on postprandial splanchnic hemodynamics.
Am. J. Gastroenterol. 96: 550-556 (2001).
*
-
Siva C, Brasington RD. Worsening of arthritis with antiretroviral therapy: the coexistence of rheumatoid arthritis and human immunodeficiency virus infection revisited.
J. Clin. Rheumatol. 7: 42-46 (2001).
-
Skelly MM, James PD, Ryder SD. Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology.
J. Hepatol. 35: 195-199 (2001).
*
-
Slatkin M, Bertorelle G. The use of intraallelic variability for testing neutrality and estimating population growth rate.
Genetics 158: 865-874 (2001).
*
-
Smale S, Natt RS, Orchard TR, Russell AS, Bjarnason I. Inflammatory bowel disease and spondylarthropathy.
Arthritis Rheum. 44: 2728-2736 (2001).
*
-
Smart DE, Vincent KJ, Arthur MJ, Eickelberg O, Castellazzi M, Mann J, Mann DA. JunD regulates transcription of the tissue inhibitor of metalloproteinases-1 and interleukin-6 genes in activated hepatic stellate cells.
J. Biol. Chem. 276: 24414-24421 (2001).
*
-
Smeltz RB, Chen J, Hu-Li J, Shevach EM. Regulation of interleukin (IL)-18 receptor alpha chain expression on CD4(+) T cells during T helper (Th)1/Th2 differentiation. Critical downregulatory role of IL-4.
J. Exp. Med. 194: 143-153 (2001).
*
-
Smirlis D, Muangmoonchai R, Edwards M, Phillips IR, Shephard EA. Orphan receptor promiscuity in the induction of cytochromes p450 by xenobiotics.
J. Biol. Chem. 276: 12822-12826 (2001).
*
-
Smirnova I, Hamblin MT, McBride C, Beutler B, Di Rienzo A. Excess of rare amino acid polymorphisms in the Toll-like receptor 4 in humans.
Genetics 158: 1657-1664 (2001).
*
-
Smith KJ, Dipreta E, Skelton H. Peroxisomes in dermatology. Part II.
J. Cutan. Med. Surg. 5: 315-322 (2001).
*
-
Smith KJ, Dipreta E, Skelton H. Peroxisomes in dermatology. Part I.
J. Cutan. Med. Surg. 5: 231-243 (2001).
*
-
Smith PD, Smythies LE, Mosteller-Barnum M, Sibley DA, Russell MW, Merger M, Sellers MT, Orenstein JM, Shimada T, Graham MF, Kubagawa H. Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities.
J. Immunol. 167: 2651-2656 (2001).
*
-
Smith SC. Autoimmune myocarditis.
Curr. Protoc. Immunol. Chapter 15: Unit 15.14 (2001).
-
Smrzova J, Ulrichova J, Dite P, Lata J. Transplantation of hepatocytes - present status and future perspectives.
Vnitr. Lek. 47: 790-796 (2001).
-
Snijders A, Elferink DG, Geluk A, van Der Zanden AL, Vos K, Schreuder GM, Breedveld FC, de Vries RR, Zanelli EH. An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs.
J. Immunol. 166: 4987-4993 (2001).
*
-
Sninsky CA. Altering the natural history of Crohn's disease?
Inflamm. Bowel Dis. 7 Suppl. 1: S34-S39 (2001).
*
-
Sobesky R, Dusoleil A, Condat B, Bedossa P, Buffet C, Pelletier G. Azathioprine-induced destructive cholangitis.
Am. J. Gastroenterol. 96: 616-617 (2001).
*
-
Sohma Y, Gray MA, Imai Y, Argent BE. 150 mM HCO3(-) - how does the pancreas do it? Clues from computer modelling of the duct cell.
JOP 2: S198-S202 (2001).
*
-
Sohn MH, Hur MW, Kim DS. Interleukin 6 gene promoter polymorphism is not associated with Kawasaki disease.
Genes Immun. 2: 357-362 (2001).
*
-
Sokol RJ, Mack C. Etiopathogenesis of biliary atresia.
Semin. Liver Dis. 21: 517-624 (2001).
-
Sokol RJ, Straka MS, Dahl R, Devereaux MW, Yerushalmi B, Gumpricht E, Elkins N, Everson G. Role of oxidant stress in the permeability transition induced in rat hepatic mitochondria by hydrophobic bile acids.
Pediatr. Res. 49: 519-531 (2001).
*
-
Soleimani M. Impaired pancreatic ductal bicarbonate secretion in cystic fibrosis.
JOP 2: S237-S242 (2001).
*
-
Soleimani M, Burnham CE. Na+:HCO(3-) cotransporters (NBC): cloning and characterization.
J. Membr. Biol. 183: 71-84 (2001).
*
-
Sollid LM, Lundin KE. Coeliac disease. An inappropriate immune response.
Lancet 358 Suppl.: S13 (2001).
*
-
Sollid LM, McAdam SN, Molberg O, Quarsten H, Arentz-Hansen H, Louka AS, Lundin KE. Genes and environment in celiac disease.
Acta Odontol. Scand. 59: 183-186 (2001).
-
Solnick JV, Schauer DB. Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases.
Clin. Microbiol. Rev. 14: 59-97 (2001).
*
-
Solomon C, Kremer R, White JH, Rhim JS. Vitamin D resistance in RAS-transformed keratinocytes: mechanism and reversal strategies.
Radiat. Res. 155: 156-162 (2001).
-
Solomon C, Macoritto M, Gao XL, White JH, Kremer R. The unique tryptophan residue of the vitamin D receptor is critical for ligand binding and transcriptional activation.
J. Bone Miner. Res. 16: 39-45 (2001).
-
Song CS, Echchgadda I, Baek BS, Ahn SC, Oh T, Roy AK, Chatterjee B. Dehydroepiandrosterone sulfotransferase gene induction by bile acid activated farnesoid X receptor.
J. Biol. Chem. 276: 42549-42556 (2001).
*
-
Song F, Whitacre CC. The role of the gut lymphoid tissue in induction of oral tolerance.
Curr. Opin. Investig. Drugs 2: 1382-1386 (2001).
-
Soroka CJ, Lee JM, Azzaroli F, Boyer JL. Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver.
Hepatology 33: 783-791 (2001).
*
-
Sparks AB, Peterson SN, Bell C, Loftus BJ, Hocking L, Cahill DP, Frassica FJ, Streeten EA, Levine MA, Fraser CM, Adams MD, Broder S, Venter JC, Kinzler KW, Vogelstein B, Ralston SH. Mutation screening of the TNFRSF11A gene encoding receptor activator of NF kappa B (RANK) in familial and sporadic Paget's disease of bone and osteosarcoma.
Calcif. Tissue Int. 68: 151-155 (2001).
-
Spengler U. Unravelling complexity - the scientific basis of genetic predisposition in autoimmune liver disease.
J. Hepatol. 35: 127-129 (2001).
*
-
Spiller RC. Effects of serotonin on intestinal secretion and motility.
Curr. Opin. Gastroenterol. 17: 99-103 (2001).
-
Spinzi G, Belloni G, Martegani A, Sangiovanni A, Del Favero C, Minoli G. Computed tomographic colonography and conventional colonoscopy for colon diseases: a prospective, blinded study.
Am. J. Gastroenterol. 96: 394-400 (2001).
*
-
Spirli C, Nathanson MH, Fiorotto R, Duner E, Denson LA, Sanz JM, Di Virgilio F, Okolicsanyi L, Casagrande F, Strazzabosco M. Proinflammatory cytokines inhibit secretion in rat bile duct epithelium.
Gastroenterology 121: 156-169 (2001).
*
-
Sporn MB, Suh N, Mangelsdorf DJ. Prospects for prevention and treatment of cancer with selective PPARgamma modulators (SPARMs).
Trends Mol. Med. 7: 395-400 (2001).
*
-
Spray C, Debelle GD, Murphy MS. Current diagnosis, management and morbidity in paediatric inflammatory bowel disease.
Acta Paediatr. 90: 400-405 (2001).
-
Spycher C, Zimmermann A, Reichen J. The diagnostic value of liver biopsy.
BMC Gastroenterol. 1: 12 (2001).
*
-
Squires RH. End-stage liver disease in children.
Curr. Treat. Options Gastroenterol. 4: 409-421 (2001).
-
Srikrishna G, Toomre DK, Manzi A, Panneerselvam K, Freeze HH, Varki A, Varki NM. A novel anionic modification of N-glycans on mammalian endothelial cells is recognized by activated neutrophils and modulates acute inflammatory responses.
J. Immunol. 166: 624-632 (2001).
*
-
St-Pierre MV, Kullak-Ublick GA, Hagenbuch B, Meier PJ. Transport of bile acids in hepatic and non-hepatic tissues.
J. Exp. Biol. 204: 1673-1686 (2001).
*
-
Stack E, DuBois RN. Role of cyclooxygenase inhibitors for the prevention of colorectal cancer.
Gastroenterol. Clin. North Am. 30: 1001-1010 (2001).
-
Stamper CC, Zhang Y, Tobin JF, Erbe DV, Ikemizu S, Davis SJ, Stahl ML, Seehra J, Somers WS, Mosyak L. Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses.
Nature 410: 608-611 (2001).
*
-
Stanca C, Jung D, Meier PJ, Kullak-Ublick GA. Hepatocellular transport proteins and their role in liver disease.
World J. Gastroenterol. 7: 157-169 (2001).
*
-
Stange EF, Riemann J, von Herbay A, Lochs H, Fleig WE, Scholmerich J, Kruis W, Porschen R, Bruch HP, Zeitz M, Schreiber S, Moser G, Matthes H, Selbmann HK, Goebell H, Caspary WF. Diagnosis and therapy of ulcerative colitis - results of an evidence-based consensus conference of the German Society of Digestive and Metabolic Diseases.
Z. Gastroenterol. 39: 19-20 (2001).
-
Stange J, Mitzner S, Klammt S, Peszynski P, Freytag J, Hickstein H, Korten G, Lohr M, Emmrich J, Liebe S, Schmidt R, Heemann U, Loock J, Philipp T, Treichel U, Gerken G. Removal of albumin bound toxins by albumin dialysis improves clinical course of liver cirrhosis complicated by severe cholestasis.
Z. Gastroenterol. 39 (Suppl. 2): 44 (2001).
-
Starnes T, Robertson MJ, Sledge G, Kelich S, Nakshatri H, Broxmeyer HE, Hromas R. Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production.
J. Immunol. 167: 4137-4140 (2001).
*
-
Starzl TE, Zinkernagel RM. Transplantation tolerance from a historical perspective.
Nat. Rev. Immunol. 1: 233-239 (2001).
*
-
Stasi R, Pagano A, Stipa E, Amadori S. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.
Blood 98: 952-957 (2001).
*
-
Staudinger J, Liu Y, Madan A, Habeebu S, Klaassen CD. Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor.
Drug Metab. Dispos. 29: 1467-1472 (2001).
*
-
Staudinger JL, Goodwin B, Jones SA, Hawkins-Brown D, MacKenzie KI, LaTour A, Liu Y, Klaassen CD, Brown KK, Reinhard J, Willson TM, Koller BH, Kliewer SA. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity.
Proc. Natl. Acad. Sci. U.S.A. 98: 3369-3374 (2001).
*
-
Stauffer Y, Marguerat S, Meylan F, Ucla C, Sutkowski N, Huber B, Pelet T, Conrad B. Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity.
Immunity 15: 591-601 (2001).
*
-
Steele BW, Wu NC, Whitcomb C. White blood cell and platelet counting performance by hematology analyzers: a critical evaluation.
Laboratory Hematology 7: 255-266 (2001). *
-
Stehlin C, Wurtz JM, Steinmetz A, Greiner E, Schule R, Moras D, Renaud JP. X-ray structure of the orphan nuclear receptor RORbeta ligand-binding domain in the active conformation.
EMBO J. 20: 5822-5831 (2001).
*
-
Steidler L. Microbiological and immunological strategies for treatment of inflammatory bowel disease.
Microbes Infect. 3: 1157-1166 (2001).
*
-
Steinhart H. Clinical perspectives - biologics in IBD: what's all the fuss?
Can. J. Gastroenterol. 15: 799-804 (2001).
*
-
Steinle A, Li P, Morris DL, Groh V, Lanier LL, Strong RK, Spies T. Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family.
Immunogenetics 53: 279-287 (2001).
-
Steinman RM. Dendritic cells and the control of immunity: enhancing the efficiency of antigen presentation.
Mt. Sinai J. Med. 68: 106-166 (2001).
*
-
Stelzner M, Somasundaram S, Lee SP, Kuver R. Ileal mucosal bile acid absorption is increased in Cftr knockout mice.
BMC Gastroenterol. 1: 10 (2001).
*
-
Stenson WF. Mechanisms of tissue protection and repair in inflammatory bowel disease.
Curr. Opin. Gastroenterol. 17: 313-317 (2001).
-
Stephens HA. MICA and MICB genes: can the enigma of their polymorphism be resolved?
Trends Immunol. 22: 378-385 (2001).
*
-
Stephensen CB. Vitamin A, infection, and immune function.
Annu. Rev. Nutr. 21: 167-192 (2001).
*
-
Stevceva L, Pavli P, Husband A, Ramsay A, Doe WF. Dextran sulphate sodium-induced colitis is ameliorated in interleukin 4 deficient mice.
Genes Immun. 2: 309-316 (2001).
*
-
Stevens A, Ray DW, Worthington J, Davis JR. Polymorphisms of the human prolactin gene - implications for production of lymphocyte prolactin and systemic lupus erythematosus.
Lupus 10: 676-683 (2001).
-
Stewart CJ, Mills PR, Carter R, O'Donohue J, Fullarton G, Imrie CW, Murray WR. Brush cytology in the assessment of pancreatico-biliary strictures: a review of 406 cases.
J. Clin. Pathol. 54: 449-455 (2001).
*
-
Stickel F, Seitz HK, Hahn EG, Schuppan D. Liver toxicity of drugs of plant origin.
Z. Gastroenterol. 39: 225-232, 234-237 (2001).
-
Stieger B. FIC1: another bile salt carrier within the enterohepatic circulation?
J. Hepatol. 35: 522-524 (2001).
*
-
Stio M, Bonanomi AG, d'Albasio G, Treves C. Suppressive effect of 1,25-dihydroxyvitamin D3 and its analogues EB 1089 and KH 1060 on T lymphocyte proliferation in active ulcerative colitis.
Biochem. Pharmacol. 61: 365-371 (2001).
*
-
Stoll SW, Chia NV, Nair RP, Woods TL, Stuart P, Henseler T, Jenisch S, Christophers E, Voorhees JJ, Elder JT. S100A2 coding sequence polymorphism: characterization and lack of association with psoriasis.
Clin. Exp. Dermatol. 26: 79-83 (2001).
-
Stover C, Endo Y, Takahashi M, Lynch NJ, Constantinescu C, Vorup-Jensen T, Thiel S, Friedl H, Hankeln T, Hall R, Gregory S, Fujita T, Schwaeble W. The human gene for mannan-binding lectin-associated serine protease-2 (MASP-2), the effector component of the lectin route of complement activation, is part of a tightly linked gene cluster on chromosome 1p36.2-3.
Genes Immun. 2: 119-127 (2001).
*
-
Strandvik B, Gronowitz E, Enlund F, Martinsson T, Wahlstrom J. Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis.
J. Pediatr. 139: 650-655 (2001).
*
-
Stricker T, Braegger CP. More questions about growth hormone in Crohn disease.
J. Pediatr. Gastroenterol. Nutr. 33: 353-354 (2001).
*
-
Sturniolo GC, Di Leo V, Ferronato A, D'Odorico A, D'Inca R. Zinc supplementation tightens "leaky gut" in Crohn's disease.
Inflamm. Bowel Dis. 7: 94-98 (2001).
*
-
Su CG, Judge TA, Lichtenstein GR. The role of biological therapy in inflammatory bowel disease.
Drugs Today (Barc.) 37: 121-133 (2001).
-
Su CG, Lewis JD. Antineoplastic and anti-inflammatory effects of PPAR ligands in colitis.
Gastroenterology 121: 1019-1021 (2001).
*
-
Suarez AA, Brunt EM, Di Bisceglie AM. A 35-year-old woman with progesterone implant contraception and multiple liver masses.
Semin. Liver Dis. 21: 453-459 (2001).
-
Sueyoshi T, Negishi M. Phenobarbital response elements of cytochrome P450 genes and nuclear receptors.
Annu. Rev. Pharmacol. Toxicol. 41: 123-143 (2001).
*
-
Sugawara Y, Makuuchi M, Takayama T, Imamura H. Living-related liver transplantation for primary biliary cirrhosis.
Transplantation 72: 1087-1091 (2001).
-
Sugimura K, Ota M, Matsuzawa J, Katsuyama Y, Ishizuka K, Mochizuki T, Mizuki N, Seki SS, Honma T, Inoko H, Asakura H. A close relationship of triplet repeat polymorphism in MHC class I chain-related gene A (MICA) to the disease susceptibility and behavior in ulcerative colitis.
Tissue Antigens 57: 9-14 (2001).
*
-
Suh JR, Herbig AK, Stover PJ. New perspectives on folate catabolism.
Annu. Rev. Nutr. 21: 255-282 (2001).
*
-
Summerfield JA. Liver failure.
ENCYCLOPEDIA OF LIFE SCIENCES Nature Publishing Group www.els.net (2001). *
-
Sun AQ, Swaby I, Xu S, Suchy FJ. Cell-specific basolateral membrane sorting of the human liver Na(+)-dependent bile acid cotransporter.
Am. J. Physiol. Gastrointest. Liver Physiol. 280: G1305-1G133 (2001).
*
-
Sunagawa T, Yonamine Y, Kinjo F, Watanabe M, Hibi T, Saito A. HLA class-I-restricted and colon-specific cytotoxic T cells from lamina propria lymphocytes of patients with ulcerative colitis.
J. Clin. Immunol. 21: 381-389 (2001).
*
-
Sund NJ, Vatamaniuk MZ, Casey M, Ang SL, Magnuson MA, Stoffers DA, Matschinsky FM, Kaestner KH. Tissue-specific deletion of Foxa2 in pancreatic beta cells results in hyperinsulinemic hypoglycemia.
Genes Dev. 15: 1706-1715 (2001).
*
-
Suri-Payer E, Cantor H. Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4(+)CD25(+) T cells.
J. Autoimmun. 16: 115-123 (2001).
-
Suri-Payer E, Wei K, Tung K. The day-3 thymectomy model for induction of multiple organ-specific autoimmune diseases.
Curr. Protoc. Immunol. Chapter 15: Unit 15.16 (2001).
-
Susick R, Moss N, Kubota H, Lecluyse E, Hamilton G, Luntz T, Ludlow J, Fair J, Gerber D, Bergstrand K, White J, Bruce A, Drury O, Gupta S, Reid LM. Hepatic progenitors and strategies for liver cell therapies.
Ann. N. Y. Acad. Sci. 944: 398-419 (2001).
*
-
Susset MA, Kunz A, Sczepanski B, Littmann M, Blank W, Braun B. Autoimmune pancreatitis (AIMP) - a clinical entity of its own?
Dtsch. Med. Wochenschr. 126: 1294-1298 (2001).
-
Sutherland LR. Budesonide: is no evidence of a difference the same as evidence of no difference?
Inflamm. Bowel Dis. 7: 58-59 (2001).
*
-
Sutkowski N, Conrad B, Thorley-Lawson DA, Huber BT. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen.
Immunity 15: 579-589 (2001).
*
-
Suwannaroj S, Lagoo A, McMurray RW. Suppression of renal disease and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE) by chenodeoxycholic acid.
Lupus 10: 562-567 (2001).
*
-
Suwannaroj S, Mootsikapun P, Vipulakorn K, Nanagara R. Salmonella group D septic arthritis and necrotizing fasciitis in a patient with rheumatoid arthritis and diabetes mellitus.
J. Clin. Rheumatol. 7: 83-85 (2001).
-
Suzuki A, Hanada T, Mitsuyama K, Yoshida T, Kamizono S, Hoshino T, Kubo M, Yamashita A, Okabe M, Takeda K, Akira S, Matsumoto S, Toyonaga A, Sata M, Yoshimura A. CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation.
J. Exp. Med. 193: 471-481 (2001).
*
-
Suzuki K. Neutrophil functions of patients with vasculitis related to myeloperoxidase-specific anti-neutrophil antibody.
Int. J. Hematol. 74: 134-143 (2001).
-
Suzuki S, Kuwana M, Yasuoka H, Tanaka K, Fukuuchi Y, Kawakami Y. Heterogeneous immunogenetic background in Japanese adults with myasthenia gravis.
J. Neurol. Sci. 189: 59-64 (2001).
-
Swain MG. Cytokines and neuroendocrine dysregulation in obstructive cholestasis: pathophysiological implications.
J. Hepatol. 35: 416-418 (2001).
*
-
Swanborg RH, Stepaniak JA. Experimental autoimmune encephalomyelitis in the rat.
Curr. Protoc. Immunol. Chapter 15: Unit 15.2 (2001).
-
Synold TW, Dussault I, Forman BM. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux.
Nat. Med. 7: 584-590 (2001).
*
-
Szalay F. Treatment of primary biliary cirrhosis.
J. Physiol. Paris 95: 407-412 (2001).
-
Tagoe C, Shah A, Yee H, Belmont HM. Aplastic anemia in systemic lupus erythematosus: a distinct presentation of acquired aplastic anemia?
J. Clin. Rheumatol. 7: 377-383 (2001).
-
Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases.
J. Clin. Invest. 107: 7-11 (2001).
*
-
Takahashi K, Aono T, Shichinohe M, Tamura M, Iwata Y, Yamanishi K, Shigeta S. Herpesvirus DNA in peripheral blood mononuclear cells of some patients with Meniere's disease.
Microbiol. Immunol. 45: 635-638 (2001).
*
-
Takahashi M, Haro H, Wakabayashi Y, Kawa-uchi T, Komori H, Shinomiya K. The association of degeneration of the intervertebral disc with 5A/6A polymorphism in the promoter of the human matrix metalloproteinase-3 gene.
J. Bone Joint Surg. Br. 83: 491-495 (2001).
-
Takahashi N, Kawada T. Physiological and pharmacological function of PPARs.
Nippon Yakurigaku Zasshi 117: 319-327 (2001).
-
Takahashi T, Honma T, Ishizuka K, Fuse I, Asakura H. A female with asymptomatic primary biliary cirrhosis associated with pernicious anemia.
J. Gastroenterol. Hepatol. 16: 1420-1424 (2001).
*
-
Takeda K, Akira S. Roles of Toll-like receptors in innate immune responses.
Genes Cells 6: 733-742 (2001).
*
-
Takeda Y, Nakao K, Nakata K, Kawakami A, Ida H, Ichikawa T, Shigeno M, Kajiya Y, Hamasaki K, Kato Y, Eguchi K. Geranylgeraniol, an intermediate product in mevalonate pathway, induces apoptotic cell death in human hepatoma cells: death receptor-independent activation of caspase-8 with down-regulation of Bcl-xL expression.
Jpn. J. Cancer Res. 92: 918-925 (2001).
*
-
Takei Y, Sawada T, Sameshima S, Nagasako K. Post-genome challenges against inflammatory bowel diseases.
Nippon Rinsho 59: 180-184 (2001).
-
Takeshita A, Koibuchi N, Oka J, Taguchi M, Shishiba Y, Ozawa Y. Bisphenol-A, an environmental estrogen, activates the human orphan nuclear receptor, steroid and xenobiotic receptor-mediated transcription.
Eur. J. Endocrinol. 145: 513-517 (2001).
*
-
Takeuchi O, Akira S. Toll-like receptors; their physiological role and signal transduction system.
Int. Immunopharmacol. 1: 625-635 (2001).
-
Takeuchi T, Nakagawa T, Maeda Y, Hirano S, Sasaki-Hayashi M, Makino S, Shimizu A. Functional defect of B lymphocytes in a patient with selective IgM deficiency associated with systemic lupus erythematosus.
Autoimmunity 34: 115-122 (2001).
-
Talwalkar JA, Kamath PS. Screening for esophageal varices among patients with cirrhosis of the liver.
Am. J. Gastroenterol. 96: 3039-3040 (2001).
*
-
Talwalkar JA, Lindor KD. Natural history and prognostic models in primary sclerosing cholangitis.
Best Pract. Res. Clin. Gastroenterol. 15: 563-575 (2001).
*
-
Tammur J, Prades C, Arnould I, Rzhetsky A, Hutchinson A, Adachi M, Schuetz JD, Swoboda KJ, Ptacek LJ, Rosier M, Dean M, Allikmets R. Two new genes from the human ATP-binding cassette transporter superfamily, ABCC11 and ABCC12, tandemly duplicated on chromosome 16q12.
Gene 273: 89-96 (2001).
*
-
Tan FK, Wang N, Kuwana M, Chakraborty R, Bona CA, Milewicz DM, Arnett FC. Association of fibrillin 1 single-nucleotide polymorphism haplotypes with systemic sclerosis in Choctaw and Japanese populations.
Arthritis Rheum. 44: 893-901 (2001).
*
-
Tan MH, Gordon M, Lebwohl O, George J, Lebwohl MG. Improvement of pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody.
Arch. Dermatol. 137: 930-933 (2001).
*
-
Tanaka A, Borchers AT, Ishibashi H, Ansari AA, Keen CL, Gershwin ME. Genetic and familial considerations of primary biliary cirrhosis.
Am. J. Gastroenterol. 96: 8-15 (2001).
*
-
Tanaka A, Igarashi M, Kakinuma M, Oh-i T, Koga M, Okuda T. The occurrence of various collagen diseases in one family: a sister with ISSc, PBC, APS, and SS and a brother with systemic lupus erythematosus.
J. Dermatol. 28: 547-653 (2001).
-
Tanaka A, Leung PS, Kenny TP, Au-Young J, Prindiville T, Coppel RL, Ansari AA, Gershwin ME. Genomic analysis of differentially expressed genes in liver and biliary epithelial cells of patients with primary biliary cirrhosis.
J. Autoimmun. 17: 89-98 (2001).
*
-
Tanaka T, Kohno H, Yoshitani S, Takashima S, Okumura A, Murakami A, Hosokawa M. Ligands for peroxisome proliferator-activated receptors alpha and gamma inhibit chemically induced colitis and formation of aberrant crypt foci in rats.
Cancer Res. 61: 2424-2428 (2001).
*
-
Tanaka Y, Koshiyama H, Nakao K, Makita Y, Kobayashi Y, Yoshida Y, Kimura M, Adachi Y. Rapid progress of acute suppurative cholangitis to secondary sclerosing cholangitis sequentially followed-up by endoscopic retrograde cholangiography.
Endoscopy 33: 633-635 (2001).
-
Taniguchi M, Geng X, Glazier KD, Dasgupta A, Lin JJ, Das KM. Cellular immune response against tropomyosin isoform 5 in ulcerative colitis.
Clin. Immunol. 101: 289-295 (2001).
*
-
Taniguchi T, Ogasawara K, Takaoka A, Tanaka N. IRF family of transcription factors as regulators of host defense.
Annu. Rev. Immunol. 19: 623-655 (2001).
*
-
Tannapfel A, Wittekind C. Anatomy and pathology of intrahepatic and extrahepatic bile duct tumors.
Pathologe 22: 114-123 (2001).
-
Tanskanen A, Hibbeln JR, Tuomilehto J, Uutela A, Haukkala A, Viinamaki H, Lehtonen J, Vartiainen E. Fish consumption and depressive symptoms in the general population in Finland.
Psychiatr. Serv. 52: 529-531 (2001).
-
Tao Y, Williams-Skipp C, Scheinman RI. Mapping of glucocorticoid receptor DNA binding domain surfaces contributing to transrepression of NF-kappa B and induction of apoptosis.
J. Biol. Chem. 276: 2329-2332 (2001).
*
-
Tarassishin L, Horwitz MS. Sites on FIP-3 (NEMO/IKKgamma) essential for its phosphorylation and NF-kappaB modulating activity.
Biochem. Biophys. Res. Commun. 285: 555-560 (2001).
*
-
Tashiro M, Schafer C, Yao H, Ernst SA, Williams JA. Arginine induced acute pancreatitis alters the actin cytoskeleton and increases heat shock protein expression in rat pancreatic acinar cells.
Gut 49: 241-250 (2001).
*
-
Tavill AS. Diagnosis and management of hemochromatosis.
Hepatology 33: 1321-1328 (2001).
*
-
Taylor KD, Plevy SE, Yang H, Landers CJ, Barry MJ, Rotter JI, Targan SR. ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease.
Gastroenterology 120: 1347-1355 (2001).
*
-
Taylor-Robinson SD, Toledano MB, Arora S, Keegan TJ, Hargreaves S, Beck A, Khan SA, Elliott P, Thomas HC. Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998.
Gut 48: 816-820 (2001).
*
-
Tazuma S, Chayama K. Hepatic hydroxylation of bile acids and chronic liver diseases: do transporters play a mechanistic role?
J. Gastroenterol. Hepatol. 16: 1313-1315 (2001).
*
-
Teich N, Keim V. Pathogenetic concepts of chronic pancreatitis.
Zentralbl. Chir. 126: 884-888 (2001).
-
Teitelbaum DH, Tracy T. Parenteral nutrition-associated cholestasis.
Semin. Pediatr. Surg. 10: 72-80 (2001).
-
Teller IC, Beaulieu JF. Interactions between laminin and epithelial cells in intestinal health and disease.
Expert Rev. Mol. Med. 3: 1-18 (2001).
*
-
Tennyson H, Levine N. Neurotropic and psychotropic drugs in dermatology.
Dermatol. Clin. 19: 179-197, x (2001).
-
Terjung B, Worman HJ. Anti-neutrophil antibodies in primary sclerosing cholangitis.
Best Pract. Res. Clin. Gastroenterol. 15: 629-642 (2001).
*
-
Terjung B, Worman HJ, Herzog V, Sauerbruch T, Spengler U. Differentiation of antineutrophil nuclear antibodies in inflammatory bowel and autoimmune liver diseases from antineutrophil cytoplasmic antibodies (p-ANCA) using immunofluorescence microscopy.
Clin. Exp. Immunol. 126: 37-46 (2001).
*
-
Terry P, Bergkvist L, Holmberg L, Wolk A. Coffee consumption and risk of colorectal cancer in a population based prospective cohort of Swedish women.
Gut 49: 87-90 (2001).
*
-
Terry P, Bergkvist L, Holmberg L, Wolk A. No association between fat and fatty acids intake and risk of colorectal cancer.
Cancer Epidemiol. Biomarkers Prev. 10: 913-914 (2001).
*
-
Terry SF, Boyd CD. Researching the biology of PXE: partnering in the process.
Am. J. Med. Genet. 106: 177-184 (2001).
-
Terry SF, Terry PF. A consumer perspective on informed consent and third-party issues.
J. Contin. Educ. Health Prof. 21: 256-264 (2001).
-
Tew MB, Reveille JD, Arnett FC, Friedman AW, McNearney T, Fischbach M, Ahn C, Tan FK. Glutathione S-transferase genotypes in systemic sclerosis and their association with clinical manifestations in early disease.
Genes Immun. 2: 236-238 (2001).
*
-
Theil DJ, Tsunoda I, Rodriguez F, Whitton JL, Fujinami RS. Viruses can silently prime for and trigger central nervous system autoimmune disease.
J. Neurovirol. 7: 220-227 (2001).
-
Thies F, Nebe-von-Caron G, Powell JR, Yaqoob P, Newsholme EA, Calder PC. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
Am. J. Clin. Nutr. 73: 539-548 (2001).
*
-
Thimme R, Chang KM, Pemberton J, Sette A, Chisari FV. Degenerate immunogenicity of an HLA-A2-restricted hepatitis B virus nucleocapsid cytotoxic T-lymphocyte epitope that is also presented by HLA-B51.
J. Virol. 75: 3984-3987 (2001).
*
-
Thomas SR, Salahifar H, Mashima R, Hunt NH, Richardson DR, Stocker R. Antioxidants inhibit indoleamine 2,3-dioxygenase in IFN-gamma-activated human macrophages: posttranslational regulation by pyrrolidine dithiocarbamate.
J. Immunol. 166: 6332-6340 (2001).
*
-
Thome M, Tschopp J. Regulation of lymphocyte proliferation and death by FLIP.
Nat. Rev. Immunol. 1: 50-58 (2001).
-
Thompson CL, Blaner WS, Van Gelder RN, Lai K, Quadro L, Colantuoni V, Gottesman ME, Sancar A. Preservation of light signaling to the suprachiasmatic nucleus in vitamin A-deficient mice.
Proc. Natl. Acad. Sci. U.S.A. 98: 11708-11713 (2001).
*
-
Thompson PD, Remus LS, Hsieh JC, Jurutka PW, Whitfield GK, Galligan MA, Encinas Dominguez C, Haussler CA, Haussler MR. Distinct retinoid X receptor activation function-2 residues mediate transactivation in homodimeric and vitamin D receptor heterodimeric contexts.
J. Mol. Endocrinol. 27: 211-227 (2001).
*
-
Thompson R, Strautnieks S. BSEP: function and role in progressive familial intrahepatic cholestasis.
Semin. Liver Dis. 21: 545-550 (2001).
*
-
Thorley-Lawson DA. Epstein-Barr virus: exploiting the immune system.
Nat. Rev. Immunol. 1: 75-82 (2001).
*
-
Thornorisdottir A, Sigurethsson JR, Erlendsdottir H, Einarsson I, Guethmundsson S, Gunnarson E, Harethardottir I, Haraldsson A. The effect of dietary fish oil on bacterial growth in vivo.
Laeknabladid. 87: 715-718 (2001).
-
Thummel KE, Brimer C, Yasuda K, Thottassery J, Senn T, Lin Y, Ishizuka H, Kharasch E, Schuetz J, Schuetz E. Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3.
Mol. Pharmacol. 60: 1399-1406 (2001).
*
-
Tian W, Boggs DA, Ding WZ, Chen DF, Fraser PA. MICA genetic polymorphism and linkage disequilibrium with HLA-B in 29 African-American families.
Immunogenetics 53: 724-728 (2001).
-
Tibble J, Sigthorsson G, Foster R, Sherwood R, Fagerhol M, Bjarnason I. Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma.
Gut 49: 402-408 (2001).
*
-
Tinley ST. Colon cancer in women.
AWHONN Lifelines 5: 26-32 (2001).
*
-
Tokuyama H, Tokuyama Y. Class switch recombination signals induce lymphocyte-derived Spo11 expression and Spo11 antisense oligonucleotide inhibits class switching.
Cell. Immunol. 211: 123-130 (2001).
*
-
Tomaselli KJ. Modulation of apoptosis as a therapeutic strategy.
Scientific World Journal 1 (1 Suppl. 3): 104 (2001).
-
Tombazzi CR, Riely CA. Liver disease in cystic fibrosis.
Rev. Med. Chil. 129: 1071-1078 (2001).
-
Tomer Y. Unraveling the genetic susceptibility to autoimmune thyroid diseases: CTLA-4 takes the stage.
Thyroid 11: 167-169 (2001).
-
Tomer Y, Greenberg DA, Barbesino G, Concepcion E, Davies TF. CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production.
J. Clin. Endocrinol. Metab. 86: 1687-1693 (2001).
*
-
Toms C, Powrie F. Control of intestinal inflammation by regulatory T cells.
Microbes Infect. 3: 929-935 (2001).
*
-
Torigian DA, Levine MS, Gill NS, Rubesin SE, Fogt F, Schultz CF, Furth EE, Laufer I. Lymphoid hyperplasia of the stomach: radiographic findings in five adult patients.
AJR Am. J. Roentgenol. 177: 71-75 (2001).
*
-
Torok N, Gores GJ. Cholangiocarcinoma.
Semin. Gastrointest. Dis. 12: 125-132 (2001).
-
Torres EA, Acosta H, Cruz M, Weinstock J, Hillyer GV. Seroprevalence of Schistosoma mansoni in Puerto Ricans with inflammatory bowel disease.
P. R. Health Sci. J. 20: 211-214 (2001).
-
Toskes PP. Alcohol consumption and chronic pancreatitis.
Mayo Clin. Proc. 76: 241 (2001).
*
-
Toyoda M, Morohashi M. Pathogenesis of acne.
Med. Electron Microsc. 34: 29-40 (2001).
*
-
Trajkovic V, Stosic-Grujicic S, Samardzic T, Markovic M, Miljkovic D, Ramic Z, Mostarica Stojkovic M. Interleukin-17 stimulates inducible nitric oxide synthase activation in rodent astrocytes.
J. Neuroimmunol. 119: 183-191 (2001).
-
Trauner M, Boyer JL. Cholestatic syndromes.
Curr. Opin. Gastroenterol. 17: 242-256 (2001).
-
Trauner M, Fickert P, Zollner G. Genetic disorders and molecular mechanisms in cholestatic liver disease - a clinical approach.
Semin. Gastrointest. Dis. 12: 66-88 (2001).
-
Trauner M, Fickert P, Zollner G. Abnormal hepatic sinusoidal bile acid transport: new insights into the pathogenesis of cholestasis?
Gastroenterology 120: 321-323 (2001).
*
-
Travis SP, Czajkowski M, McGovern DP, Watson RG, Bell AL. Treatment of intestinal Behcet's syndrome with chimeric tumour necrosis factor alpha antibody.
Gut 49: 725-728 (2001).
*
-
Triboulot C, Hichami A, Denys A, Khan NA. Dietary (n-3) polyunsaturated fatty acids exert antihypertensive effects by modulating calcium signaling in T cells of rats.
J. Nutr. 131: 2364-2369 (2001).
*
-
Trimarchi HM, Iotti A, Iotti R, Freixas EA, Peters R. Immunoglobulin A nephropathy and ulcerative colitis. A focus on their pathogenesis.
Am. J. Nephrol. 21: 400-405 (2001).
-
Trotter JF. Cancer surveillance following orthotopic liver transplantation.
Gastrointest. Endosc. Clin. N. Am. 11: 199-214 (2001).
-
Trotter JF, Talamantes M, McClure M, Wachs M, Bak T, Trouillot T, Kugelmas M, Everson GT, Kam I. Right hepatic lobe donation for living donor liver transplantation: impact on donor quality of life.
Liver Transpl. 7: 485-493 (2001).
*
-
Trotter JF, Wachs M, Bak T, Trouillot T, Stolpman N, Everson GT, Kam I. Liver transplantation using sirolimus and minimal corticosteroids (3-day taper).
Liver Transpl. 7: 343-351 (2001).
*
-
Trotter JF, Wachs ME, Trouillot TE, Bak T, Kugelmas M, Kam I, Everson G. Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimus.
Liver Transpl. 7: 401-408 (2001).
*
-
Trowsdale J, Barten R, Haude A, Stewart CA, Beck S, Wilson MJ. The genomic context of natural killer receptor extended gene families.
Immunol. Rev. 181: 20-38 (2001).
*
-
Truninger K, Ammann RW, Blum HE, Witt H. Genetic aspects of chronic pancreatitis: insights into aetiopathogenesis and clinical implications.
Swiss Med. Wkly. 131: 565-574 (2001).
*
-
Truninger K, Malik N, Ammann RW, Muellhaupt B, Seifert B, Muller HJ, Blum HE. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis.
Am. J. Gastroenterol. 96: 2657-2661 (2001).
*
-
Tryggvason K, Romert A, Eriksson U. Biosynthesis of 9-cis-retinoic acid in vivo. The roles of different retinol dehydrogenases and a structure-activity analysis of microsomal retinol dehydrogenases.
J. Biol. Chem. 276: 19253-19258 (2001).
*
-
Tsai SM, Lee KT, Tsai LY. Effects of S-adenosyl-L-methionine on liver damage in experimental obstructive jaundice.
Kaohsiung J. Med. Sci. 17: 455-460 (2001).
-
Tsao BP, Grossman JM. Genetics and systemic lupus erythematosus.
Curr. Rheumatol. Rep. 3: 183-190 (2001).
-
Tsuchiya N, Kawasaki A, Tsao BP, Komata T, Grossman JM, Tokunaga K. Analysis of the association of HLA-DRB1, TNFalpha promoter and TNFR2 (TNFRSF1B) polymorphisms with SLE using transmission disequilibrium test.
Genes Immun. 2: 317-322 (2001).
*
-
Tsuji A, Nishikawa T, Mori M, Suda K, Nishimori I, Nishimura M. Quantitative trait locus analysis for chronic pancreatitis and diabetes mellitus in the WBN/Kob rat.
Genomics 74: 365-369 (2001).
*
-
Tsujii M. COX-2 inhibitor and colon cancer.
Gan To Kagaku Ryoho 28: 1799-1805 (2001).
-
Tsukamoto H, Lu SC. Current concepts in the pathogenesis of alcoholic liver injury.
FASEB J. 15: 1335-1349 (2001).
*
-
Tsukamoto H, Takei Y, McClain CJ, Joshi-Barve S, Hill D, Schmidt J, Deaciuc I, Barve S, Colell A, Garcia-Ruiz C, Kaplowitz N, Fernandez-Checa JC, Yokoyama H, Okamura Y, Nakamura Y, Ishii H, Chawla RK, Barve S, Joshi-Barve S, Watson W, Nelson W, et al. How is the liver primed or sensitized for alcoholic liver disease?
Alcohol Clin. Exp. Res. 25: 171S-181S (2001).
-
Tsuneyama K, Harada K, Kono N, Hiramatsu K, Zen Y, Sudo Y, Gershwin ME, Ikemoto M, Arai H, Nakanuma Y. Scavenger cells with Gram-positive bacterial lipoteichoic acid infiltrate around the damaged interlobular bile ducts of primary biliary cirrhosis.
J. Hepatol. 35: 156-163 (2001).
*
-
Tsuneyama K, Harada K, Yasoshima M, Hiramatsu K, Mackay CR, Mackay IR, Gershwin ME, Nakanuma Y. Monocyte chemotactic protein-1, -2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathogenesis.
J. Pathol. 193: 102-109 (2001).
*
-
Tsuneyama K, Nose M, Nisihara M, Katayanagi K, Harada K, Nakanuma Y. Spontaneous occurrence of chronic non-suppurative destructive cholangitis and antimitochondrial autoantibodies in MRL/lpr mice: possible animal model for primary biliary cirrhosis.
Pathol. Int. 51: 418-424 (2001).
*
-
Tsutsumi A, Sasaki K, Wakamiya N, Ichikawa K, Atsumi T, Ohtani K, Suzuki Y, Koike T, Sumida T. Mannose-binding lectin gene: polymorphisms in Japanese patients with systemic lupus erythematosus, rheumatoid arthritis and Sjogren's syndrome.
Genes Immun. 2: 99-104 (2001).
*
-
Tu AY, Albers JJ. Functional analysis of the transcriptional activity of the mouse phospholipid transfer protein gene.
Biochem. Biophys. Res. Commun. 287: 921-926 (2001).
*
-
Tung BY, Emond MJ, Haggitt RC, Bronner MP, Kimmey MB, Kowdley KV, Brentnall TA. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
Ann. Intern. Med. 134: 89-95 (2001).
*
-
Tuokko J, Nejentsev S, Luukkainen R, Toivanen A, Ilonen J. HLA haplotype analysis in Finnish patients with rheumatoid arthritis.
Arthritis Rheum. 44: 315-322 (2001).
*
-
Turner MA, Fulcher AS. The cystic duct: normal anatomy and disease processes.
Radiographics 21: 3-22 (2001).
*
-
Turri D, Rosselli M, Simioni P, Tormene D, Grimaudo S, Martorana G, Siragusa S, Mariani G, Cottone M, Siracusa S. Factor V Leiden and prothrombin gene mutation in inflammatory bowel disease in a Mediterranean area.
Dig. Liver Dis. 33: 559-562 (2001).
-
Tuysuz B, Dursun A, Kutlu T, Sokucu S, Cine N, Suoglu O, Erkan T, Erginel-Unaltuna N, Tumay G. HLA-DQ alleles in patients with celiac disease in Turkey.
Tissue Antigens 57: 540-542 (2001).
*
-
Tyndall A. Immunoablation and haemopoietic stem cell transplantation for severe autoimmune disease with special reference to systemic lupus erythematosus.
Lupus 10: 214-215 (2001).
*
-
Tyndall A, Passweg J, Gratwohl A. Haemopoietic stem cell transplantation in the treatment of severe autoimmune diseases 2000.
Ann. Rheum. Dis. 60: 702-707 (2001).
*
-
Tyndall A; EBMT/EULAR International Data Base; European Group for Blood and Marrow Transplantation and European League Against Rheumatism. Autologous hematopoietic stem cell transplantation for severe autoimmune disease with special reference to rheumatoid arthritis.
J. Rheumatol. Suppl. 64: 5-7 (2001).
-
Tzimas G, Nau H. The role of metabolism and toxicokinetics in retinoid teratogenesis.
Curr. Pharm. Des. 7: 803-831 (2001).
-
Uauy R, Hoffman DR, Peirano P, Birch DG, Birch EE. Essential fatty acids in visual and brain development.
Lipids 36: 885-895 (2001).
-
Ubogu EE, Zaidat OO, Suarez JI. Acute motor-sensory axonal neuropathy associated with active systemic lupus erythematosus and anticardiolipin antibodies.
J. Clin. Rheumatol. 7: 326-331 (2001).
-
Uchimura K, Nakamuta M, Enjoji M, Irie T, Sugimoto R, Muta T, Iwamoto H, Nawata H. Activation of retinoic X receptor and peroxisome proliferator-activated receptor-gamma inhibits nitric oxide and tumor necrosis factor-alpha production in rat Kupffer cells.
Hepatology 33: 91-99 (2001).
*
-
Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer.
N. Engl. J. Med. 345: 784-789 (2001).
*
-
Ueno Y, Ishii M, Igarashi T, Mano Y, Yahagi K, Kisara N, Kobayashi Y, Niitsuma H, Kobayashi K, Shimosegawa T. Primary biliary cirrhosis with antibody against carbonic anhydrase II associates with distinct immunological backgrounds.
Hepatol. Res. 20: 18-27 (2001).
-
Uhlig HH, Hultgren Hornquist E, Ohman Bache L, Rudolph U, Birnbaumer L, Mothes T. Antibody response to dietary and autoantigens in G alpha i2-deficient mice.
Eur. J. Gastroenterol. Hepatol. 13: 1421-1429 (2001).
-
Ulbrich AG, Florido MP, Nudelman V, Reis ES, Baracho GV, Isaac L. Hereditary human complement C3 deficiency owing to reduced levels of C3 mRNA.
Scand. J. Immunol. 53: 622-626 (2001).
*
-
Ulven SM, Gundersen TE, Sakhi AK, Glover JC, Blomhoff R. Quantitative axial profiles of retinoic acid in the embryonic mouse spinal cord: 9-cis retinoic acid only detected after all-trans-retinoic acid levels are super-elevated experimentally.
Dev. Dyn. 222: 341-353 (2001).
*
-
Umar A, Viner JL, Hawk ET. The future of colon cancer prevention.
Ann. N. Y. Acad. Sci. 952: 88-108 (2001).
*
-
Uomo G, Manes G, Rabitti PG. Role of hereditary pancreatitis and CFTR gene mutations in the aetiology of acute relapsing pancreatitis of unknown origin. How are they important?
JOP 2: 368-372 (2001).
*
-
Uomo G, Talamini G, Rabitti PG. Antioxidant treatment in hereditary pancreatitis. A pilot study on three young patients.
Dig. Liver Dis. 33: 58-62 (2001).
-
Urushihara N, Ariki N, Oyama T, Chouda Y, Yagi T, Inoue T, Tomiyama Y, Nishiuchi R, Oda M, Tanaka N. Secondary sclerosing cholangitis and portal hypertension after O157 enterocolitis: extremely rare complications of hemolytic uremic syndrome.
J. Pediatr. Surg. 36: 1838-1340 (2001).
-
Usami M, Muraki K, Iwamoto M, Ohata A, Matsushita E, Miki A. Effect of eicosapentaenoic acid (EPA) on tight junction permeability in intestinal monolayer cells.
Clin. Nutr. 20: 351-359 (2001).
-
Usha V, Gomathy S. Rifampicin monotherapy for acute guttate psoriasis - better avoided.
Indian J. Dermatol. Venereol. Leprol. 67: 220 (2001).
*
-
Usman A, Kimyai-Asadi A, Stiller MJ, Alam M. Lichenoid eruption following hepatitis B vaccination: first North American case report.
Pediatr. Dermatol. 18: 123-126 (2001).
-
Uthoff SM, Eichenberger MR, Lewis RK, Fox MP, Hamilton CJ, McAuliffe TL, Grimes HL, Galandiuk S. Identification of candidate genes in ulcerative colitis and Crohn's disease using cDNA array technology.
Int. J. Oncol. 19: 803-810 (2001).
-
Vales-Gomez M, Erskine RA, Deacon MP, Strominger JL, Reyburn HT. The role of zinc in the binding of killer cell Ig-like receptors to class I MHC proteins.
Proc. Natl. Acad. Sci. U.S.A. 98: 1734-1739 (2001).
*
-
van Belzen MJ, Mulder CJ, Pearson PL, Houwen RH, Wijmenga C. The tissue transglutaminase gene is not a primary factor predisposing to celiac disease.
Am. J. Gastroenterol. 96: 3337-3340 (2001).
*
-
van Bodegraven AA, Schoorl M, Baak JP, Linskens RK, Bartels PC, Tuynman HA. Hemostatic imbalance in active and quiescent ulcerative colitis.
Am. J. Gastroenterol. 96: 487-493 (2001).
*
-
Van Cromphaut SJ, Dewerchin M, Hoenderop JG, Stockmans I, Van Herck E, Kato S, Bindels RJ, Collen D, Carmeliet P, Bouillon R, Carmeliet G. Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects.
Proc. Natl. Acad. Sci. U.S.A. 98: 13324-13329 (2001).
*
-
Van Damme N, De Keyser F, Demetter P, Baeten D, Mielants H, Verbruggen G, Cuvelier C, Veys EM, De Vos M. The proportion of Th1 cells, which prevail in gut mucosa, is decreased in inflammatory bowel syndrome.
Clin. Exp. Immunol. 125: 383-390 (2001).
*
-
Van Damme N, Elewaut D, Baeten D, Demetter P, Cuvelier C, Verbruggen G, Mielants H, Veys EM, De Vos M, De Keyser F. Gut mucosal T cell lines from ankylosing spondylitis patients are enriched with alphaEbeta7 integrin.
Clin. Exp. Rheumatol. 19: 681-687 (2001).
-
van de Graaf SA, Ris-Stalpers C, Pauws E, Mendive FM, Targovnik HM, de Vijlder JJ. Up to date with human thyroglobulin.
J. Endocrinol. 170: 307-321 (2001).
*
-
Van de Water J, Ishibashi H, Coppel RL, Gershwin ME. Molecular mimicry and primary biliary cirrhosis: premises not promises.
Hepatology 33: 771-775 (2001).
*
-
van den Bogaerde J, Kamm MA, Knight SC. Immune sensitization to food, yeast and bacteria in Crohn's disease.
Aliment. Pharmacol. Ther. 15: 1647-1653 (2001).
*
-
van der Geld YM, Limburg PC, Kallenberg CG. Proteinase 3, Wegener's autoantigen: from gene to antigen.
J. Leukoc. Biol. 69: 177-190 (2001).
*
-
van der Linden MW, van der Slik AR, Zanelli E, Giphart MJ, Pieterman E, Schreuder GM, Westendorp RG, Huizinga TW. Six microsatellite markers on the short arm of chromosome 6 in relation to HLA-DR3 and TNF-308A in systemic lupus erythematosus.
Genes Immun. 2: 373-380 (2001).
*
-
van Eden W, Wagenaar-Hilbers JP, Wauben MH. Adjuvant arthritis in the rat.
Curr. Protoc. Immunol. Chapter 15: Unit 15.4 (2001).
-
van Heel DA, Carey AH, Jewell DP. Identification of novel polymorphisms in the beta7 integrin gene: family-based association studies in inflammatory bowel disease.
Genes Immun. 2: 455-460 (2001).
*
-
van Heel DA, Jewell DP. Genetics of inflammatory bowel disease - an update.
Acta Gastroenterol. Belg. 64: 160-164 (2001).
-
van Hogezand RA, Witte AM, Veenendaal RA, Wagtmans MJ, Lamers CB. Proximal Crohn's disease: review of the clinicopathologic features and therapy.
Inflamm. Bowel Dis. 7: 328-337 (2001).
*
-
Van Kruiningen HJ, Cortot A, Colombel JF. The importance of familial clusterings in Crohn's disease.
Inflamm. Bowel Dis. 7: 170-173 (2001).
*
-
Van Kruiningen HJ, Freda BJ. A clustering of Crohn's disease in Mankato, Minnesota.
Inflamm. Bowel Dis. 7: 27-33 (2001).
*
-
van Laar JM, Verburg RJ, Fibbe WE, Breedveld FC. Intensive immunosuppression and autologous stem cell transplantation for patients with severe rheumatoid arthritis: the Leiden experience.
J. Rheumatol. Suppl. 64: 25-27 (2001).
-
van Leeuwen JP, van Driel M, van den Bemd GJ, Pols HA. Vitamin D control of osteoblast function and bone extracellular matrix mineralization.
Crit. Rev. Eukaryot. Gene Expr. 11: 199-226 (2001).
-
van Mil SW, Klomp LW, Bull LN, Houwen RH. FIC1 disease: a spectrum of intrahepatic cholestatic disorders.
Semin. Liver Dis. 21: 535-544 (2001).
-
Van Seuningen I, Pigny P, Perrais M, Porchet N, Aubert JP. Transcriptional regulation of the 11p15 mucin genes. Towards new biological tools in human therapy, in inflammatory diseases and cancer?
Front. Biosci. 6: D1216-D1234 (2001).
-
van Veen HW, Higgins CF, Konings WN. Multidrug transport by ATP binding cassette transporters: a proposed two-cylinder engine mechanism.
Res. Microbiol. 152: 365-374 (2001).
-
van Veen HW, Higgins CF, Konings WN. Molecular basis of multidrug transport by ATP-binding cassette transporters: a proposed two-cylinder engine model.
J. Mol. Microbiol. Biotechnol. 3: 185-192 (2001).
-
Van Vlierberghe H, Delanghe JR, De Bie S, Praet M, De Paepe A, Messiaen L, De Vos M, Leroux-Roels G. Association between Cys282Tyr missense mutation and haptoglobin phenotype polymorphism in patients with chronic hepatitis C.
Eur. J. Gastroenterol. Hepatol. 13: 1077-1081 (2001).
-
Van Vlierberghe H, Langlois M, Delanghe J, Horsmans Y, Michielsen P, Henrion J, Cartuyvels R, Billiet J, De Vos M, Leroux-Roels G. Haptoglobin phenotype 2-2 overrepresentation in Cys282Tyr hemochromatotic patients.
J. Hepatol. 35: 707-711 (2001).
*
-
Vaneckova I, Vylitova-Pletichova M, Beskid S, Zicha J, Pacha J. Intracellular pH regulation in colonocytes of rat proximal colon.
Biochim. Biophys. Acta 1536: 103-115 (2001).
*
-
Vargas-Alarcon G, Salgado N, Granados J, Gomez-Casado E, Martinez-Laso J, Alcocer-Varela J, Arnaiz-Villena A, Alarcon-Segovia D. Class II allele and haplotype frequencies in Mexican systemic lupus erythematosus patients: the relevance of considering homologous chromosomes in determining susceptibility.
Hum. Immunol. 62: 814-820 (2001).
-
Vartdal F. Genetic background for immune-mediated diseases.
Acta Odontol. Scand. 59: 212-215 (2001).
-
Vasen HF, van Duijvendijk P, Buskens E, Bulow C, Bjork J, Jarvinen HJ, Bulow S. Decision analysis in the surgical treatment of patients with familial adenomatous polyposis: a Dutch-Scandinavian collaborative study including 659 patients.
Gut 49: 231-235 (2001).
*
-
Vasicek D, Vasickova K, Kaiser P, Drozenova R, Citek J, Hala K. Analysis of genetic regulation of chicken spontaneous autoimmune thyroiditis, an animal model of human Hashimoto's thyroiditis.
Immunogenetics 53: 776-785 (2001).
-
Vazquez M, Roglans N, Cabrero A, Rodriguez C, Adzet T, Alegret M, Sanchez RM, Laguna JC. Bezafibrate induces acyl-CoA oxidase mRNA levels and fatty acid peroxisomal beta-oxidation in rat white adipose tissue.
Mol. Cell Biochem. 216: 71-78 (2001).
*
-
Vazquez-Mellado J, Morales EM, Pacheco-Tena C, Burgos-Vargas R. Relation between adverse events associated with allopurinol and renal function in patients with gout.
Ann. Rheum. Dis. 60: 981-983 (2001).
*
-
Veal CD, Clough RL, Barber RC, Mason S, Tillman D, Ferry B, Jones AB, Ameen M, Balendran N, Powis SH, Burden AD, Barker JN, Trembath RC. Identification of a novel psoriasis susceptibility locus at 1p and evidence of epistasis between PSORS1 and candidate loci.
J. Med. Genet. 38: 7-13 (2001).
*
-
Vecchi M, Meucci G, Gionchetti P, Beltrami M, Di Maurizio P, Beretta L, Ganio E, Usai P, Campieri M, Fornaciari G, de Franchis R. Oral versus combination mesalazine therapy in active ulcerative colitis: a double-blind, double-dummy, randomized multicentre study.
Aliment. Pharmacol. Ther. 15: 251-256 (2001).
*
-
Velasco N, Hernandez G, Wainstein C, Castillo L, Maiz A, Lopez F, Guzman S, Bugedo G, Acosta AM, Bruhn A. Influence of polymeric enteral nutrition supplemented with different doses of glutamine on gut permeability in critically ill patients.
Nutrition 17: 907-911 (2001).
-
Veldhuyzen van Zanten SJ. Recurrent diarrhoea and weight loss associated with cessation of smoking in a patient with undiagnosed coeliac disease.
Gut 49: 588 (2001).
*
-
Veljaca M. Anti-inflammatory peptides and proteins in inflammatory bowel disease.
Curr. Opin. Investig. Drugs 2: 1387-1394 (2001).
-
Veloso FT, Ferreira JT, Barros L, Almeida S. Clinical outcome of Crohn's disease: analysis according to the Vienna classification and clinical activity.
Inflamm. Bowel Dis. 7: 306-313 (2001).
*
-
Velsor LW, van Heeckeren A, Day BJ. Antioxidant imbalance in the lungs of cystic fibrosis transmembrane conductance regulator protein mutant mice.
Am. J. Physiol. Lung Cell. Mol. Physiol. 281: L31-L38 (2001).
*
-
Vento P, Kiviluoto T, Jarvinen HJ, Karkkainen P, Kivilaakso E, Soinila S. Expression of inducible and endothelial nitric oxide synthases in pouchitis.
Inflamm. Bowel Dis. 7: 120-127 (2001).
*
-
Venuprasad K, Parab P, Prasad DV, Sharma S, Banerjee PR, Deshpande M, Mitra DK, Pal S, Bhadra R, Mitra D, Saha B. Immunobiology of CD28 expression on human neutrophils. I. CD28 regulates neutrophil migration by modulating CXCR-1 expression.
Eur. J. Immunol. 31: 1536-1543 (2001).
-
Verburg RJ, Kruize AA, van den Hoogen FH, Fibbe WE, Petersen EJ, Preijers F, Sont JK, Barge RM, Bijlsma JW, van de Putte LB, Breedveld FC, van Laar JM. High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy.
Arthritis Rheum. 44: 754-760 (2001).
*
-
Vergani D, Mieli-Vergani G. Autoimmune hepatitis.
Curr. Opin. Gastroenterol. 17: 562-567 (2001).
-
Verhasselt V, Vosters O, Beuneu C, Nicaise C, Stordeur P, Goldman M. Induction of FOXP3-expressing regulatory CD4+ T cells by human mature autologous dendritic cells.
Eur. J. Immunol. 34: 762-772 (2001).
*
-
Verlinden L, Verstuyf A, Quack M, Van Camp M, Van Etten E, De Clercq P, Vandewalle M, Carlberg C, Bouillon R. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
J. Bone Miner. Res. 16: 625-638 (2001).
-
Vermeire S, Peeters M, Vlietinck R, Joossens S, Den Hond E, Bulteel V, Bossuyt X, Geypens B, Rutgeerts P. Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families.
Inflamm. Bowel Dis. 7: 8-15 (2001).
*
-
Vermeire S, Satsangi J, Peeters M, Parkes M, Jewell DP, Vlietinck R, Rutgeerts P. Evidence for inflammatory bowel disease of a susceptibility locus on the X chromosome.
Gastroenterology 120: 834-840 (2001).
*
-
Vestereng VH, Kovacs JA. Recombinant CD40 ligand administration does not decrease intensity of Pneumocystis carinii infection in scid mice.
J. Eukaryot. Microbiol. 2001: 153S-154S (2001).
-
Veugelers M, De Cat B, Delande N, Esselens C, Bonk I, Vermeesch J, Marynen P, Fryns JP, David G. A 4-Mb BAC/PAC contig and complete genomic structure of the GPC5/GPC6 gene cluster on chromosome 13q32.
Matrix Biol. 20: 375-385 (2001).
-
Vierling JM. Animal models for primary sclerosing cholangitis.
Best Pract. Res. Clin. Gastroenterol. 15: 591-610 (2001).
*
-
Villarreal J, Crosdale D, Ollier W, Hajeer A, Thomson W, Ordi J, Balada E, Villardell M, Teh LS, Poulton K. Mannose binding lectin and FcgammaRIIa (CD32) polymorphism in Spanish systemic lupus erythematosus patients.
Rheumatology (Oxford) 40: 1009-1012 (2001).
*
-
Visvanathan K, Charles A, Bannan J, Pugach P, Kashfi K, Zabriskie JB. Inhibition of bacterial superantigens by peptides and antibodies.
Infect. Immun. 69: 875-884 (2001).
*
-
Vlachogiannakos J, Tang AK, Patch D, Burroughs AK. Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver disease.
Gut 49: 303-308 (2001).
*
-
Vleggaar FP, van Buuren HR, van Berge Henegouwen GP, Hop WC, van Erpecum KJ. No beneficial effects of transdermal nicotine in patients with primary sclerosing cholangitis: results of a randomized double-blind placebo-controlled cross-over study.
Eur. J. Gastroenterol. Hepatol. 13: 171-175 (2001).
-
Vleggaar FP, van Buuren HR, Zondervan PE, ten Kate FJ, Hop WC; Dutch Multicentre PBC study group. Jaundice in non-cirrhotic primary biliary cirrhosis: the premature ductopenic variant.
Gut 49: 276-281 (2001).
*
-
Vogel A, Liermann H, Harms A, Strassburg CP, Manns MP, Obermayer-Straub P. Autoimmune regulator AIRE: evidence for genetic differences between autoimmune hepatitis and hepatitis as part of the autoimmune polyglandular syndrome type 1.
Hepatology 33: 1047-1052 (2001).
*
-
Vogel G. Pharmacology. How the body's 'garbage disposal' may inactivate drugs.
Science 291: 35-37 (2001).
*
-
Vogel U, Hedayati M, Dybdahl M, Grossman L, Nexo BA. Polymorphisms of the DNA repair gene XPD: correlations with risk of basal cell carcinoma revisited.
Carcinogenesis 22: 899-904 (2001).
*
-
Volpe R. Autoimmune disease.
ENCYCLOPEDIA OF LIFE SCIENCES Nature Publishing Group www.els.net (2001). *
-
von Lintig J, Dreher A, Kiefer C, Wernet MF, Vogt K. Analysis of the blind Drosophila mutant ninaB identifies the gene encoding the key enzyme for vitamin A formation invivo.
Proc. Natl. Acad. Sci. U.S.A. 98: 1130-1135 (2001).
*
-
von Lintig J, Wyss A. Molecular analysis of vitamin A formation: cloning and characterization of beta-carotene 15,15'-dioxygenases.
Arch. Biochem. Biophys. 385: 47-52 (2001).
*
-
von Moltke LL, Greenblatt DJ, Giancarlo GM, Granda BW, Harmatz JS, Shader RI. Escitalopram (S-citalopram) and its metabolites in vitro: cytochromes mediating biotransformation, inhibitory effects, and comparison to R-citalopram.
Drug Metab. Dispos. 29: 1102-1109 (2001).
*
-
Vons C, Loux N, Simon L, Mahieu-Caputo D, Dagher I, Andreoletti M, Borgnon J, Di Rico V, Bargy F, Capron F, Weber A, Franco D. Transplantation of hepatocytes in nonhuman primates: a preclinical model for the treatment of hepatic metabolic diseases.
Transplantation 72: 811-818 (2001).
-
Vorechovsky I, Kralovicova J, Laycock MD, Webster AD, Marsh SG, Madrigal A, Hammarstrom L. Short tandem repeat (STR) haplotypes in HLA: an integrated 50-kb STR/linkage disequilibrium/gene map between the RING3 and HLA-B genes and identification of STR haplotype diversification in the class III region.
Eur. J. Hum. Genet. 9: 590-598 (2001).
*
-
Vos K, van der Horst-Bruinsma IE, Hazes JM, Breedveld FC, le Cessie S, Schreuder GM, de Vries RR, Zanelli E. Evidence for a protective role of the human leukocyte antigen class II region in early rheumatoid arthritis.
Rheumatology (Oxford) 40: 133-139 (2001).
*
-
Vos K, Visser H, Schreuder GM, de Vries RR, Zwinderman AH, Breedveld FC, Hazes JM, Zanelli EH. Human leukocyte antigen-DQ and DR polymorphisms predict rheumatoid arthritis outcome better than DR alone.
Hum. Immunol. 62: 1217-1225 (2001).
-
Voshol PJ, Koopen NR, de Vree JM, Havinga R, Princen HM, Oude Elferink RP, Groen AK, Kuipers F. Dietary cholesterol does not normalize low plasma cholesterol levels but induces hyperbilirubinemia and hypercholanemia in Mdr2 P-glycoprotein-deficient mice.
J. Hepatol. 34: 202-209 (2001).
*
-
Voskoboinik I, Greenough M, La Fontaine S, Mercer JF, Camakaris J. Functional studies on the Wilson copper P-type ATPase and toxic milk mouse mutant.
Biochem. Biophys. Res. Commun. 281: 966-970 (2001).
*
-
Vosshenrich CA, Di Santo JP. Cytokines: IL-21 joins the gamma(c)-dependent network?
Curr. Biol. 11: R175-R177 (2001).
*
-
Vuckovic S, Florin TH, Khalil D, Zhang MF, Patel K, Hamilton I, Hart DN. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
Am. J. Gastroenterol. 96: 2946-2956 (2001).
*
-
Wada K, Nakajima A, Blumberg RS. PPARgamma and inflammatory bowel disease: a new therapeutic target for ulcerative colitis and Crohn's disease.
Trends Mol. Med. 7: 329-331 (2001).
*
-
Wada R, Kawamura C, Inoue S, Watanabe K, Kaimori M, Yagihashi S. Granulomatous colitis associated with botryomycosis of Propionibacterium acnes.
Arch. Pathol. Lab. Med. 125: 1491-1493 (2001).
-
Wadstrom T, Ljungh A, Willen R. Primary biliary cirrhosis and primary sclerosing cholangitis are of infectious origin!
Gut 49: 454 (2001).
*
-
Wagman LD, Robertson JM, O'Neil B. Chapter 15. Liver, gallbladder, and biliary tract cancers.
In "Cancer Management: A Multidisciplinary Approach" (Wagman L, Venook AP, Robertson JR, O’Neil BH eds.), Fifth Edition, p. 303-321 (2001). *
-
Wagner CA, Ott M, Klingel K, Beck S, Melzig J, Friedrich B, Wild KN, Broer S, Moschen I, Albers A, Waldegger S, Tummler B, Egan ME, Geibel JP, Kandolf R, Lang F. Effects of the serine/threonine kinase SGK1 on the epithelial Na(+) channel (ENaC) and CFTR: implications for cystic fibrosis.
Cell. Physiol. Biochem. 11: 209-218 (2001).
-
Wajant H, Scheurich P. Tumor necrosis factor receptor-associated factor (TRAF) 2 and its role in TNF signaling.
Int. J. Biochem. Cell Biol. 33: 19-32 (2001).
*
-
Wakefield AJ, Montgomery SM. Immunohistochemical analysis of measles related antigen in IBD.
Gut 48: 136-137 (2001).
*
-
Waldegger S, Moschen I, Ramirez A, Smith RJ, Ayadi H, Lang F, Kubisch C. Cloning and characterization of SLC26A6, a novel member of the solute carrier 26 gene family.
Genomics 72: 43-50 (2001).
*
-
Waldron-Lynch F, Adams C, Amos C, Zhu DK, McDermott MF, Shanahan F, Molloy MG, O'Gara F. Tumour necrosis factor 5' promoter single nucleotide polymorphisms influence susceptibility to rheumatoid arthritis (RA) in immunogenetically defined multiplex RA families.
Genes Immun. 2: 82-87 (2001).
*
-
Walkowiak J, Herzig KH, Witt M, Pogorzelski A, Piotrowski R, Barra E, Sobczynska-Tomaszewska A, Trawinska-Bartnicka M, Strzykala K, Cichy W, Sands D, Rutkiewicz E, Krawczynski M. Analysis of exocrine pancreatic function in cystic fibrosis: one mild CFTR mutation does not exclude pancreatic insufficiency.
Eur. J. Clin. Invest. 31: 796-801 (2001).
*
-
Wallace FA, Miles EA, Evans C, Stock TE, Yaqoob P, Calder PC. Dietary fatty acids influence the production of Th1- but not Th2-type cytokines.
J. Leukoc. Biol. 69: 449-457 (2001).
*
-
Wallace JL. Prostaglandin biology in inflammatory bowel disease.
Gastroenterol. Clin. North Am. 30: 971-980 (2001).
-
Wallace TM, Veldhuyzen van Zanten SJ. Frequency of use and standards of care for the use of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease: a systematic review of the literature and a survey of Canadian gastroenterologists.
Can. J. Gastroenterol. 15: 21-28 (2001).
*
-
Wallin R, Wajih N, Greenwood GT, Sane DC. Arterial calcification: a review of mechanisms, animal models, and the prospects for therapy.
Med. Res. Rev. 21: 274-301 (2001).
*
-
Walsh BT, Pope C, Reid M, Gall EP, Yocum DE, Clark LC. SLE in a United States-Mexico border community.
J. Clin. Rheumatol. 7: 3-9 (2001).
-
Wan YY, Cai Y, Li J, Yuan Q, French B, Gonzalez FJ, French S. Regulation of peroxisome proliferator activated receptor alpha-mediated pathways in alcohol fed cytochrome P450 2E1 deficient mice.
Hepatol. Res. 19: 117-130 (2001).
-
Wanchu A, Khullar M, Sud K, Sakhuja V, Thennarasu K, Sud A, Bambery P. Serum and urine nitrite and citrulline levels among patients with systemic lupus erythematosus: a possible addition to activity parameters?
J. Clin. Rheumatol. 7: 10-15 (2001).
-
Wandstrat A, Wakeland E. The genetics of complex autoimmune diseases: non-MHC susceptibility genes.
Nat. Immunol. 2: 802-809 (2001).
*
-
Wang J, Near S, Young K, Connelly PW, Hegele RA. ABCC6 gene polymorphism associated with variation in plasma lipoproteins.
J. Hum. Genet. 46: 699-705 (2001).
-
Wang MX, Morgan T, Lungo W, Wang L, Sze GZ, French SW. "Piecemeal" necrosis: renamed troxis necrosis.
Exp. Mol. Pathol. 71: 137-146 (2001).
*
-
Wang N, Silver DL, Thiele C, Tall AR. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein.
J. Biol. Chem. 276: 23742-23747 (2001).
*
-
Wang R, Salem M, Yousef IM, Tuchweber B, Lam P, Childs SJ, Helgason CD, Ackerley C, Phillips MJ, Ling V. Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis.
Proc. Natl. Acad. Sci. U.S.A. 98: 2011-2016 (2001).
*
-
Wang W, Kramer PM, Yang S, Pereira MA, Tao L. Reversed-phase high-performance liquid chromatography procedure for the simultaneous determination of S-adenosyl-L-methionine and S-adenosyl-L-homocysteine in mouse liver and the effect of methionine on their concentrations.
J. Chromatogr. B. Biomed. Sci. Appl. 762: 59-65 (2001).
-
Wang W, Seward DJ, Li L, Boyer JL, Ballatori N. Expression cloning of two genes that together mediate organic solute and steroid transport in the liver of a marine vertebrate.
Proc. Natl. Acad. Sci. U.S.A. 98: 9431-9436 (2001).
*
-
Wang W, Xue S, Ingles SA, Chen Q, Diep AT, Frankl HD, Stolz A, Haile RW. An association between genetic polymorphisms in the ileal sodium-dependent bile acid transporter gene and the risk of colorectal adenomas.
Cancer Epidemiol. Biomarkers Prev. 10: 931-936 (2001).
*
-
Wang X, Mosmann T. In vivo priming of CD4 T cells that produce interleukin (IL)-2 but not IL-4 or interferon (IFN)-gamma, and can subsequently differentiate into IL-4- or IFN-gamma-secreting cells.
J. Exp. Med. 194: 1069-1080 (2001).
*
-
Wang Y, Pelisson I, Melana SM, Go V, Holland JF, Pogo BG. MMTV-like env gene sequences in human breast cancer.
Arch. Virol. 146: 171-180 (2001).
*
-
Wang ZY, Morinobu A, Kanagawa S, Kumagai S. Polymorphisms of the mannose binding lectin gene in patients with Sjogren's syndrome.
Ann. Rheum. Dis. 60: 483-486 (2001).
*
-
Ward R, Meagher A, Tomlinson I, O'Connor T, Norrie M, Wu R, Hawkins N. Microsatellite instability and the clinicopathological features of sporadic colorectal cancer.
Gut 48: 821-829 (2001).
*
-
Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia.
N. Engl. J. Med. 344: 1286-1292 (2001).
*
-
Warrington KJ, Takemura S, Goronzy JJ, Weyand CM. CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems.
Arthritis Rheum. 44: 13-20 (2001).
*
-
Wassink TH, Piven J, Vieland VJ, Huang J, Swiderski RE, Pietila J, Braun T, Beck G, Folstein SE, Haines JL, Sheffield VC. Evidence supporting WNT2 as an autism susceptibility gene.
Am. J. Med. Genet. 105: 406-413 (2001).
-
Watanabe S, Deguchi A, Uchida N, Kurokohchi K, Arima K, Nishioka M, Hasui H. Histopathologic comparison of anti-mitochondrial antibody-positive primary biliary cirrhosis and autoimmune cholangiopathy.
Hepatol. Res. 19: 41-51 (2001).
-
Watanabe T, Wu TT, Catalano PJ, Ueki T, Satriano R, Haller DG, Benson AB 3rd, Hamilton SR. Molecular predictors of survival after adjuvant chemotherapy for colon cancer.
N. Engl. J. Med. 344: 1196-1206 (2001).
*
-
Watkins BA, Li Y, Lippman HE, Seifert MF. Omega-3 polyunsaturated fatty acids and skeletal health.
Exp. Biol. Med. (Maywood) 226: 485-497 (2001).
*
-
Watkins RE, Wisely GB, Moore LB, Collins JL, Lambert MH, Williams SP, Willson TM, Kliewer SA, Redinbo MR. The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity.
Science 292: 2329-2333 (2001).
*
-
Watts GF. Treating patients with low high-density lipoprotein cholesterol: choices, issues and opportunities.
Curr. Control Trials Cardiovasc. Med. 2: 118-122 (2001).
*
-
Way JM, Gorgun CZ, Tong Q, Uysal KT, Brown KK, Harrington WW, Oliver WR Jr, Willson TM, Kliewer SA, Hotamisligil GS. Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists.
J. Biol. Chem. 276: 25651-2563 (2001).
*
-
Way JM, Harrington WW, Brown KK, Gottschalk WK, Sundseth SS, Mansfield TA, Ramachandran RK, Willson TM, Kliewer SA. Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor gamma activation has coordinate effects on gene expression in multiple insulin-sensitive tissues.
Endocrinology 142: 1269-1277 (2001).
*
-
Weber DJ, Rutala WA. The emerging nosocomial pathogens Cryptosporidium, Escherichia coli O157:H7, Helicobacter pylori, and hepatitis C: epidemiology, environmental survival, efficacy of disinfection, and control measures.
Infect. Control Hosp. Epidemiol. 22: 306-315 (2001).
*
-
Weber P. Vitamin K and bone health.
Nutrition 17: 880-887 (2001).
*
-
Wehrle-Haller B, Meller M, Weston JA. Analysis of melanocyte precursors in Nf1 mutants reveals that MGF/KIT signaling promotes directed cell migration independent of its function in cell survival.
Dev. Biol. 232: 471-483 (2001).
*
-
Wei B, Dalwadi H, Gordon LK, Landers C, Bruckner D, Targan SR, Braun J. Molecular cloning of a Bacteroides caccae TonB-linked outer membrane protein identified by an inflammatory bowel disease marker antibody.
Infect. Immun. 69: 6044-6054 (2001).
*
-
Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy.
J. Hepatol. 34: 768-773 (2001).
*
-
Weitgasser R, Sungler P, Hauser-Kronberger C, Dietze O, Sattlegger P, Hacker GW. Immunohistochemical assessment of an asymptomatic glucagonoma in a patient with hypergastrinemia and marked antral angiodysplasia.
Appl. Immunohistochem. Mol. Morphol. 9: 92-96 (2001).
-
Wellington K, Jarvis B. Silymarin: a review of its clinical properties in the management of hepatic disorders.
BioDrugs 15: 465-489 (2001).
-
Wen L, Chen NY, Tang J, Sherwin R, Wong FS. The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model.
J. Clin. Invest. 107: 871-880 (2001).
*
-
Wen L, Ma Y, Bogdanos DP, Wong FS, Demaine A, Mieli-Vergani G, Vergani D. Pediatric autoimmune liver diseases: the molecular basis of humoral and cellular immunity.
Curr. Mol. Med. 1: 379-389 (2001).
*
-
Wendland BE, Aghdassi E, Tam C, Carrrier J, Steinhart AH, Wolman SL, Baron D, Allard JP. Lipid peroxidation and plasma antioxidant micronutrients in Crohn disease.
Am. J. Clin. Nutr. 74: 259-264 (2001).
*
-
Werner EA, DeLuca HF. Metabolism of a physiological amount of all-trans-retinol in the vitamin A-deficient rat.
Arch. Biochem. Biophys. 393: 262-270 (2001).
*
-
Wester AL, Vatn MH, Fausa O. Secondary amyloidosis in inflammatory bowel disease: a study of 18 patients admitted to Rikshospitalet University Hospital, Oslo, from 1962 to 1998.
Inflamm. Bowel Dis. 7: 295-300 (2001).
*
-
Westermann J, Ehlers EM, Exton MS, Kaiser M, Bode U. Migration of naive, effector and memory T cells: implications for the regulation of immune responses.
Immunol. Rev. 184: 20-37 (2001).
*
-
Westermann J, Engelhardt B, Hoffmann JC. Migration of T cells in vivo: molecular mechanisms and clinical implications.
Ann. Intern. Med. 135: 279-295 (2001).
*
-
Westrope C, Acharya A. Diarrhea and gallbladder hydrops in an immunocompetent child with Cryptosporidium infection.
Pediatr. Infect. Dis. J. 20: 1179-1181 (2001).
-
Weyman RL, Voigt M. Consecutive occurrence of primary biliary cirrhosis and autoimmune hepatitis: a case report and review of the literature.
Am. J. Gastroenterol. 96: 585-587 (2001).
*
-
Whalen BJ, Mordes JP, Rossini AA. The BB rat as a model of human insulin-dependent diabetes mellitus.
Curr. Protoc. Immunol. Chapter 15: Unit 15.3 (2001).
-
Whary MT, Cline J, King A, Ge Z, Shen Z, Sheppard B, Fox JG. Long-term colonization levels of Helicobacter hepaticus in the cecum of hepatitis-prone A/JCr mice are significantly lower than those in hepatitis-resistant C57BL/6 mice.
Comp. Med. 51: 413-417 (2001).
-
Wheeler G. Repifermin (Human Genome Sciences/GlaxoSmithKline).
IDrugs 4: 813-819 (2001).
-
Whitcomb DC, Somogyi L. Lessons from hereditary pancreatitis.
Croat. Med. J. 42: 484-487 (2001).
*
-
Whitney KD, Watson MA, Goodwin B, Galardi CM, Maglich JM, Wilson JG, Willson TM, Collins JL, Kliewer SA. Liver X receptor (LXR) regulation of the LXRalpha gene in human macrophages.
J. Biol. Chem. 276: 43509-43515 (2001).
*
-
Wiekowski MT, Leach MW, Evans EW, Sullivan L, Chen SC, Vassileva G, Bazan JF, Gorman DM, Kastelein RA, Narula S, Lira SA. Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death.
J. Immunol. 166: 7563-7570 (2001).
*
-
Wiencke K, Spurkland A, Schrumpf E, Boberg KM. Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles.
Hepatology 34: 625-630 (2001).
*
-
Wiesner RH. Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease.
Best Pract. Res. Clin. Gastroenterol. 15: 667-680 (2001).
*
-
Wiesner RH, McDiarmid SV, Kamath PS, Edwards EB, Malinchoc M, Kremers WK, Krom RA, Kim WR. MELD and PELD: application of survival models to liver allocation.
Liver Transpl. 7: 567-580 (2001).
*
-
Wiesner RH, Menon KV. Late hepatic allograft dysfunction.
Liver Transpl. 7: 60-73 (2001).
*
-
Wiezer MJ, Boelens PG, Vuylsteke RJ, Nijveldt RJ, Meijer C, Cuesta MA, Meijer S, van Leeuwen PA. Perioperative treatment with bactericidal/permeability-increasing protein (rBPI21) in major liver surgery: a concise summary.
Ann. Acad. Med. Singapore 30: 226-233 (2001).
-
Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, Cummins AG. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis.
Gut 48: 206-211 (2001).
*
-
Wilcox ER, Burton QL, Naz S, Riazuddin S, Smith TN, Ploplis B, Belyantseva I, Ben-Yosef T, Liburd NA, Morell RJ, Kachar B, Wu DK, Griffith AJ, Riazuddin S, Friedman TB. Mutations in the gene encoding tight junction claudin-14 cause autosomal recessive deafness DFNB29.
Cell 104: 165-172 (2001).
*
-
Wildi S, Kleeff J, Maruyama H, Maurer CA, Buchler MW, Korc M. Overexpression of activin A in stage IV colorectal cancer.
Gut 49: 409-417 (2001).
*
-
Williams DA. Inflammatory cytokines and mucosal injury.
J. Natl. Cancer Inst. Monogr. 29: 26-30 (2001).
*
-
Williams EJ, Benyon RC, Trim N, Hadwin R, Grove BH, Arthur MJ, Unemori EN, Iredale JP. Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo.
Gut 49: 577-583 (2001).
*
-
Wills-Karp M, Santeliz J, Karp CL. The germless theory of allergic disease: revisiting the hygiene hypothesis.
Nat. Rev. Immunol. 1: 69-75 (2001).
*
-
Willson TM, Jones SA, Moore JT, Kliewer SA. Chemical genomics: functional analysis of orphan nuclear receptors in the regulation of bile acid metabolism.
Med. Res. Rev. 21: 513-522 (2001).
*
-
Willson TM, Lambert MH, Kliewer SA. Peroxisome proliferator-activated receptor gamma and metabolic disease.
Annu. Rev. Biochem. 70: 341-367 (2001).
*
-
Wilson CB, Marcuse EK. Vaccine safety/vaccine benefits: science and the public's perception.
Nat. Rev. Immunol. 1: 160-165 (2001).
*
-
Wilson DC, Rashid M, Durie PR, Tsang A, Kalnins D, Andrew M, Corey M, Shin J, Tullis E, Pencharz PB. Treatment of vitamin K deficiency in cystic fibrosis: effectiveness of a daily fat-soluble vitamin combination.
J. Pediatr. 138: 851-855 (2001).
*
-
Wilson SR, Burns PN. Liver mass evaluation with ultrasound: the impact of microbubble contrast agents and pulse inversion imaging.
Semin. Liver Dis. 21: 147-159 (2001).
-
Wiltshire S, Hattersley AT, Hitman GA, Walker M, Levy JC, Sampson M, O'Rahilly S, Frayling TM, Bell JI, Lathrop GM, Bennett A, Dhillon R, Fletcher C, Groves CJ, Jones E, Prestwich P, Simecek N, Rao PV, Wishart M, Bottazzo GF, Foxon R, Howell S, et al. A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q.
Am. J. Hum. Genet. 69: 553-569 (2001).
*
-
Winawer SJ, Zauber AG. Colonoscopic polypectomy and the incidence of colorectal cancer.
Gut 48: 753-754 (2001).
*
-
Wine JJ. Cystic fibrosis: the 'bicarbonate before chloride' hypothesis.
Curr. Biol. 11: R463-R466 (2001).
*
-
Winegar DA, Brown PJ, Wilkison WO, Lewis MC, Ott RJ, Tong WQ, Brown HR, Lehmann JM, Kliewer SA, Plunket KD, Way JM, Bodkin NL, Hansen BC. Effects of fenofibrate on lipid parameters in obese rhesus monkeys.
J. Lipid Res. 42: 1543-1551 (2001).
*
-
Winterberg DH, van Tijn DA, Smitt JH, Winterberg S, Vomberg PP. Two neonates with vesicular skin lesions due to incontinentia pigmenti.
Ned. Tijdschr. Geneeskd. 145: 2178-2182 (2001).
-
Witczak-Malinowska K, Gorycki T, Stalke P, Michalska Z, Jankowska M. Value of magnetic resonance cholangiography (MRC) in primary sclerosing cholangitis (PSC).
Med. Sci. Monit. 7 Suppl. 1: 114-117 (2001).
-
Witt H. Gene mutations in children with chronic pancreatitis.
Pancreatology 1: 432-438 (2001).
-
Witt H, Hennies HC, Becker M. SPINK1 mutations in chronic pancreatitis.
Gastroenterology 120: 1060-1061 (2001).
*
-
Witt H, Landt O. Rapid detection of the Wilson's disease H1069Q mutation by melting curve analysis with the LightCycler.
Clin. Chem. Lab. Med. 39: 953-955 (2001).
-
Witt H, Simon P, Lerch MM. Genetic aspects of chronic pancreatitis.
Dtsch. Med. Wochenschr. 126: 988-993 (2001).
-
Wolan DW, Teyton L, Rudolph MG, Villmow B, Bauer S, Busch DH, Wilson IA. Crystal structure of the murine NK cell-activating receptor NKG2D at 1.95 A.
Nat. Immunol. 2: 248-254 (2001).
*
-
Wolfrum C, Borrmann CM, Borchers T, Spener F. Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha- and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus.
Proc. Natl. Acad. Sci. U.S.A. 98: 2323-2328 (2001).
*
-
Wolfson C. Multiple sclerosis and antecedent infections.
Epidemiology 12: 298-299 (2001).
*
-
Wollheim FA. Enteropathic arthritis: how do the joints talk with the gut?
Curr. Opin. Rheumatol. 13: 305-309 (2001).
-
Wollina U, Graefe T, Oelzner P, Hein G, Schreiber G. Pseudoainhum of all fingers associated with Reynolds' syndrome and breast cancer: report of a case and review of the literature.
J. Am. Acad. Dermatol. 44: 381-384 (2001).
-
Wong CK, Ho CY, Ko FW, Chan CH, Ho AS, Hui DS, Lam CW. Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma.
Clin. Exp. Immunol. 125: 177-183 (2001).
*
-
Wong F, Girgrah N, Graba J, Allidina Y, Liu P, Blendis L. The cardiac response to exercise in cirrhosis.
Gut 49: 268-275 (2001).
*
-
Wong F, Liu P, Blendis L. Sodium homeostasis with chronic sodium loading in preascitic cirrhosis.
Gut 49: 847-851 (2001).
*
-
Wong RC, Field K. MPO-ANCA may produce a combination of P-ANCA and atypical cytoplasmic ANCA indirect immunofluorescent patterns on certain ethanol fixed neutrophil substrates.
J. Clin. Pathol. 54: 335 (2001).
*
-
Wooten MD, Panwalker AP. Septic arthritis caused by Burkholderia pseudomallei: case report and review of the literature.
J. Clin. Rheumatol. 7: 242-247 (2001).
-
Worley P, Roberts-Thomson I, Dymock R, Maddern G. Benign inflammatory pseudotumour of the biliary tract masquerading as a Klatskin tumour.
HPB (Oxford) 3: 179-181 (2001).
*
-
Wu B, Goluszko E, Christadoss P. Experimental autoimmune myasthenia gravis in the mouse.
Curr. Protoc. Immunol. Chapter 15: Unit 15.8 (2001).
-
Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction.
N. Engl. J. Med. 345: 1230-1236 (2001).
*
-
Wu X, Di Rienzo A, Ober C. A population genetics study of single nucleotide polymorphisms in the interleukin 4 receptor alpha (IL4RA) gene.
Genes Immun. 2: 128-134 (2001).
*
-
Wu ZY, Wang N, Lin MT, Fang L, Murong SX, Yu L. Mutation analysis and the correlation between genotype and phenotype of Arg778Leu mutation in Chinese patients with Wilson disease.
Arch. Neurol. 58: 971-976 (2001).
*
-
Wun HL, Leung DT, Wong KC, Chui YL, Lim PL. Molecular mimicry: anti-DNA antibodies may arise inadvertently as a response to antibodies generated to microorganisms.
Int. Immunol. 13: 1099-1107 (2001).
*
-
Wurbel MA, Malissen M, Guy-Grand D, Meffre E, Nussenzweig MC, Richelme M, Carrier A, Malissen B. Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early T- and B-cell development and a reduction in T-cell receptor gammadelta(+) gut intraepithelial lymphocytes.
Blood 98: 2626-2632 (2001).
*
-
Wyss A, Wirtz GM, Woggon WD, Brugger R, Wyss M, Friedlein A, Riss G, Bachmann H, Hunziker W. Expression pattern and localization of beta,beta-carotene 15,15'-dioxygenase in different tissues.
Biochem. J. 354: 521-529 (2001).
*
-
Xie HG, Kim RB, Wood AJ, Stein CM. Molecular basis of ethnic differences in drug disposition and response.
Annu. Rev. Pharmacol. Toxicol. 41: 815-850 (2001).
*
-
Xie W, Radominska-Pandya A, Shi Y, Simon CM, Nelson MC, Ong ES, Waxman DJ, Evans RM. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids.
Proc. Natl. Acad. Sci. U.S.A. 98: 3375-3380 (2001).
*
-
Xin X, Nakamura K, Liu H, Nakayama EE, Goto M, Nagai Y, Kitamura Y, Shioda T, Iwamoto A. Novel polymorphisms in human macrophage inflammatory protein-1 alpha (MIP-1alpha) gene.
Genes Immun. 2: 156-158 (2001).
*
-
Xiong H, Plevy S. Case report: Crohn's disease of the mouse.
Inflamm. Bowel Dis. 7: 347-348 (2001).
*
-
Xu C, Dai Y, Lorentzen JC, Dahlman I, Olsson T, Hillert J. Linkage analysis in multiple sclerosis of chromosomal regions syntenic to experimental autoimmune disease loci.
Eur. J. Hum. Genet. 9: 458-463 (2001).
*
-
Xu HE, Lambert MH, Montana VG, Plunket KD, Moore LB, Collins JL, Oplinger JA, Kliewer SA, Gampe RT Jr, McKee DD, Moore JT, Willson TM. Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors.
Proc. Natl. Acad. Sci. U.S.A. 98: 13919-13924 (2001).
*
-
Xu J, Teran-Garcia M, Park JH, Nakamura MT, Clarke SD. Polyunsaturated fatty acids suppress hepatic sterol regulatory element-binding protein-1 expression by accelerating transcript decay.
J. Biol. Chem. 276: 9800-9807 (2001).
*
-
Xu L, Hui L, Wang S, Gong J, Jin Y, Wang Y, Ji Y, Wu X, Han Z, Hu G. Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma.
Cancer Res. 61: 3176-3181 (2001).
*
-
Xu P, Liang X, Jankovic J, Le W. Identification of a high frequency of mutation at exon 8 of the ATP7B gene in a Chinese population with Wilson disease by fluorescent PCR.
Arch. Neurol. 58: 1879-1882 (2001).
*
-
Xu W, Presnell SR, Parrish-Novak J, Kindsvogel W, Jaspers S, Chen Z, Dillon SR, Gao Z, Gilbert T, Madden K, Schlutsmeyer S, Yao L, Whitmore TE, Chandrasekher Y, Grant FJ, Maurer M, Jelinek L, Storey H, Brender T, Hammond A, Topouzis S, Clegg CH, Foster DC. A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist.
Proc. Natl. Acad. Sci. U.S.A. 98: 9511-9516 (2001).
*
-
Xu XC, Wong WY, Goldberg L, Baer SC, Wolf JE, Ramsdell WM, Alberts DS, Lippman SM, Lotan R. Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis.
Cancer Res. 61: 4306-4310 (2001).
*
-
Xu XR, Huang J, Xu ZG, Qian BZ, Zhu ZD, Yan Q, Cai T, Zhang X, Xiao HS, Qu J, Liu F, Huang QH, Cheng ZH, Li NG, Du JJ, Hu W, Shen KT, Lu G, Fu G, Zhong M, Xu SH, Gu WY, Huang W, Zhao XT, Hu GX, Gu JR, Chen Z, Han ZG. Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver.
Proc. Natl. Acad. Sci. U.S.A. 98: 15089-15094 (2001).
*
-
Yabushita K, Yamamoto K, Ibuki N, Okano N, Matsumura S, Okamoto R, Shimada N, Tsuji T. Aberrant expression of cytokeratin 7 as a histological marker of progression in primary biliary cirrhosis.
Liver 21: 50-55 (2001).
-
Yabuuchi H, Shimizu H, Takayanagi S, Ishikawa T. Multiple splicing variants of two new human ATP-binding cassette transporters, ABCC11 and ABCC12.
Biochem. Biophys. Res. Commun. 288: 933-939 (2001).
*
-
Yachha SK, Srivastava A, Chetri K, Saraswat VA, Krishnani N. Autoimmune liver disease in children.
J. Gastroenterol. Hepatol. 16: 674-677 (2001).
*
-
Yagishita N, Yamamoto Y, Yoshizawa T, Sekine K, Uematsu Y, Murayama H, Nagai Y, Krezel W, Chambon P, Matsumoto T, Kato S. Aberrant growth plate development in VDR/RXR gamma double null mutant mice.
Endocrinology 142: 5332-5341 (2001).
*
-
Yamada R, Tanaka T, Unoki M, Nagai T, Sawada T, Ohnishi Y, Tsunoda T, Yukioka M, Maeda A, Suzuki K, Tateishi H, Ochi T, Nakamura Y, Yamamoto K. Association between a single-nucleotide polymorphism in the promoter of the human interleukin-3 gene and rheumatoid arthritis in Japanese patients, and maximum-likelihood estimation of combinatorial effect that two genetic loci have on susceptibility …
Am. J. Hum. Genet. 68: 674-685 (2001).
*
-
Yamaguchi T, Ihara K, Matsumoto T, Tsutsumi Y, Nomura A, Ohga S, Hara T. Inflammatory bowel disease-like colitis in glycogen storage disease type 1b.
Inflamm. Bowel Dis. 7: 128-132 (2001).
*
-
Yamamoto H, Watanabe T, Mizuno H, Endo K, Fukushige J, Hosokawa T, Kazusaka A, Fujita S. The antioxidant effect of DL-alpha-lipoic acid on copper-induced acute hepatitis in Long-Evans Cinnamon (LEC) rats.
Free Radic. Res. 34: 69-80 (2001).
-
Yamanaka T, Straumfors A, Morton H, Fausa O, Brandtzaeg P, Farstad I. M cell pockets of human Peyer's patches are specialized extensions of germinal centers.
Eur. J. Immunol. 31: 107-117 (2001).
*
-
Yamato Y, Kimura A, Murai T, Yoshimura T, Kurosawa T, Terazawa S, Takao A, Maeda K, Nakashima E, Yamashita Y, Kato H. 3beta-hydroxy-delta5-C27-steroid dehydrogenase deficiency: diagnosis and treatment.
J. Paediatr. Child. Health 37: 516-519 (2001).
-
Yamauchi T, Kamon J, Waki H, Murakami K, Motojima K, Komeda K, Ide T, Kubota N, Terauchi Y, Tobe K, Miki H, Tsuchida A, Akanuma Y, Nagai R, Kimura S, Kadowaki T. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance.
J. Biol. Chem. 276: 41245-41254 (2001).
*
-
Yamauchi T, Waki H, Kamon J, Murakami K, Motojima K, Komeda K, Miki H, Kubota N, Terauchi Y, Tsuchida A, Tsuboyama-Kasaoka N, Yamauchi N, Ide T, Hori W, Kato S, Fukayama M, Akanuma Y, Ezaki O, Itai A, Nagai R, Kimura S, Tobe K, Kagechika H, Shudo K, et al. Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes.
J. Clin. Invest. 108: 1001-1013 (2001).
*
-
Yamazaki K, Gleich GJ, Kita H. Bile acids induce eosinophil degranulation by two different mechanisms.
Hepatology 33: 582-590 (2001).
*
-
Yanase T, Mu YM, Nishi Y, Goto K, Nomura M, Okabe T, Takayanagi R, Nawata H. Regulation of aromatase by nuclear receptors.
J. Steroid Biochem. Mol. Biol. 79: 187-192 (2001).
-
Yang CS, Landau JM, Huang MT, Newmark HL. Inhibition of carcinogenesis by dietary polyphenolic compounds.
Annu. Rev. Nutr. 21: 381-406 (2001).
*
-
Yang H, Taylor KD, Rotter JI. Inflammatory bowel disease. I. Genetic epidemiology.
Mol. Genet. Metab. 74: 1-21 (2001).
*
-
Yang S, Tamai R, Akashi S, Takeuchi O, Akira S, Sugawara S, Takada H. Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture.
Infect. Immun. 69: 2045-2053 (2001).
*
-
Yang SK, Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease in Asia.
Inflamm. Bowel Dis. 7: 260-270 (2001).
*
-
Yang WL, Frucht H. Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells.
Carcinogenesis 22: 1379-1383 (2001).
*
-
Yang YY, Lin HC, Lee WC, Hou MC, Lee FY, Chang FY, Lee SD. Portopulmonary hypertension: distinctive hemodynamic and clinical manifestations.
J. Gastroenterol. 36: 181-186 (2001).
*
-
Yang Z, Qu X, Yu CY. Features of the two gene pairs RD-SKI2W and DOM3Z-RP1 located between complement component genes factor B and C4 at the MHC class III region.
Front. Biosci. 6: D927-D935 (2001).
-
Yasutomo K, Horiuchi T, Kagami S, Tsukamoto H, Hashimura C, Urushihara M, Kuroda Y. Mutation of DNASE1 in people with systemic lupus erythematosus.
Nat. Genet. 28: 313-314 (2001).
*
-
Yazdanbakhsh M, van den Biggelaar A, Maizels RM. Th2 responses without atopy: immunoregulation in chronic helminth infections and reduced allergic disease.
Trends Immunol. 22: 372-377 (2001).
*
-
Ye P, Garvey PB, Zhang P, Nelson S, Bagby G, Summer WR, Schwarzenberger P, Shellito JE, Kolls JK. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection.
Am. J. Respir. Cell Mol. Biol. 25: 335-340 (2001).
*
-
Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P, Oliver P, Huang W, Zhang P, Zhang J, Shellito JE, Bagby GJ, Nelson S, Charrier K, Peschon JJ, Kolls JK. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense.
J. Exp. Med. 194: 519-527 (2001).
*
-
Ye Q, Hyndman D, Green NC, Li L, Jia Z, Flynn TG. The crystal structure of an aldehyde reductase Y50F mutant-NADP complex and its implications for substrate binding.
Chem. Biol. Interact. 130-132: 651-658 (2001).
*
-
Yea SS, Yang YI, Jang WH, Lee YJ, Bae HS, Paik KH. Association between TNF-alpha promoter polymorphism and Helicobacter pylori cagA subtype infection.
J. Clin. Pathol. 54: 703-706 (2001).
*
-
Yeatman TJ. Colon cancer.
ENCYCLOPEDIA OF LIFE SCIENCES Nature Publishing Group www.els.net (2001). *
-
Yen JH, Chen CJ, Tsai WC, Lin CH, Ou TT, Wu CC, Liu HW. Tumor necrosis factor promoter polymorphisms in patients with rheumatoid arthritis in Taiwan.
J. Rheumatol. 28: 1788-1792 (2001).
-
Yen JH, Moore BE, Nakajima T, Scholl D, Schaid DJ, Weyand CM, Goronzy JJ. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis.
J. Exp. Med. 193: 1159-1167 (2001).
*
-
Yerushalmi B, Dahl R, Devereaux MW, Gumpricht E, Sokol RJ. Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition.
Hepatology 33: 616-626 (2001).
*
-
Yokoyama K, Mitomi H, Kobayashi K, Katsumata T, Saigenji K, Okayasu I. Obliterative arteritis with nitric oxide synthase and HLA-DR expression in Crohn's colitis.
Hepatogastroenterology 48: 401-407 (2001).
-
Yoon KH, Ng SC. Early onset methotrexate-induced pancytopenia and response to G-CSF: a report of two cases.
J. Clin. Rheumatol. 7: 17-20 (2001).
-
Yoshida Y, Higashi T, Nouso K, Nakatsukasa H, Nakamura SI, Watanabe A, Tsuji T. Effects of zinc deficiency/zinc supplementation on ammonia metabolism in patients with decompensated liver cirrhosis.
Acta Med. Okayama 55: 349-355 (2001).
*
-
Yoshikawa T, Shimano H, Amemiya-Kudo M, Yahagi N, Hasty AH, Matsuzaka T, Okazaki H, Tamura Y, Iizuka Y, Ohashi K, Osuga J, Harada K, Gotoda T, Kimura S, Ishibashi S, Yamada N. Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter.
Mol. Cell. Biol. 21: 2991-3000 (2001).
*
-
Young-Min SA, Beeton C, Laughton R, Plumpton T, Bartram S, Murphy G, Black C, Cawston TE. Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls.
Ann. Rheum. Dis. 60: 846-851 (2001).
*
-
Younossi ZM, Boparai N, McCormick M, Price LL, Guyatt G. Assessment of utilities and health-related quality of life in patients with chronic liver disease.
Am. J. Gastroenterol. 96: 579-583 (2001).
*
-
Younossi ZM, Boparai N, Price LL, Kiwi ML, McCormick M, Guyatt G. Health-related quality of life in chronic liver disease: the impact of type and severity of disease.
Am. J. Gastroenterol. 96: 2199-2205 (2001).
*
-
Yu CQ, Hu BP, Zheng LY, Ding YM. The analysis and discussion of clinical features and treatment of tumor-like Sjogren's syndrome in 46 cases.
Shanghai Kou Qiang Yi Xue 10: 302-304 (2001).
-
Yu S, Cao WQ, Kashireddy P, Meyer K, Jia Y, Hughes DE, Tan Y, Feng J, Yeldandi AV, Rao MS, Costa RH, Gonzalez FJ, Reddy JK. Human peroxisome proliferator-activated receptor alpha (PPARalpha) supports the induction of peroxisome proliferation in PPARalpha-deficient mouse liver.
J. Biol. Chem. 276: 42485-42491 (2001).
*
-
Yuan YH, ten Hove T, The FO, Slors JF, van Deventer SJ, te Velde AA. Chemokine receptor CXCR3 expression in inflammatory bowel disease.
Inflamm. Bowel Dis. 7: 281-286 (2001).
*
-
Yuki N. Infectious origins of, and molecular mimicry in, Guillain-Barre and Fisher syndromes.
Lancet Infect. Dis. 1: 29-37 (2001).
-
Yun HR, Koh HK, Kim SS, Chung WT, Kim DW, Hong KP, Song GG, Chang HK, Choe JY, Bae SC, Salmon JE, Yoo DH, Kim TY, Kim SY. FcgammaRIIa/IIIa polymorphism and its association with clinical manifestations in Korean lupus patients.
Lupus 10: 466-472 (2001).
-
Yurt B, Kocak N, Ozen H, Yuce A, Gurakan F, Kale G. Non-Wilsonian cirrhosis in Turkish children.
Indian Pediatr. 38: 1035-1038 (2001).
-
Zachos M, Griffiths AM. Enteral feeding and Crohn disease.
Curr. Opin. Gastroenterol. 17: 167-170 (2001).
-
Zagorski Z, Biziorek B, Rakowska E, Jedrzejewski D. Zinsser-Engman-Cole syndrome (dyskeratosis congenita) with severe sicca syndrome, panuveitis and corneal perforation - a case report.
Klin. Monatsbl. Augenheilkd. 218: 455-458 (2001).
-
Zamani M, Spaepen M, Sghar SS, Huang C, Westerhof W, Nieuweboer-Krobotova L, Cassiman JJ. Linkage and association of HLA class II genes with vitiligo in a Dutch population.
Br. J. Dermatol. 145: 90-94 (2001).
*
-
Zanlungo S, Nervi F. The ACAT2 gene encodes a gatekeeper of intestinal cholesterol absorption that regulates cholesterolemia and gallstone disease.
Hepatology 33: 760-761 (2001).
*
-
Zauberman A, Lapter S, Zipori D. Smad proteins suppress CCAAT/enhancer-binding protein (C/EBP) beta- and STAT3-mediated transcriptional activation of the haptoglobin promoter.
J. Biol. Chem. 276: 24719-24725 (2001).
-
Zauli D, Grassi A, Cassani F, Ballardini G, Bortolotti R, Muratori L, Fusconi M, Bianchi FB. Autoimmune serology of primary sclerosing cholangitis.
Dig. Liver Dis. 33: 391-392 (2001).
-
Zavattari P, Lampis R, Motzo C, Loddo M, Mulargia A, Whalen M, Maioli M, Angius E, Todd JA, Cucca F. Conditional linkage disequilibrium analysis of a complex disease superlocus, IDDM1 in the HLA region, reveals the presence of independent modifying gene effects influencing the type 1 diabetes risk encoded by the major HLA-DQB1, -DRB1 disease loci.
Hum. Mol. Genet. 10: 881-889 (2001).
*
-
Zein CO, Lindor KD. Primary sclerosing cholangitis.
Semin. Gastrointest. Dis. 12: 103-112 (2001).
-
Zelcer N, Saeki T, Reid G, Beijnen JH, Borst P. Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3).
J. Biol. Chem. 276: 46400-46407 (2001).
*
-
Zeng H, Chen ZS, Belinsky MG, Rea PA, Kruh GD. Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport.
Cancer Res. 61: 7225-7232 (2001).
*
-
Zeniya M. Autoimmune liver disease and its variant.
Nippon Shokakibyo Gakkai Zasshi 98: 1257-1262 (2001).
-
Zhang J, Kuehl P, Green ED, Touchman JW, Watkins PB, Daly A, Hall SD, Maurel P, Relling M, Brimer C, Yasuda K, Wrighton SA, Hancock M, Kim RB, Strom S, Thummel K, Russell CG, Hudson JR Jr, Schuetz EG, Boguski MS. The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants.
Pharmacogenetics 11: 555-572 (2001).
-
Zhang J, Roschke V, Baker KP, Wang Z, Alarcon GS, Fessler BJ, Bastian H, Kimberly RP, Zhou T. Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus.
J. Immunol. 166: 6-10 (2001).
*
-
Zhang M, Chiang JY. Transcriptional regulation of the human sterol 12alpha-hydroxylase gene (CYP8B1): roles of hepatocyte nuclear factor 4alpha in mediating bile acid repression.
J. Biol. Chem. 276: 41690-41699 (2001).
*
-
Zhang W, Laborde PM, Coombes KR, Berry DA, Hamilton SR. Cancer genomics: promises and complexities.
Clin. Cancer Res. 7: 2159-2167 (2001).
*
-
Zhang Y, Repa JJ, Gauthier K, Mangelsdorf DJ. Regulation of lipoprotein lipase by the oxysterol receptors, LXRalpha and LXRbeta.
J. Biol. Chem. 276: 43018-43024 (2001).
*
-
Zhang Y, Taylor BR, Shannon K, Clapp DW. Quantitative effects of Nf1 inactivation on in vivo hematopoiesis.
J. Clin. Invest. 108: 709-715 (2001).
*
-
Zhang Y, Yin L, Hillgartner FB. Thyroid hormone stimulates acetyl-coA carboxylase-alpha transcription in hepatocytes by modulating the composition of nuclear receptor complexes bound to a thyroid hormone response element.
J. Biol. Chem. 276: 974-983 (2001).
*
-
Zhou H. A study on bactericidal/permeability increasing protein (BPI) as a natural inhibitor of endotoxin.
Zhonghua Shao Shang Za Zhi 17: 102-104 (2001).
-
Zhu J, Zou L, Zhu S, Mix E, Shi F, Wang H, Volkmann I, Winblad B, Schalling M, Ljunggren H. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade enhances incidence and severity of experimental autoimmune neuritis in resistant mice.
J. Neuroimmunol. 115: 111-117 (2001).
-
Zhu ZW, Friess H, Wang L, Abou-Shady M, Zimmermann A, Lander AD, Korc M, Kleeff J, Buchler MW. Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders.
Gut 48: 558-564 (2001).
*
-
Zima T, Fialova L, Mestek O, Janebova M, Crkovska J, Malbohan I, Stipek S, Mikulikova L, Popov P. Oxidative stress, metabolism of ethanol and alcohol-related diseases.
J. Biomed. Sci. 8: 59-70 (2001).
*
-
Zimmermann A. Tumors of the bile ducts - pathological aspects.
Med. Sci. Monit. 7 Suppl. 1: 91-100 (2001).
-
Zirwas MJ, Seraly MP. Pruritus of unknown origin: a retrospective study.
J. Am. Acad. Dermatol. 45: 892-896 (2001).
-
Zivna H, Zivny P, Palicka V, Nozicka J. The differences in selected biochemical markers and histological findings after bile duct ligation in male and female rats.
Adv. Clin. Path. 5: 147-153 (2001).
-
Zivny JH, Moldoveanu Z, Vu HL, Russell MW, Mestecky J, Elson CO. Mechanisms of immune tolerance to food antigens in humans.
Clin. Immunol. 101: 158-168 (2001).
*
-
Zollner G, Fickert P, Zenz R, Fuchsbichler A, Stumptner C, Kenner L, Ferenci P, Stauber RE, Krejs GJ, Denk H, Zatloukal K, Trauner M. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.
Hepatology 33: 633-646 (2001).
*
-
Zouali H, Chamaillard M, Lesage S, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, Montague S, Gassull M, Christensen S, Finkel Y, Gower-Rousseau C, Modigliani R, Macry J, Selinger-Leneman H, Thomas G, Hugot JP; GETAID. Genetic refinement and physical mapping of a chromosome 16q candidate region for inflammatory bowel disease.
Eur. J. Hum. Genet. 9: 731-742 (2001).
*
-
Zouboulis CC. Is acne vulgaris a genuine inflammatory disease?
Dermatology 203: 277-279 (2001).
-
Zouboulis CC. Exploration of retinoid activity and the role of inflammation in acne: issues affecting future directions for acne therapy.
J. Eur. Acad. Dermatol. Venereol. 15 Suppl. 3: 63-67 (2001).
-
Zouboulis CC. Retinoids - which dermatological indications will benefit in the near future?
Skin Pharmacol. Appl. Skin Physiol. 14: 303-315 (2001).
-
Zuniga J, Vargas-Alarcon G, Hernandez-Pacheco G, Portal-Celhay C, Yamamoto-Furusho JK, Granados J. Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE).
Genes Immun. 2: 363-366 (2001).
*
Number of references = 2668
|
|
David and Judy Rhodes
Last Update: 3/10/2010
| | |
